Natura &Co Holding (NTCOY) 20-F/A 20 Apr 21 2020 FY Annual report (foreign) (amended) Financial data

Cover page

Cover page	12 Months Ended
	Dec. 31, 2020shares
Document Information [Line Items]
Document Type	20-F/A
Amendment Flag	true
Amendment Description	This Amendment No. 1 to the Annual Report on Form 20-F of Natura &Co Holding S.A. (the “Company”) amends the Company’s Annual Report on Form 20-F for the year ended December 31, 2020 (the “Original 20-F”), which was filed with the Securities and Exchange Commission on April 19, 2021. The Company is filing this Amendment No. 1 solely to furnish Exhibit 101. Exhibit 101 includes information about the Company in eXtensible Business Reporting Language (XBRL). Except as described above, this Amendment No. 1 does not amend any information set forth in the Original 20-F, and the Company has not updated disclosures included therein to reflect any events that occurred subsequent to April 19, 2021.
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Central Index Key	0001776967
Current Fiscal Year End Date	--12-31
Entity Registrant Name	Natura &Co Holding S.A.
Document Period End Date	Dec. 31, 2020
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding	1,375,018,140
Entity Address, Country	BR
Common Shares [Member]
Document Information [Line Items]
Title of 12(b) Security	Common shares, no par value (the "Natura &Co Holding Shares")
No Trading Symbol Flag	true
Trading Symbol	NYSE
American Depositary Shares [Member]
Document Information [Line Items]
Title of 12(b) Security	American Depositary Shares (the "Natura &Co Holding ADSs") (as evidenced by American Depositary Receipts)
Trading Symbol	NTCO
Security Exchange Name	NYSE

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
CURRENT
Cash and cash equivalents	R$ 5821672	R$ 4513582
Short-term investments	2,520,648	1,025,845
Trade receivable	3,597,535	1,685,764
Inventories	4,544,270	1,430,550
Recoverable taxes	1,071,349	395,640
Income tax and social contribution	242,091	113,478
Derivative financial instruments	139,856
Other current assets	616,120	265,198
Current assets other than assets held for sale	18,553,541	9,430,057
Assets held for sale	181,279
Total current assets	18,734,820	9,430,057
NON-CURRENT
Recoverable taxes	932,212	409,214
Income tax and social contribution	478,524	334,671
Deferred income tax and social contribution	1,339,725	374,448
Judicial deposits	566,190	337,255
Derivative financial instruments	1,768,122	737,378
Short-term investments	16,104	7,402
Other non-current assets	1,527,668	83,836
Total long-term assets	6,628,545	2,284,204
Property, plant and equipment	5,235,057	1,773,889
Intangibles	26,917,128	5,076,501
Right of use	3,402,047	2,619,861
Total non-current assets	42,182,777	11,754,455
TOTAL ASSETS	60,917,597	21,184,512
CURRENT
Borrowings, financing and debentures	3,805,649	3,354,355
Leases	1,059,661	542,088
Trade payable and reverse factoring operations	6,774,205	1,829,756
Payroll, profit sharing and social charges	1,340,683	560,376
Tax liabilities	785,367	320,890
Income tax and social contribution	441,253	388,238
Dividends and interest on shareholders' equity payable		95,873
Derivative financial instruments	61,201	11,806
Provision for tax, civil and labor risks	58,756	18,650
Other current liabilities	1,832,811	396,391
Total current liabilities	16,159,586	7,518,423
NON-CURRENT
Borrowings, financing and debentures	10,017,264	7,432,019
Lease	2,798,794	1,975,477
Payroll, profit sharing and social charges	43,763
Tax liabilities	109,454	122,569
Deferred income tax and social contribution	1,288,045	450,561
Provision for tax, civil and labor risks	2,000,444	201,416
Other non-current liabilities	1,113,139	121,702
Total non-current liabilities	17,370,903	10,303,744
TOTAL LIABILITIES	33,530,489	17,822,167
SHAREHOLDERS' EQUITY
Capital stock	12,377,999	1,485,436
Treasury shares	(11,667)
Capital reserves	11,052,135	999,931
Legal profit reserve	120,166	154,039
Retained losses	(759,937)	(92,066)
Equity valuation adjustment	4,585,631	815,005
Shareholders' equity attributed to the Company's controlling shareholders	27,364,327	3,362,345
Non-controlling interest in shareholders' equity of subsidiaries	22,781
Total shareholders' equity	27,387,108	3,362,345
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	R$ 60917597	R$ 21184512

STATEMENT OF INCOME

STATEMENT OF INCOME - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CONTINUING OPERATIONS
NET REVENUE		R$ 36921980	R$ 14444690	R$ 13397419
Cost of Sales		(13,229,715)	(4,033,454)	(3,782,843)
GROSS PROFIT		23,692,265	10,411,236	9,614,576
OPERATING INCOME (EXPENSES)
Selling, Marketing and Logistics expenses		(15,702,787)	(6,395,586)	(5,828,713)
Administrative, R&D, IT and project expenses		(5,955,996)	(2,405,576)	(2,251,341)
Impairment losses on trade receivables		(727,695)	(209,515)	(237,884)
Shareholders' equity
Other operating (expenses) income, net		(516,190)	(49,311)	(39,945)
OPERATING INCOME BEFORE FINANCIAL RESULT		789,597	1,351,248	1,256,693
Financial income		4,738,391	1,955,784	2,056,421
Financial expenses		(5,773,810)	(2,795,874)	(2,639,709)
Taxes on formation of the Company	[1]		(206,592)
NET INCOME (LOSS) BEFORE INCOME TAX AND SOCIAL CONTRIBUTION		(245,822)	304,566	673,405
Income tax and social contribution		(274,744)	(149,099)	(125,026)
NET (LOSS) INCOME FROM CONTINUING OPERATIONS		(520,566)	155,467	548,379
DISCONTINUED OPERATIONS
NET LOSS OF DISCONTINUED OPERATIONS		(143,112)
NET INCOME (LOSS) FOR THE YEAR		(663,678)	155,467	548,379
ATTRIBUTABLE TO
Controlling shareholders of the company		(650,196)	155,467	548,379
Non-controlling shareholders		(13,482)
NET INCOME (LOSS) FOR THE YEAR		R$ 663678	R$ 155467	R$ 548379
(LOSS) EARNINGS PER SHARE IN THE YEAR -R$
Basic		R$ 0.5220	R$ 0.1796	R$ 0.6335
Diluted		R$ 0.5220	R$ 0.1779	R$ 0.6324
[1]	Tax levied on the formation of the Company resulting from the difference between Natura's accounting balances and the acquisition cost used for the purpose of the contribution of shares issued by Natura to the Company's capital stock (note 24). Management believes that, although the amount of the aforementioned special capital reserve constitutes part of the taxable profit for tax purposes in Brazil, the nature of this amount is different from the nature of other sources of taxable profit under the scope of IAS 12. The main differences are (i) the Company did not generate taxable profits and this tax is mainly related to the increase in equity that generates the special reserve for statutory purposes; (ii) the creation of the special reserve is, in substance, a matter of reclassification; (iii) the tax is levied on the entity as a result of an additional increase in the equity of the contribution made to the Company; and (iv) the Company's future profits, as well as Natura's future and historical profits will continue to be taxed in accordance with tax legislation. The tax on the formation of the Company was recognized in the income statement and presented as "Taxes on the formation of the Company".

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
STATEMENT OF COMPREHENSIVE INCOME
NET (LOSS) INCOME FOR THE YEAR	R$ 663678	R$ 155467	R$ 548379
Other comprehensive income to be reclassified to income statement in subsequent periods:
Conversion of financial statements of controlled companies abroad	3,360,831	244,100	483,212
Unrealized losses on the revaluation of balances between companies	350,950
Exchange rate effect on the conversion from hyperinflationary economy	32,160	17,666	(19,074)
Earnings from cash flow hedge operations	178,006	107,337	(45,202)
Tax effects on losses from cash flow hedge operations	(61,658)	(36,768)	15,384
Equity in earnings from cash flow hedge operation
Equity in tax effects on earnings from cash flow hedge operations
Other comprehensive income not reclassified to income statement in subsequent periods:
Actuarial gain (loss)	(104,650)	(14,374)	(7,030)
Tax effects on actuarial gain (loss)	23,694	4,887	11,532
Equity on actuarial gain (loss)
Equity on tax effects on actuarial gain (loss)
Comprehensive income for the year, net of tax effects	3,115,655	478,315	987,201
ATTRIBUTABLE TO
The Company´s shareholders	3,120,429	478,315	987,201
Noncontrolling shareholders	(4,774)
Comprehensive income for the year, net of tax effects	R$ 3115655	R$ 478315	R$ 987201

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - BRL (R$) R$ in Thousands	Total	Sharesholders' equity attributed to controlling shareholders [member]	Capital stock [member]	Treasury shares [member]	Surplus on issue/sale of shares [member]	Special reserve [member]	Tax incentive reserve	Additional paid-in capital [member]	Legal [member]	Tax incentive [member]	Retained earnings [member]	Appropriation of earnings	Other comprehensive income [member]	Non-Controlling Shareholders [member]	Transaction with shareholders [member]
Beginning balance at Dec. 31, 2017	R$ 1634746	R$ 1726812	R$ 427073	R$ 32544	R$ 75588		R$ 17378	R$ 62755	R$ 18650	R$ 20957	R$ 1083619		R$ 53336		R$ 92066
Net (loss) income for the year	548,379	548,379										R$ 548379
Other comprehensive income	438,822	438,822											438,822
Comprehensive income for the year, net of tax effects	987,201
Changes in stock option plans and restricted shares:
Provision for stock option plans and restricted shares	52,543	52,543						52,543
Exercise of stock option plans and restricted shares	1,067	1,067		13,136	(3,372)			(8,697)
Changes in tax incentive reserves							R$ 17378			17,378
Mandatory minimum dividends	(56,661)	(56,661)										(56,661)
Mandatory minimum interest on capital stock	(111,449)	(111,449)										(111,449)
Retained earnings reserve											336,532	(336,532)
Tax incentive reserve										43,737		(43,737)
Adjustment effect of hyperinflationary economy	66,655	66,655						150,513			(83,858)
Ending balance at Dec. 31, 2018	2,574,102	2,666,168	427,073	(19,408)	72,216			257,114	18,650	82,072	1,336,293		492,158		(92,066)
Net (loss) income for the year	155,467	392,391										392,391
Exchange rate effect on the conversion from hyperinflationary economy.	17,666	17,666											17,666
Other comprehensive income	305,182	305,182											305,182
Comprehensive income for the year, net of tax effects	478,315	715,239										392,391	322,848
Capital increase	52,673	52,673	52,673
Changes in stock option plans and restricted shares:
Provision for stock option plans and restricted shares	104,078	104,078						104,078
Exercise of stock option plans and restricted shares	(2,562)	(2,562)		15,615	16,156			(34,333)
Cancellation of shares - RCA 16.12.19 - Protocol and convention of incorporation				3,793	(3,793)
Interest on equity declared and not yet distributed (mandatory minimum)	(110,671)	(110,671)										(110,671)
Retained earnings reserve											206,268	(206,268)
Tax incentive reserve										75,452		(75,452)
Adjustment effect of hyperinflationary economy	59,818	59,818						61,870			(2,052)
AGE 17.09.2019 - Capitalization of part of the balance of the Profit Reserve account			1,242,165								(1,242,165)
Ending balance (Previously stated [member]) at Dec. 31, 2019	3,392,677	3,484,743	1,721,911		84,579			388,729	18,650	157,524	298,344		815,006		(92,066)
Ending balance (Predecessor adjustments [member]) at Dec. 31, 2019	(30,331)	(30,331)	(236,475)		708,760	R$ 206592		(388,729)	R$ 18650	(157,524)	(299,772)	155,467
Ending balance at Dec. 31, 2019	3,362,345	3,454,412	1,485,436		793,339	206,592					(1,428)	155,467	815,006		(92,066)
Net (loss) income for the year	(663,678)	(650,196)										(650,196)		R$ 13482
Exchange rate effect on the conversion from hyperinflationary economy.	32,160	32,160											32,160
Other comprehensive income	3,747,173	3,738,465											3,738,465	8,708
Comprehensive income for the year, net of tax effects	3,115,655	3,120,429										(650,196)	3,770,625	(4,774)
Changes in stock option plans and restricted shares:
Provision for stock option plans and restricted shares	163,322	163,322						163,322
Exercise of stock option plans and restricted shares	(5,200)	(5,200)	59,251	43,269				(111,281)				3,561
Retained earnings reserve						155,467						(155,467)
Subscription of shares through the Board of Directors' Meeting held on January 3, 2020	13,302,449	13,274,894	3,397,746		9,877,148									27,555
Subscription of shares through the Board of Directors' Meeting held on June 30, 2020	2,001,118	2,001,118	2,000,000		1,118
Subscription of shares through the Board of Directors' Meeting held on July 27, 2020	14,723	14,723	14,723
Subscription of shares through the Board of Directors' Meeting held on September 30, 2020	18,863	18,863	18,863
Subscription of shares through the Board of Directors' Meeting held on October 8, 2020	5,614,750	5,614,750	5,614,750
Share repurchase	54,936	54,936		54,936
Expenses on the issue of equity values	(212,770)	(212,770)	(212,770)
Tax incentive reserve										113,302		(113,302)
Adjustment effect of hyperinflationary economy	66,788	66,788						58,496			8,292
Ending balance at Dec. 31, 2020	R$ 27387108	R$ 27456393	R$ 12377999	R$ 11667	R$ 10671605	R$ 362059		R$ 110537		R$ 113302	R$ 6864	R$ 759937	R$ 4585631	R$ 22781	R$ 92066

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
CASH FLOW FROM OPERATING ACTIVITIES
Net (loss) income for the year	R$ 663678	R$ 155467	R$ 548379
Adjustments to reconciliate net income for the year with net cash generated by operating activities:
Depreciation and amortization	2,718,856	1,117,416	589,911
Interest on short-term investments	(103,310)	(78,414)	(129,296)
Reversal from swap and forward derivative contracts	(1,090,299)	(38,703)	(543,398)
Provision for tax, civil and labor risks	198,568	(24,509)	40,193
Inflation adjustment of judicial deposits	(11,242)	(13,352)	(13,780)
Inflation adjustment of contingencies	37,966	9,758	4,346
Income tax and social contribution	274,744	149,099	125,026
Company formation tax		206,592
Income from sale and write-off of property, plant and equipment and intangible	35,555	34,518	24,573
Equity in subsidiaries
Interest and exchange rate variation on leases	62,250	127,398	52,011
Interest and exchange rate variation on borrowings and financing	2,003,147	582,519	1,187,869
Exchange differences on translation of foreign operations	(71,974)	5,764	(3,535)
Provision (reversal of provision) for losses from property, plant and equipment and intangible	155,463	3,541
Provision (reversal of provision) for stock option plans	(44,142)	59,232	40,505
Actual losses and provision for losses with trade receivables, net of reversals	640,676	209,505	237,884
Provision (reversal of provision) for inventory losses, net	341,799	147,140	22,743
Provision (reversal of provision) for post-employment health care plan	46,583	19,969	(34,914)
Effect from hyperinflationary economy	55,277	51,659	45,198
Other provision (reversals)	(114,286)	(134,212)	(26,145)
Adjustments to reconcile profit (loss)	4,471,953	2,590,387	2,167,570
INCREASE (DECREASE) IN:
Trade receivable	(1,308,030)	(212,812)	(415,459)
Inventories	(1,444,671)	(194,698)	(112,331)
Recoverable taxes	(770,102)	(6,369)	84,982
Other assets	152,811	(56,440)	(67,864)
Domestic and foreign trade payable	1,004,231	117,080	158,978
Payroll, profit sharing and social charges, net	749,609	(15,855)	215,412
Tax liabilities	382,695	91,520	(170,098)
Other liabilities	(31,135)	21,204	(52,247)
Increase (decrease) in (assets) liabilities	3,207,361	2,334,017	1,808,943
OTHER CASH FLOWS FROM OPERATING ACTIVITIES
Payment of income tax and social contribution	(331,450)	(321,262)	(269,966)
Release of judicial deposits	66,192	9,674	(364)
Payments related to tax, civil and labor lawsuits	(134,551)	(27,179)	(36,464)
Payments due to settlement of derivative transactions	(38,835)	(66,420)	(30,967)
Payment of interest on lease	(225,420)	(134,579)	(22,691)
Payment of interest on borrowings, financing and debentures	(1,257,665)	(493,895)	(604,224)
CASH GENERATED BY (USED IN) OPERATING ACTIVITIES	1,285,632	1,300,356	844,267
CASH FLOW FROM INVESTING ACTIVITIES
Cash from acquisition of subsidiary	2,661,878
Additions of property, plant and equipment and intangible	(674,211)	(586,395)	(485,016)
Proceeds from sale of property, plant and equipment and intangible	104,204	22,682	6,641
Short-term investments	(10,371,483)	(7,161,530)	(8,483,684)
Redemption of short-term investments	9,008,931	7,345,389	9,187,748
Redemption of interest on short-term investments	52,667	65,504	163,407
Receipt of dividends from subsidiaries
Investment in subsidiaries	(102,898)
CASH GENERATED BY (USED IN) INVESTING ACTIVITIES	679,088	(314,350)	389,096
CASH FLOW FROM FINANCING ACTIVITIES
Repayment of lease - principal	(843,338)	(497,905)	(46,241)
Repayment of borrowings, financing and debentures – principal	(8,483,892)	(2,643,575)	(6,552,249)
New borrowings, financing, and debentures	1,354,765	5,346,145	5,015,278
Acquisition of treasury shares, after receipt of option strike price	51,145	(2,562)	1,067
Payment of dividends and interest on equity for the previous year	(133,937)	(152,938)	(201,652)
Receipt of funds due to settlement of derivative transactions	211,722	3,992	32,401
Acquired company's liability incurred by acquiror	(370,791)
Capital Payment		52,673
Capital Increase	7,436,684	206,592
CASH GENERATED BY (USED IN) FINANCING ACTIVITIES	(777,642)	2,312,422	(1,751,396)
Effect of exchange rate variation on cash and cash equivalents	121,012	106	39,950
DECREASE IN CASH AND CASH EQUIVALENTS	1,308,090	3,298,534	(478,083)
Opening balance of cash and cash equivalents	4,513,582	1,215,048	1,693,131
Closing balance of cash and cash equivalents	5,821,672	4,513,582	1,215,048
DECREASE IN CASH AND CASH EQUIVALENTS	R$ 1308090	R$ 3298534	R$ 478083

General Information

General Information	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
General Information	1. GENERAL INFORMATION NATURA &CO HOLDING S.A. (“Natura &Co”), previously Natura Holding S.A., was incorporated on January 21, 2019 under the Brazilian laws and is engaged in holding investments in other entities in the cosmetics, fragrances and personal hygiene business through the development, manufacturing, distribution and sales of related products. Natura &Co and its subsidiaries is referred to as the “Company”. The brands under management by the Company include "Natura", “Avon”, "The Body Shop" and "Aesop". In addition to using the retail market, e-commerce, business-to-business (B 2 In December 2019, Natura &Co became the holder of 100 3 3 3 3 3 4

Management Statement And Basis

Management Statement And Basis Of Presentation Of The Financial Statements	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Management Statement And Basis Of Presentation Of The Financial Statements	2. MANAGEMENT STATEMENT AND BASIS FOR PRESENTATION OF THE FINANCIAL STATEMENTS The consolidated financial statements have been prepared and are being presented in accordance with the International Financial Reporting Standards (“IFRS”), issued by the International Accounting Standards Board (“IASB”). The financial statements show all the relevant information specific to the financial statements, and only that, which are consistent with those used by Management. The consolidated financial statements as of December 31, 2019 and for the two-year period then ended were recast to give retrospective effect to the changes in the Company’s reportable segments (note 25). The Company’s comparative historical consolidated information presented, for the statements of income, comprehensive income, changes in equity and, cash flows for the year ended December 31, 2019, do not include information from the subsidiary Avon Products Inc., since the acquisition was completed on January 3, 2020. The financial statements were approved by the Board of Directors and authorized for issuance on the meeting held on April 19, 2021 a) Basis of presentation of Company's consolidated financial statements The consolidated financial statements were prepared based on the historical cost, except for derivative financial instruments, financial investments and carbon credits recognized in other current and non-current assets that were measured at fair value and are expressed in thousands of Brazilian Reais (“R$”), rounded to the nearest thousand, as well as the disclosure of amounts in other currencies, when necessary, were also expressed in thousands. Items disclosed in other currencies are duly identified, whenever applicable.

Summary of Significant Accounti

Summary of Significant Accounting Polices	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Significant Accounting Polices	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The main accounting policies applied in the preparation of these consolidated financial statements are defined below. These policies have been applied consistently in all years presented, with the exception of (i) the presentation of segment information (note 2 5 4 19 3.1 Current versus non-current classification The Company presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is (i) expected to be realized or intended to be sold or consumed in the normal operating cycle; (ii) held primarily for the purpose of trading; (iii) expected to be realized within twelve twelve A liability is current when (i) it is expected to be settled in the normal operating cycle; (ii) it is held primarily for the purpose of trading; (iii) it is due to be settled within twelve twelve Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed on note 3 18 3.2 Foreign currenc y translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each the companies operates ("functional currency"). 3.2.1 Transactions and balances in a currency other than the functional currency Foreign currency transactions, that is, any currency other than the functional currency, are converted into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. The financial statements are presented in thousands of Brazilian R eais Balance sheet account balances are remeasured using the exchange rates prevailing at the end of the reporting period. Foreign exchange gains and losses arising on the settlement of such transactions and the remeasured of monetary assets and monetary liabilities denominated in foreign currency are recognized in the statement of income, as “Financial income” and “Financial expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the statement of income and statement of cash flows and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into reais The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”), which became a hyperinflationary economy as of July 1, 2018 (see below), in which the balance sheet is translated into Brazilian R eais 3.2.3 Hyperinflationary economy Starting from July 2018, Argentina has been considered a hyperinflationary economy. As per IAS 29 2017 , and Argentina’s Domestic Retail Price Index (“IPIM”) up to December 31, 2016. Consequently, as required by IAS 29 2018 , year in which the existence of hyperinflation was first identified). Non-monetary assets and liabilities booked at historical cost and equity items of Natura Argentina were adjusted for inflation based on the aforementioned indices, and effects of hyperinflation resulting from changes in the overall purchasing power were presented in the statement of income. The statement of income is adjusted at the end of each reporting period based on the variation in the general price index for the period. The net effect of inflation adjustment in 20 20 29 For the translation of the accounting balances of the subsidiary Natura Argentina to the presentation currency (R$) used in the Company's consolidated financial statements, the following procedures, as required by IAS 21 Ø Assets, liabilities and equity items balances were translated at the exchange rate prevailing at the reporting date ( 0.06 189 Ø Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date ( 0.06 189 The accumulated inflation for the year ended December 31, 2020 was 36.1 54.5 2019 As of December 31, 2020 29 20,625 13,947 2019 106,206 68,940 2019 The translation of the statement of income at the exchange rate on the reporting date, instead of average monthly exchange rate of the year, resulted in a positive impact on OCI for the fiscal year ended December 31, 2020 32,160 17,666 3.3 Consolida tion The following procedures are applied in the preparation of the consolidated financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. The Company has interests in subsidiaries only. In accordance with the equity method, the portion attributable to the Company on the net profit or loss for the year of these investments is recorded in the statement of income under the line “Equity income”. All intra-group balances, income and expenses and unrealized gains and losses arising from intra-group transactions are eliminated completely. The OCI of subsidiaries is recorded directly in the Company's equity under the item “OCI”. Below is a list of the Company's subsidiaries as of December 31, 2020, 2019 2018 Ownership - % 2020 2019 2018 Direct ownership: Avon Products, Inc. 100.00 - - Natura Cosméticos S.A. 100.00 100.00 - Natura &Co International S.à r.l . ( 1 100.00 - - ( 1 Natura &Co International S.à.r.l., was incorporated in 2020 under the laws of Luxembourg with the purpose of acquiring, managing and selling interests in domestic and foreign companies, other than raising and borrowing funds to other consolidated entities of the Company. In the preparation of the consolidated financial statements, financial statements as at the same reporting date and consistent with the Company's accounting policies were used. Investments were eliminated in proportion to the investor's interest in shareholders' equity and in the results of subsidiaries, assets and liabilities balances, income and expenses and unrealized results, net of income tax and social contribution, resulting from operations between the companies. Direct subsidiaries activities are as follows: Ø Natura S.A.: is a publicly-held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term. Founded in 1969 Paulo, Brazil, it is among the ten brand, most of products are developed from natural ingredients originating from Brazilian biodiversity and distributed predominantly through direct sales by independent beauty consultants. The subsidiary's focus is the sale of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores, with 61 43 2019 7 2020 9 2019 474 256 2019 Holding Pty Ltd. (Aesop) subsidiaries are also classified in this entity. Ø Avon Products, .: a global manufacturer and marketer of beauty and related products, with operations started in 1886 one b) Ownership interest of non-controlling shareholders The Company opted to measure any non-controlling interest initially by the proportionate interest in acquiree’s identifiable net assets on the acquisition date. Changes in the Company’s interest in a subsidiary that do not result in loss of control are recorded as “Transactions with shareholders” in the statement of changes in equity. As at December 31, 2020 2019 3.4 Business combinations and goodwill Business combinations (except for those involving entities under common control) are accounted for by applying the acquisition method. The consideration transferred is measured at fair value as at the date of the acquisition, as well as the identifiable assets acquired, and liabilities assumed. The consideration transferred does not include amounts related to the settlement of pre-existing relationships, which are generally recognized in the statement of income for the year. The Company determines that it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to continue producing outputs. The financial assets and liabilities assumed are assessed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and pertinent conditions as at the acquisition date. Acquisition-related costs are recorded as expenses as incurred and recognized as other operating expenses. Any goodwill arising from the transaction is tested annually for impairment, and when circumstances indicate that the carrying value may be impaired. Goodwill is initially measured at cost, as the excess of the aggregate amount of (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition-date; over the net of the amounts of the identifiable assets acquired and the liabilities assumed. When this aggregate amount is lower than the net of the amounts of the identifiable assets acquired and the liabilities assumed, a gain on a bargain purchase is recognized immediately in the statement of income. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the Company’s cash-generating units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units. In a business combination involving entities under common control, in which all of the combining entities or business are ultimately controlled by the same party or parties both before and after the business combination, and that control is not transitory, the Company applies the predecessor accounting method. When applying this method, the financial statements consider the historical accounting records of the acquired entity as equivalent to the Company's records, reflecting (a) the operating results and equity position of the acquired company in previous years; (b) the operating results of the Company and its acquired entity resulting from the restructuring; (c) the Company's assets and liabilities at historical cost (and at the preceding fair value, when applicable); and (d) the earnings per share of the Company in all years presented (adjusted when applicable). In these cases, therefore, there is no calculation of goodwill and any effect recorded in equity. 3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, bank deposits and short-term investments realizable within 90 3.6 Financial instruments 3.6.1 Initial recognition and measurement Upon initial recognition, a financial asset is measured at fair value and, subsequently, is measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and Company’s business model for the management of these financial assets. The business model for managing financial assets refers to how the company manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of both holding to collect contractual cash flows and selling. Except for trade receivable that do not contain a significant financing component or to which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair value plus transaction costs, in the case of financial asset not measured at fair value through profit or loss. In general, all financial assets are subsequently measured at fair value through profit or loss. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the statement of income when the asset is derecognized, modified, or impaired. The financial assets of the Company classified as at amortized cost include trade receivable, other current assets (except for carbon credits measured at fair value, as disclosed in note 3 9 6.6 Financial assets at fair value through OCI (debt instruments) For debt instruments at fair value through OCI, interest income, foreign exchange remeasurement and impairment losses or reversals are recognized in the statement of income and calculated in the same manner as for financial assets measured at amortized cost. The resulting changes in fair value are recognized in OCI; upon derecognition, the cumulative fair value change recognized in OCI is recycled to profit or loss. The Company does not hold any financial asset classified under this category. Financial assets classified as at fair value through OCI (equity instruments) Upon initial recognition, the Company can elect to irrevocably classify its equity investments as equity instruments designated at fair value through OCI when they meet the definition of equity under IAS 32 Gains and losses on these financial assets are never classified to profit or loss. Dividends are recognized as other operating income (expenses), net, in the statement of income when the right of payment has been established, except when the Company benefits from such proceeds as a recovery of part of the financial asset’s cost, in which case, such gains are recorded in OCI. Equity instruments classified as at fair value through OCI are not subject to impairment assessment. The Company does not hold any financial asset classified under this category. Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify as at fair value through OCI. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category. Derecognition (write-off) of financial instruments A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is derecognized when the rights to receive cash flows from the asset have expired, when the Company transfer its rights or risk to receive cash flows of the asset or when the Company have assumed an obligation to pay the full amount of received cash flows, without significant delay to a third party under an on-lending agreement and either (i) the Company transfer substantially all risks and benefits of the asset, or (ii) the Company neither transferred nor retained substantially all risks and benefits of the asset, but transferred the control of asset. When the Company transfer its rights to receive cash flows of an asset or execute an on-lending agreement, it assesses whether, and at which extent, they have retained the risks and benefits of ownership. When the Company neither transfers or retains substantially all risks and benefits of the asset, nor transferred the control over the asset, the Company continue to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognize an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company have retained. Impairment of financial assets The Company recognize an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expect to receive, discounted at an approximation of the original effective interest rate. ECLs are recognized in two 12 12 For trade receivable, the Company apply a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognize a loss allowance based on lifetime ECLs at each reporting date. The Company have recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note 5 6 The Company consider a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowings, financing and debentures, net of directly attributable transaction costs. The Company financial liabilities include borrowings, financing and debentures (note 19 6 20 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition as at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also includes derivative financial instruments entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IAS 39 Gains or losses on liabilities held for trading are recognized in the statement of income. Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 3.6.3 3.9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowings and financing are subsequently measured at amortized cost using the effective interest method. Gains and losses are recognized in profit or loss when the liabilities are derecognized as well as through the effective interest rate amortization process. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest method. The effective interest amortization is included as finance costs in the statement of income. This category generally applies to borrowings and financing granted and contracted, subject to interest, included in note 19 Derecognition A financial liability is derecognized when the obligation under the liability is discharged, cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized in the statement of income. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) they are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against the foreign exchange risks related to balance sheet positions, acquisitions of inputs and property, plant and equipment, forecasted exports and forecasted foreign-denominated cash outflows for capital increases in foreign subsidiaries. They are measured at fair value, and changes in fair value are recognized through profit or loss, except when they are designated as cash flow hedges, to which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured based on information on each contracted transaction and related market inputs as at reporting date, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; or (iii) hedges of a net investment in a foreign operation. Even with the adoption of IFRS 9 39 7.2.21 9 At the inception of a hedge relationship, the Company formally designate and document the hedge relationship to which it wishes to apply hedge accounting, the risk management objective and the strategy for undertaking the hedge. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. During the years ended on December 31, 2020 2019 2018 . Cash flow hedges Consists in providing hedge against changes in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect profit or loss. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the item “Gain (loss) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in equity, while the ineffective portion of hedge is immediately recognized in finance income (expenses). For the years ended on December 31, 2020 2019 2018 6 6 80 125 Hedge accounting is discontinued when the Company terminate the hedge relationship, the hedge instrument matures or is sold, revoked or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated shareholders ’ as of a certain If a planned transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is reclassified to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. Conversely, if a planned transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecasted transaction is no longer expected, cumulative gains or losses deferred in equity are immediately recognized in the statement of income. The Company assesses, throughout the hedge term, the effectiveness of its derivative financial instruments, as well as changes in their fair value. For the years ended December 31, 2020 2019 2018 6 6 3.7 Trade receivable Trade receivable correspond to amounts receivable for the sale of goods and services in the normal course of the activities of the Company and are recognized to the extent that the consideration that is unconditional is due by the customer (that is, only the passage of time required before payment of the consideration is due). 3.8 Inventories Inventories are valued at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company consider the following items when determining its provision for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “Cost of sales”. 3.9 Carbon Credits – Carbon Neutral Program In 2007 37 The liability is estimated through annually audited inventories of carbon emissions and measured at fair value based on the market price for the acquisition of licenses for neutralization. On December 31, 2020, the balance recorded as "Other non-current liabilities" (see note 2 3 2007 2020 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs will generate carbon credits after completion or maturation of these projects. Such expenses were recorded at their respective fair value in the line item “Other current assets” (see note 15 Upon effective delivery of the related carbon credit certificates to the Company, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities. The difference between the carrying amounts of assets and liabilities as at December 31, 2020 3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the statement of income. The estimated useful lives of the assets are mentioned in note 1 6 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the net carrying amount and are recognized in the statement of income as “Other operating income (expenses), net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company 3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the period in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the statement of profit or loss in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying value may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis. An intangible asset is derecognized upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of profit or loss in the line item “other operating income (expenses), net”. The main classes of intangibles are set forth below. 3.11.1 Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives described in note 1 7 System acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will flow into the entity and when the asset is controlled by the Company, taking into consideration its economic and technologic viability. The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated useful life. The expenditures related to software maintenance are expensed when incurred. 3.11.2 patents Separately acquired trademarks and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair value on the acquisition date. For trademarks and patents with definite useful lives, amortization is calculated on a straight-line basis at the annual rates described in note 1 7 3.11.3 Relationships with retail clients, franchisees and sub-franchisees acquired in business c

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS	12 Months Ended
	Dec. 31, 2020
Disclosure of detailed information about business combination [abstract]
BUSINESS COMBINATIONS	4. BUSINESS COMBINATION Avon acquisition On January 3 rd , 2020 100 The following table summarizes the calculation of the fair value of the compensation transferred on January 3 rd 2020 In millions of R$, except for the number of shares Number of Avon outstanding common shares as of January 3 rd, 2020 536,383,776 Multiplied by the exchange ratio of 0.600 321,830,266 Multiplied by the market price of Natura &Co shares on January 3 d, 2020 41,0 Consideration in the issuance of shares 13,195,041 Consideration to the transferred compensation (a) 171,073 Fair value of the consideration to be transferred 13,366,114 (a) Related to the effects of replacements and settlements of share-based payment plans, of which the amount of R$ 80 thousand refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and R$ 91 The fair values of the identifiable assets and liabilities of Avon as at the date of acquisition were: In thousands of R$ Purchase consideration transferred ( 1 13,366,114 Fair value of acquired assets: Cash and cash equivalents 2,636,108 Trade receivable ( 2 ) 1,135,269 Inventories 1,919,683 Other current assets 1,031,136 Non-current assets held for sale 199,050 Property, plant and equipment 2,912,482 Deferred income tax and social contribution 667,034 Right of use ( 3 ) 564,669 Other non-current assets 475,096 Judicial deposits 283,885 Recoverable taxes 531,930 Employee benefit plan (other assets) 553,297 Intangibles ( 4 ) 5,846,812 Fair value of liabilities assumed: Borrowings, financing and debentures 7,256,583 Trade payable 2,915,418 Salaries, profit sharing and social charges 621,203 Dividends and interest on equity payable 405,916 Derivative financial instruments 15,518 Operating expenses accruals 999,653 Provision for restructuring (other liabilities) 152,896 Lease liabilities 777,200 Tax liabilities 341,258 Income tax and social contribution 30,068 Provision for tax, civil and labor risks ( 5 ) 1,693,096 Liabilities from discontinued operations (other liabilities) 64,844 Deferred income tax and social contribution ( 6 592,534 Other liabilities 1,007,623 Total identifiable net assets at fair value 1,882,641 Non-controlling interest 27,555 Goodwill arising on acquisition ( 7 ) 11,511,028 (1) Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange. (2) The fair value of the trade receivable amounts to R$ 1,135 269 (3) The Company measured the acquired lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms. (4) The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235 Fair value for the intangibles “Avon” tradename, power brands and developed technology has been calculated based on the income approach and the relief-from-royalty method. The relief from royalty method is often used to calculate the value of a trademark or trade name. This method is based on the concept that if an entity owns a trademark, it does not have to pay for the use of it and therefore is relieved from paying a royalty. The amount of that theoretical payment is used as a surrogate for income attributable to the intangibles. The valuation is arrived at by computing the present value of the after-tax royalty savings, calculated by applying an appropriate royalty rate to the projected revenue, using an appropriate discount rate. Fair value for relationship with sales representatives has been calculated based on the Multi Period Excess Earnings Method (“MEEM”), method that isolates the income/cash flow that is related to the intangible asset being valued and estimates fair value through the sum of the discounted future excess earnings attributable to the intangible asset. Nature Fair value Useful life “Avon” tradename Represents the fair value of the "Avon" tradename. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions. 2,022,163 Indefinite Power brands Represents the fair value of Avon's main brands. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions as well as the relative importance of the respective brands for Avon’s revenue generation. 517,592 20 Developed technology Represents the fair value of all technology necessary to develop Avon products, including formulae, labeling data, manufacturing processes, regulatory approvals, product packaging, and designs. the relief-from-royalty method has been applied based on existing contractual relations involving Avon’s developed technology. 1,131,573 5 Sales Representatives Represents the fair value of the relationship between Avon and its sales representatives. Fair value is calculated based on the number of active representatives by country as of the valuation date, multiplied by the respective average ticket price as well as projected information on the average ticket growth which includes future inflation. The churn rate and the projected information have been considered as significant assumptions. 1,884,249 7 12 5,555,577 (5 Contingent liabilities assumed in the acquisition that are considered present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3 37 872,993 820,103 The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value: In thousands of R$ Tax 1,381,418 Civil 92,988 Labor 218,690 Total 1,693,096 (6) Consists of deferred tax liabilities of approximately R$ 81,423 511,111 (7) Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes. Since the acquisition date, Avon contributed with R$ 18,612,091 1,542,596 rd 2020 no three 2020 The disclosure of the net assets acquired in the financial statements of December 31, 2019 (in a note of subsequent events, given the date of acquisition) was made based on a preliminary assessment of fair value, since the Company was in the period of measurement of net assets at fair value. The table below demonstrate the differences between these preliminary effects presented on December 31, 2019 and the final effects presented in these consolidated financial statements: As reported in 2019 Measurement period adjustments 2020 Total estimated consideration to be transferred 13,366,114 - 13,366,114 (-) Fair value of assets acquired: Inta n gibles ( 1 5,709,326 137,486 5,846,812 Other assets 12,911,674 ( 2,035 12,909,639 (+) Fair value of liabilities assumed: Provis i on for risks and contingencies ( 2 651,000 1,042,096 1,693,096 Deferred income tax and social contribution ( 3 671,693 ( 79,159 592,534 Other liabilities 14,571,307 16,873 14,588,180 (-) Net assets 2,727,000 ( 844,359 1,882,641 (+) Non-controlling interests 27,555 - 27,555 Goodwill from business combination 10,666,669 844,359 11,511,028 (1) During the measurement period, the Company completed the identification and measurement of intangible assets obtained with the acquisition . (2) During the measurement period, the Company completed the identification and measurement of the contingent liabilities assumed evaluated as present obligations, as discussed above. (3) Reflects tax effects arising from the adjustments identified in the measurement period.

Critical Accounting Estimates A

Critical Accounting Estimates And Assumptions	12 Months Ended
	Dec. 31, 2020
Critical Accounting Estimates And Assumptions [Abstract]
Critical Accounting Estimates And Assumptions	5. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS The preparation of the consolidated financial statements requires management to make certain judgments and use assumptions and estimates based on experience and other factors considered relevant, which affect the values of assets and liabilities and which may present results that differ from actual results. The areas that require a higher level of judgment and have greater complexity, as well as the areas in which assumptions and estimates are significant for the financial statements, are disclosed below. 5.1 Deferred Income tax and social contribution Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the level of future taxable profits, together with future tax planning strategies and other sources of income. The Company has R$ 13,369,187 2020 880,516 2019 5.2 The Company is a part of several legal and administrative procedures as described in note 2 2 5.3 The cost of the post-employment healthcare plan is determined using actuarial valuations. An actuarial valuation involves making various assumptions that may differ from actual developments in the future. These are based on a series of financial and demographic assumptions, such as the discount rate, medical inflation, and percentage of adhesion to the plan, which are disclosed in note 2 3 5.4 Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about it. The stock option plan, restricted share plan and strategy acceleration program are measured at fair value at the grant date and the expense is recognized in profit or loss during the vesting period and in “Additional paid-in capital” in shareholders’ equity. At the balance sheet dates, Management reviews the estimates as to the number of stock options/restricted shares and, where applicable, recognizes the effect arising from this review in profit or loss for period against shareholders’ equity. The assumptions and models used to estimate the fair value of the stock option plan, restricted share plan and strategy acceleration program are disclosed in note 2 8 . 1 5.5 An impairment loss exists when the carrying amount of an asset or CGU exceeds its recoverable amount, which is the higher of fair value less cost of disposal and value in use. Fair value less costs of disposal is calculated based on information available about similar assets sold or market prices less additional costs to dispose of the asset. Value in use is calculated based on the discounted cash flow model. Cash flows derive from a budget prepared for the following three five 5.6 for trade receivable expected credit losses The allowance for expected losses on trade receivable from customers is estimated based on the loss risk in an aging list model. The characteristics of the Company's trade receivable are (i) immaterial financial component; (ii) non-complex receivables portfolio; and (iii) low credit risk. For trade receivable, the Company applies the simplified approach in calculating expected credit losses (“ECL”) based on expected credit losses at each reporting date. The allowance determined based on (i) each of the subsidiaries credit losses historical experience, observed in each group of the accounts receivable aging list, and (ii) adjustments for specific prospective factors for defaulters and the economic environment. An estimated range is used based on the weighted average of the losses for the last 12 5.7 The allowance for losses on inventories is estimated using a methodology to contemplate discontinued products, materials with slow turnover, materials with an expired expiration date or close to the expiration date, and materials outside the quality parameters. 5.8 The Company cannot readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (“IBR”) to measure lease liabilities. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Company “would have to pay”, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary’s functional currency). The Company estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates. 5.9 When the fair value of financial assets and liabilities recorded in the balance sheet cannot be measured based on prices quoted in active markets, the fair value is measured based on valuation techniques, including the discounted cash flow model. The inputs considered in these models are obtained from observable markets, when possible. In situations where these inputs cannot be obtained from observable markets, a degree of judgment is necessary to establish the respective fair values. Associated judgments include assessment of liquidity risk, credit risk and volatility. Changes in the assumptions related to these factors could affect the fair value of financial instruments. 5.10 As disclosed in note 3.4 The disclosures associated with these topics are included in note 4

Financial Risk Management

Financial Risk Management	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Financial risk management	6. FINANCIAL RISK MANAGEMENT 6.1 General considerations and policies Risks and financial instruments are managed through policies, the definition of strategies and implementation of control systems, defined by the risk management committees of the entities of the group, and approved by the Company's Board of Directors. The compliance of treasury financial instruments positions, including derivatives, in relation to these policies, is presented and assessed on a monthly basis by the Company’s Treasury Committee and subsequently submitted to the analysis of the Audit and Risk Management and Finance Committees, the Executive Committee and the Board of Directors. Risk management of Natura &Co group operations is performed by the Company's Corporate Treasury, which is also responsible for approving short-term investments and borrowings transactions. Risk management of the subsidiaries Aesop, The Body Shop, Avon International and Natura &Co Latam is conducted by local treasury teams, subject to monitoring and approval of the Company’s Corporate Treasury. 6.2 Financial risk factors The activities of the Company and its subsidiaries expose it to several financial risks: market risk (including currency and interest risks), credit risk and liquidity risk. The Company’s overall risk management program is focused on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance, using derivatives to hedge certain risk exposures. a) Market risk The Company and the subsidiaries are exposed to market risks arising from their business activities. These risks mainly comprise possible fluctuations in exchange and interest rates. To hedge the current balance sheet positions of the Company from market risks, the following derivative financial instruments are used, which are comprised of the balances presented below, as of December 31, 2020 2019 Description Fair value (Level 2 2020 2019 Financial derivatives 1,857,869 727,068 Operational derivatives ( 11,092 ( 1,496 Total 1,846,777 725,572 b) Foreign currency risk The Company are exposed to foreign currency risk resulting from financial instruments in currencies other than their functional currencies, as well as to operating cash flows in foreign currencies. To reduce this exposure, policies were implemented to hedge the Company from foreign currency risk, which establish exposure levels related to these risks. The treasury procedures defined by the current policies include monthly projection and assessment of the consolidated foreign exchange rate exposure of the Company, on which Management’s decision-making is based. The Company’s foreign currency hedge policy considers the amounts of foreign currency of receivables and payables balances from commitments already assumed and recorded in the financial statements, as well as future cash flows, with a six Pursuant to the Foreign Exchange Hedge Policy, the derivatives entered into by the Company or its subsidiaries should eliminate the foreign currency risk of financial instruments in currencies other than their functional currencies and should also limit losses due to foreign exchange rate variations on future cash flows. To protect from the foreign exchange exposures in relation to foreign currency, the Company enter into transactions with derivative financial instruments such as swap and forward exchange contracts (“NDF”). c) Derivatives instruments to hedge foreign exchange rate risk The Company classifies derivatives into “Financial” and “Operational”. “Financial” derivatives include swaps or forwards engaged to hedge from foreign currency risk of borrowings, financing, debt securities and intercompany borrowings denominated in foreign currency. “Operating” derivatives are used to hedge from foreign currency risk from the business’s operating cash flows. As of December 31, 2020 and 2019, the derivative balances are composed as follows: Financial derivatives Principal (notional) Fair value Gain (loss) Description 2020 2019 2020 2019 2020 2019 Swap contracts : (a) Asset position: Long position - U.S. dollar 2,576,890 2,664,001 4,683,900 3,729,691 421,897 312,984 Liability position: CDI floating rate: Short position in CDI ( 2,576,890 ( 2,664,001 ( 2,803,797 ( 3,002,623 ( 172,885 ( 248,028 Forward contracts (NDF): Liability position: CDI floating rate: Short position in CDI 1,409,102 - ( 22,234 - ( 16,778 - Total net derivative financial instruments: 1,409,102 - 1,857,869 727,068 232,234 64,956 (a) Swap transactions consist of swapping the exchange rate fluctuation for a correction related to a percentage of the fluctuation of the Interbank Deposit Rate (post-fixed CDI), in the case of Brazil . For the derivatives held by the Company as of December 31, 2020 2019 Operatin g derivatives As at December 31, 2020 and 2019 Principal (notional) amount Fair value Description 2020 2019 2020 2019 Net position - GBP and USD 1,585,280 200,896 ( 7,670 ( 2,008 Forward contracts 165,830 1,302,869 ( 3,422 512 Total derivative instruments, net 1,751,110 1,503,765 ( 11,092 ( 1,496 Sensitivity analysis For the foreign currency risk sensitivity analysis, Management of the Company believes that it is important to consider, in addition to the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the financial instruments entered into by the Company to hedge certain exposures on December 31, 2020 2019 2020 2019 Borrowings and financing in foreign currency in Brazil (a) ( 4,246,692 ( 3,381,959 Receivables in foreign currency in Brazil 236,782 10,007 Trade payable in foreign currencies in Brazil ( 14,459 ( 10,543 Fair value of the financial derivatives 4,680,478 3,729,691 Net asset exposure 656,109 347,196 (a) Excluding transaction costs. This analysis considers only financial assets and liabilities registered in Brazil in foreign currency, since exposure to the foreign exchange rate variation in other countries is close to zero The following table shows the projection of the incremental loss that would have been recognized in profit or loss for the subsequent year, if the current net foreign exchange exposure remains static, based on the following scenarios: Parity - R$ vs US$ 5.1967 5.1880 3.8910 2.5940 Scenario Scenario Scenario I Scenario II Operation/Instrument Real Probable Depreciation 25 Depreciation 50 Assets denominated in US$ Fair value of “financial” derivatives 4,680,478 ( 7,881 ( 1,570,668 ( 4,696,241 Trade receivable recorded in Brazil in foreign currency 236,782 ( 399 ( 79,459 ( 237,579 Liabilities denominated in US$ Borrowings and financing in Brazil in foreign currency (a) ( 4,246,692 7,151 1,425,099 4,260,994 Trade payable registered in Brazil in foreign currency ( 14,459 24 4,852 14,508 Impact on net income and equity ( 1,105 ( 220,176 ( 658,318 The probable scenario considers future US dollar rates for a 90 B 3 ”) as at December 31, 2020 in line with the first maturities of financial instruments with exchange exposure, R$ 5.19 / US$ 1.00 25 R$ 3.89 / US$ 1.00 50 R$ 2.59 / US$ 1.00 ), respectively. Management uses the probable scenario in the assessment of possible changes in the exchange rate and presents the referred scenario in compliance with IFRS 7 The Company does not use derivative financial instruments for speculative purposes. At the subsidiary Avon, the sensitivity analysis is prepared based on the foreign exchange contracts outstanding at December 31, 2020 2020 10 25 50 82,889 207,223 414,447 10 25 50 82,889 207,223 414,447 Derivative instruments designated for hedge accounting The Company formally designated its operations subject to hedge accounting for derivative financial instruments for hedging borrowings denominated in foreign currency of Natura Cosméticos S.A. and Natura Distribuidora de México, S.A. de C.V and to protect operating cash flows from The Body Shop's foreign currency purchase and sales transactions, documenting the following: Ø Ø Ø Ø Ø Ø Ø Ø The outstanding positions of derivative financial instruments designated as cash flow hedge on December 31, 2020 Cash flow hedge instrument Other comprehensive income Hedged item Notional currency Notional value Fair value (a) Accumulated contract gain (loss) Gain in the 12 Currency Swap – US$/R$ Currency BRL 2,576,020 1,879,348 249,021 183,342 Forward contract (The Body Shop) Currency BRL 1,096,227 ( 4,882 ( 4,882 ( 5,135 Forward contract (Natura Indústria) Currency BRL 17,807 ( 702 ( 702 ( 201 Total 3,690,054 1,873,764 243,437 178,006 The changes in cash flow hedge reserve recorded in OCI are shown below: Cash flow hedge Balance as of December 31, 2018 ( 27,840 Change in the fair value of hedge instrument recognized in OCI 107,337 Tax effects on fair value of hedge instrument ( 36,768 Cash flow hedge Balance as of December 31, 2019 42,729 Change in the fair value of hedge instrument recognized in OCI 178,006 Tax effects on fair value of hedge instrument ( 61,658 Cash flow hedge Balance as of December 31, 2020 159,077 The Company designates as cash flow hedge the derivative financial instruments used to offset variations arising from foreign currency exposure, in the market value of contracted debts, other than the functional currency. d) Interest rate risk The interest rate risk arises from financial investments and short and long-term borrowings and financing. Financial instruments issued at variable rates expose the Company and its subsidiaries to cash flow risk associated with interest rates. Financial instruments issued at fixed rates expose the Company and its subsidiaries to the fair value risk associated with the interest rate. The Company’s cash flow risk associated with interest rate arises from investments and short-term and long-term borrowings and financing issued at floating rates. The Company's Management holds , for the most part, the indexes of its exposures to deposit and lending interest rates tied to floating rates. Financial investments are adjusted by the Interbank Deposit Rate ( “ CD I ” ) whereas borrowings and financing are adjusted by the Long-Term Interest Rate (“ TJLP ”), CDI and fixed rates, according to the contracts entered into with financial institutions and through the negotiation of securities with investors in that market. Sensitivity analysis On December 31, 2020 The following table presents the exposure to interest rate risks of transactions related to CDI, including derivative transactions (borrowings, financing and debentures in Brazil were considered in full, given that 99.1 Total borrowings and financing - in local currency (note 19 ( 9,591,809 Operations in foreign currency with derivatives related to CDI (a) ( 4,231,104 Short-term investments (notes 7 8 3,865,319 Net exposure ( 9,957,594 a) This refers to transactions involving derivatives related to CDI to hedge the borrowings and financing arrangements raised in foreign currency in Brazil. The sensitivity analysis considers the exposure of borrowings and financing, net of short-term investments, linked to CDI (notes 7 8 The following tables show the projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current net liability exposure is static and the following scenarios: Description Risk Probable scenario Scenario II Scenario III Net liability Rate increase ( 3,626 ( 33,235 ( 62,844 The probable scenario considers future interest rates for 90 B 3 2020 25 2.45 50 2.94 a CDI rate of 1.96 e) Credit risk Credit risk refers to risk of a counterparty not complying with its contract obligations, which would result in financial losses for the Company. The Company’s and its subsidiaries sales are made to a high number of Natura and Avon consultants and this risk is managed through a credit granting process. The result of this management is reflected in the “Allowance for expected credit losses” under “Trade receivables”, as shown in note 9 The Company is also subject to credit risks related to financial instruments entered for the management of its business, mainly represented by cash and cash equivalents, short-term investments and derivative instruments. The Company believes that the credit risk of transactions with financial institutions is low, as these are considered as first tier by the Management. The short-term investments policy adopted by the Company’s Management establishes the financial institutions with which the Company is allowed to do business, in addition to defining limits on funds allocation percentages and absolute amounts that may be allocated in each of these financial institutions. f) Liquidity risk Prudent liquidity risk management implies maintaining sufficient cash, bonds and securities, funds available through credit facilities and the ability to settle market positions. Management monitors the Company’s and its subsidiaries liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in the following table: 2020 2019 Total current assets 18,734,820 9,430,057 Total current liabilities ( 16,159,586 ( 7,518,423 Total net working capital 2,575,234 1,911,634 As at December 31, 2020 Description Less than one One five Over five Total expected cash flow Interest to be accrued Carrying amount Borrowings, financing and debentures 4,047,276 9,165,849 1,551,721 14,764,846 ( 941,933 13,822,913 Leases 1,231,622 2,644,292 734,771 4,610,685 ( 752,230 3,858,455 Payables to related parties, trade payables and reverse factoring operations 6,774,205 - - 6,774,205 - 6,774,205 The Company currently have a credit line of up to £ 70 seventy line has been used by the subsidiary since the first quarter of 2020 150,000 one fifty 2019 was closed during the first half of 2020 6.3 Covid- 19 The Company is monitoring the evolution of the Covid- 19 2020 Considering the uncertainties associated with the adversities observed in the economic scenario, Management also assesses the possible effects on the consolidated financial statements, as discussed below: 6.3.1 Revenues The Company's and its subsidiaries' businesses were affected by the pandemic mainly at the beginning of the year, with results recovering from the decreasing restrictions in the markets in which it operates, mainly in Brazil, as some of the main markets in Europe follow more restrictive measures to open stores and shops. The transition to the digital environment continued across all our brands, making it possible to offset the impact of store closures, with an increase in e-commerce sales, in addition to the growth seen in direct sales revenues. 6.3.2 Provision for expected losses on accounts receivable from customers The Company have been evaluating the impact of the crisis on accounts receivable, due to the possibility of increasing credit risk, with the aim of ensuring the sustainability of the chain and supporting its customer network. Changes in provisions for expected losses are presented in note 9 2020 6.3.3 Impairment of non-financial assets In the first quarter, the Company revised the projections used in the goodwill impairment tests considering the adverse scenario brought about by the pandemic and as a result the need to recognize an impairment provision was not identified. In the fourth quarter, the Company carried out the annual goodwill impairment test, as indicated in notes 3.12 1 7 Retail operations (mainly composed of physical stores) are not considered essential by government authorities, which led to the closure of part of these locations during different periods of 2020 148,050 1 8 6.3.4 L eases During the year, the Company renegotiated contracts and obtained discounts on store lease payments, as mentioned in note 1 8 6.3.5 Operational continuity Management is not aware of any material uncertainty that could generate significant doubts about its ability to continue operating indefinitely. 6.3.6 Capital management and liquidity risk and covenants The Company uses part of the resources from private funding and capital increase (see notes 19 2 4 ), to accelerate its investments in the digitization of operations, which were intensified as a result of the Covid- 19 6.4 Cyber - incident In June 2020, the subsidiary Avon became aware that it was exposed to a cyber-incident in its Information Technology (“IT”) environment that interrupted some systems and partially affected Avon's operations. Avon involved leading external experts in cybersecurity and general IT controls, initiating a comprehensive containment and correction effort, as well as a forensic investigation. By mid-August, Avon had reestablished all its main business processes and resumed operations in all of its markets, including all of its distribution centers. The cyber incident did not have a significant impact on the revenue performance of the subsidiary for the year ended December 31, 2020 2020 Although it has no indication that the accuracy and completeness of any financial information has been affected as a result of the incident, the subsidiary has performed extensive procedures to validate the accuracy and completeness of its financial information. 6.5 The Company’s capital management objectives are to ensure that the Company is continuously capable of offering return to its shareholders and benefits to other stakeholders, in addition to maintaining an ideal capital structure to reduce this capital cost. The Company monitors capital based on the financial leverage ratios. This ratio corresponds to the net debt divided by equity. The net debt corresponds to total borrowings and financings (including short and long-term borrowings and financings, as shown in the consolidated statement of financial position), deducted from cash and cash equivalents and short-term investments (except for “Crer Para Ver” funds). 6.6 Fair value estimate Financial instruments that are measured at fair value at the reporting date as prescribed by IFRS 13 Ø Level 1 Valuation based on quoted (unadjusted) prices in active markets for identical assets and liabilities on the reporting date. A market is seen as active if quoted prices are readily and regularly available from a Commodities and Securities Exchange, a broker, industry group, pricing service or regulatory agency, and those prices represent actual market transactions, which occur regularly on a purely commercial basis; Ø Level 2 Used for financial instruments that are not traded in active markets (for example, over-the-counter derivatives), whose valuation is based on techniques that, in addition to the quoted prices included in Level 1 Ø Level 3 Valuation determined by virtue of information, for assets or liabilities, that is not based on data adopted by the market (i.e., unobservable information). The carrying amounts and fair values of the Company’s financial instruments as at December 31, 2020 2019 Description Carrying amount Fair value Note Classification by category Fair value hierarchy 2020 2019 2020 2019 Financial assets Cash and cash equivalent 7 Cash and banks Amortized cost Level 2 4,436,123 3,110,220 4,436,123 3,110,220 Certificate of bank deposits Amortized cost Level 2 808,988 211,261 808,988 211,261 Repurchase transactions Fair value through profit or loss Level 2 576,108 1,192,101 576,108 1,192,101 5,821,219 4,513,582 5,821,219 4,513,582 Short term investments 8 Government bonds Fair value through profit or loss Level 1 864,940 221,900 864,940 221,900 Restricted cash Fair value through profit or loss Level 2 40,425 - 40,425 - Financial treasury bill Fair value through profit or loss Level 2 505,152 374,690 505,152 374,690 Loan investment fund Fair value through profit or loss Level 2 817,253 407,928 817,253 407,928 Dynamo Beauty Ventures Ltd fund Fair value through profit or loss Level 3 16,104 7,402 16,104 7,402 Certificate of bank deposits Fair value through profit or loss Level 2 292,878 21,327 292,878 21,327 2,536,752 1,033,247 2,536,752 1,033,247 Trade receivable 9 Amortized cost Level 2 3,597,535 1,685,764 3,597,535 1,685,764 Judicial deposits 13 Amortized cost Level 2 566,190 337,255 566,190 337,255 Carbon Credits 15 Fair value through profit or loss Level 2 4,097 3,508 4,097 3,508 Sublease receivables 15 Amortized cost Level 2 357,538 - 357,538 - “Financial” and “operating” derivatives Fair value through profit or loss - hedging instrument Level 2 1,768,122 737,378 1,768,122 737,378 “Financial” and “operating” derivatives Fair value through profit or loss Level 2 139,856 - 139,856 - 1,907,978 737,378 1,907,978 737,378 Financial liabilities Borrowings, financing and debentures 20 Local currency borrowings Amortized cost Level 2 ( 9,591,809 ( 7,412,443 ( 9,466,921 ( 7,445,672 Foreign currency borrowings Amortized cost Level 2 ( 4,231,104 ( 3,373,931 ( 4,459,081 ( 3,541,541 ( 13,822,913 ( 10,786,374 ( 13,926,002 ( 10,987,213 Carbon Credits 23 Fair value through profit or loss Level 2 ( 5,560 ( 4,519 ( 5,560 ( 4,519 “Financial” and “operating” derivatives Fair value through profit or loss - hedging instrument Level 2 - ( 10,158 - ( 10,158 “Financial” and “operating” derivatives Fair value through profit or loss Level 2 ( 61,201 ( 1,648 ( 61,201 ( 1,648 ( 61,201 ( 11,806 ( 61,201 ( 11,806 Lease liabilities 19 Amortized cost Level 2 ( 3,858,455 ( 2,517,565 ( 3,858,455 ( 2,517,565 Trade payables and supply chain finance operations 21 Amortized cost Level 2 ( 6,774,205 ( 1,829,756 ( 6,774,205 ( 1,829,756 The Company estimates that cash and cash equivalents, trade receivable, trade payable and other current liabilities balances are equivalent to their book values, mainly due to the short-term maturities of these instruments. The carrying amounts of financial investments in Bank Deposit Certificates measured at amortized cost approximate their fair values as the operations are carried out at floating interest rates. The carrying amounts of borrowings, financing and debentures are measured at their amortized cost and disclosed at fair value, which does not differ materially from carrying amounts as the agreed interest rates are consistent with current market rates. The fair value of foreign exchange derivatives (swap and forward) is determined based on future exchange rates at the reporting date, with the resulting value discounted to present value. The fair value of the investment in the Dynamo Beauty Fund, classified at level 3 the Company determined that market agents would take into account for these discounts when defining the investment price. 1 15.4 185 There were no transfers between measurement levels in the fair value hierarchy for the year ended December 31, 2020 for these assets and liabilities.

Cash And Cash Equivalent

Cash And Cash Equivalent	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Cash and cash equivalent	7. CASH AND CASH EQUIVALENTS 2020 2019 Cash and banks 4,436,576 3,110,220 Certificate of Bank Deposits (a) 808,988 211,261 Repurchase transactions (b) 576,108 1,192,101 5,821,672 4,513,582 (a) As of December 31, 2020, Certificate of Bank Deposits (“CDB”) short-term investments are remunerated at an average rate of 103.2 106.9 2019 (b) Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2020 100.0 99.9 2019

Short-Term Investments

Short-Term Investments	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Short-Term Investments	8. SHORT-TERM INVESTMENTS 2020 2019 Loan investment funds 817,253 407,928 Certificate of Bank Deposits ( b ) 292,878 21,327 Treasury bills ( c ) 505,152 374,690 Government bonds ( LFT ) ( d ) 864,940 221,900 Dynamo Beauty Ventures Ltd. Fund 16,104 7,402 Restricted cash 40,425 - 2,536,752 1,033,247 Current 2,520,648 1,025,845 Non-current 16,104 7,402 (a) The Company and subsidiaries concentrate most of their investments in an exclusive investment fund, which holds interest in shares of the Essential Investment Fund. The values of the quotas held by the Company are presented under the heading “Exclusive Investment Fund”. The financial statements of the Exclusive Investment Fund, in which the group has exclusive participation ( 100 (b) Investments in CDBs classified as short-term investments are remunerated at an average rate of 100.0 106.9 2019 2020 57,609 38,018 2019 (c) As of December 31, 2020 136.61 106 2019 (d) As of December 31, 2020 105.9 100.4 2019 The composition of the securities that make up the portfolio of the Essential Investment Fund, in which the Company hold 100 2020 2019 2020 2019 Certificate of Bank Deposits (CDB) 292,878 21,327 Repurchase transactions (cash and cash equivalent) 576,108 1,192,101 Financial letter 505,152 374,690 Government bonds (LFT) 864,940 221,900 2,239,078 1,810,018

Trade Receivables

Trade Receivables	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Trade Receivables	9. TRADE RECEIVABLE 2020 2019 Trade receivable 4,029,643 1,793,759 Allowance for expected credit losses ( 432,108 ( 107,995 3,597,535 1,685,764 Maximum exposure to credit risk at the reporting date is the carrying amount of each aging range, net of the allowance for expected credit losses, as shown in the aging list below: 2020 2019 Current 1,988,583 1,501,958 Past due: Up to 30 1,506,460 142,069 31 60 173,121 36,466 61 90 111,735 27,789 91 180 249,744 85,477 Allowance for expected credit losses ( 432,108 ( 107,995 3,597,535 1,685,764 The changes in the allowance for expected credit losses for the year ended December 31, 2020 2019 Balance as of December 31, 2018 ( 129,242 Additions ( 209,515 Write-offs (a) 232,034 Exchange variation ( 1,272 Balance as of December 31, 2019 ( 107,995 Additions ( 640,676 Write-offs /reversals (a) 372,659 Exchange variation ( 56,096 Balance as of December 31, 2020 ( 432,108 (a) 180 The following table shows trade receivable by exposure to doubtful accounts on December 31, 2020 Trade receivable Allowance for expected credit losses Current 1,988,583 ( 53,352 Past due: Up to 30 1,506,460 ( 76,848 31 60 173,121 ( 56,124 61 90 111,735 ( 54,172 91 180 249,744 ( 191,612 4,029,643 ( 432,108

Inventories

Inventories	12 Months Ended
	Dec. 31, 2020
Disclosure of Inventories [Abstract]
Inventories	10. INVENTORIES 2020 2019 Finished products 3,592,864 1,253,145 Raw materials and packaging 1,015,156 253,063 Consumables 170,188 82,228 Work in progress 36,025 27,346 Allowance for losses ( 269,963 ( 185,232 4,544,270 1,430,550 The changes in the provision for inventory losses for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 ( 178,268 Additions, net (a) ( 147,140 Write-offs (b) 136,431 Exchange rate variation 3,745 Balance as of December 31, 2019 ( 185,232 Additions, net (a) ( 341,799 Write-offs (b) 354,692 Exchange rate variation ( 97,624 Balance as of December 31, 2020 ( 269,963 (a) Refer to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the Company’s and its subsidiaries policy. (b) Consist of write-offs of products discarded by the Company.

Recoverable Taxes

Recoverable Taxes	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Recoverable Taxes	11. RECOVERABLE TAXES 2020 2019 ICMS on purchase of goods (a) 681,147 434,832 Taxes on purchase of goods –subsidiaries abroad 230,260 39,475 ICMS on purchases of property, plant and equipment 9,578 10,628 PIS and COFINS on purchases of property, plant and equipment (b) - 3,826 PIS and COFINS on purchase of goods (c) 780,841 280,087 Withholding PIS, COFINS and CSLL 1,669 2,378 Withholding income tax 23,637 - IPI ( Tax on Manufactured Products ) ( d) 77,096 30,190 Others 199,333 3,438 2,003,561 804,854 Current 1,071,349 395,640 Non-current 932,212 409,214 (a) Accumulated Brazilian tax on the circulation of goods, interstate and inter-municipal transport and communication services (“ICMS”) tax credits were mainly generated from the purchases, which tax rate is higher than average sales rates and by increase in exports. (b) Brazilian taxes on the acquisition of fixed assets: Social Integration Programs (“PIS”) and Contribution for Social Security Financing (“COFINS”). (c) The accumulated tax credits for PIS and COFINS basically arise from credits on purchases of raw materials used in production. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. (d) The balance will be used to IPI payable in future operations of the Company's subsidiaries.

Income Tax And Social Contribut

Income Tax And Social Contribution	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Income Tax And Social Contribution	12. INCOME TAX AND SOCIAL CONTRIBUTION 12.1 Deferred Deferred Corporate Income Tax (IRPJ) and Social Contribution on Net Income (CSLL), results from temporary differences in the Group. For certain subsidiaries and the Company, deferred tax balances on tax losses were also recognized. The amounts are as follows: i) Breakdown of deferred income tax and social contribution – Assets: 2020 2019 Tax loss carryforwards and negative basis of social contribution tax 456,567 193,566 Allowance for doubtful accounts 133,162 51,151 Allowance for losses on inventories 101,237 50,593 Provision for tax, civil and labor contingencies 57,560 53,377 Provision for ICMS – ST 19,552 24,659 Allowances for losses on advances to suppliers 265 898 Accrued benefits sharing and partnerships 25,912 17,483 Provision for profit sharing 77,434 54,427 Provision carbon credits 9,848 8,297 Profit not realized in inventories 40,706 32,899 INSS with Suspended Liability - 17,757 Lease 30,493 22,268 Other expenses provision (a) 332,985 60,886 Post-employment healthcare plan 35,553 33,589 Net Operating Loss and Other Deduction Carryforwards 263,121 - Stock option plan 334,416 112,095 Other temporary differences 208,279 35,323 Deferred income tax and social contribution assets 2,127,090 769,268 Effect of changes in fair value of derivative instruments, including hedge accounting transactions ( 638,071 ( 247,163 Amortization and depreciation - useful life differences ( 104,750 ( 118,632 Fair value of identifiable net assets in business combinations of Emeis Holdings Pty Ltd - ( 24,516 Provision/(reversal) for losses - property and intangible assets ( 44,544 ( 4,509 Deferred income tax and social contribution liability ( 787,365 ( 394,820 Total of Deferred income tax and social contribution 1,339,725 374,448 a) Refers to temporary differences arising from the provision for invoices for services and suppliers recorded for which invoices have not yet been issued. Management assesses the possibility of offsetting deferred income tax assets and deferred income tax liabilities according to each jurisdiction. As a result, there is only one Management monitors the performance of all its entities and evaluates whether deferred tax assets can be realized from the four loss carryback potential, reversing taxable temporary differences, tax planning opportunities and forecasts of future taxable income. The Company does not have deferred tax assets that cannot be supported by one ii) Breakdown of deferred income tax and social contribution – Liabilities: 2020 2019 Fair value of identifiable net assets in business combination (a) 1,288,045 450,561 a) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of Avon, The Body Shop and Aesop. The Company has not recognized certain deferred tax assets on losses. These losses relate to subsidiaries that have a history of losses and may not be used to offset taxable income elsewhere in the Company. The subsidiaries neither have any taxable temporary difference nor any tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Company has determined that it cannot recognize deferred tax assets on the tax losses carried forward. Description Amount Indefinite Expiration Definite Expiration Net Operating Loss (a) 11,733,876 10,401,642 1,332,234 Credits (b) 96,893 - 96,893 Other Future Deductible Items 1,538,418 100,068 1,438,350 Total 13,369,187 10,501,710 2,867,477 a) During 2021 R$ 31 million are expected, the remaining expirations would start to occur in 2022 loss/deduction carryforwards subject to expiration in 2031 b) During 2021 R$ 26 million are expected, the remaining expirations would start to occur in 2022 utilizable credits subject to expiration in 2027 In addition, R$ 2,4 2022 2026 Management continuously evaluates tax planning opportunities to prevent tax attributes from expiring unutilized. As of December 31, 2020, there are no prudent and feasible tax planning opportunities that management would and could implement. In addition, for the attributes noted above, there are no other sources of income available and as a result, these attributes remain unrecognized. Management continuously evaluates all sources of income to allow unrecognized deferred tax asset to become recognized when it is probable that there are sufficient sources of income to allow for their recognition. Generally, recognition will occur when there is a history of profits that can be sustained and relied upon in the future and/or when facts/circumstances change indicating that a history of losses has been overcome due to elimination of loss making factors, changes in operations and other factors 12.2 Reconciliation of income tax and social contribution: 2020 2019 2018 Income / (loss) After income tax and social contribution - 304,566 - Taxes on Company Formation (a) - 206,592 - Income / (loss) before income tax and social contribution (b) ( 388,935 511,158 673,405 Income tax and social contribution at the rate of 34 132,238 ( 173,794 ( 228,958 Benefit of expenses with research and technological innovation 23,033 19,228 - Tax incentives 10,018 12,457 10,724 Subsidy for investments (c) 128,173 24,864 12,505 Effect from differences of tax rates of entities abroad ( 166,394 26,907 14,077 Recognition of prior-year tax losses - USA and Mexico - - 70,065 Taxation of profits of subsidiaries abroad ( 56,194 ( 60,305 ( 12,694 Unrecognized tax benefits ( 104,160 ( 8,893 ( 11,799 Tax Benefits of interest on equity (IOE) 10,275 37,628 40,208 Exercise of stock options and restricted stock plans ( 9,770 9,697 - Non-Deductible Donation/Contribution ( 12,509 ( 4,136 ( 5,451 UK Tax Law Rate Change (d) ( 63,428 - - Post-employment healthcare plan - - 30,082 Withholding Taxes ( 63,754 - - Imputed Income ( 67,529 ( 1,156 ( 830 Other permanent differences ( 34,743 ( 31,596 ( 42,955 Income tax and social contribution expenses ( 274,744 ( 149,099 ( 125,026 Income tax and social contribution - current ( 292,828 ( 94,780 ( 182,324 Income tax and social contribution - deferred 18,084 ( 54,319 57,298 Effective Rate- % ( 70.6 29.2 18.6 (a) Tax levied on the formation of the Company resulting from the difference between Natura's accounting balances and the acquisition cost used for the purpose of the contribution of shares issued by Natura to the Company's capital stock (note 24 aforementioned special capital reserve constitutes part of the taxable profit for tax purposes in Brazil, the nature of this amount is different from the nature of other sources of taxable profit under the scope of IAS 12 i ) the Company did not generate taxable profits and this tax is mainly related to the increase in equity that generates the special reserve for statutory purposes; (ii) the creation of the special reserve is, in substance, a matter of reclassification; (iii) the tax is levied on the entity as a result of an additional increase in the equity of the contribution made to the Company; and (iv) the Company's future profits, as well as Natura's future and historical profits will continue to be taxed in accordance with tax legislation. The tax on the formation of the Company was recognized in the income statement and presented as "Taxes on the formation of the Company". (b) The loss before tax consolidated related to 2020 (c) The Company has tax incentives arising from its ordinary operations (Grant Investment). (d) During 2020 17 19 Such increase was accrued through deferred income tax expense during 2020 The movement in deferred asset and liability income tax and social contribution for the period ended December 31, 2020 were as follows: Asset Liability Balance at December 31, 2019 374,448 ( 450,561 Effect on profit or loss ( 19,639 37,723 Reserve for grant of options and restricted shares 96,181 - Effect on other comprehensive income ( 61,658 - Currency Translation Effect 283,359 ( 314,527 Business combination 667,034 ( 560,680 Balance at December 31, 2020 1,339,725 ( 1,288,045

Judicial Deposits

Judicial Deposits	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Judicial Deposits	13. JUDICIAL DEPOSITS Represent the restricted assets of the Group and are related to amounts deposited and held in court until the resolution of the disputes to which they are related. The judicial deposits held by the Company and its subsidiaries as at December 31, 2020 2019 2020 2019 Unaccrued tax lawsuits (a) 262,654 203,403 Accrued tax lawsuits (b) 252,961 116,415 Unaccrued civil lawsuits 9,671 2,541 Accrued civil lawsuits 2,189 426 Unaccrued labor lawsuits 14,166 8,683 Accrued labor lawsuits 24,549 5,787 Total judicial deposits 566,190 337,255 (a) The tax procedure related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 22.1.1 (b) The tax procedure related to these judicial deposits refer, substantially, to the sum of the amounts disclosed in note 22.2.1 21 Changes in the balance escrow deposits for the period ended December 31, 2020 2019 Balance at December 31, 2018 333,577 New deposits 2,542 Redemptions ( 7,556 Interests 13,352 Payments / Write-offs for expenses ( 4,660 Balance at December 31, 2019 337,255 Acquisition of subsidiary 283,885 New deposits 18,377 Redemptions ( 64,761 Interests 11,242 Payments / Write-offs for expenses ( 17,739 Exchange variance ( 2,069 Balance at December 31, 2020 566,190 In addition to judicial deposits, the Group have insurance policies to guarantee certain lawsuits. Details of these insurances are presented in note 3 4

Assets Held For Sale

Assets Held For Sale	12 Months Ended
	Dec. 31, 2020
Assets Held for Sale Disclosure [Abstract]
Assets held for sale	14. ASSETS HELD FOR SALE The assets classified as held for sale were acquired in the acquisition process of Avon (note 4 Balance as of December 31, 2019 - Avon acquisition 199,050 Additions (a) 25,779 Transfer to fixed assets ( b ) ( 29,610 Sale ( c ) ( 61,760 Exchange rate variation 47,820 Balance as of December 31, 2020 181,279 a) During the fourth quarter of 2020 b) During the first quarter of 2020 two one c) During the third quarter of 2020 two As of December 31, 2020, assets held for sale include Avon properties, located in Brazil, Spain and Saudi Arabia.

Other Current And Non-Current A

Other Current And Non-Current Assets	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Other Current And Non-Current Assets	15. OTHER CURRENT AND NON-CURRENT ASSETS 2020 2019 Marketing and advertising advances 42,233 28,669 Suppliers advances 257,099 102,225 Employees advances 65,180 13,983 Rent advances and guarantee deposits 169,958 96,202 Prepaid insurance expenses 200,074 29,647 Surplus pension plan (b) 683,425 - Customs broker advances - Import taxes 34,016 34,932 Sublease receivables (c) 357,538 - Carbon credits 4,097 3,508 Receivables from service providers (d) 135,030 - Others 195,138 39,868 2,143,788 349,034 Current 616,120 265,198 Non-current 1,527,668 83,836 a) Mainly related to: (i) advances of rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 b) Pension plan arising from the acquisition of Avon (note 4 2 8 2 c) Refers to the sublease receivable from the New York office owned by Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

Property, Plant And Equipment

Property, Plant And Equipment	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Property, Plant And Equipment	16. PROPERTY, PLANT AND EQUIPMENT Useful life range (in years) 2019 Company acquisition Additions Write-offs impairment Transfers Exchange rate variation 2020 Cost: Vehicles 2 5 45,578 25,789 14,594 ( 17,274 - 1,184 9,356 79,227 Templates 3 192,556 - 1,243 ( 19,713 - 5,650 8,116 187,852 Tools and accessories 3 20 11,974 52,410 11,625 ( 1,743 - 5,888 5,524 85,678 Facilities 3 60 309,772 1,431 81 ( 3,599 - 8,791 ( 23,005 293,471 Machinery and accessories 3 15 866,451 740,328 20,098 ( 5,134 - 58,649 139,301 1,819,693 Leasehold improvements 2 20 615,103 58,548 34,324 ( 8,761 - 51,588 213,155 963,957 Buildings 14 60 386,957 1,203,081 12,275 - ( 115 48,551 248,427 1,899,176 Furniture and fixture 2 25 397,727 32,566 32,530 ( 6,300 ( 26 11,239 98,812 566,548 Land - 35,157 570,572 57 - - 4,252 51,575 661,613 IT equipment 3 15 297,228 112,369 27,254 ( 10,652 - 36,554 81,019 543,772 Other assets - - 36,423 - - - - 264 36,687 Projects in progress - 156,011 78,965 440,170 ( 592 - ( 305,305 39,136 408,385 Total cost 3,314,514 2,912,482 594,251 ( 73,768 ( 141 ( 72,959 871,680 7,546,059 Accumulated depreciation Vehicles ( 16,924 - ( 24,150 10,081 - ( 2,093 44 ( 33,042 Templates ( 175,938 - ( 10,092 19,684 - - ( 190 ( 166,536 Tools and accessories ( 3,255 - ( 42,932 - - 10 7,018 ( 39,159 Facilities ( 167,362 - ( 19,933 285 - 1,044 9,240 ( 176,726 Machinery and accessories ( 416,736 - ( 193,657 2,759 - ( 1,202 30,074 ( 578,762 Leasehold improvements ( 267,371 - ( 130,631 7,124 ( 4,900 ( 4,107 ( 80,669 ( 480,554 Buildings ( 101,785 - ( 88,593 - - - 10,649 ( 179,729 Furniture and fixture ( 193,973 - ( 81,287 4,744 ( 284 4,093 ( 51,904 ( 318,611 IT equipment ( 197,281 - ( 96,768 8,591 ( 36 - ( 26,362 ( 311,856 Other assets - - ( 25,078 - - - ( 949 ( 26,027 Total accumulated depreciation ( 1,540,625 - ( 713,121 53,268 ( 5,220 ( 2,255 ( 103,049 ( 2,311,002 Net total 1,773,889 2,912,482 ( 118,870 ( 20,500 ( 5,361 ( 75,214 768,631 5,235,057 Useful life range (in years) 2018 Additions Write-offs impairment Transfers Other changes including exchange rate variation 2019 Cost Vehicles 2 5 78,072 12,463 ( 41,883 - 99 ( 3,173 45,578 Templates 3 203,814 1,499 ( 23,823 - 10,874 192 192,556 Tools and accessories 3 20 8,161 314 ( 445 - 3,910 34 11,974 Facilities 3 60 310,282 49 - - ( 1,534 975 309,772 Machinery and accessories 3 15 819,919 9,563 ( 1,259 - 54,336 ( 16,108 866,451 Leasehold improvements 2 20 577,217 46,869 ( 23,243 ( 1,958 20,645 ( 4,427 615,103 Buildings 14 60 940,002 2,245 - ( 887 ( 555,221 818 386,957 Furniture and fixture 2 25 362,817 40,118 ( 3,031 ( 3,514 16,978 ( 15,641 397,727 Land - 30,525 - - - 4,653 ( 21 35,157 IT equipment 3 15 263,524 21,976 ( 3,902 - 18,483 ( 2,853 297,228 Projects in progress - 103,463 204,107 ( 2,247 - ( 146,598 ( 2,714 156,011 Total cost 3,697,796 339,203 ( 99,833 ( 6,359 ( 573,375 ( 42,918 3,314,514 Accumulated depreciation Vehicles ( 31,784 ( 15,832 27,478 - ( 7 3,221 ( 16,924 Templates ( 191,501 ( 8,314 23,739 - 148 ( 10 ( 175,938 Tools and accessories ( 2,954 ( 687 410 - - ( 24 ( 3,255 Facilities ( 147,309 ( 20,703 - - 1,234 ( 584 ( 167,362 Machinery and accessories ( 379,050 ( 56,617 657 - - 18,274 ( 416,736 Leasehold improvements ( 217,167 ( 90,281 19,089 - 5,292 15,696 ( 267,371 Buildings ( 191,422 ( 7,315 - - 96,558 394 ( 101,785 Furniture and fixture ( 138,078 ( 78,988 2,734 - ( 184 20,543 ( 193,973 IT equipment ( 161,817 ( 44,606 3,443 - ( 936 6,635 ( 197,281 Total accrued depreciation ( 1,461,082 ( 323,343 77,550 - 102,105 64,145 ( 1,540,625 Net total 2,236,714 15,860 ( 22,283 ( 6,359 ( 471,270 21,227 1,773,889

Intangibles

Intangibles	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Intangibles	17. INTANGIBLES Useful life 2019 Acquisition of subsidiary Additions Write-offs Reversal (provision) of impairment Transfers Other changes including exchange rate variation 2020 Cost Software 2.5 10 1,313,090 291,555 82,718 ( 15,095 - 258,092 128,790 2,059,150 Trademarks and patents (Defined useful life) 20 25 116,805 517,592 - - - - 260,181 894,578 Trademarks and patents (Indefinite useful life) - 2,171,585 2,022,163 - - - - 1,553,309 5,747,057 Goodwill Avon (Note 4 - 11,511,028 - - - - 1,788,821 13,299,849 Goodwill Emeis Brazil Pty Ltd. (a) - 100,237 - - - - - 41,853 142,090 Goodwill The Body Shop (b) - 1,434,369 34,251 - - - - 478,121 1,946,741 Goodwill acquisition of TBS stores - 1,456 - - - - - - 1,456 Relationship with retail clients 10 1,987 - - - - - 798 2,785 Key money (indefinite useful life) (c) - 17,801 - - - - 1,315 7,653 26,769 Key money (Defined useful life) (d) 3 18 12,447 - 150 - ( 2,051 1,647 ( 1,333 10,860 Relationship with franchisees and sub franchisees and sales representatives (e) 7 15 602,958 1,884,249 - - - - 472,312 2,959,519 Technology developed (by acquired subsidiary) 5 - 1,131,573 - - - - 463,468 1,595,041 Other intangible assets 2 10 110,288 159 176,015 ( 15,024 - ( 175,414 12,251 108,275 Total cost 5,883,023 17,392,570 258,883 ( 30,119 ( 2,051 85,640 5,206,224 28,794,170 Accumulated amortization Software ( 649,347 - ( 365,184 44 - ( 3,643 ( 4,368 ( 1,022,498 Trademarks and patents ( 44,108 - ( 36,548 - - - ( 19,387 ( 100,043 Key money ( 2,197 - ( 535 - - 10 ( 6,149 ( 8,871 Relationship with retail clients ( 1,939 - ( 252 - - - ( 648 ( 2,839 Relationship with franchisees and sub franchisees and sales representatives ( 95,772 - ( 278,048 - - - ( 45,241 ( 419,061 Technology developed - - ( 294,713 - - - ( 24,296 ( 319,009 Other intangible assets ( 13,159 - ( 6,496 15,020 - - ( 86 ( 4,721 Total accumulated amortization ( 806,522 - ( 981,776 15,064 - ( 3,633 ( 100,175 ( 1,877,042 Net total 5,076,501 17,392,570 ( 722,893 ( 15,055 ( 2,051 82,007 5,106,049 26,917,128 Useful life range (years) 2018 Additions Write-offs Reversal (provision) of impairment Transfers Other changes including exchange variation 2019 Cost Software 2.5 10 1,089,900 83,064 ( 546 - 118,442 22,230 1,313,090 Trademarks and patents (Defined useful life) 20 25 111,801 - - - ( 154 5,158 116,805 Trademarks and patents (Indefinite useful life) - 2,040,067 - - - - 131,518 2,171,585 Goodwill Emeis Brazil Pty Ltd. (a) - 96,867 - - - - 3,370 100,237 Goodwill The Body Shop (b) - 1,348,670 - - - - 85,699 1,434,369 Goodwill acquisition of The Body Shop stores - 1,456 - - 1,456 Relationship with retail clients 10 1,740 - - - - 247 1,987 Key money (indefinite useful life) (c) - 102,310 - - - ( 101,001 16,492 17,801 Key money (Defined useful life) (d) 3 18 48,888 - - 2,818 ( 39,283 24 12,447 Relationship with franchisees and sub franchisees (e) 7 15 590,588 - ( 17,958 - ( 371 30,699 602,958 Technology developed (by acquired subsidiary) 5 - - - - - - - Other intangible assets 2 10 121,697 145,483 ( 1,133 - ( 146,364 ( 9,395 110,288 Total cost 5,553,984 228,547 ( 19,637 2,818 ( 168,731 286,042 5,883,023 Accumulated amortization Software ( 483,666 ( 169,174 6,817 - 270 ( 3,594 ( 649,347 Trademarks and patents ( 37,898 ( 4,330 - - 154 ( 2,034 ( 44,108 Key money ( 2,835 - - - 7,336 ( 6,698 ( 2,197 Relationships with retail clients ( 1,149 ( 194 - - - ( 596 ( 1,939 Relationship with franchisees and sub franchisees ( 55,508 ( 43,150 - - 371 2,515 ( 95,772 Technology developed - - - - - - - Other intangible assets ( 22,383 ( 1,601 585 - 261 9,979 ( 13,159 Total accrued amortization ( 603,439 ( 218,449 7,402 - 8,392 ( 428 ( 806,522 Net total 4,950,545 10,098 ( 12,235 2,818 ( 160,339 285,614 5,076,501 a) Goodwill related to the acquisition of Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests . In addition, on June 30, 2020, The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd , for R$ 133,275 2,632,000 st , 2020 and resulted in an assigned amount of goodwill of R$ 34,251 c) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard IFRS 16 st , 2019 3.29 r ight of u se asset, refers to contracts that the standard exempts on the initial date, that is, short-term contracts. The remaining balance is not amortized and is subject to an annual impairment test . d) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard ( IFRS 16 st , 2019 of Use asset, refers to contracts that the standard exempt on the initial date, that is, short-term contracts. The remaining balance is amortized over the term of the agreements. e) The balance refers to identifiable intangible assets from relationship with The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 . In 2019 In addition, the balance position classified as the acquisition of a subsidiary represents the fair value of the relationship between Avon and its sales representatives. a) Impairment test ing of intangible assets as an indefinite useful li fe Goodwill from the expected future profitability of acquired companies and intangibles assets with indefinite useful life was allocated to the CGU groups. The accordance with IAS 36 must test it for impairment Annually. CGUs group with intangible assets with indefinite useful life as of December 31, 2020 2019 CGU groups Trademarks and patents Goodwill Total 2020 2019 2020 2019 2020 2019 Natura &Co Latam 5,403 2,566 9,994,861 - 10,000,264 2,566 Avon International 2,850,397 - 3,304,988 - 6,155,385 - TBS International 2,891,257 2,169,019 1,946,741 1,434,369 4,837,998 3,603,388 Aesop International - - 142,090 100,238 142,090 100,238 Total 5,747,057 2,171,585 15,388,680 1,534,607 21,135,737 3,706,192 The main assumptions used to calculate the fair value less cost to sell as at December 31, 2020 Aesop The Body Shop Avon International Natura &Co Latam Measurement of recoverable value (fair value less cost to sell) Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five Budgeted gross margin Gross margins are based on average amounts obtained in the 2 5 Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Perpetuity growth rate (*) Constant growth of 4.20 Constant growth of 4.10 Constant growth of 4.30 Constant growth of 5.50 Discount rate (WACC) Discount rates represent the risk assessment in the current market, specific to each group of CGU, taking into account the value of money over time and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. These cash flows were discounted using a discount rate of 13.42 11.14 7.80 9.11 (*) The rates are based on published market analyzes and projections with regard to the operating segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable. (**) Due to the Covid- 19 2020 The Company performed a sensitivity analysis of variables: (i) the discount rate and (ii) the growth rate in perpetuity, due to their potential impacts on cash flows. An increase of 1 1 2020

Right of Use And Lease

Right of Use And Lease	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Right of Use And Lease	18. RIGHT OF USE AND LEASES a) Right of use asset Useful life in Years (a ) 2019 Acquisition of subsidiary Additions Write-offs Impairment ( b ) Transfers ( c ) Exchange rate variation 2020 Cost Vehicles 3 40,018 42,467 61,878 ( 441 - - 13,945 157,867 Machinery and equipment 3 10 15,578 14,034 11,265 - - - 12,171 53,048 Facilities 3 10 784,900 489,740 146,695 ( 16,094 - - 211,592 1,616,833 IT equipment 10 283 18,429 6,211 ( 323 - - 5,400 30,000 Retail stores 3 10 2,350,377 - 384,502 ( 25,189 ( 148,050 ( 2,962 779,426 3,338,104 Tools and accessories 3 2,803 - - - - - 384 3,187 Total cost 3,193,959 564,670 610,551 ( 42,047 ( 148,050 ( 2,962 1,022,918 5,199,039 Accumulated depreciation Vehicles ( 8,109 - ( 54,558 192 - - ( 947 ( 63,422 Machinery and equipment ( 4,317 - ( 14,899 - - - ( 1,829 ( 21,045 Facilities ( 97,190 - ( 291,431 12,448 - - ( 23,592 ( 399,765 IT equipment ( 214 - ( 18,694 - - - ( 253 ( 19,161 Retail stores ( 463,332 - ( 643,441 3,527 - - ( 188,100 ( 1,291,346 Tools and accessories ( 936 - ( 936 - - - ( 381 ( 2,253 Total accrued depreciation ( 574,098 - ( 1,023,959 16,167 - - ( 215,102 ( 1,796,992 Net total 2,619,861 564,670 ( 413,408 ( 25,880 ( 148,050 ( 2,962 807,816 3,402,047 Useful life in Years ( i ) First-time adoption (Note 3.29 Additions Write-offs Transfers (ii) Other changes 2019 Cost Value: Vehicles 3 - 40,069 ( 146 - 95 40,018 Machinery and equipment 3 10 - 14,954 ( 40 - 664 15,578 Facilities 3 10 103,945 187,294 - 481,235 12,426 784,900 IT equipment 10 - 279 - - 4 283 Retail stores 3 10 1,819,951 416,250 ( 76,022 150,374 39,824 2,350,377 Tools and accessories 3 - 2,650 - - 153 2,803 Total cost 1,923,896 661,496 ( 76,208 631,609 53,166 3,193,959 Depreciation value: Vehicles - ( 8,083 38 - ( 64 ( 8,109 Machinery and equipment - ( 4,126 - - ( 191 ( 4,317 Facilities - ( 95,734 - - ( 1,456 ( 97,190 IT equipment - ( 209 - - ( 5 ( 214 Retail stores - ( 466,590 ( 2,968 - 6,226 ( 463,332 Tools and accessories - ( 882 - - ( 54 ( 936 Total accrued depreciation - ( 575,624 ( 2,930 - 4,456 ( 574,098 Net total 1,923,896 85,872 ( 79,138 631,609 57,622 2,619,861 (a) The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms. (b) Of the total amount of impairment recorded in 2020 144,500 (c) Refers to key money related to store rentals. This amount is transferred from right of use to intangible assets when a new commercial agreement with the lessor is not yet signed. 2020 2019 Value s recognized in the income statement for the year ended December 31, 2020 and 2019 Financial expense on lease 229,544 134,579 Amortization of right of use 1,023,959 575,624 Appropriation in the result of variable lease installments not included in the measurement of rental liabilities 45,952 31,023 Sublease revenue ( 27,079 ( 2,698 Short-term rental expenses and low-value assets 72,546 126,067 Benefits granted by lessor related to Covid- 19 ( 58,700 - Other lease-related expenses 40,206 22,214 Impairment losses 144,500 - Total 1,470,928 886,809 Values recognized in the financing cash flow statement: Lease payments (principal) 843,338 497,905 Values recognized in the operating cash flow statement: Lease payments (interest) 225,420 134,579 Variable lease payments, not included in the measurement of rental liabilities 13,033 11,199 Short-term and low-value assets leases payments 51,675 69,162 Lease-related payments 41,944 26,460 Total 1,175,410 739,305 b) Lease liabilit y 2020 2019 Current 1,059,661 542,088 Non-current 2,798,794 1,975,477 Total 3,858,455 2,517,565 The following tables shows the changes in the balance of lease obligations for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 446,235 First-time adoption of IFRS 16 1,949,739 New agreements 627,889 Payment of leasing (principle) ( 497,905 Payment of leasing (interest) ( 134,579 Recognition of financial charges 134,579 Write-offs (a) ( 86,319 Translation effects (other comprehensive income) 77,926 Balance as of December 31, 2019 2,517,565 New leases 559,905 Acquisition of subsidiary 777,200 Lease payments (principal) ( 843,338 Lease payments (interest) ( 225,420 Recognition of financial charges 229,544 Write-offs ( a) ( 193,174 Exchange rate variation 1,036,173 Balance as of December 31, 2020 3,858,455 (a) Refers mainly to the termination of contracts related to store leases. The maturity analysis of the lease liability non-current balance of are shown bellow: 2020 2019 2021 - 374,746 2022 611,048 361,688 2023 600,785 358,274 2024 598,380 363,802 2025 988,581 516,967 Total 2,798,794 1,975,477 The table below shows the rates applied, according to the lease terms: As described in note 3.13.2 Contractual Payments Maturity Average discount rate 2020 2021 2022 2023 2024 2025 Onwards 2025 2020 2022 1.9 10.5 566,802 32,692 8,946 - - - - 2023 2025 1.9 14.0 32,802 304,688 305,886 302,042 298,194 271,790 - 2026 2028 1.9 10.2 69,488 74,145 78,169 83,769 90,725 98,267 661,521 2029 2031 8.2 13.6 4,778 4,778 4,778 4,778 4,778 4,778 16,324 Total 673,870 416,303 397,779 390,589 393,697 374,835 677,845 Projected inflation 1 3.40 3.40 3.40 3.60 3.60 3.60 3.80 1 Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

Borrowings, Financing And Deben

Borrowings, Financing And Debentures	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Borrowings, Financing And Debentures	19. BORROWINGS, FINANCING AND DEBENTURES Raised in local currency: Ref. 2020 2019 Financing Agency for Studies and Projects FINEP 73,076 101,988 Debentures A 4,042,515 4,251,231 BNDES 7,789 35,390 BNDES – FINAME 15 183 Promissory notes B 773,949 2,883,382 Working capital – Mexico Operation 14,453 31,802 Working capital – Aesop Operation - 100,438 Working capital – The Body Shop Operation C 500,835 - Working capital – Avon Operation 145,495 - Notes – Avon ( 1 D 4,033,682 - Total in local currency 9,591,809 7,404,414 Raised in Foreign currency: BNDES 1,639 8,030 Export Credit Note (NCE) - 81,210 Representative debt securities (“Notes”) ( 1 E 3,969,226 3,090,490 Resolution nº 4131 62 F 260,239 202,230 Total in foreign currency 4,231,104 3,381,960 Grand total 13,822,913 10,786,374 Current 3,805,649 3,354,355 Non-current 10,017,264 7,432,019 Debentures Current 2,169,786 246,017 Non-current 1,872,729 4,005,214 ( 1 Balances resulting from the business combinations with Avon (Note 4 Reference Currency Maturity Charges Effective interest rate Guarantees A Real August, 2024 Interest of 109 112 1.4 1.75 1.00 1.15 109.5 113.1 1.15 1.79 None B Real Until April, 2021 Interest of 3.25 CDI + 3.30 Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda. C British Pounds March, 2021 Libor 2.00 Libor 2.00 Approval of subsidiary Natura Cosméticos S.A. D Dollar March, 2023 and March 2043 Interest of 7.00 8.95 Interest of 7.00 8.95 None E Dollar February, 2023 Interest of 5.375 6,1 None F Dollar May, 2022 Libor 1.1 Libor 1.1 Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda. Changes in the balances of borrowings, financings and debentures for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 7,994,145 New borrowings and financing 5,346,145 Amortization ( 2,643,575 Financial charges accrued 494,422 Payment of financial charges ( 499,798 Foreign exchange changes (unrealized) 88,097 Foreign exchange changes 5,903 Translation effects (OCI) 1,035 Balance at December 31, 2019 10,786,374 Assumed in a business combination (note 4 7,250,735 New borrowings and financing 1,354,765 Amortization ( 8,483,892 Accrued finance costs 1,029,705 Finance costs payment ( 1,293,094 Exchange rate variation (unrealized) 973,442 Exchange rate variation (realized) 35,429 Translation effects (OCI) 2,169,449 Balance as of December 31, 2020 13,822,913 The maturities of non-current portion of borrowings, financing and debentures liabilities are present bellow: 2020 2019 2021 - 2,279,759 2022 586,002 527,596 2023 6,306,782 3,052,769 2024 3,124,480 1,571,895 Total 10,017,264 7,432,019 19.1 Main changes in borrowings and financing i) Debentures On February 25, 2014, the Company conducted the 5 , in the total amount of R$ 600,000 shares. A total of 60,000 20,000 in the 1 February 24, 2017 214,385 20,000 in the 2 February 25, 2018 and 20,000 in the 3 February 25, 2019 107.0 107.5 108.0 On March 16, 2015, the Company carried out the 6 , amounting to R$ 800,000 80,000 of which 40,000 1 March 16, 2018 25,000 2 March 16, 2019 15,000 3 March 16, 2020 107.0 %, 108.25 109.0 On September 28, 2017, the Company carried out the 7 , in the total amount of R$ 2,600,000 260,000 77,273 1 September 25, 2020 182,727 in the 2 September 25, 2021 CDI rate + 1.4 CDI rate + 1.75 On February 16, 2018, the Company carried out the 8 1,400,000 paid in three 3 August 14, 2018 August 14, 2019 1,000,000 , and remuneration corresponding to 110.0 balance of the 8 400,000 On September 21, 2018, the Company carried out the 9 of non-convertible unsecured debentures, with personal guarantee, in three 1,000,000 1,000,000 8 consisted of 100,000 38,904 1 September 21, 2020 30,831 2 September 21, 2021 30,265 3 September 21, 2022 109.5 110.5 112.0 On July 22, 2019, the Company carried out the 10 unsecured debentures in four 1,576,450 157,645 non-convertible and unsecured debentures were issued in four 10,000 40,000 1 August 26, 2024 9,570 2 August 26, 2024 68,623 3 August 26, 2024 39,452 4 August 26, 2024 100 plus 1 for the 1 100 plus 1.15 The funds from the 10 1 : full amortization of the 8 400,000 2 3 6 92,820 3 1 7 664,090 4 1 9 382,960 The appropriation of costs related to the issuance of debentures in the year ended December 31, 2020 3,888 4,760 2019 9,466 2020 13,354 2019 ii) Promissory notes On January 14, 2020, partial optional early redemption of the Promissory Notes of the 1 1,830,000 On April 29, 2020, the 2 500,000 and the 4 250,000 On June 29, 2020, took place the total optional early redemption of the 1 370,000 , and the partial optional early redemption of the 1 140,000 Accrued costs related to the emission of the Promissory Notes in the year ended December 31, 2020 amounted to R$ 25,205 11,135 R$ 2,121 20,962 iii) Working capital - The Body Shop As presented in Note No. 6.2 , The Body Shop had on December 31, 2019 a credit line of up to £ 70 seventy , corresponding to R$ 500,835 line was used during the second quarter of 2020 Libor 2 iv) Debt Securities Representative ("Notes") - Avon The subsidiary Avon has the following debt securities representative (“notes”) issued: Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 461,883 2,400,267 7.00 March 15, 2023 Unguaranteed 216,085 1,122,929 8.95 March 15, 2043 The effects of allocating fair values from the business combination (note 4 449,712 19.2 C ovenants The restrictive clauses associated with the debt contracts of the Company and its subsidiaries, establish the maintenance of minimum financial indicators resulting from the ratio of the division of the net treasury debt by the EBITDA of the last 12 and 2019

Trade Payables And Reverse Fact

Trade Payables And Reverse Factoring Operations	12 Months Ended
	Dec. 31, 2020
Trade Payables And Reverse Factoring Operations [Abstract]
Trade Payables And Reverse Factoring Operations	20. TRADE PAYABLE AND REVERSE FACTORING OPERATIONS 2020 2019 Domestic trade payables 5,462,377 1,581,759 Foreign trade payables (a) 1,014,356 105,073 Subtotal 6,476,733 1,686,832 Reverse factoring operations (b) 297,472 142,924 Total 6,774,205 1,829,756 (a) Refers to imports mainly denominated in US dollars, Euros and British pounds (b) The Group have contracts signed with Banco Itaú Unibanco S.A. to structure a “supply chain finance” the operation with the Company’s main suppliers. Further details on these operations are included in note 3 1 6

Tax Liabilities

Tax Liabilities	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Tax Liabilities	21. TAX LIABILITIES 2020 2019 ICMS (ordinary) 134,165 120,300 ICMS-ST provision (a) 61,521 72,423 Taxes on invoicing – foreign abroad 364,291 145,992 Social Security Tax (INSS) - suspension of the enforceability - 50,147 Withholding tax (IRRF) 131,368 48,593 Other taxes payable - foreign subsidiaries 48,365 1,180 Income tax 15,943 1,207 PIS and COFINS payable 11,857 - INSS and service tax (ISS) payable 32,954 3,218 Others 94,357 399 894,821 443,459 Current 785,367 320,890 Noncurrent 109,454 122,569 (a) The Company's subsidiaries have discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company’s subsidiaries, and in some cases, the amounts are deposited in court, as mentioned in note 13

Provision For Tax, Civil And La

Provision For Tax, Civil And Labor Risks	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Provision For Tax, Civil And Labor Risks	22. PROVISION FOR TAX, CIVIL AND LABOR RISKS The Group are involved in certain legal proceedings arising in the normal course of its business, which include civil, tax, social security, labor, business and others. The Company's management believes that, based on the elements existing on the base date of these financial statements, the provision for tax, civil, labor, commercial and other risks is enough to cover possible losses on administrative and legal proceedings, as shown below. 22.1 Contingencies assessed as probable risk of loss The changes in the tax, civil and labor provision and contingent liabilities are presented below: Tax Civil Labor Business Total 2020 2019 2020 2019 2020 2019 2020 2020 2019 Balance at the beginning of the year 127,842 163,852 30,653 32,300 61,571 65,655 - 220,066 261,807 Acquisition of subsidiary ( 1 671,667 - 37,364 - 163,962 - 820,103 1,693,096 - Additions 169,824 14,497 186,182 14,072 44,566 45,983 9,772 410,344 74,552 Reversals ( 71,797 ( 54,168 ( 62,013 ( 4,766 ( 4,601 ( 40,127 ( 67,482 ( 205,893 ( 99,061 Payments ( 54,590 ( 1,150 ( 31,169 ( 11,418 ( 48,792 ( 14,611 - ( 134,551 ( 27,179 Inflation adjustment 5,623 4,440 4,164 309 6,508 5,009 21,671 37,966 9,758 Exchange rate variation 83,202 371 12,525 156 27,284 ( 338 13,629 136,640 189 Transfers ( 2 - - ( 99,309 - 841 - - ( 98,468 - Balance at the end of the year 931,771 127,842 78,397 30,653 251,339 61,571 797,693 2,059,200 220,066 Current 58,756 18,650 Non-current 2,000,444 201,416 (1) Amounts arising from lawsuits with probability of possible and remote loss of tax nature in the amount of R$ 709,751 labor in the amount of R$ 54,728 55,624 3 4 additionally, the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value, in the amount of R$ 872,993 (2) Balance arising from other obligations of the subsidiary Avon, related to reclassifications of processes previously recognized as contingent liabilities to other trade payable. 22.1.1 ax The tax contingencies and classified as probable loss, mainly involve (i) discussions about the illegality of changes in state laws to collection of ICMS, and (ii) discussions related to the exclusion of IPI charges from the income tax calculation basis, withhold income tax, as well as several lawsuits related to income tax and social contribution taxation. Part of the amount not paid is being discussed in court, and in some cases, the amounts are deposited in court, as mentioned in note 13 22.1.2 commercial and other On December 31, 2020, the Group are parties to commercial and other civil lawsuits and procedures, mainly related to indemnity claims. Provisions are periodically reviewed based on the evolution of processes and the evolution of jurisprudence to reflect the best estimate. a) Talc-related disputes The subsidiary Avon has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Avon sold in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Avon ’s products, were designed to contain asbestos. As of December 31, 2020, there were 164 . During the three months ended December 31, 2020, 31 14 We believe that the claims asserted against us in these cases are without merit. We are defending vigorously against these claims and will continue to do so. To date, the Avon has not proceeded to trial in any case filed against it and there have been no findings of liability enforceable against the Company. However, nationwide trial results in similar cases filed against other manufacturers of cosmetic talc products have ranged from outright dismissals to very large jury awards of both compensatory and punitive damages. Given the inherent uncertainties of litigation, we cannot predict the outcome of all individual cases pending against the Company, and we are only able to make a specific estimate for a small number of individual cases that have advanced to the later stages of legal proceedings. For the remaining cases, we provide an estimate of exposure on an aggregated and ongoing basis, which takes into account the historical outcomes of all cases we have resolved to date. Any accruals currently recorded on the Avon’s balance sheet with respect to these cases are not material. However, any adverse outcomes, either in an individual case or in the aggregate, could be material. Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will be covered by insurance. [JV 3 [NM 4 22.1.3 The Group as of December 31, 2020 are parties to labor claims filed by former employees and service providers, mainly related to the payment of severance pay, overtime, salary premiums and monies owed as a result of join liability and discussion about the recognition of any employment relationship. None of these processes is individually relevant. Provisions are periodically reviewed based on the progress of lawsuits and history of losses on labor claims to reflect the best estimate. 22.2 Contingencies assessed as possible risk of loss The Group have contingencies whose expectation of loss assessed by the Company's Management and supported by the legal advisors is classified as possible and, therefore, no provision has been recorded. On December 31, 2020, the contingencies classified as possible loss probability totaled R$ 9,559,550 3,642,219 797,693 0 22.2.1 Tax The tax cases with possible losses totaling R$ 9,205,601 3,503,392 Below are the most relevant tax contingencies related to the following matters: a) Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts, due to the alleged non-observance of the minimum tax base, provided for in the legislation, when sales transactions destined to interdependent wholesalers. Currently, tax assessment notices are pending judgment at the administrative court level. As at December 31, 2020 $ 1,963,984 b) Lawsuits in which the industrial establishment equivalence is discussed, as provided for in the Decree nº 8.393 2015 2020 R$ 1,660,532 389,017 2019 c) Administrative and judicial processes that discuss the illegality of changes in Federal State laws regarding the collection of ICMS and ICMS-ST. As at December 31, 2020 1,503,657 (R$ 406,002 2019 d) Infraction notices in which the Brazilian Federal Revenue Office requires IRPJ and CSLL tax debts to challenge the tax deductibility of the amortization of goodwill generated in the context of a corporate reorganization between related parties. Currently, the legality of the administrative decisions that rejected the motions for clarification presented to challenge the special appeals dismissed is being discussed in the courts. As at December 31, 2020 1,396,782 (R$ 1,379,189 2019 e) Infraction notices in which the Finance Department of the São Paulo Federal State requires the collection of ICMS-ST, which was fully collected by the recipient of the goods, the distributor. Currently, the process is pending judgment at the administrative court level. As of December 31, 2020 529,660 (R$ 521,903 2019 f) Infraction notices in which the Brazilian Federal Revenue Office requires IPI tax debts for disagreeing with the tax classification adopted by the Company for some products. The tax assessment notices are awaiting judgment at the administrative court level. As at December 31, 2020 524,500 (R$ 218,204 2019 22.2.2 , com m ercial and other As of December 31, 2020, civil, commercial and other lawsuits with possible losses total R$ 133,302 61,532 Below are the most relevant contingencies related to the following matters: a ) S hareholder disputes On February 14, 2019, a purported shareholder’s class action complaint (Bevinal v. Avon Products, Inc., et al., No. 19 1420 st , 2017 10 20 1934 2020 75,352 14,500 10,393 2,000 rd , 2021 22.2.3 As of December 31, 2020, contingencies classified as possible loss, totaled R$ 220,648 77,295 22.3 Contingent assets The updated amounts of PIS and COFINS installment refund requests calculated with the inclusion of ICMS in tax base, not recorded until December 31, 2020 133,397 26,933 2019 The Group , supported by the positioning of its legal counsel, observe the IAS 37

Other Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Other Liabilities	23. OTHER LIABILITIES 2020 2019 Pension and p ost-employment healthcare plans (a) 783,184 98,792 Deferred revenue from performance obligations with customers (b) 422,353 76,250 Provisions for incentives to consultants (c) 292,034 - Provisions for operating expenses (marketing / technology, etc.) (d) 535,276 156,895 Discontinued operations (e) 153,140 - Provision for store renovation 99,702 15,997 Crer Para Ver (f) 75,508 51,543 Provisions for rentals (g) 70,598 26,568 Provision for restructuring (h) 68,954 3,401 Long-term incentives ( i ) 52,745 3,022 Provisions for apportionment of benefits and partnerships payable 10,005 7,860 Other provisions (j) 373,891 67,846 Carbon credit 5,560 4,519 Exclusivity contract 3,000 5,400 Total 2,945,950 518,093 Current 1,832,811 396,391 Non-current 1,113,139 121,702 a) As of December 31, 2020, Avon's pension and post-retirement plans amounts to R$ 648,990 134,194 98,792 b) Refers to the deferral of revenue related performance obligations of loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$ 318,686 103,667 c) Provision for incentive and recognition programs for consultants. d) Refers to the Group's operating provisions mainly due to spending on provision of technology services, marketing and advertising, etc., to comply with the accrual basis. e) As of December 17, 2015, Avon has contracts that resulted in the separation of operations in the United States, Canada and Puerto Rico. These transactions were closed on March 1 st 2016 143,112 f) Refers to Social program contribution for developing the quality of education. g) Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16 h) Provision for costs directly related to the plan for changes in the organizational structure, mainly of Avon and The Body Shop organizational structures. i) Refers substantially to the variable remuneration plans for Avon executives. j) Refers to provisions for insurance coverage, indemnities and long-term contractual obligations. Post-employment health care and Pension plan a) Defined benefit pension and postretirement plans (Avon) The Avon subsidiary have contributory and noncontributory defined benefit retirement plans for substantially all of its employees. The benefits of these plans are generally based on the employee's length of service and the average compensation near retirement, with certain plans have vesting requirements. The plans are funded based on legal requirements and cash flow. The Avon subsidiary's largest defined benefit pension plan outside the United States (“US”) is in the United Kingdom (“UK”). The UK defined benefit pension plan was frozen for future accruals as of April 1 st 2013 st 2015 st 2015 2 8 3 The most recent actuarial valuation of plan assets and the present value of the defined benefit obligation was carried out on December 31, 2020. The present value of the defined benefit obligation and the respective cost of current services and cost of past services were measured at projected unit credit method. The change in actuarial liabilities for the year ended December 31, 2020 is shown below: Pension Plan Post-retirement benefits Total Balance at beginning of year 413,070 107,735 520,805 Cost of services - current 28,015 - 28,015 Interest cost 13,760 3,610 17,370 Administrative costs 2,476 - 2,476 Company contributions ( 17,212 - ( 17,212 Benefits paid ( 4,611 ( 27,852 ( 32,463 Actuarial gain (loss) in OCI 74,460 2,063 76,523 Reclassifications ( 14,451 - ( 14,451 Plan amendments - ( 21,147 ( 21,147 Special termination benefits - ( 29,915 ( 29,915 Transfers - ( 25,273 ( 25,273 Others ( 2,814 985 ( 1,829 Foreign currency changes 117,268 28,823 146,091 Balance at end of year 609,961 39,029 648,990 The significant actuarial assumptions for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions are as follows: 2020 Pension Plan Post-retirement benefits Discount rate 0.30 8.50 3.95 Rate of compensation increase 1.80 6.60 n/a The analysis of the quantitative sensitivity analysis of discount rates and increase in compensation, if the behavior of such rate increased or decreased by 0.5 Rate Chance PVO Discount rate 1.53 0.5 ( 331,549 Discount rate 1.53 0.5 372,084 Rate of compensation increase 2.74 0.5 12,472 Rate of compensation increase 2.74 0.5 ( 11,952 The sensitivity analysis presented above have been determined based on a method that extrapolates the impact on the defined benefit obligation, as a result of reasonable changes in main assumptions occurring at the reporting date, keeping all other assumptions constant. The sensitivity analysis is based on a change in a significant assumption, keeping all other assumptions constant. The sensitivity analysis presented may not be representative of the actual change in the defined benefit obligation as it is unlikely that the changes in assumptions would occur in isolation of one The following are the expected payments of contributions to the defined benefit plan in future years: 2021 103,363 2022 89,038 2023 87,706 2024 86,157 2025 83,276 2026 2030 395,832 The average duration of the defined benefit plan obligation at the end of the reporting period is 9.13 b) Post-employment healthcare plan (Natura Cosméticos ) Post-employment healthcare plan as detailed in note 3 20.4 2020 2019 19.8 20.8 Ø 1,064 2019 1,175 Ø 537 2019 477 The actuarial liability was calculated, on December 31, 2020 and 2019 2020 2019 Discount rate 7.02 7.39 Initial growth rate of medical cost 3.75 7.17 Inflation rate 3.10 3.80 Final growth rate of medical cost 6.97 7.17 Growth rate of medical costs due to aging - costs Per age range 1.25 4.75 Per age range 1.54 4.5 Growth rate of medical costs by aging - contributions 0.00 0.00 Percentage of adherence to the plan in retirement Bradesco Plan 69.00 84.00 87.00 Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT- 2000 AT- 2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service Maintaining the initial level of growth in medical costs at a real rate of 3.75 7.39 7.02 3,891 The table below sets forth the Medical Inflation Rate and the Discount Rate sensitivity analysis, if such rates increased or decreased by 0.5 1 Rate Chance VPO Discount rate 7.02 0.5 110,383 Discount rate 7.02 0.5 165,801 Rate of compensation 6.97 1 164,501 Rate of compensation 6.97 1 110,866 The changes of actuarial liabilities for the years ended December 31, 20 20 2019 2020 2019 Balance at the beginning of the year ( 98,792 ( 78,904 Cost of the Company´s current service ( 620 ( 816 Cost of interest ( 7,223 ( 7,125 Expenses paid 2,069 2,427 Actuarial gains (losses) in OCI ( 29,628 ( 14,374 Total ( 134,194 ( 98,792

Shareholder's Equity

Shareholder's Equity	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Shareholder's Equity	24. SHAREHOLDER’S EQUITY 24.1 As of December 31, 2020 12,377,999 of 1,375,158,636 (R$ 1,485,436,464 865,659,942 24.2 olicy for dividends and interest on equity distribution The shareholders are entitled to receive every year a mandatory minimum dividend of 30 Ø Increase in the amounts resulting from the reversal, in the period, of previously recognized reserves for contingencies. Ø Decrease in the amounts intended for the recognition, in the period, of the legal reserve and reserve for contingencies. Ø Whenever the amount of the minimum mandatory dividend exceeds the realized portion of net income for the year, management may propose, and the General Meeting approves, allocate the excess to the constitution of the unrealized profit reserve (article 197 6,404 / 76 ). The Board of Directors may pay or credit interest on equity in accordance with applicable law. 24.3 As of December 31, 2020, the “Treasury shares” has the following composition: Number of shares Amount R$ (thousands) Average price per share - R$ Balance as of December 31, 2019 - - - Used ( 1,102,001 ( 52,849 47.53 Acquisition 1,418,702 64,516 45.48 Balance as of December 31, 2020 316,701 11,667 38.04 The minimum and maximum cost of the balance of treasury shares on December 31, 2020 and 2019 are R$ 25.00 49.71 24.4 reserve The acquisition of the subsidiary Avon resulted in the issuance of Natura &Co shares for the total subscription amount of R$ 13,274,894 R$ 3,397,746 R$ 9,877,148 The approval of the capital increase of R$ 2,000,000 June 30, 2020, allocated the amount R$ 1,118 The capital reserve had decreased of R$ 147,592 58,496 29 of R$ 52,041 The capital reserve as at December 31, 2020 11,052,470 999,931 2019 24.5 As of December 31, 2020, the profit reserve increased by R$ 155,884 ) R$ 8,292 IAS 29 2020 and (ii) R$ 147,592 The profit reserve Balance as of December 31, 2020 6,864 1,428 2019 24.6 valuation adjustment – Other comprehensive income The Company recognizes in this equity item the exchange rate variation effect from investments in foreign subsidiaries, including exchange rate variations in a hyperinflationary economy, actuarial gains and losses arising from the employee benefit plan, and the effect from cash flow hedge operations. For exchange rate variation, the accumulated effect will be reversed to the statement of income as a gain or loss only in the event of disposal or write-off of the investment. For actuarial losses and gains, the amounts will be recognized when the actuarial liability is remeasured. The cash flow hedge transactions are transferred to the statement of income in case an ineffective portion is identified or when the hedge relationship is terminated.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Segment Information	25. SEGMENT INFORMATION The determination of the Company’s operating segments is based on its Corporate Governance structure, which divides the business into the following segments for purposes of decision making and Management analysis. Since January 3, 2020, as a result of the acquisition of Avon (note 4 Ø Natura &Co Operation – all , Avon, Aesop and TBS operations located in Brazil and Latin America; Ø Avon International – all Avon operations, with the exception of Avon operations located in Brazil and Latin America; Ø TBS International – all The Body Shop operations, with the exception of The Body Shop operations located in Brazil and Latin America; and Ø Aesop International - all Aesop operations, with the exception of Aesop operations located in Brazil and Latin America. In addition to the segment analysis, the Company's Management also analyzes revenues at various levels, mainly through the sales channels: direct sales, operations in the retail market, e-commerce, B 2 Revenue by segment is as follows for the year ended December 31, 2020: Ø Natura &Co Latam - 56 Ø Avon International - 25 Ø TBS International - 14 Ø Aesop International - 5 The accounting practices for each segment are described in note 3 The following tables provide the summarized financial information related to the segments and geographic distribution of the Company's commercial operations for December 31, 2020 and 2019 Additionally, as described above, as a result of the acquisition of Avon in 2020 , the comparative figures originally disclosed in the 2019 25.1 Operating segments 2020 Reconciliation to net income (loss) for the year Net revenues Performance assessed by Depreciation Financial Financial Income tax Net income Natura &Co LATAM 20,542,345 2,369,515 ( 874,584 3,402,578 ( 3,891,641 ( 428,191 577,679 Avon International 9,097,375 185,914 ( 814,678 979,267 ( 1,442,216 ( 121,603 ( 1,213,315 TBS International 5,332,922 935,255 ( 761,224 82,736 ( 157,705 ( 66,626 32,436 Aesop International 1,949,338 606,544 ( 268,092 23,152 ( 72,056 ( 55,219 234,328 Corporate expenses - ( 731,889 ( 278 250,658 ( 210,192 396,895 ( 294,806 Total 36,921,980 3,365,339 ( 2,718,856 4,738,391 ( 5,773,810 ( 274,744 ( 663,678 2019 Reconciliation to net income (loss) for the year Net revenues Performance assessed by Depreciation Financial Financial Income tax Net income (loss) Natura &Co Latam 9,113,856 1,372,172 ( 370,953 1,893,333 ( 2,613,294 41,623 322,880 TBS International 4,028,660 806,357 ( 559,921 44,953 ( 99,765 ( 37,736 153,888 Aesop International 1,302,174 351,944 ( 186,542 9,337 ( 34,204 ( 47,768 92,768 Corporate expenses - ( 61,809 - 8,161 ( 48,611 ( 311,810 ( 414,069 Total 14,444,690 2,468,664 ( 1,117,416 1,955,784 ( 2,795,874 ( 355,691 155,467 2018 Reconciliation to net income (loss) for the year Net revenues Performance Depreciation Financial Financial Income tax Net income Natura &Co Latam 8,540,167 1,442,041 ( 318,506 1,925,524 ( 2,501,451 ( 149,709 397,900 TBS International 3,795,721 341,518 ( 206,004 126,289 ( 136,019 25,994 151,778 Aesop International 1,061,531 165,084 ( 65,401 4,608 ( 2,239 ( 36,004 66,047 Corporate expenses - ( 102,039 - - - 34,693 ( 67,346 Total 13,397,419 1,846,604 ( 589,911 2,056,421 ( 2,639,709 ( 125,026 548,379 2020 2019 Non-current Total assets Current Non-current liabilities Non- Total assets Current Non- Natura &Co Latam 20,228,016 27,644,907 12,410,585 9,060,600 4,574,087 9,328,858 3,116,454 8,235,678 Avon International 12,486,733 19,097,959 405,975 5,625,774 - - - - TBS International 7,821,884 10,474,191 2,291,459 1,812,991 6,146,960 7,369,250 1,065,447 1,477,149 Aesop International 1,395,628 2,148,869 488,662 618,531 1,033,408 1,435,830 255,616 590,917 Corporate 250,516 1,551,671 562,905 253,007 - 3,050,574 3,080,906 - Total 42,182,777 60,917,597 16,159,586 17,370,903 11,754,455 21,184,512 7,518,423 10,303,744 2019 2018 Non-current Non-current assets Non-current Non-current Non-current Total assets Current Non- Natura &Co Latam 4,574,087 9,328,858 3,116,454 8,235,678 3,992,000 8,904,065 3,650,203 7,652,955 Avon International - - - - - - - - TBS International 6,146,960 7,369,250 1,065,447 1,477,149 4,518,655 5,709,760 681,660 504,592 Aesop International 1,033,408 1,435,830 255,616 590,917 413,136 765,724 235,018 81,019 Corporate - 3,050,574 3,080,906 - - - - - Total 11,754,455 21,184,512 7,518,423 10,303,744 8,923,790 15,379,549 4,566,881 8,238,566 25.2 Revenue and n on-current assets, by geographical area of operations No individual or aggregate customer (economic group) represents more than 10 Net revenues Net revenues Net revenues Non-current Non-current 2020 2019 2018 2020 2019 Asia 2,929,063 782,940 666,154 768,878 368,430 North America 5,120,953 1,750,957 919,826 5,939,728 981,673 Mexico 3,205,609 767,361 616,883 3,263,833 183,250 Other 1,915,344 983,596 302,943 2,675,895 798,423 South America 16,484,363 8,340,025 8,534,263 14,810,020 4,378,675 Brazil 11,113,810 6,324,227 6,082,896 12,159,245 4,197,258 Argentina 1,999,461 794,749 711,425 1,041,392 63,050 Other 3,371,092 1,221,049 1,739,942 1,609,383 118,367 Europe, Middle East and Africa (EMEA) 11,580,586 2,909,968 2,660,243 19,615,198 5,306,111 United Kingdom 4,117,699 2,115,385 1,877,475 17,059,017 4,678,139 Other 7,462,887 794,583 782,768 2,556,181 627,972 Oceania 807,015 660,800 616,933 1,048,952 719,566 Total 36,921,980 14,444,690 13,397,419 42,182,777 11,754,455 There is no other individual foreign country that represents more than 10 2019 2018

Revenues

Revenues	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Revenues	26. REVENUES Gross revenues: 2020 2019 2018 Domestic market 15,373,742 8,907,766 8,575,971 Foreign market 31,784,934 10,739,036 9,936,334 Other sales 538,942 61,302 49,657 Subtotal 47,697,618 19,708,104 18,561,962 Returns and cancellations ( 617,140 ( 73,183 ( 54,522 Commercial discounts and rebates ( 1,062,204 ( 1,292,134 ( 1,421,251 Taxes on sales ( 9,096,294 ( 3,898,097 ( 3,688,770 Subtotal ( 10,775,638 ( 5,263,414 ( 5,164,543 Total net revenues 36,921,980 14,444,690 13,397,419

Operating Expenses and Cost of

Operating Expenses and Cost of Sales	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Operating Expenses and Cost of Sales	27. OPERATING EXPENSES AND COST OF SALES 2020 2019 2018 Cost of sales 13,229,715 4,033,454 3,782,843 Selling, marketing and logistics expenses 15,702,787 6,395,586 5,828,713 Administrative, R&D, IT and project expenses 5,955,996 2,405,576 2,251,341 Total 34,888,498 12,834,616 11,862,897 Classified by nature Cost of sales 13,229,715 4,033,454 3,782,843 Raw material/packaging material/resale 11,222,801 3,457,481 3,223,446 Employee benefits expense (note 28 638,525 293,374 276,848 Depreciation and amortization 215,355 57,443 65,157 Other 1,153,034 225,156 217,392 Selling, marketing and logistics expenses 15,702,787 6,395,586 5,828,713 Logistics costs 2,479,156 797,055 750,238 Employee benefits expense (note 28 4,198,147 1,667,202 1,656,611 Marketing, sales force and other selling expenses 7,723,827 3,164,875 3,191,895 Depreciation and amortization 1,301,657 766,454 229,969 Administrative, R&D, IT and project expenses 5,955,996 2,405,576 2,251,341 Innovation expenses 270,256 89,675 102,436 Employee benefits expense (note 28 2,498,024 1,223,586 1,036,866 Other administrative expenses 1,985,872 798,796 817,254 Depreciation and amortization 1,201,844 293,519 294,785 Total 34,888,498 12,834,616 11,862,897

Employee Benefits

Employee Benefits	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Employee Benefits	28. EMPLOYEE BENEFITS 2020 2019 2018 Payroll, profit sharing and bonuses 5,407,990 2,315,517 2,350,182 Pension Plan 186,373 93,528 41,923 Share-based payments (note 28.1 163,345 58,855 40,505 Charges on restricted shares (note 28.1 68,617 59,753 22,428 Health care, food and other benefits 684,992 253,510 177,135 Charges, taxes and social contributions 635,248 231,384 181,240 INSS 188,131 171,615 156,912 Total 7,334,696 3,184,162 2,970,325 28.1 Share-based payment The Board of Directors meets annually to, within the bases of the plans approved by the General Meeting, establish share-based payment plans, indicating the managers and employees who may receive options to purchase or subscribe the Company's shares and the total amount to be distributed. The subsidiary Emeis Holdings Pty Ltd., made available until June 2019 to eligible executives a long-term incentive program, based on criteria linked to specific operational goals and objectives established and approved at the beginning of the relationship between the parties, being such obligation recorded in liabilities and their remeasurement with effect in the result. The share-based payment plans were originally granted considering Natura Cosméticos shares that were traded at B 3 1 2019 Options granted in 2020 On March 27, 2020 2020 The “Co-Investment Plan” consists of the granting of the Company’s common shares to a group of employees who may invest part of their participation on the Profit Share Program (up to 50 3 The “Long-Term Incentive Plan”, granted on September 29, 2020 3 50 3 50 4 The changes in the number of outstanding stock options and their related weighted-average prices, as well as variations in the amount of restricted stocks, share are as follows: Stock Option Plan and Strategy Acceleration Plan Average exercise price per option 1 - R$ Options (thousands) 1 Balance as of December 31, 2019 16.51 17,568 Arising from the acquisition of Avon (note 4 0.01 1,994 Granted 0.01 117 Expired / Cancelled 21.25 ( 167 Exercised 16.65 ( 2,267 Balance as of December 31, 2020 16.49 17,245 Restricted shares (thousands) 1 Performance shares (thousands) 2 Balance as of December 31, 2019 3,092 688 Granted 5,026 - Expired ( 22 ( 51 Exercised ( 1,136 - Balance as of December 31, 2020 6,960 637 a) The number of restricted shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019. b) The number of performance shares granted, expired and exercised are shown considering the split of shares approved at the General Meeting on September 17, 2019. Out of the 17,245 2020 17,568 2019 3,405 604 2019 The expense related to the fair value of the restricted options and shares, including the charges related to the restricted shares, recognized in the year ended December 31, 2020 231,939 119,659 2019 The outstanding stock options and the restricted stock as at the end of the period have the following maturity dates and exercise prices: As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Exercise price - R$ Fair value – R$ Existing options (thousands) ¹ Remaining contractual life (years) Vested options (thousands) March 18, 2013 4 37.60 6.05 300 0.2 300 March 17, 2014 4 25.16 4.27 96 1.2 96 March 16, 2015 From 2 4 13.60 4.85 5.29 184 2.2 184 July 28, 2015 (Strategy acceleration) From 4 5 12.90 6.20 6.23 1,020 2.6 1,020 March 15, 2016 From 2 4 12.84 7.16 7.43 184 3.3 182 July 11, 2016 (Strategy acceleration) From 4 5 11.41 6.84 6.89 1,924 3.6 606 March 10, 2017 From 2 4 12.59 6.65 6.68 598 4.3 272 March 10, 2017 (Strategy acceleration) From 4 5 12.59 6.87 6.89 2,210 4.3 - March 12, 2018 From 2 4 16.96 7.96 8.21 1,846 5.3 488 March 12, 2018 (Strategy acceleration) From 3 5 12.16 16.96 8.21 9.67 3,800 5.3 - April 12, 2019 From 3 4 23.54 11.71 11.82 1,636 6.3 - April 12, 2019 (Strategy acceleration) From 4 5 23.54 11.51 11.71 1,900 6.3 - Between December 31, 2002 to May 09, 2017 1 0.01 19.80 65 - 65 Between March 14 to December 17, 2018 From 1 3 0.01 19.70 319 0.4 55 Between March 13 to December 16, 2019 From 1 3 0.01 19.58 1,046 0.2 1.4 33 June 8, 2020 1 0.01 16.86 117 0.7 104 17,245 3,405 ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019 As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Existing stock ( thousands) 1 Fair value (R$) Remaining contractual life (years) March 10, 2017 From 2 4 208 11.69 12.51 0.4 March 12, 2018 – Plan I From 2 4 470 15.18 15.9 0.5 1.5 March 12, 2018 – Plan III From 1 3 74 15.54 16.27 0.5 March 12, 2018 – Extraordinary Plan I From 1 3 4 15.54 16.28 0.4 August 13, 2018 – Extraordinary Plan VI From 1.6 3.6 50 12.24 13.13 0.5 1.5 April 12, 2019 – Plan I From 2 4 814 21.62 22.53 0.5 2.5 April 12, 2019 – Plan II From 1 3 312 22.14 22.85 0.5 1.5 March 27, 2020 – Co-Investment Plan From 1 3 1,789 29.00 0.5 2.5 September 29, 2020 – Long-term Incentive Plan From 3 4 3,239 73.46 3 4 6,960 ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019. As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) ¹ Fair value (R$) Remaining contractual life (years) Undelivered shares (thousands) May 21, 2019 From 3 4 637 23.10 45.70 1.5 2.5 - 637 - ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019. As of December 31, 2020, the market price was R$ 52.50 38.67 28 . 2 Products Inc. plans Share-Based Compensation Plans Prior to being acquired by the Company, Avon Products Inc. (“Avon”) had two 2013 2013 2016 2016 2016 2013 Stock options and restricted shares were issued in the 2016 2013 2016 On January 3 rd 2020 2013 2016 Under the Natura &Co Stock-Based Compensation Plan, Avon issued nominal cost options and performance stock units. Nominal cost options were granted in exchange for Avon restricted stock units and performance restricted stock units and vested as a single tranche in line with the vesting date of the original Avon awards. Nominal cost options will automatically exercise on vest date. Performance stock units generally vest after three Stock Options Prior to being acquired by the Company, Avon granted premium-priced stock options, in which the exercise price was equal to a 25 three On January 3 rd 2020 Restricted Stock Units (RSU) and Performance Restricted Stock Units ( PR S U ) Prior to being acquired by the Company, during the years 2019 2018 2017 2016 three 400 three 2019 2018 2017 2016 On January 3, 2020, upon the completion of the Transaction with Natura &Co, each outstanding Restricted Stock Unit ("RSU") was converted into an award denominated in Natura &Co Holding shares equal to the number of Avon Common Shares subject to each RSU immediately prior to the Transaction multiplied by the Exchange Ratio of 0.30 0.30 2 8 . 3 The Company and some of its subsidiaries grant defined contribution retirement plans to eligible employees and, through some of their subsidiaries abroad, grant defined benefit plans to employees that are eligible. Defined contribution plans The Company, through its subsidiary Avon, offers a defined contribution plan for employees in the United Kingdom (“UK”), which allows eligible participants to contribute eligible compensation through payroll deductions. The Company double employee contributions up to the first 5 10 39,200 2020 The Company, through its subsidiary Avon, offers a qualified defined contribution plan for U.S.-based employees, the Avon Personal Savings Account Plan (the "PSA"), which allows eligible participants to contribute up to 25 3 fifty 4 6 2020 5,200 2020 For U.S.-based employees hired on or after January 1, 2015 3 6 three Defined benefit pension and postretirement plans The Company, through its subsidiary Avon and certain subsidiaries, have contributory and noncontributory defined benefit retirement plans for substantially all employees of those subsidiaries. Benefits under these plans are generally based on an employee’s length of service and average compensation near retirement, and certain plans have vesting requirements. The actuarial liability for the health care plan of the Company and its subsidiaries refers to a post-employment benefit plan for employees and former employees who made fixed contributions to the cost of the health plan until April 30, 2010, date when the design of the health plan was changed, and the employees' fixed contributions were eliminated. For those who have contributed to the medical plan for ten ten one Avon’s largest defined benefit pension plan outside the United States (“US”) is in the UK, which has been frozen for future accruals as of April 1 st 2013 st 2015 st 2015

Financial Income (Expenses)

Financial Income (Expenses)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Financial Income (Expenses)	29. FINANCIAL INCOME (EXPENSES) 2020 2019 2018 FINANCIAL INCOME: Interest on short-term investments 167,967 83,115 129,296 Gains on monetary and exchange rate variations (a) 1,886,940 854,025 477,297 Gains on swap and forward transactions (c) 2,532,487 961,185 1,323,470 Gains on swap and forward derivatives mark to market 12,314 1,709 2,760 Monetary adjustment reversal on provision for tax risks and tax obligations 42,378 25,469 89,151 Other financial income 96,305 30,281 34,447 Subtotal 4,738,391 1,955,784 2,056,421 FINANCIAL EXPENSES: Interest on financing ( 1,104,863 ( 503,040 ( 631,475 Interest on leases ( 229,544 ( 134,579 - Losses on monetary and exchange rate variations (b) ( 2,308,134 ( 937,925 ( 1,073,549 Losses on swap and forward transactions (d) ( 1,579,695 ( 964,116 ( 794,504 Losses on swap and forward derivatives mark to market ( 13,691 ( 1,452 ( 2,197 Adjustment of provision for tax, civil and labor risks and tax liabilities ( 15,626 ( 13,822 ( 22,026 Appropriation of funding costs (debentures and notes) ( 11,082 ( 22,671 ( 37,400 Interest on pension plan ( 10,323 - Hyperinflationary economy adjustment (Argentina) ( 20,625 ( 13,947 ( 25,066 Debt structuring expenses for Avon acquisition ( 110,741 ( 115,781 - Other financial expenses ( 369,486 ( 88,541 ( 53,492 Subtotal ( 5,773,810 ( 2,795,874 ( 2,639,709 Net financial income (expenses), net ( 1,035,419 ( 840,090 ( 583,288 The breakdown set forth below is intended to better explain the results of the foreign exchange rate hedging transactions entered into by the Company as well as its related items recorded in the financial income (expenses) and shown in the previous table: 2020 2019 2018 (a) Gains on monetary and exchange rate variations 1,886,940 854,025 477,297 Gains on exchange rate variation on borrowings, financing and debentures 714,681 677,462 402,345 Exchange rate variation on imports 35,218 11,221 6,385 Exchange rate variation on export receivables 69,365 26,144 42,901 Exchange rate variation on trade payable from foreign subsidiaries 450,468 132,397 25,666 Exchange variations of bank accounts in foreign currency 617,208 6,801 - (b) Losses on monetary and exchange rate variations ( 2,308,134 ( 937,925 ( 1,073,549 Losses on exchange rate variation on borrowings, financing and debentures ( 1,301,812 ( 768,939 ( 996,034 Exchange rate variation on imports ( 58,623 ( 33,718 ( 40,140 Exchange rate variation on export receivables ( 55,829 ( 23,393 ( 18,323 Exchange rate variation on trade payable from foreign subsidiaries ( 365,214 ( 86,764 ( 13,075 Exchange rate variation on financing ( 525,173 ( 297 ( 5,977 Exchange variations of bank accounts in foreign currency ( 1,483 ( 24,814 - (c) Gains on swap and forward transactions 2,532,487 961,185 1,323,470 Revenue from swap exchange coupons 207,783 182,897 170,555 Gains from exchange variations on swap instruments 2,324,704 778,288 1,152,915 (d) Losses on swap and forward transactions ( 1,579,695 ( 964,116 ( 794,504 Losses on exchange rate variation on swap instruments ( 691,941 ( 690,409 ( 402,708 Financial costs of swap instruments ( 869,890 ( 273,707 ( 391,796 Loss on interest rate swap ( 17,864 -

Other Operating Income (Expense

Other Operating Income (Expenses), Net	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Other Operating Income (Expenses), Net	30. OTHER OPERATING INCOME (EXPENSES), NET Other operating income, net 2020 2019 2018 Result on write-off of property, plant and equipment 11,855 6,098 1,188 ICMS-ST (a) 18,653 42,336 ( 27,126 Exclusion of ICMS from PIS/COFINS base (d) - 52,631 57,242 PIS/COFINS credits (c) - 42,983 - Proceeds from the sale of customer portfolio (b) - 23,092 16,254 Tax contingencies (h) 45,057 21,402 ( 706 ICMS credit - - 2,290 Tax credits - taxation change (c) 60,177 - 23,677 Reintrega credits - - 3,058 Other operating income 10,757 - - Total other operating income 146,499 188,542 75,877 Other operating expenses, net Crer para Ver (e) ( 54,500 ( 36,156 ( 29,686 Expense on the sale of customer portfolio ( 7,498 - - Acquisition related cost (f) ( 303,916 ( 141,348 - Tax contingencies ( 10,100 - - Transformation and integration plan (g) ( 256,700 ( 51,520 ( 98,465 Other operating expenses ( 29,975 ( 8,829 12,329 Total other operating expenses ( 662,689 ( 237,853 ( 115,822 Other operating income (expenses), net ( 516,190 ( 49,311 ( 39,945 a) Refers to the requirement of ICMS tax substitution, for different Federal States (details in note 22). During 2020, provisions were reversed due to the revision of the likelihood of loss of certain States. b) Refers to the revenue from the sale of securities portfolio of customers past due over 180 c) Tax credits from prior periods related to the change on PIS and COFINS taxation. d) The Company and its subsidiary Indústria e Comércio de Cosméticos Natura Ltda. are currently litigating the non-inclusion of ICMS in the PIS and COFINS contributions calculation base. Since 2007, the Company is legally authorized to pay contributions excluding ICMS, but the balance ICMS has been provisioned for as Taxes Payable. On September 30, 2017, based on the conclusion from the judgment made by the Plenary Session of the Federal Supreme Court on the Extraordinary Appeal, with general repercussion in society, which ruled unconstitutional the inclusion of ICMS in the PIS and COFINS calculation base, the Company reverted the tax obligation. On December 31, 2019, the Company recognized principal credit of R$ 52,631 e) Allocation of operating profit from sales of “Crer Para Ver” line of non-cosmetic products to Natura Institute, specifically directed to social projects for developing the quality of education. f) Refers to expenses related to the acquisition process, of Avon, which stand out: financial structuring expenses (R$ 115,696 ), legal expenses (R$ 17,281 ), regulatory expenses (R$ 18,030 ) and executive compensation plans (R$ 152,909 ). g) Expenses related to the implementation of the transformation plan of The Body Shop and integration of Avon, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) redesign of the organization. h) One of our subsidiaries is a party to proceedings relating to the unconstitutionality of the Fator Acidentário de Prevenção, or FAP, and the increase in the rate related to Riscos Ambientais do Trabalho, or RAT, both of which labor taxes. During the year ended December 31, 2020, based on the analysis of our legal advisors, our management reassessed the chance of loss of in the legal proceedings relating to this matter. As a result of reassessment, our subsidiary reversed the provision originally constituted.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Earnings Per Share	31. EARNINGS PER SHARE Basic earnings per share are calculated by dividing the profit (loss) attributable to holders of Company by weighted average number of ordinary shares outstanding, excluding common shares purchased by the Company and held as treasury shares. 2020 2019 2018 Net income (loss) attributable to owners of the Company ( 650,196 155,467 548,379 Weighted average number of issued shares (a) 1,246,180,219 865,660,042 865,660,042 Weighted average number of treasury shares (a) ( 572,130 - - Weighted average number of outstanding shares 1,245,608,090 865,660,042 865,660,042 Basic earnings (loss) per share - R$ (b) ( 0.5220 0.1796 0.6335 (a) 2019 (b) one Diluted earnings per share are calculated by adjusting the weighted average number of common shares outstanding, assuming the conversion of all potential common shares that would cause dilution. The Company has stock options, restricted shares and strategy acceleration that would have a dilutive effect on any earnings per share. Considering that in the year ended December 31, 2020 2020 Diluted earnings per share for the year ended on December 31, 2019 and 2018 2019 2018 Net income attributable to the Company’s controlling shareholders 155,467 548,379 Weighted average number of issued shares (a) 865,660,042 865,660,042 Adjustment for stock options and restricted shares (a) 8,124,575 1,529,528 Weighted average number of ordinary shares for diluted earnings calculation 873,784,617 867,189,570 Diluted earnings per share - R$ 0.1779 0.6324 (a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and their retrospective effects. The basic earnings per share for net loss of discontinued operations for the year ended December 31, 2020 are presented below: 2020 Net loss attributable to the Company’s controlling shareholders ( 143,112 Weighted average number of issued shares (a) 1,246,180,219 Weighted average number of treasury shares (a) ( 572,130 Weighted average number of outstanding shares 1,245,608,089 Basic l oss per share - R$ (b) ( 0.1149 (a)

Related-Party Transactions

Related-Party Transactions	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Related-Party Transactions	32. RELATED-PARTY TRANSACTIONS In the course of the Company's operations, rights and obligations are generated between related parties, arising from administrative expenses and provision of services. 32.1 Transactions with related parties In the year ended December 31, 2020 148,274 32.2 Transactions with uncontrolled and unconsolidated related parties Natura Institute holds shares in the investment fund “Fundo de Investimento Essencial”. As of December 31, 2020 R$ 3,414 3,766 2019 On June 5, 2012, an agreement was entered between Indústria e Comércio de Cosméticos Natura Ltda., and Bres Itupeva Empreendimentos Imobiliários Ltda., (“Bres Itupeva”), for the construction and leasing of processing center to distribution and warehousing of products (HUB), in Itupeva (SP). In 2019 39,346 (R$ 44,244 2019 13,086 Natura Cosméticos S.A. and Raia Drogasil S.A. entered into a purchase and sale agreement and other covenants for selling products in Raia and Drogasil. Mr. Guilherme Peirão Leal and Mr. Pedro Luiz Barreiros Passos, members of the Natura Cosméticos S.A. controlling group, indirectly hold shareholding interest in Raia Drogasil S.A. during the financial year 2020 . In the year ended December 31, 2020 692 0.5 Para Ver line, in the amount of R$ 35,000 23,000 2019 32.3 Key management personnel compensation The total compensation of the Company’s Management is as follows: 2020 2019 2018 Compensation Compensation Compensation Fixed Variable Total Fixed Variable Total Fixed Variable Total (a) (b) (a) (b) (a) (b) Board of Directors 16,123 65,011 81,134 22,056 30,919 52,975 13,141 24,860 38,001 Executive Board 49,187 80,218 129,405 32,963 42,142 75,105 32,739 68,540 101,279 65,310 145,229 210,539 55,019 73,061 128,080 45,880 93,400 139,280 a) The line item “Executive Board” includes the amount of R$ 1,201 2020 536 b) Refers to profit sharing regarding the Restricted Stock Plan and Strategy Acceleration Program, including charges, as applicable, to be determined in the year. The amounts include additions to and/or reversals of provisions made in the previous year, due to final assessment of the targets determined to the board members and officers, statutory and non-statutory, in relation to profit sharing. 32.4 Share-based payments Breakdown of the Company officers and executives’ share-based payments compensation: Grant of options 2020 2019 2018 Stock option balance (number) 1 (a) Average fair value of stock options 1 – R$ Average exercise price 1 - R$ (b) Stock option balance (number) 1 (a) Average fair value of stock options 1 – R$ Average exercise price 1 - R$ (b) Stock option balance (number) 1 (a) Average fair value of stock options 1 Average exercise price 1 (b) Officers 12,847,760 8.64 16.49 13,059,677 8.4 16.51 11,156,406 7.47 15.96 Restricted shares 2020 2019 2018 Stock option balance (number) 1 (a) Average exercise price 1 (b) Stock option balance (number) 1 (a) Average exercise price 1 (b) Stock option balance (number) 1 (a) Average exercise price 1 (b) Officers 5,293,874 51.2 1,012,641 19.23 751,794 14.81 ( 1) The number of stock options granted, expired and exercised and their respective fair values is shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019 ( 2 ) The number of restricted stock and performance shares granted, expired and exercised is shown already considering the stock split approved at the Extraordinary General Meeting on September 17, 2019 (a) Refers to the balance of the options and restricted shares vested and non-vested, not exercised, at the reporting dates. (b) Refers to the weighted-average exercise price of the option at the time of the stock option plans, adjusted for interest based on the Extended Consumer Price Index (IPCA ) through the end of the reporting period. The new Stock Option Plan implemented in 2015

Commitments

Commitments	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Commitments	33. COMMITMENTS 33.1 The subsidiary Indústria e Comércio de Cosméticos Natura Ltda., has commitments arising from electric power supply agreements, with physical delivery, for its manufacturing activities, as described below:  Agreements started in 2018 2020 265 363  Agreements started in 2019 2022 155 305  Agreements started in 2020 2022 204 238 The amounts are carried based on electric power consumption estimates in accordance with the contract period, whose prices are based on volumes, also estimated, resulting from the subsidiary’s continuous operations. Total minimum supply payments, measured at nominal value, according to the contract, are: 2020 2019 2018 Less than one 1,413,904 17,918 1,268 One five 885,990 13,160 4,940 Total 2,299,894 31,078 6,208

Insurance

Insurance	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Insurance	34 The Company and its subsidiaries have in place an insurance policy that considers principally risk concentration and materiality, taking into consideration the nature of its activities and the guidance of its insurance advisors. As at December 31, 2020 Item Type of coverage Amount insured 2020 2019 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 3,062,806 2,322,801 Vehicles Fire, theft and collision for the Company and subsidiaries vehicles 232,459 212,027 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment 1,894,813 1,582,000 Transport Damages to products in transit 46,019 32,309 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 730,740 532,510 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

Additional Information Relating

Additional Information Relating To The Statements Of Cash Flows	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Additional Information Relating To The Statements Of Cash Flows	35 The following table presents additional information on transactions related to the cash flow statement: 2020 2019 2018 Non-cash items Hedge accounting, net of tax effects 116,348 70,569 51,165 Dividends and interest on equity declared and not yet paid - 110,671 111,449 Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 172,104 ( 18,645 6,797 Consideration for acquisition of subsidiary 13,366,114 - -

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Subsequent Events	36 Contract with Bresco IX Empreendimentos Imobiliários Ltda. On January 8, 2021, the subsidiary Natura Cosméticos signed a build-to-suit construction and lease agreement with the related party Bresco IX Empreendimentos Imobiliários Ltda. (“Bresco IX”) for the build-to-suit construction of a distribution center in the city of Murici, Federal State of Alagoas, for a later lease. The lease agreement foresees a total investment of R$ 113,742 15 Bresco IX's hiring process followed market values and all hiring requirements, as well as governance policies and procedures of the Company and its subsidiaries (unaudited). Promissory notes On April 15, 2021, Natura &Co Holding and Natura Cosméticos redeemed the aggregate principal amount due under their respective promissory notes, equivalent to R$ 500.0 250.0 Working Capital – The Body Shop As of December 31, 2020, The Body Shop had a credit facility of up to £ 70 LIBOR plus 2

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Policies)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Current versus non-current classification	3.1 Current versus non-current classification The Company presents assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it is (i) expected to be realized or intended to be sold or consumed in the normal operating cycle; (ii) held primarily for the purpose of trading; (iii) expected to be realized within twelve twelve A liability is current when (i) it is expected to be settled in the normal operating cycle; (ii) it is held primarily for the purpose of trading; (iii) it is due to be settled within twelve twelve Deferred tax assets and liabilities are classified as non-current assets and liabilities, as disclosed on note 3 18
Foreign currency translation	3.2 Foreign currenc y translation Functional currency The items included in the financial statements of the Company and each of the companies included in the consolidated financial statements are measured using the currency of the main economic environment in which each the companies operates ("functional currency"). 3.2.1 Transactions and balances in a currency other than the functional currency Foreign currency transactions, that is, any currency other than the functional currency, are converted into the functional currency of the entities included in these consolidated financial statements using the exchange rates prevailing on the dates of the transactions. The financial statements are presented in thousands of Brazilian R eais Balance sheet account balances are remeasured using the exchange rates prevailing at the end of the reporting period. Foreign exchange gains and losses arising on the settlement of such transactions and the remeasured of monetary assets and monetary liabilities denominated in foreign currency are recognized in the statement of income, as “Financial income” and “Financial expenses”. 3.2.2 Subsidiaries with different functional currency In preparing the consolidated financial statements, the statement of income and statement of cash flows and all other changes of assets and liabilities of foreign subsidiaries, whose functional currency is not the Brazilian Real, are translated into Brazilian Reais at the monthly average exchange rates, which approximates the exchange rate in effect on the date of the transactions. The balance sheet is translated into reais The translation calculation is different for Natura Cosméticos S.A. – Argentina (“Natura Argentina”), which became a hyperinflationary economy as of July 1, 2018 (see below), in which the balance sheet is translated into Brazilian R eais 3.2.3 Hyperinflationary economy Starting from July 2018, Argentina has been considered a hyperinflationary economy. As per IAS 29 2017 , and Argentina’s Domestic Retail Price Index (“IPIM”) up to December 31, 2016. Consequently, as required by IAS 29 2018 , year in which the existence of hyperinflation was first identified). Non-monetary assets and liabilities booked at historical cost and equity items of Natura Argentina were adjusted for inflation based on the aforementioned indices, and effects of hyperinflation resulting from changes in the overall purchasing power were presented in the statement of income. The statement of income is adjusted at the end of each reporting period based on the variation in the general price index for the period. The net effect of inflation adjustment in 20 20 29 For the translation of the accounting balances of the subsidiary Natura Argentina to the presentation currency (R$) used in the Company's consolidated financial statements, the following procedures, as required by IAS 21 Ø Assets, liabilities and equity items balances were translated at the exchange rate prevailing at the reporting date ( 0.06 189 Ø Revenues and expenses of the year were translated at the exchange rate prevailing at the reporting date ( 0.06 189 The accumulated inflation for the year ended December 31, 2020 was 36.1 54.5 2019 As of December 31, 2020 29 20,625 13,947 2019 106,206 68,940 2019 The translation of the statement of income at the exchange rate on the reporting date, instead of average monthly exchange rate of the year, resulted in a positive impact on OCI for the fiscal year ended December 31, 2020 32,160 17,666
Consolidation	3.3 Consolida tion The following procedures are applied in the preparation of the consolidated financial statements: a) Investments in subsidiaries The Company controls an entity when it is exposed to, or is entitled to, the variable returns arising from its involvement with the entity and can affect those returns by exercising its power over the entity. The financial statements of subsidiaries are included in the consolidated financial statements from the date when the Company obtains control until the date when the control ceases to exist. The Company has interests in subsidiaries only. In accordance with the equity method, the portion attributable to the Company on the net profit or loss for the year of these investments is recorded in the statement of income under the line “Equity income”. All intra-group balances, income and expenses and unrealized gains and losses arising from intra-group transactions are eliminated completely. The OCI of subsidiaries is recorded directly in the Company's equity under the item “OCI”. Below is a list of the Company's subsidiaries as of December 31, 2020, 2019 2018 Ownership - % 2020 2019 2018 Direct ownership: Avon Products, Inc. 100.00 - - Natura Cosméticos S.A. 100.00 100.00 - Natura &Co International S.à r.l . ( 1 100.00 - - ( 1 Natura &Co International S.à.r.l., was incorporated in 2020 under the laws of Luxembourg with the purpose of acquiring, managing and selling interests in domestic and foreign companies, other than raising and borrowing funds to other consolidated entities of the Company. In the preparation of the consolidated financial statements, financial statements as at the same reporting date and consistent with the Company's accounting policies were used. Investments were eliminated in proportion to the investor's interest in shareholders' equity and in the results of subsidiaries, assets and liabilities balances, income and expenses and unrealized results, net of income tax and social contribution, resulting from operations between the companies. Direct subsidiaries activities are as follows: Ø Natura S.A.: is a publicly-held corporation, established in accordance with the laws of the Federative Republic of Brazil on June 6, 1993, for an indefinite term. Founded in 1969 Paulo, Brazil, it is among the ten brand, most of products are developed from natural ingredients originating from Brazilian biodiversity and distributed predominantly through direct sales by independent beauty consultants. The subsidiary's focus is the sale of cosmetics and fragrances in general. It also operates through e-commerce and has an expanded network of its own physical stores, with 61 43 2019 7 2020 9 2019 474 256 2019 Holding Pty Ltd. (Aesop) subsidiaries are also classified in this entity. Ø Avon Products, .: a global manufacturer and marketer of beauty and related products, with operations started in 1886 one b) Ownership interest of non-controlling shareholders The Company opted to measure any non-controlling interest initially by the proportionate interest in acquiree’s identifiable net assets on the acquisition date. Changes in the Company’s interest in a subsidiary that do not result in loss of control are recorded as “Transactions with shareholders” in the statement of changes in equity. As at December 31, 2020 2019
Business combinations and goodwill	3.4 Business combinations and goodwill Business combinations (except for those involving entities under common control) are accounted for by applying the acquisition method. The consideration transferred is measured at fair value as at the date of the acquisition, as well as the identifiable assets acquired, and liabilities assumed. The consideration transferred does not include amounts related to the settlement of pre-existing relationships, which are generally recognized in the statement of income for the year. The Company determines that it has acquired a business when the acquired set of activities and assets include an input and a substantive process that together significantly contribute to the ability to create outputs. The acquired process is considered substantive if it is critical to the ability to continue producing outputs, and the inputs acquired include an organized workforce with the necessary skills, knowledge, or experience to perform that process or it significantly contributes to the ability to continue producing outputs. The financial assets and liabilities assumed are assessed for appropriate classification and designation in accordance with the contractual terms, economic circumstances and pertinent conditions as at the acquisition date. Acquisition-related costs are recorded as expenses as incurred and recognized as other operating expenses. Any goodwill arising from the transaction is tested annually for impairment, and when circumstances indicate that the carrying value may be impaired. Goodwill is initially measured at cost, as the excess of the aggregate amount of (i) the consideration transferred, measured at fair value; (ii) the amount of any non-controlling interest in the acquiree; and (iii) in a business combination achieved in stages, the fair value of the acquirer’s previously held equity interest in the acquiree at the acquisition-date; over the net of the amounts of the identifiable assets acquired and the liabilities assumed. When this aggregate amount is lower than the net of the amounts of the identifiable assets acquired and the liabilities assumed, a gain on a bargain purchase is recognized immediately in the statement of income. Subsequently, goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business combination is, from the acquisition date, allocated to each of the Company’s cash-generating units (“CGU”) that are expected to benefit from the combination, irrespective of whether other assets or liabilities of the acquiree are assigned to those units. In a business combination involving entities under common control, in which all of the combining entities or business are ultimately controlled by the same party or parties both before and after the business combination, and that control is not transitory, the Company applies the predecessor accounting method. When applying this method, the financial statements consider the historical accounting records of the acquired entity as equivalent to the Company's records, reflecting (a) the operating results and equity position of the acquired company in previous years; (b) the operating results of the Company and its acquired entity resulting from the restructuring; (c) the Company's assets and liabilities at historical cost (and at the preceding fair value, when applicable); and (d) the earnings per share of the Company in all years presented (adjusted when applicable). In these cases, therefore, there is no calculation of goodwill and any effect recorded in equity.
Cash and cash equivalents	3.5 Cash and cash equivalents Cash and cash equivalents are maintained for the purpose of meeting short-term cash commitments, not for investment or other purposes. Cash and cash equivalents include cash, bank deposits and short-term investments realizable within 90
Financial Instruments	3.6 Financial instruments 3.6.1 Initial recognition and measurement Upon initial recognition, a financial asset is measured at fair value and, subsequently, is measured at amortized cost, at fair value through other comprehensive income (“FVTOCI”), or at fair value through profit or loss (“FVTPL”). The classification of financial assets at initial recognition depends on the characteristics of the contractual cash flows of the financial asset and Company’s business model for the management of these financial assets. The business model for managing financial assets refers to how the company manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through OCI are held within a business model with the objective of both holding to collect contractual cash flows and selling. Except for trade receivable that do not contain a significant financing component or to which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair value plus transaction costs, in the case of financial asset not measured at fair value through profit or loss. In general, all financial assets are subsequently measured at fair value through profit or loss. Subsequent measurement Financial assets at amortized cost Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment analysis. Gains or losses are recognized in the statement of income when the asset is derecognized, modified, or impaired. The financial assets of the Company classified as at amortized cost include trade receivable, other current assets (except for carbon credits measured at fair value, as disclosed in note 3 9 6.6 Financial assets at fair value through OCI (debt instruments) For debt instruments at fair value through OCI, interest income, foreign exchange remeasurement and impairment losses or reversals are recognized in the statement of income and calculated in the same manner as for financial assets measured at amortized cost. The resulting changes in fair value are recognized in OCI; upon derecognition, the cumulative fair value change recognized in OCI is recycled to profit or loss. The Company does not hold any financial asset classified under this category. Financial assets classified as at fair value through OCI (equity instruments) Upon initial recognition, the Company can elect to irrevocably classify its equity investments as equity instruments designated at fair value through OCI when they meet the definition of equity under IAS 32 Gains and losses on these financial assets are never classified to profit or loss. Dividends are recognized as other operating income (expenses), net, in the statement of income when the right of payment has been established, except when the Company benefits from such proceeds as a recovery of part of the financial asset’s cost, in which case, such gains are recorded in OCI. Equity instruments classified as at fair value through OCI are not subject to impairment assessment. The Company does not hold any financial asset classified under this category. Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss are presented in the statement of financial position at fair value with net changes in fair value recognized in the statement of income. This category includes derivative instruments and short-term investments which the Company had not irrevocably elected to classify as at fair value through OCI. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category. Derecognition (write-off) of financial instruments A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is derecognized when the rights to receive cash flows from the asset have expired, when the Company transfer its rights or risk to receive cash flows of the asset or when the Company have assumed an obligation to pay the full amount of received cash flows, without significant delay to a third party under an on-lending agreement and either (i) the Company transfer substantially all risks and benefits of the asset, or (ii) the Company neither transferred nor retained substantially all risks and benefits of the asset, but transferred the control of asset. When the Company transfer its rights to receive cash flows of an asset or execute an on-lending agreement, it assesses whether, and at which extent, they have retained the risks and benefits of ownership. When the Company neither transfers or retains substantially all risks and benefits of the asset, nor transferred the control over the asset, the Company continue to recognize the asset transferred to the extent of its continued involvement. In this case, the Company also recognize an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company have retained. Impairment of financial assets The Company recognize an allowance for expected credit losses (“ECL”) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expect to receive, discounted at an approximation of the original effective interest rate. ECLs are recognized in two 12 12 For trade receivable, the Company apply a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit risk, but instead recognize a loss allowance based on lifetime ECLs at each reporting date. The Company have recorded a provision that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors and the economic environment. Further details are disclosed in note 5 6 The Company consider a financial asset in default when internal or external information indicates that the Company is unlikely to receive the outstanding contractual amounts in full. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. 3.6.2 Initial recognition and measurement All financial liabilities are recognized initially at fair value and, in the case of borrowings, financing and debentures, net of directly attributable transaction costs. The Company financial liabilities include borrowings, financing and debentures (note 19 6 20 Subsequent measurement For purposes of subsequent measurement, financial liabilities are classified in two Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities classified upon initial recognition as at fair value through profit or loss. Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also includes derivative financial instruments entered into by the Company that are not designated as hedging instruments in hedge relationships as defined by IAS 39 Gains or losses on liabilities held for trading are recognized in the statement of income. Financial liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 3.6.3 3.9 Financial liabilities at amortized cost This is the most relevant category for the Company. After initial recognition, interest-bearing borrowings and financing are subsequently measured at amortized cost using the effective interest method. Gains and losses are recognized in profit or loss when the liabilities are derecognized as well as through the effective interest rate amortization process. Amortized cost is calculated by considering any premium or discount on acquisition and fees or costs that are an integral part of the effective interest method. The effective interest amortization is included as finance costs in the statement of income. This category generally applies to borrowings and financing granted and contracted, subject to interest, included in note 19 Derecognition A financial liability is derecognized when the obligation under the liability is discharged, cancelled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognized in the statement of income. Offsetting of financial instruments Financial assets and financial liabilities are offset, and the net amount is reported in the statement of financial position if there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and settle the liabilities simultaneously. The offsetting of financial instruments is also applied to bank balances subject to the central treasury management system (“cash pooling”) instituted with the financial institution, in which the current account positions of the Company (including overdraft balances) they are offset since the Company has a legally enforceable right to settle at the net amount and intends to settle the positions on a net basis. 3.6.3 Derivative financial instruments Derivative instruments transactions contracted by the Company consist of swaps and non-deliverable forwards (“NDF”) intended exclusively to hedge against the foreign exchange risks related to balance sheet positions, acquisitions of inputs and property, plant and equipment, forecasted exports and forecasted foreign-denominated cash outflows for capital increases in foreign subsidiaries. They are measured at fair value, and changes in fair value are recognized through profit or loss, except when they are designated as cash flow hedges, to which changes in fair value are recorded in OCI. The fair value of derivative instruments is measured based on information on each contracted transaction and related market inputs as at reporting date, such as interest and exchange rates. For the purpose of hedge accounting, hedges are classified as (i) fair value hedges when hedging the exposure to changes in the fair value of a recognized asset or liability or an unrecognized firm commitment; (ii) cash flow hedges when hedging the exposure to variability in cash flows that is either attributable to a particular risk associated with a recognized asset or liability or a highly probable forecast transaction or the foreign currency risk in an unrecognized firm commitment; or (iii) hedges of a net investment in a foreign operation. Even with the adoption of IFRS 9 39 7.2.21 9 At the inception of a hedge relationship, the Company formally designate and document the hedge relationship to which it wishes to apply hedge accounting, the risk management objective and the strategy for undertaking the hedge. The documentation includes identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the Company will assess the effectiveness of changes in the hedging instrument’s fair value in offsetting the exposure to changes in the hedged item’s fair value or cash flows attributable to the hedged risk. Such hedges are expected to be highly effective in achieving offsetting changes in fair value or cash flows and are assessed on an ongoing basis to determine that they actually have been highly effective throughout the financial reporting periods for which they were designated. During the years ended on December 31, 2020 2019 2018 . Cash flow hedges Consists in providing hedge against changes in cash flows attributable to a specific risk related to a known asset or liability or a highly probable forecast transaction and that may affect profit or loss. The effective portion of changes in fair value of derivative instruments that is designated and qualified as cash flow hedge is recognized in OCI and accumulated in the item “Gain (loss) from cash flow hedge operations” and “tax effect on gain (loss) from cash flow hedge operations”. In a cash flow hedge, the effective portion of gain or loss from the hedge instrument is recognized directly in OCI, in equity, while the ineffective portion of hedge is immediately recognized in finance income (expenses). For the years ended on December 31, 2020 2019 2018 6 6 80 125 Hedge accounting is discontinued when the Company terminate the hedge relationship, the hedge instrument matures or is sold, revoked or executed, or no longer qualifies to hedge accounting. Any gains or losses recognized in OCI and accumulated shareholders ’ as of a certain If a planned transaction results in the subsequent recognition of a non-financial asset or liability, the cumulative gain or loss in OCI is reclassified to profit or loss during the same year for which the non-financial asset acquired or non-financial liability assumed affects the profit or loss. For example, when the non-financial asset is depreciated or sold. Conversely, if a planned transaction results in the subsequent recognition of a financial asset or liability, the cumulative gain or loss in OCI is recycled to profit or loss during the same period for which the financial asset acquired or financial liability assumed affects the profit or loss. For example, when financial income or expense is recognized. When the forecasted transaction is no longer expected, cumulative gains or losses deferred in equity are immediately recognized in the statement of income. The Company assesses, throughout the hedge term, the effectiveness of its derivative financial instruments, as well as changes in their fair value. For the years ended December 31, 2020 2019 2018 6 6
Trade receivable	3.7 Trade receivable Trade receivable correspond to amounts receivable for the sale of goods and services in the normal course of the activities of the Company and are recognized to the extent that the consideration that is unconditional is due by the customer (that is, only the passage of time required before payment of the consideration is due).
Inventories	3.8 Inventories Inventories are valued at the lower of cost and net realizable value. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale. The Company consider the following items when determining its provision for inventory losses: discontinued products, products with slow turnover, expired products or products nearing the expiration date and products that do not meet quality standards, recorded as “Cost of sales”.
Carbon Credits – Carbon Neutral Program	3.9 Carbon Credits – Carbon Neutral Program In 2007 37 The liability is estimated through annually audited inventories of carbon emissions and measured at fair value based on the market price for the acquisition of licenses for neutralization. On December 31, 2020, the balance recorded as "Other non-current liabilities" (see note 2 3 2007 2020 The Company elected to make purchases of carbon credits by investing in projects with environmental benefits arising from the voluntary market. Thus, the costs will generate carbon credits after completion or maturation of these projects. Such expenses were recorded at their respective fair value in the line item “Other current assets” (see note 15 Upon effective delivery of the related carbon credit certificates to the Company, the obligation of being carbon neutral is effectively fulfilled; therefore, the asset balances are offset against those of the liabilities. The difference between the carrying amounts of assets and liabilities as at December 31, 2020
Property, plant and equipment	3.10 Property, plant and equipment Property, plant and equipment is measured at cost of acquisition or construction, plus interest capitalized during construction period, in the case of qualifying assets, and reduced by accumulated depreciation and impairment losses, if applicable. Depreciation methods, useful lives and residual values are reviewed at each reporting date and adjusted, if applicable. Land is not depreciated. Depreciation of the other assets is calculated to reduce the cost of items of property, plant and equipment less their estimated residual values using the straight-line method over their useful lives and is recognized in the statement of income. The estimated useful lives of the assets are mentioned in note 1 6 Gains and losses on disposals are calculated by comparing the proceeds from the sale with the net carrying amount and are recognized in the statement of income as “Other operating income (expenses), net”. Subsequent expenditure is capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company
Intangible assets	3.11 Intangible assets Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment losses. Internally generated intangibles, excluding capitalized development costs, are not capitalized and the related expenditure is reflected in profit or loss in the period in which the expenditure is incurred. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at each reporting date. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization expense on intangible assets with finite lives is recognized in the statement of profit or loss in the expense category that is consistent with the function of the intangible assets. Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, and when circumstances indicate that the carrying value may be impaired, either individually or at the CGU level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis. An intangible asset is derecognized upon disposal (i.e., at the date the receiver of the asset obtains control) or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included in the statement of profit or loss in the line item “other operating income (expenses), net”. The main classes of intangibles are set forth below. 3.11.1 Licenses of software and enterprise management systems acquired are capitalized and amortized according to the useful lives described in note 1 7 System acquisition and implementation costs are capitalized as intangible assets when the asset is identified, when there is evidence that future economic benefits will flow into the entity and when the asset is controlled by the Company, taking into consideration its economic and technologic viability. The amounts incurred on software development recognized as assets are amortized under the straight-line method over its estimated useful life. The expenditures related to software maintenance are expensed when incurred. 3.11.2 patents Separately acquired trademarks and patents are stated at their historical cost. Trademarks and patents acquired in a business combination are recognized at fair value on the acquisition date. For trademarks and patents with definite useful lives, amortization is calculated on a straight-line basis at the annual rates described in note 1 7 3.11.3 Relationships with retail clients, franchisees and sub-franchisees acquired in business combinations are recognized at fair value on the acquisition date and their amortization is calculated on a straight-line basis, based on rates shown in note 1 7 3.11.4 Key money with defined useful life is recorded at the acquisition cost and amortized on a straight-line basis during the rental period, as shown in note 1 7 3.11.5 technologies Developed technologies include technology for product development (including formulas, labeling data, manufacturing processes, regulatory approvals, product packaging and designs) arising from business combination, and are recognized at fair value on the date of acquisition and its amortization is calculated using the straight-line method, based on the rates shown in note 1 7
Impairment of non-financial assets	3.12 Impairment of non-financial assets The Company assess, at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset’s or the CGU fair value less costs of disposal and its value in use. The recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects the entity’s weighted average cost of capital in which the generating cash unit operates, and that reflects the current perceptions of market participants. The Company bases its impairment calculation on most recent budgets and forecast calculations, which are prepared separately for each of the Company’s CGU to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five Impairment losses are recognized in the statement of profit or loss in expense categories consistent with the function of the impaired asset. For assets excluding goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment losses no longer exist or have decreased. If such indication exists, the Company estimates the asset’s or CGU recoverable amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the asset’s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income. Goodwill is tested for impairment annually as at December 31, and when circumstances indicate that the carrying amount may be impaired. Impairment is determined for goodwill by assessing the recoverable amount of each CGU (or group of CGU) to which the goodwill relates. When the recoverable amount of the CGU is less than it carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed in future periods. Intangible assets with indefinite useful lives are tested for impairment annually as at December 31, at the CGU level, as appropriate, and when circumstances indicate that the carrying value may be impaired.
Leases	3.13 Leases On January 1, 2019, the Company applied IFRS 16 one 17 The Company assess at contract inception whether a contract is, or contains, a lease. That is, if the contract conveys the right to control the use of an identified asset for a period in exchange for consideration. The Company (as a lessee) apply a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company recognize lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets. 3.13.1 Right-of-use assets are recognized at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, disclosed in note 1 8 The right-of-use assets are also subject to impairment, as disclosed on note 3.1 2 3.13.2 At the lease commencement date, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease term. The lease payments include fixed payments less any lease incentives receivable, variable lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for terminating the lease, if the lease term reflects the Company exercising the option to terminate the lease. Variable lease payments that do not depend on an index or a rate are recognized as expenses (unless they are incurred to produce inventories) in the period in which the event or condition that triggers the payment occurs. In calculating the present value of lease payments, the Company use its incremental borrowing rate at the lease commencement date because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in the lease payments (i.e., changes to future payments resulting from a change in an index or rate used to determine such lease payments) or a change in the assessment of an option to purchase the underlying asset. The Company’s and its subsidiaries lease liabilities are disclosed in note 1 8 3.13.3 The Company apply the short-term lease recognition exemption to its short-term leases regardless of its nature (that is, those leases that have a lease term of 12
Non-current assets held for sale and discontinued operations	3.14 Non-current assets held for sale and discontinued operations The Company classify non-current assets and disposal groups as held for sale if their carrying amounts will be recovered principally through a sale transaction rather than through continuous use. Non-current assets and disposal groups classified as held for sale are measured at the lower of their carrying amount and fair value less costs to sell. Costs to sell are the incremental costs directly attributable to the disposal of an asset (disposal group), excluding finance costs and income tax expense. The criteria for held for sale classification is regarded as met only when the sale is highly probable, and the asset or disposal group is available for immediate sale in its present condition. Actions required to complete the sale should indicate that it is unlikely that significant changes to the sale will be made or that the decision to sell will be withdrawn. Management must be committed to the plan to sell the asset and the sale expected to be completed within one Property, plant and equipment and intangible assets are not depreciated or amortized once classified as held for sale. Assets and liabilities classified as held for sale are presented separately as current items in the statement of financial position. A disposal group qualifies as discontinued operation if it is a component of an entity that either has been disposed of, or is classified as held for sale, and: (i) represents a separate major line of business or geographical area of operations; (ii) is part of a single coordinated plan to dispose of a separate major line of business or geographical area of operations; or (iii) is a subsidiary acquired exclusively for the purpose of resale. Discontinued operations are excluded from the results of continuing operations and are presented as a single amount as profit or loss after tax from discontinued operations in the statement of income. The amounts presented as held for sale and discontinued operations come from Avon's business combination process. These amounts refer to the discontinuity of the acquired company's operations in North America and reflect the costs incurred in resolving contingencies associated with that operation. The Company presents these effects as part of its discontinued operations since it considers the discontinued operations of the subsidiary Avon as an extension of the Company and for assessing that this presentation reliably represents the essence of the associated transaction .
Borrowing costs	3.15 Borrowing costs Borrowing costs attributable to the acquisition, construction or production of a qualifying asset that necessarily requires a significant effort to be ready for its intended use or sale are capitalized as part of the cost of the corresponding asset. All other borrowing costs are expensed in the period they are incurred. Borrowing costs consist of interest and other costs incurred by an entity related to a borrowing.
Trade payables under a supply chain finance arrangement	3.16 Trade payables under a supply chain finance arrangement The Company enter in a supply chain finance arrangement with a financial institution to facilitate administrative procedures for suppliers to advance receivables related to the routine purchases of the Company. In this operation, the financial institution separately offers to pay the supplier in advance in exchange for a discount and, when there is the agreement between the bank and the supplier (the decision to join this transaction is solely and exclusively of the supplier), the Company pay the financial institution on the original payment date at the full-face value of the originating payable. This operation does not change the amounts, nature and timing of the liability (including previously agreed-upon terms, prices and conditions) and it does not affect the Company with financial charges practiced by the financial institution, on performing a thorough analysis of suppliers by category. There is not guarantee granted by the Company. Additionally, the payments made by the Company represent purchases of goods and services, are directly related to invoices from suppliers and does not change the Company's cash flows. Thus, the Company continue to recognize the liability as a trade payable and these transactions are presented as operating activities in the statement of cash flows.
Provisions for risks	3.17 Provisions for risks Provisions are recognized when the Company has a legal or constructive obligation as a result of past events, and it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and its value can be reliably estimated. Provisions are quantified at the present value of the expected outflow of resources embodying economic benefits to settle the obligations using the appropriate discount rate according to risks related to the liability. The provisions for tax, civil, and labor risks are adjusted for inflation through the end of the reporting period to cover probable losses, based on the nature of the risk and the opinion of the Company’s legal advisors. Contingent assets are not recognized by the Company and are only disclosed, in case of probable receipt of economic benefits. If it is practically certain that economic benefits will be received, the asset and the corresponding gain are recorded in the financial statements of the year corresponding to the change in the estimate. A contingent liability recognized in a business combination is initially measured at its fair value. Subsequently, it is measured at the higher of the amount that would be recognized in accordance with the requirements for provisions above or the amount initially recognized less (when appropriate) cumulative amortization recognized in accordance with the requirements for revenue recognition.
Current and deferred income tax and social contribution	3.18 Current and deferred income tax and social contribution Current income tax assets and liabilities are measured at the amount expected to be recovered from or paid to the tax authorities based on the tax rates and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date in the countries where the Company operates and generates taxable income. Management periodically assesses the tax treatment assumed in the determination of taxes on profit with respect to situations in which the applicable tax regulation gives rise to interpretations that may be different and considers whether it is likely that the tax authority would accept the uncertain tax treatment. The Company assesses these taxes balances based on the most probable or expected value, depending on which method is assessed as the one The Company have material uncertain tax positions, any of which an unfavorable outcome under litigation could result in a material adverse impact to our financial statements. In Brazil, they include the corporate income tax (“IRPJ”) and the social contribution on net income (“CSLL”), which are calculated based on taxable income by applying the 15 10 240 9 30 Deferred taxes represent tax debits and credits on temporary differences between tax base and accounting base of assets and liabilities on accrued tax losses. Deferred tax and contribution assets and liabilities are classified as “non-current” as required by IAS 12 The carrying amount of deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred tax asset to be recovered. Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the reporting date and reflect the uncertainties relating to these taxes, when applicable. Deferred tax assets and liabilities are offset if there is a legal feasible right to offset tax liabilities against tax assets, and if they are related to taxes registered by the same tax authority under the same taxable entity. Thus, for presentation purposes, tax asset and liability balances are disclosed separately.
Borrowings and financing	3.19 Borr ow ing s and financing Borrowings and financing are initially recognized at fair value, net of transaction costs incurred and are, subsequently, measured at amortized cost. Any difference between raised and settled the amounts is recognized in the statement of income, using the effective interest rate method during the period in which the borrowings and financing are outstanding. Borrowings and financing costs, whether specific or not, that are directly attributable to the acquisition, construction or production of a qualifying asset in accordance with the Company's policy, are capitalized as part of the asset’s cost when it is likely to result in future economic benefits to the entity and that such costs can be reliably measured. Other borrowing costs are recognized as expenses in the period in which they are incurred.
Employee benefits	3.20 Employee benefits 3.20.1 The obligations of short-term benefits for employees are recognized as payroll expenses as the corresponding service is rendered. The liability is recognized at the amount of the expected payment if the Company has a legal or constructive obligation to pay the amount due to services rendered by the employee in the past and the obligation can be reliably estimated. 3.20.2 The Company recognizes a liability and an expense for profit sharing based on criteria that it considers the profit attributable to its shareholders after certain adjustments and which is tied to the achievement of specific operational goals and objectives, which are established and approved in the beginning of each fiscal year. 3.20.3 s Obligations to contribute to defined contribution plans are recognized in the statement of income as personnel expenses when the related services are rendered by employees. Contributions paid in advance are recognized as an asset to the extent that a cash refund or a reduction in future payments is possible. 3.20.4 efined benefit plans The Company's net obligation for defined benefit plans (retirement and post-employment health care) is calculated for each plan based on the estimated amount of future benefit that the beneficiaries receive in return for services in exercises previous years. This amount is discounted to its present value and is presented net of any plan asset’s fair value. The calculation of the defined benefit plan obligation is carried out annually by a qualified actuary using the Projected Unit Credit Method. When the calculation results in a potential asset for the Company, the asset to be recognized is limited to the present value of economic benefits available in the form of future reimbursements or reductions in future plan contributions. To calculate the present value of economic benefits, any minimum cost requirements are considered. The current service cost and accrued interest on the present value of the liability are recognized in the statement of income and the actuarial gains and losses, generated by the remeasurement of the liability due to changes in actuarial assumptions, are recognized in OCI. In case of changes or reductions in the plan, the effects of the cost of past services are recognized in the statement of income on its occurrence date.
Share-based payment	3.21 Share-based payment The Company's executives are granted the following stock option plans, settled exclusively with its own shares: i) ii) iii) The plans are measured at fair value at the grant date. In determining the fair value, the Company uses an adequate valuation method, details of which are disclosed in note 2 8 1 The cost of transactions settled with equity instruments is recognized, together with a corresponding increase in shareholders’ equity under the heading "Additional paid-in capital", throughout the period in which the service conditions are fulfilled, ending on the date on which the employee acquires the full right to the award (acquisition date). The cumulative expense recognized for equity instruments transactions settled on each base date up to the acquisition date reflects the extent to which the vesting period has transpired and the Company’s best estimate of the number of equity instruments to be acquired. The expense or credit of the period is recorded in the line item "Selling or Administrative expenses" in the statement of income, depending on the internal department where the eligible employee is allocated. For the stock option plan and the strategy-acceleration program, despite the expiration of the term for exercise, the recognized expense is not reversed since the right has been acquired by executives. When an award of equity instruments settlement is cancelled (except when the cancellation occurs due to loss of right over the equity instrument for not fulfilling the grants conditions), it is treated as if it had been acquired on the date of cancellation, and any expense not recognized is registered immediately. This includes any award for which Company, or the counterparty have the option not to fulfill the non-acquisition obligation. All cancellations of transactions settled with equity securities are treated in the same way. The dilution effect of options granted is reflected as additional share dilution in the calculation of diluted earnings per share (note 3 1
Dividends and interest on equity	3.22 Dividends and interest on equity The proposed distribution of dividends and interest on capital made by Management that is within the portion equivalent to the minimum mandatory dividend is recorded in the line item “Dividends and interest on equity” in current liabilities, as it is considered as a legal obligation provided for by the Company’s bylaws. However, the portion of dividends exceeding minimum dividends declared by management after the reporting date, but before the authorization date for the issuing of the financial statements, is recognized in the line item “Additional proposed dividend”, in shareholders' equity. For corporate and accounting purposes, interest on capital is stated as allocation of income directly in shareholders’ equity.
Treasury shares	3.23 Treasury shares The Company’s own equity instruments which are reacquired (treasury shares) are recognized at acquisition cost and deducted from shareholders' equity. No gain or loss is recognized in profit or loss on the purchase, sale, issuance or cancellation of the Company's own equity instruments.
Government grants	3.24 Government grants Government grants are recognized where there is reasonable assurance that the grant will be received, and all attached conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that the related costs, for which it is intended to offset, are accounted for. When the grant relates to an asset, it is recognized as income in equal amounts over the expected useful life of the related asset. Government grants received relate to measures introduced by governments where the Company operate as a measure to mitigate the impacts of the Covid- 19 192,686 2020 2019 2018
Reportable Segments	3.25 Reportable segments The information per business segment is presented in note 2 5 The main decision-making body of the Company, which is responsible for defining the allocation of resources and for the performance assessment of the operating segments, is the Board of Directors. Additionally, the Company has a Group’s Operational Committee (“GOC”), that includes the CEOs of Natura &Co, Natura &Co Latam, Avon International, The Body Shop and Aesop, in addition to representatives of key business areas (Finance, Human Resources, Business Strategy and Development, Legal, Innovation and Sustainability, Operations and Corporate Governance), which advises the Board of Directors and is responsible for, among others things, monitoring the implementation of short and long-term strategies and making recommendations to the Board of Directors regarding the management of the Company, from the perspective of its results, allocation of resources among business units, cash flow and talent management.
Revenue from contracts with customers	3.26 Revenue from contract with customer Revenue from contracts with customer is recognized when control of the goods or services are transferred to the customer at an amount that reflects the consideration to which the Company expect to be entitled in exchange for those goods or services. The Company have concluded that it is the principal in its revenue arrangements. The Company considers whether there are other promises in the contract that are separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price, the Company considers the effects of variable consideration, existence of a significant financing component, noncash consideration, and consideration payable to the customer (if any). Below are set forth the nature and other considerations on the transaction price and the moment in which the performance obligation is fulfilled for each of the main revenue streams. 3.26.1 Revenue from sales is generated by sales to the Company’s subsidiaries consultants (our customers) based on the fair value of consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. Revenue from direct sales is recognized when the performance obligation is fulfilled, i.e., when the promised product is physically delivered, and the consultant obtains control over the product. Revenue from direct sales is generated and accrued initially in the sales subsidiary ledger of the Company’s subsidiaries from the moment when the dispatch slip is issued in the customers’ name. However, since revenues are recorded only when the final delivery of products actually occurs, the Company registers a provision to eliminate the amount of revenue related to products dispatched and not yet received by the consultants on each reporting date. 3.26.2 charges and penalties for late payments The Company’ subsidiaries Natura, Avon and The Body Shop International Limited (“The Body Shop” or “TBS”) charges its customers (consultants) additional charges and penalties for late payments in the settlement of sales receivables. Due to the level of uncertainty in collecting these amounts (variable consideration), the subsidiaries recognize revenue from additional charges and penalties for late payments only upon its collection. 3.26.3 In direct and indirect subsidiaries, responsible for Natura, Avon, Aesop and TBS brands, which operate in the retail market, retail sales revenues are measured based on the fair value of consideration received/receivable, excluding discounts, rebates and taxes or charges on sales. These revenues are recognized when the performance obligation is fulfilled, i.e., when the promised product is physically transferred, and the consumer obtains control over the product. 3.26.4 3.26.4.1 p oints campaign) The Company subsidiaries offer points campaign (loyalty program), in which customers accumulate points while buying the Company's products to be exchanged (redeemed) for products in the future. Measurement of points is based on their expected cost, plus a margin. The amount allocated to the loyalty program is deferred and the revenue is recognized upon redemption of the points accumulated by Natura, Avon and TBS consultants for retail and direct sales, or when they expire or are no longer considered redeemable. The loyalty program points are valid for up to approximately 5 6 3.26.4.2 Natura and Avon consultants’ performance The Company’s subsidiaries have performance recognition programs, in which it awards its consultants based on achievement of targets and objectives. The Company’s subsidiaries believe that this performance recognition program has a high value and hence is considered a performance obligation. Measurement of performance recognition programs is based on their expected cost, plus a margin. The amount allocated to performance recognition programs is deferred and revenue is recognized when awards are delivered to the Company’s Consultants. 3.26.4.3 The Company organize events to encourage and recognize the best Consultants. The Company believe that these events have an added value for consultants, in addition to generating in them an expectation to participate in these events. Thus, the Company believes that these events are a performance obligation. Measurement of events is based on their expected cost, plus a margin. The amount allocated to events is deferred and the revenue is recognized when the event is held. 3.26.4.4 opening ) Upon execution of the agreement, the Company charges from franchisees a fixed amount, part of which is allocated to courses, training and consultancy to train and instruct the franchisee to sell “Natura” and “The Body Shop” brand products. In addition, other part of the charged amounts refers to outfit (specific products to be used at the franchisee store) and franchisee’s store opening event. The Company and subsidiaries believe that these items represent a material right and, for such, they are considered a performance obligation. Measurement is based on the market value of these items, which are initially recognized as deferred revenue. When the franchisee’s store is opened, this deferred revenue is allocated to the statement of income. 3.26.4.5 Franchisees ( a dvertis ing fund ) Upon the execution of the agreement, the Company charges from franchisees a fixed amount, a part of which is for the advertising fund (monthly delivery of showcases). The Company believes that this item represents a material right and, for such, it was considered a performance obligation. Measurement is based on the market value of this item, which is initially recognized as deferred revenue. This revenue is deferred and allocated to the statement of income upon the delivery of showcases to the franchisees. 3.26.4.6 - right of use) Upon the execution of the agreement, the Company’s subsidiaries charge from franchisees a fixed amount, part of which is for the use of the “Natura” brand. The Company believe that this item represents a material right and, for such, it was considered a performance obligation. Measurement is based on residual value, i.e., the remaining value after excluding the market value of courses, training and consultancy services, outfit and inauguration, and the advertising fund. The amount is initially recognized as deferred revenue, which is allocated to profit or loss, on a straight-line basis, over the term of the franchise agreement. 3.26.4.7 revenues Sales by franchisees and sub-franchisees of the subsidiary The Body Shop are recognized when performance obligations are satisfied, goods are transferred to the customer and the customer is in control. The performance obligation is the license to operate in the market. Revenues are allocated to the license and are recognized over time, in accordance with the license agreement. Under IFRS 15 3.26.4.8 “ free-of-charge ” products and promotional gifts The Company grant incentives related to “free-of-charge” products and promotional gifts for its customers (Natura and Avon Consultants and/or end consumers). Since it is considered a material right, the Company recognize it as a performance obligation. Considering that the delivery of products and the fulfillment of the performance obligation to delivery “free-of-charge” products or promotional gifts occurs at the same time, the Company concluded that an allocation of prices and monitoring these two
Sales taxes	3.27 S ales taxes Expenses and assets are recognized net of sales taxes, except (i) when sales taxes incurred on the purchase of goods or services are not recoverable from the tax authorities, in which case the sales tax is recognized as part of the acquisition cost. the asset or expense item, as the case may be; (ii) when the amounts receivable and payable are presented together with the value of taxes on sales; and (iii) when the net amount of taxes on sales, recoverable or payable, is included as a component of the amounts receivable or payable in the balance sheet. 3.27.1 The Company filed lawsuits to challenge the non-inclusion of ICMS in the calculation basis of contributions to PIS and COFINS. On March 31, 2017, the Company, based on the conclusion of the judgment by the Plenary of the Supreme Federal Court, of Extraordinary Appeal No. 574.706 297,216 Despite the fact that the Extraordinary Appeal No. 574.706 574,706 The Company recognize tax credits arising from lawsuits for the exclusion of ICMS from the PIS and COFINS basis, as a result of the unappealable conclusion of these lawsuits. Existing credits for the lawsuits that have not yet been concluded, are considered contingent assets in the financial statements (note 2 2 3 3.27.2 calculating credits of PIS and COFINS contributions The Company claim that PIS and COFINS credits are measured and calculated reliably and based on the best interpretation of current legislation and the country's jurisprudential scenario, whose evolution is permanently assessed by the Company and its legal advisors.
New standards and interpretations issued but not yet effective	3.28 New standards and interpretations issued but not yet effective The new and amended standards and interpretations that are issued, but not yet effective, up to the date of issuance of the Company’s and its subsidiaries financial statements are disclosed below, except for those which, in Management's assessment, have no potential effect on the financial statements. The Company intend to adopt these standards, if applicable, when they become effective. 3.28.1 1 : C lassification of liabilitie s as current or non-current In January 2020, the IASB issued amendments to paragraphs 69 76 1 The amendments are effective for annual reporting periods beginning after January 1 2023 3.28.2 3 In May 2020, the IASB issued amendments to IFRS 3 1989 The Board also added an exception to the recognition principle of IFRS 3 2 37 21 At the same time, the Board decided to clarify existing guidance in IFRS 3 The amendments are effective for annual reporting periods beginning after January 1 2022 and, although not having any current impact on the Company, they may be applicable to new business combinations in the future. 3.28.3 9 , Financial Instruments – Fees in the “ 10 ” test for derecognition of financial liabilities As part of its 2018 2020 9 The amendment is effective for annual reporting periods beginning on or after January 1 2022 3.28.4 9 39 7 4 16 2 In 2020 9 39 7 4 16 1 3 29 2 Considering the extinction of LIBOR LIBOR LIBOR It is important to note that the clauses for changing the indexes of the debt contracts of the Company indexed to LIBOR 2 two LIBOR The Company mapped all of its contracts subject to LIBOR 761,074 LIBOR The Company understands that it will not be necessary to change the risk management strategy due to the change in the indexes of financial contracts linked to LIBOR LIBOR LIBOR
New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1st, 2020	3.29 New standards, amendments and interpretations of standards adopted for the first time for the year beginning on January 1 2020 The Company applied for the first-time certain standards and amendments, which are effective for annual periods beginning on or after January 1 2020 3.29.1 endments to IFRS 3 - Definition of a Business The amendment to IFRS 3 3.29.2 7 9 39 (Phase 1 The amendments to IFRS 9 39 3.29.3 1 8 , Definition of Material The amendments provide a new definition of “material” that states “information is material if omitting, misstating or obscuring it could reasonably be expected to influence decisions that the primary users of general purpose financial statements make on the basis of those financial statements, which provide financial information about a specific reporting entity.” The amendments clarify that materiality will depend on the nature or magnitude of information, either individually or in combination with other information, in the context of the financial statements. A misstatement of information is material if it could reasonably be expected to influence decisions made by the primary users. These amendments had no impact on the financial statements of, nor is there expected to be any future impact to the Company and subsidiaries. 3.29.4 The Conceptual Framework is not a standard, and none of the concepts contained therein override the concepts or requirements in any standard. The purpose of the Conceptual Framework is to assist the IASB in developing standards, to help preparers develop consistent accounting policies where there is no applicable standard in place and to assist all parties to understand and interpret the standards. This will affect those entities which developed their accounting policies based on the Conceptual Framework. The revised Conceptual Framework includes some new concepts, updated definitions and recognition criteria for assets and liabilities and clarifies some important concepts. These amendments had no impact on the financial statements of the Company and subsidiaries. 3.29.5 16 19 On May 28, 2020 19 16 16 19 19 19 16 The amendment applies to annual reporting periods beginning on or after June 1 2020 16 58,700

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Information About Company Principal Subsidiaries	Below is a list of the Company's subsidiaries as of December 31, 2020, 2019 2018 Ownership - % 2020 2019 2018 Direct ownership: Avon Products, Inc. 100.00 - - Natura Cosméticos S.A. 100.00 100.00 - Natura &Co International S.à r.l . ( 1 100.00 - - ( 1 Natura &Co International S.à.r.l., was incorporated in 2020 under the laws of Luxembourg with the purpose of acquiring, managing and selling interests in domestic and foreign companies, other than raising and borrowing funds to other consolidated entities of the Company.

BUSINESS COMBINATIONS (Tables)

BUSINESS COMBINATIONS (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure of detailed information about business combination [abstract]
Schedule of preliminary fair value calculation of consideration transferred	The following table summarizes the calculation of the fair value of the compensation transferred on January 3 rd 2020 In millions of R$, except for the number of shares Number of Avon outstanding common shares as of January 3 rd, 2020 536,383,776 Multiplied by the exchange ratio of 0.600 321,830,266 Multiplied by the market price of Natura &Co shares on January 3 d, 2020 41,0 Consideration in the issuance of shares 13,195,041 Consideration to the transferred compensation (a) 171,073 Fair value of the consideration to be transferred 13,366,114 (a) Related to the effects of replacements and settlements of share-based payment plans, of which the amount of R$ 80 thousand refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and R$ 91
Schedule of preliminary allocation prepared by Company and resulting goodwill	The fair values of the identifiable assets and liabilities of Avon as at the date of acquisition were: In thousands of R$ Purchase consideration transferred ( 1 13,366,114 Fair value of acquired assets: Cash and cash equivalents 2,636,108 Trade receivable ( 2 ) 1,135,269 Inventories 1,919,683 Other current assets 1,031,136 Non-current assets held for sale 199,050 Property, plant and equipment 2,912,482 Deferred income tax and social contribution 667,034 Right of use ( 3 ) 564,669 Other non-current assets 475,096 Judicial deposits 283,885 Recoverable taxes 531,930 Employee benefit plan (other assets) 553,297 Intangibles ( 4 ) 5,846,812 Fair value of liabilities assumed: Borrowings, financing and debentures 7,256,583 Trade payable 2,915,418 Salaries, profit sharing and social charges 621,203 Dividends and interest on equity payable 405,916 Derivative financial instruments 15,518 Operating expenses accruals 999,653 Provision for restructuring (other liabilities) 152,896 Lease liabilities 777,200 Tax liabilities 341,258 Income tax and social contribution 30,068 Provision for tax, civil and labor risks ( 5 ) 1,693,096 Liabilities from discontinued operations (other liabilities) 64,844 Deferred income tax and social contribution ( 6 592,534 Other liabilities 1,007,623 Total identifiable net assets at fair value 1,882,641 Non-controlling interest 27,555 Goodwill arising on acquisition ( 7 ) 11,511,028 (1) Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange. (2) The fair value of the trade receivable amounts to R$ 1,135 269 (3) The Company measured the acquired lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms. (4) The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235 Fair value for the intangibles “Avon” tradename, power brands and developed technology has been calculated based on the income approach and the relief-from-royalty method. The relief from royalty method is often used to calculate the value of a trademark or trade name. This method is based on the concept that if an entity owns a trademark, it does not have to pay for the use of it and therefore is relieved from paying a royalty. The amount of that theoretical payment is used as a surrogate for income attributable to the intangibles. The valuation is arrived at by computing the present value of the after-tax royalty savings, calculated by applying an appropriate royalty rate to the projected revenue, using an appropriate discount rate. Fair value for relationship with sales representatives has been calculated based on the Multi Period Excess Earnings Method (“MEEM”), method that isolates the income/cash flow that is related to the intangible asset being valued and estimates fair value through the sum of the discounted future excess earnings attributable to the intangible asset. (5 Contingent liabilities assumed in the acquisition that are considered present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3 37 872,993 820,103 The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value: (6) Consists of deferred tax liabilities of approximately R$ 81,423 511,111 (7) Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes.
Schedule of fair value of intangible assets	Nature Fair value Useful life “Avon” tradename Represents the fair value of the "Avon" tradename. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions. 2,022,163 Indefinite Power brands Represents the fair value of Avon's main brands. The relief-from-royalty method has been applied considering a benchmark of similar royalty transactions as well as the relative importance of the respective brands for Avon’s revenue generation. 517,592 20 Developed technology Represents the fair value of all technology necessary to develop Avon products, including formulae, labeling data, manufacturing processes, regulatory approvals, product packaging, and designs. the relief-from-royalty method has been applied based on existing contractual relations involving Avon’s developed technology. 1,131,573 5 Sales Representatives Represents the fair value of the relationship between Avon and its sales representatives. Fair value is calculated based on the number of active representatives by country as of the valuation date, multiplied by the respective average ticket price as well as projected information on the average ticket growth which includes future inflation. The churn rate and the projected information have been considered as significant assumptions. 1,884,249 7 12 5,555,577
Schedule of the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value	The table below shows the total amount of contingent liabilities assumed on the date of the transaction, including the attributed fair value: In thousands of R$ Tax 1,381,418 Civil 92,988 Labor 218,690 Total 1,693,096
Schedule of variation between preliminary effects and final effects presented in business combination	The table below demonstrate the differences between these preliminary effects presented on December 31, 2019 and the final effects presented in these consolidated financial statements: As reported in 2019 Measurement period adjustments 2020 Total estimated consideration to be transferred 13,366,114 - 13,366,114 (-) Fair value of assets acquired: Inta n gibles ( 1 5,709,326 137,486 5,846,812 Other assets 12,911,674 ( 2,035 12,909,639 (+) Fair value of liabilities assumed: Provis i on for risks and contingencies ( 2 651,000 1,042,096 1,693,096 Deferred income tax and social contribution ( 3 671,693 ( 79,159 592,534 Other liabilities 14,571,307 16,873 14,588,180 (-) Net assets 2,727,000 ( 844,359 1,882,641 (+) Non-controlling interests 27,555 - 27,555 Goodwill from business combination 10,666,669 844,359 11,511,028

Financial Risk Management (Tabl

Financial Risk Management (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Derivative Instruments	To hedge the current balance sheet positions of the Company from market risks, the following derivative financial instruments are used, which are comprised of the balances presented below, as of December 31, 2020 2019 Description Fair value (Level 2 2020 2019 Financial derivatives 1,857,869 727,068 Operational derivatives ( 11,092 ( 1,496 Total 1,846,777 725,572
Summary of Derivative Positions	Principal (notional) Fair value Gain (loss) Description 2020 2019 2020 2019 2020 2019 Swap contracts : (a) Asset position: Long position - U.S. dollar 2,576,890 2,664,001 4,683,900 3,729,691 421,897 312,984 Liability position: CDI floating rate: Short position in CDI ( 2,576,890 ( 2,664,001 ( 2,803,797 ( 3,002,623 ( 172,885 ( 248,028 Forward contracts (NDF): Liability position: CDI floating rate: Short position in CDI 1,409,102 - ( 22,234 - ( 16,778 - Total net derivative financial instruments: 1,409,102 - 1,857,869 727,068 232,234 64,956
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold	As at December 31, 2020 and 2019 Principal (notional) amount Fair value Description 2020 2019 2020 2019 Net position - GBP and USD 1,585,280 200,896 ( 7,670 ( 2,008 Forward contracts 165,830 1,302,869 ( 3,422 512 Total derivative instruments, net 1,751,110 1,503,765 ( 11,092 ( 1,496
Disclosure Of Net Asset Exposure	For the foreign currency risk sensitivity analysis, Management of the Company believes that it is important to consider, in addition to the assets and liabilities with exposure to fluctuations in exchange rates recorded in the balance sheet, the fair value of the financial instruments entered into by the Company to hedge certain exposures on December 31, 2020 2019 2020 2019 Borrowings and financing in foreign currency in Brazil (a) ( 4,246,692 ( 3,381,959 Receivables in foreign currency in Brazil 236,782 10,007 Trade payable in foreign currencies in Brazil ( 14,459 ( 10,543 Fair value of the financial derivatives 4,680,478 3,729,691 Net asset exposure 656,109 347,196 (a) Excluding transaction costs.
Disclosure Of Net Foreign Exchange Exposure	The following table shows the projection of the incremental loss that would have been recognized in profit or loss for the subsequent year, if the current net foreign exchange exposure remains static, based on the following scenarios: Parity - R$ vs US$ 5.1967 5.1880 3.8910 2.5940 Scenario Scenario Scenario I Scenario II Operation/Instrument Real Probable Depreciation 25 Depreciation 50 Assets denominated in US$ Fair value of “financial” derivatives 4,680,478 ( 7,881 ( 1,570,668 ( 4,696,241 Trade receivable recorded in Brazil in foreign currency 236,782 ( 399 ( 79,459 ( 237,579 Liabilities denominated in US$ Borrowings and financing in Brazil in foreign currency (a) ( 4,246,692 7,151 1,425,099 4,260,994 Trade payable registered in Brazil in foreign currency ( 14,459 24 4,852 14,508 Impact on net income and equity ( 1,105 ( 220,176 ( 658,318
Disclosure of Detailed Information About Cash Flow Hedged Items	The outstanding positions of derivative financial instruments designated as cash flow hedge on December 31, 2020 Cash flow hedge instrument Other comprehensive income Hedged item Notional currency Notional value Fair value (a) Accumulated contract gain (loss) Gain in the 12 Currency Swap – US$/R$ Currency BRL 2,576,020 1,879,348 249,021 183,342 Forward contract (The Body Shop) Currency BRL 1,096,227 ( 4,882 ( 4,882 ( 5,135 Forward contract (Natura Indústria) Currency BRL 17,807 ( 702 ( 702 ( 201 Total 3,690,054 1,873,764 243,437 178,006
Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income	The changes in cash flow hedge reserve recorded in OCI are shown below: Cash flow hedge Balance as of December 31, 2018 ( 27,840 Change in the fair value of hedge instrument recognized in OCI 107,337 Tax effects on fair value of hedge instrument ( 36,768 Cash flow hedge Balance as of December 31, 2019 42,729 Change in the fair value of hedge instrument recognized in OCI 178,006 Tax effects on fair value of hedge instrument ( 61,658 Cash flow hedge Balance as of December 31, 2020 159,077
Disclosure of Detailed Information About Interest Rate Risks of Transactions	Total borrowings and financing - in local currency (note 19 ( 9,591,809 Operations in foreign currency with derivatives related to CDI (a) ( 4,231,104 Short-term investments (notes 7 8 3,865,319 Net exposure ( 9,957,594 a) This refers to transactions involving derivatives related to CDI to hedge the borrowings and financing arrangements raised in foreign currency in Brazil.
Summary of Net Exposure to Interest Rate Risk by Scenario	The following tables show the projection of incremental loss that would have been recognized in profit or loss for the following year, assuming that the current net liability exposure is static and the following scenarios: Description Risk Probable scenario Scenario II Scenario III Net liability Rate increase ( 3,626 ( 33,235 ( 62,844
Summary of Working Capital Calculation	Management monitors the Company’s and its subsidiaries liquidity level considering the expected cash flows in exchange for unused credit facilities, as shown in the following table: 2020 2019 Total current assets 18,734,820 9,430,057 Total current liabilities ( 16,159,586 ( 7,518,423 Total net working capital 2,575,234 1,911,634
Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities	As at December 31, 2020 Description Less than one One five Over five Total expected cash flow Interest to be accrued Carrying amount Borrowings, financing and debentures 4,047,276 9,165,849 1,551,721 14,764,846 ( 941,933 13,822,913 Leases 1,231,622 2,644,292 734,771 4,610,685 ( 752,230 3,858,455 Payables to related parties, trade payables and reverse factoring operations 6,774,205 - - 6,774,205 - 6,774,205
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments	The carrying amounts and fair values of the Company’s financial instruments as at December 31, 2020 2019 Description Carrying amount Fair value Note Classification by category Fair value hierarchy 2020 2019 2020 2019 Financial assets Cash and cash equivalent 7 Cash and banks Amortized cost Level 2 4,436,123 3,110,220 4,436,123 3,110,220 Certificate of bank deposits Amortized cost Level 2 808,988 211,261 808,988 211,261 Repurchase transactions Fair value through profit or loss Level 2 576,108 1,192,101 576,108 1,192,101 5,821,219 4,513,582 5,821,219 4,513,582 Short term investments 8 Government bonds Fair value through profit or loss Level 1 864,940 221,900 864,940 221,900 Restricted cash Fair value through profit or loss Level 2 40,425 - 40,425 - Financial treasury bill Fair value through profit or loss Level 2 505,152 374,690 505,152 374,690 Loan investment fund Fair value through profit or loss Level 2 817,253 407,928 817,253 407,928 Dynamo Beauty Ventures Ltd fund Fair value through profit or loss Level 3 16,104 7,402 16,104 7,402 Certificate of bank deposits Fair value through profit or loss Level 2 292,878 21,327 292,878 21,327 2,536,752 1,033,247 2,536,752 1,033,247 Trade receivable 9 Amortized cost Level 2 3,597,535 1,685,764 3,597,535 1,685,764 Judicial deposits 13 Amortized cost Level 2 566,190 337,255 566,190 337,255 Carbon Credits 15 Fair value through profit or loss Level 2 4,097 3,508 4,097 3,508 Sublease receivables 15 Amortized cost Level 2 357,538 - 357,538 - “Financial” and “operating” derivatives Fair value through profit or loss - hedging instrument Level 2 1,768,122 737,378 1,768,122 737,378 “Financial” and “operating” derivatives Fair value through profit or loss Level 2 139,856 - 139,856 - 1,907,978 737,378 1,907,978 737,378 Financial liabilities Borrowings, financing and debentures 20 Local currency borrowings Amortized cost Level 2 ( 9,591,809 ( 7,412,443 ( 9,466,921 ( 7,445,672 Foreign currency borrowings Amortized cost Level 2 ( 4,231,104 ( 3,373,931 ( 4,459,081 ( 3,541,541 ( 13,822,913 ( 10,786,374 ( 13,926,002 ( 10,987,213 Carbon Credits 23 Fair value through profit or loss Level 2 ( 5,560 ( 4,519 ( 5,560 ( 4,519 “Financial” and “operating” derivatives Fair value through profit or loss - hedging instrument Level 2 - ( 10,158 - ( 10,158 “Financial” and “operating” derivatives Fair value through profit or loss Level 2 ( 61,201 ( 1,648 ( 61,201 ( 1,648 ( 61,201 ( 11,806 ( 61,201 ( 11,806 Lease liabilities 19 Amortized cost Level 2 ( 3,858,455 ( 2,517,565 ( 3,858,455 ( 2,517,565 Trade payables and supply chain finance operations 21 Amortized cost Level 2 ( 6,774,205 ( 1,829,756 ( 6,774,205 ( 1,829,756

Cash And Cash Equivalent (Table

Cash And Cash Equivalent (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule of Detailed Information About Cash And Cash Equivalents	2020 2019 Cash and banks 4,436,576 3,110,220 Certificate of Bank Deposits (a) 808,988 211,261 Repurchase transactions (b) 576,108 1,192,101 5,821,672 4,513,582 (a) As of December 31, 2020, Certificate of Bank Deposits (“CDB”) short-term investments are remunerated at an average rate of 103.2 106.9 2019 (b) Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2020 100.0 99.9 2019

Short-Term Investments (Tables)

Short-Term Investments (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule of Short-Term Investments	2020 2019 Loan investment funds 817,253 407,928 Certificate of Bank Deposits ( b ) 292,878 21,327 Treasury bills ( c ) 505,152 374,690 Government bonds ( LFT ) ( d ) 864,940 221,900 Dynamo Beauty Ventures Ltd. Fund 16,104 7,402 Restricted cash 40,425 - 2,536,752 1,033,247 Current 2,520,648 1,025,845 Non-current 16,104 7,402 (a) The Company and subsidiaries concentrate most of their investments in an exclusive investment fund, which holds interest in shares of the Essential Investment Fund. The values of the quotas held by the Company are presented under the heading “Exclusive Investment Fund”. The financial statements of the Exclusive Investment Fund, in which the group has exclusive participation ( 100 (b) Investments in CDBs classified as short-term investments are remunerated at an average rate of 100.0 106.9 2019 2020 57,609 38,018 2019 (c) As of December 31, 2020 136.61 106 2019 (d) As of December 31, 2020 105.9 100.4 2019
Schedule of Detailed Information About Investment Portfolio	The composition of the securities that make up the portfolio of the Essential Investment Fund, in which the Company hold 100 2020 2019 2020 2019 Certificate of Bank Deposits (CDB) 292,878 21,327 Repurchase transactions (cash and cash equivalent) 576,108 1,192,101 Financial letter 505,152 374,690 Government bonds (LFT) 864,940 221,900 2,239,078 1,810,018

Trade Receivables (Tables)

Trade Receivables (Tables)	12 Months Ended
	Dec. 31, 2020
Statement [Line Items]
Schedule of Detailed Information About Trade Receivables	2020 2019 Trade receivable 4,029,643 1,793,759 Allowance for expected credit losses ( 432,108 ( 107,995 3,597,535 1,685,764
Schedule of Trade Receivables by Exposure to Doubtful Accounts	The following table shows trade receivable by exposure to doubtful accounts on December 31, 2020 Trade receivable Allowance for expected credit losses Current 1,988,583 ( 53,352 Past due: Up to 30 1,506,460 ( 76,848 31 60 173,121 ( 56,124 61 90 111,735 ( 54,172 91 180 249,744 ( 191,612 4,029,643 ( 432,108
Trade receivables [member]
Statement [Line Items]
Schedule of Carrying Amount of Each Aging Range	Maximum exposure to credit risk at the reporting date is the carrying amount of each aging range, net of the allowance for expected credit losses, as shown in the aging list below: 2020 2019 Current 1,988,583 1,501,958 Past due: Up to 30 1,506,460 142,069 31 60 173,121 36,466 61 90 111,735 27,789 91 180 249,744 85,477 Allowance for expected credit losses ( 432,108 ( 107,995 3,597,535 1,685,764
Schedule of Allowance For Credit Losses	The changes in the allowance for expected credit losses for the year ended December 31, 2020 2019 Balance as of December 31, 2018 ( 129,242 Additions ( 209,515 Write-offs (a) 232,034 Exchange variation ( 1,272 Balance as of December 31, 2019 ( 107,995 Additions ( 640,676 Write-offs /reversals (a) 372,659 Exchange variation ( 56,096 Balance as of December 31, 2020 ( 432,108 (a) 180

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure of Inventories [Abstract]
Schedule of Inventories	2020 2019 Finished products 3,592,864 1,253,145 Raw materials and packaging 1,015,156 253,063 Consumables 170,188 82,228 Work in progress 36,025 27,346 Allowance for losses ( 269,963 ( 185,232 4,544,270 1,430,550
Schedule of Changes In The Provision For Inventory Losses	The changes in the provision for inventory losses for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 ( 178,268 Additions, net (a) ( 147,140 Write-offs (b) 136,431 Exchange rate variation 3,745 Balance as of December 31, 2019 ( 185,232 Additions, net (a) ( 341,799 Write-offs (b) 354,692 Exchange rate variation ( 97,624 Balance as of December 31, 2020 ( 269,963 (a) Refer to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the Company’s and its subsidiaries policy. (b) Consist of write-offs of products discarded by the Company.

Recoverable Taxes (Tables)

Recoverable Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule of Current Tax Assets	2020 2019 ICMS on purchase of goods (a) 681,147 434,832 Taxes on purchase of goods –subsidiaries abroad 230,260 39,475 ICMS on purchases of property, plant and equipment 9,578 10,628 PIS and COFINS on purchases of property, plant and equipment (b) - 3,826 PIS and COFINS on purchase of goods (c) 780,841 280,087 Withholding PIS, COFINS and CSLL 1,669 2,378 Withholding income tax 23,637 - IPI ( Tax on Manufactured Products ) ( d) 77,096 30,190 Others 199,333 3,438 2,003,561 804,854 Current 1,071,349 395,640 Non-current 932,212 409,214 (a) Accumulated Brazilian tax on the circulation of goods, interstate and inter-municipal transport and communication services (“ICMS”) tax credits were mainly generated from the purchases, which tax rate is higher than average sales rates and by increase in exports. (b) Brazilian taxes on the acquisition of fixed assets: Social Integration Programs (“PIS”) and Contribution for Social Security Financing (“COFINS”). (c) The accumulated tax credits for PIS and COFINS basically arise from credits on purchases of raw materials used in production. The realization of these credits normally occurs through offsetting with sales operations in the domestic market. (d) The balance will be used to IPI payable in future operations of the Company's subsidiaries.

Income Tax And Social Contrib_2

Income Tax And Social Contribution (Tables)	12 Months Ended
	Dec. 31, 2020
Deferred tax assets and liabilities [abstract]
Summary of breakdown of deferred income tax and social contribution – Assets	i) Breakdown of deferred income tax and social contribution – Assets: 2020 2019 Tax loss carryforwards and negative basis of social contribution tax 456,567 193,566 Allowance for doubtful accounts 133,162 51,151 Allowance for losses on inventories 101,237 50,593 Provision for tax, civil and labor contingencies 57,560 53,377 Provision for ICMS – ST 19,552 24,659 Allowances for losses on advances to suppliers 265 898 Accrued benefits sharing and partnerships 25,912 17,483 Provision for profit sharing 77,434 54,427 Provision carbon credits 9,848 8,297 Profit not realized in inventories 40,706 32,899 INSS with Suspended Liability - 17,757 Lease 30,493 22,268 Other expenses provision (a) 332,985 60,886 Post-employment healthcare plan 35,553 33,589 Net Operating Loss and Other Deduction Carryforwards 263,121 - Stock option plan 334,416 112,095 Other temporary differences 208,279 35,323 Deferred income tax and social contribution assets 2,127,090 769,268 Effect of changes in fair value of derivative instruments, including hedge accounting transactions ( 638,071 ( 247,163 Amortization and depreciation - useful life differences ( 104,750 ( 118,632 Fair value of identifiable net assets in business combinations of Emeis Holdings Pty Ltd - ( 24,516 Provision/(reversal) for losses - property and intangible assets ( 44,544 ( 4,509 Deferred income tax and social contribution liability ( 787,365 ( 394,820 Total of Deferred income tax and social contribution 1,339,725 374,448 a) Refers to temporary differences arising from the provision for invoices for services and suppliers recorded for which invoices have not yet been issued.
Summary of breakdown of deferred income tax and social contribution –Liabilities	ii) Breakdown of deferred income tax and social contribution – Liabilities: 2020 2019 Fair value of identifiable net assets in business combination (a) 1,288,045 450,561 a) The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of Avon, The Body Shop and Aesop.
Schedule of tax losses carryforwards for which no deferred tax asset recognised	The Company has not recognized certain deferred tax assets on losses. These losses relate to subsidiaries that have a history of losses and may not be used to offset taxable income elsewhere in the Company. The subsidiaries neither have any taxable temporary difference nor any tax planning opportunities available that could partly support the recognition of these losses as deferred tax assets. On this basis, the Company has determined that it cannot recognize deferred tax assets on the tax losses carried forward. Description Amount Indefinite Expiration Definite Expiration Net Operating Loss (a) 11,733,876 10,401,642 1,332,234 Credits (b) 96,893 - 96,893 Other Future Deductible Items 1,538,418 100,068 1,438,350 Total 13,369,187 10,501,710 2,867,477 a) During 2021 R$ 31 million are expected, the remaining expirations would start to occur in 2022 loss/deduction carryforwards subject to expiration in 2031 b) During 2021 R$ 26 million are expected, the remaining expirations would start to occur in 2022 utilizable credits subject to expiration in 2027 In addition, R$ 2,4 2022 2026 Management continuously evaluates tax planning opportunities to prevent tax attributes from expiring unutilized. As of December 31, 2020, there are no prudent and feasible tax planning opportunities that management would and could implement. In addition, for the attributes noted above, there are no other sources of income available and as a result, these attributes remain unrecognized. Management continuously evaluates all sources of income to allow unrecognized deferred tax asset to become recognized when it is probable that there are sufficient sources of income to allow for their recognition. Generally, recognition will occur when there is a history of profits that can be sustained and relied upon in the future and/or when facts/circumstances change indicating that a history of losses has been overcome due to elimination of loss making factors, changes in operations and other factors
Summary of reconciliation of income tax and social contribution	12.2 Reconciliation of income tax and social contribution: 2020 2019 2018 Income / (loss) After income tax and social contribution - 304,566 - Taxes on Company Formation (a) - 206,592 - Income / (loss) before income tax and social contribution (b) ( 388,935 511,158 673,405 Income tax and social contribution at the rate of 34 132,238 ( 173,794 ( 228,958 Benefit of expenses with research and technological innovation 23,033 19,228 - Tax incentives 10,018 12,457 10,724 Subsidy for investments (c) 128,173 24,864 12,505 Effect from differences of tax rates of entities abroad ( 166,394 26,907 14,077 Recognition of prior-year tax losses - USA and Mexico - - 70,065 Taxation of profits of subsidiaries abroad ( 56,194 ( 60,305 ( 12,694 Unrecognized tax benefits ( 104,160 ( 8,893 ( 11,799 Tax Benefits of interest on equity (IOE) 10,275 37,628 40,208 Exercise of stock options and restricted stock plans ( 9,770 9,697 - Non-Deductible Donation/Contribution ( 12,509 ( 4,136 ( 5,451 UK Tax Law Rate Change (d) ( 63,428 - - Post-employment healthcare plan - - 30,082 Withholding Taxes ( 63,754 - - Imputed Income ( 67,529 ( 1,156 ( 830 Other permanent differences ( 34,743 ( 31,596 ( 42,955 Income tax and social contribution expenses ( 274,744 ( 149,099 ( 125,026 Income tax and social contribution - current ( 292,828 ( 94,780 ( 182,324 Income tax and social contribution - deferred 18,084 ( 54,319 57,298 Effective Rate- % ( 70.6 29.2 18.6 (a) Tax levied on the formation of the Company resulting from the difference between Natura's accounting balances and the acquisition cost used for the purpose of the contribution of shares issued by Natura to the Company's capital stock (note 24 aforementioned special capital reserve constitutes part of the taxable profit for tax purposes in Brazil, the nature of this amount is different from the nature of other sources of taxable profit under the scope of IAS 12 i ) the Company did not generate taxable profits and this tax is mainly related to the increase in equity that generates the special reserve for statutory purposes; (ii) the creation of the special reserve is, in substance, a matter of reclassification; (iii) the tax is levied on the entity as a result of an additional increase in the equity of the contribution made to the Company; and (iv) the Company's future profits, as well as Natura's future and historical profits will continue to be taxed in accordance with tax legislation. The tax on the formation of the Company was recognized in the income statement and presented as "Taxes on the formation of the Company". (b) The loss before tax consolidated related to 2020 (c) The Company has tax incentives arising from its ordinary operations (Grant Investment). (d) During 2020 17 19 Such increase was accrued through deferred income tax expense during 2020
Summary of changes in deferred asset and liability income tax and social contribution	The movement in deferred asset and liability income tax and social contribution for the period ended December 31, 2020 were as follows: Asset Liability Balance at December 31, 2019 374,448 ( 450,561 Effect on profit or loss ( 19,639 37,723 Reserve for grant of options and restricted shares 96,181 - Effect on other comprehensive income ( 61,658 - Currency Translation Effect 283,359 ( 314,527 Business combination 667,034 ( 560,680 Balance at December 31, 2020 1,339,725 ( 1,288,045

Judicial Deposits (Tables)

Judicial Deposits (Tables)	12 Months Ended
	Dec. 31, 2020
Judicial Deposits [Abstract]
Summary of detailed information about judicial deposits	The judicial deposits held by the Company and its subsidiaries as at December 31, 2020 2019 2020 2019 Unaccrued tax lawsuits (a) 262,654 203,403 Accrued tax lawsuits (b) 252,961 116,415 Unaccrued civil lawsuits 9,671 2,541 Accrued civil lawsuits 2,189 426 Unaccrued labor lawsuits 14,166 8,683 Accrued labor lawsuits 24,549 5,787 Total judicial deposits 566,190 337,255 (a) The tax procedure related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 22.1.1 (b) The tax procedure related to these judicial deposits refer, substantially, to the sum of the amounts disclosed in note 22.2.1 21
Summary of detailed information about changes in judicial deposits	Changes in the balance escrow deposits for the period ended December 31, 2020 2019 Balance at December 31, 2018 333,577 New deposits 2,542 Redemptions ( 7,556 Interests 13,352 Payments / Write-offs for expenses ( 4,660 Balance at December 31, 2019 337,255 Acquisition of subsidiary 283,885 New deposits 18,377 Redemptions ( 64,761 Interests 11,242 Payments / Write-offs for expenses ( 17,739 Exchange variance ( 2,069 Balance at December 31, 2020 566,190

Assets Held For Sale (Tables)

Assets Held For Sale (Tables)	12 Months Ended
	Dec. 31, 2020
Assets Held for Sale Disclosure [Abstract]
Schedule of the changes in assets classified as held for sale	Balance as of December 31, 2019 - Avon acquisition 199,050 Additions (a) 25,779 Transfer to fixed assets ( b ) ( 29,610 Sale ( c ) ( 61,760 Exchange rate variation 47,820 Balance as of December 31, 2020 181,279 a) During the fourth quarter of 2020 b) During the first quarter of 2020 two one c) During the third quarter of 2020 two

Other Current And Non-Current_2

Other Current And Non-Current Assets (Tables)	12 Months Ended
	Dec. 31, 2020
Other Assets [Abstract]
Summary of detailed information about other assets	2020 2019 Marketing and advertising advances 42,233 28,669 Suppliers advances 257,099 102,225 Employees advances 65,180 13,983 Rent advances and guarantee deposits 169,958 96,202 Prepaid insurance expenses 200,074 29,647 Surplus pension plan (b) 683,425 - Customs broker advances - Import taxes 34,016 34,932 Sublease receivables (c) 357,538 - Carbon credits 4,097 3,508 Receivables from service providers (d) 135,030 - Others 195,138 39,868 2,143,788 349,034 Current 616,120 265,198 Non-current 1,527,668 83,836 a) Mainly related to: (i) advances of rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exemptions on IFRS 16 b) Pension plan arising from the acquisition of Avon (note 4 2 8 2 c) Refers to the sublease receivable from the New York office owned by Avon. d) Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

Property, Plant And Equipment (

Property, Plant And Equipment (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary Of Detailed Information About Property, Plant And Equipment	Useful life range (in years) 2019 Company acquisition Additions Write-offs impairment Transfers Exchange rate variation 2020 Cost: Vehicles 2 5 45,578 25,789 14,594 ( 17,274 - 1,184 9,356 79,227 Templates 3 192,556 - 1,243 ( 19,713 - 5,650 8,116 187,852 Tools and accessories 3 20 11,974 52,410 11,625 ( 1,743 - 5,888 5,524 85,678 Facilities 3 60 309,772 1,431 81 ( 3,599 - 8,791 ( 23,005 293,471 Machinery and accessories 3 15 866,451 740,328 20,098 ( 5,134 - 58,649 139,301 1,819,693 Leasehold improvements 2 20 615,103 58,548 34,324 ( 8,761 - 51,588 213,155 963,957 Buildings 14 60 386,957 1,203,081 12,275 - ( 115 48,551 248,427 1,899,176 Furniture and fixture 2 25 397,727 32,566 32,530 ( 6,300 ( 26 11,239 98,812 566,548 Land - 35,157 570,572 57 - - 4,252 51,575 661,613 IT equipment 3 15 297,228 112,369 27,254 ( 10,652 - 36,554 81,019 543,772 Other assets - - 36,423 - - - - 264 36,687 Projects in progress - 156,011 78,965 440,170 ( 592 - ( 305,305 39,136 408,385 Total cost 3,314,514 2,912,482 594,251 ( 73,768 ( 141 ( 72,959 871,680 7,546,059 Accumulated depreciation Vehicles ( 16,924 - ( 24,150 10,081 - ( 2,093 44 ( 33,042 Templates ( 175,938 - ( 10,092 19,684 - - ( 190 ( 166,536 Tools and accessories ( 3,255 - ( 42,932 - - 10 7,018 ( 39,159 Facilities ( 167,362 - ( 19,933 285 - 1,044 9,240 ( 176,726 Machinery and accessories ( 416,736 - ( 193,657 2,759 - ( 1,202 30,074 ( 578,762 Leasehold improvements ( 267,371 - ( 130,631 7,124 ( 4,900 ( 4,107 ( 80,669 ( 480,554 Buildings ( 101,785 - ( 88,593 - - - 10,649 ( 179,729 Furniture and fixture ( 193,973 - ( 81,287 4,744 ( 284 4,093 ( 51,904 ( 318,611 IT equipment ( 197,281 - ( 96,768 8,591 ( 36 - ( 26,362 ( 311,856 Other assets - - ( 25,078 - - - ( 949 ( 26,027 Total accumulated depreciation ( 1,540,625 - ( 713,121 53,268 ( 5,220 ( 2,255 ( 103,049 ( 2,311,002 Net total 1,773,889 2,912,482 ( 118,870 ( 20,500 ( 5,361 ( 75,214 768,631 5,235,057 Useful life range (in years) 2018 Additions Write-offs impairment Transfers Other changes including exchange rate variation 2019 Cost Vehicles 2 5 78,072 12,463 ( 41,883 - 99 ( 3,173 45,578 Templates 3 203,814 1,499 ( 23,823 - 10,874 192 192,556 Tools and accessories 3 20 8,161 314 ( 445 - 3,910 34 11,974 Facilities 3 60 310,282 49 - - ( 1,534 975 309,772 Machinery and accessories 3 15 819,919 9,563 ( 1,259 - 54,336 ( 16,108 866,451 Leasehold improvements 2 20 577,217 46,869 ( 23,243 ( 1,958 20,645 ( 4,427 615,103 Buildings 14 60 940,002 2,245 - ( 887 ( 555,221 818 386,957 Furniture and fixture 2 25 362,817 40,118 ( 3,031 ( 3,514 16,978 ( 15,641 397,727 Land - 30,525 - - - 4,653 ( 21 35,157 IT equipment 3 15 263,524 21,976 ( 3,902 - 18,483 ( 2,853 297,228 Projects in progress - 103,463 204,107 ( 2,247 - ( 146,598 ( 2,714 156,011 Total cost 3,697,796 339,203 ( 99,833 ( 6,359 ( 573,375 ( 42,918 3,314,514 Accumulated depreciation Vehicles ( 31,784 ( 15,832 27,478 - ( 7 3,221 ( 16,924 Templates ( 191,501 ( 8,314 23,739 - 148 ( 10 ( 175,938 Tools and accessories ( 2,954 ( 687 410 - - ( 24 ( 3,255 Facilities ( 147,309 ( 20,703 - - 1,234 ( 584 ( 167,362 Machinery and accessories ( 379,050 ( 56,617 657 - - 18,274 ( 416,736 Leasehold improvements ( 217,167 ( 90,281 19,089 - 5,292 15,696 ( 267,371 Buildings ( 191,422 ( 7,315 - - 96,558 394 ( 101,785 Furniture and fixture ( 138,078 ( 78,988 2,734 - ( 184 20,543 ( 193,973 IT equipment ( 161,817 ( 44,606 3,443 - ( 936 6,635 ( 197,281 Total accrued depreciation ( 1,461,082 ( 323,343 77,550 - 102,105 64,145 ( 1,540,625 Net total 2,236,714 15,860 ( 22,283 ( 6,359 ( 471,270 21,227 1,773,889

Intangibles (Tables)

Intangibles (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill	Useful life 2019 Acquisition of subsidiary Additions Write-offs Reversal (provision) of impairment Transfers Other changes including exchange rate variation 2020 Cost Software 2.5 10 1,313,090 291,555 82,718 ( 15,095 - 258,092 128,790 2,059,150 Trademarks and patents (Defined useful life) 20 25 116,805 517,592 - - - - 260,181 894,578 Trademarks and patents (Indefinite useful life) - 2,171,585 2,022,163 - - - - 1,553,309 5,747,057 Goodwill Avon (Note 4 - 11,511,028 - - - - 1,788,821 13,299,849 Goodwill Emeis Brazil Pty Ltd. (a) - 100,237 - - - - - 41,853 142,090 Goodwill The Body Shop (b) - 1,434,369 34,251 - - - - 478,121 1,946,741 Goodwill acquisition of TBS stores - 1,456 - - - - - - 1,456 Relationship with retail clients 10 1,987 - - - - - 798 2,785 Key money (indefinite useful life) (c) - 17,801 - - - - 1,315 7,653 26,769 Key money (Defined useful life) (d) 3 18 12,447 - 150 - ( 2,051 1,647 ( 1,333 10,860 Relationship with franchisees and sub franchisees and sales representatives (e) 7 15 602,958 1,884,249 - - - - 472,312 2,959,519 Technology developed (by acquired subsidiary) 5 - 1,131,573 - - - - 463,468 1,595,041 Other intangible assets 2 10 110,288 159 176,015 ( 15,024 - ( 175,414 12,251 108,275 Total cost 5,883,023 17,392,570 258,883 ( 30,119 ( 2,051 85,640 5,206,224 28,794,170 Accumulated amortization Software ( 649,347 - ( 365,184 44 - ( 3,643 ( 4,368 ( 1,022,498 Trademarks and patents ( 44,108 - ( 36,548 - - - ( 19,387 ( 100,043 Key money ( 2,197 - ( 535 - - 10 ( 6,149 ( 8,871 Relationship with retail clients ( 1,939 - ( 252 - - - ( 648 ( 2,839 Relationship with franchisees and sub franchisees and sales representatives ( 95,772 - ( 278,048 - - - ( 45,241 ( 419,061 Technology developed - - ( 294,713 - - - ( 24,296 ( 319,009 Other intangible assets ( 13,159 - ( 6,496 15,020 - - ( 86 ( 4,721 Total accumulated amortization ( 806,522 - ( 981,776 15,064 - ( 3,633 ( 100,175 ( 1,877,042 Net total 5,076,501 17,392,570 ( 722,893 ( 15,055 ( 2,051 82,007 5,106,049 26,917,128 Useful life range (years) 2018 Additions Write-offs Reversal (provision) of impairment Transfers Other changes including exchange variation 2019 Cost Software 2.5 10 1,089,900 83,064 ( 546 - 118,442 22,230 1,313,090 Trademarks and patents (Defined useful life) 20 25 111,801 - - - ( 154 5,158 116,805 Trademarks and patents (Indefinite useful life) - 2,040,067 - - - - 131,518 2,171,585 Goodwill Emeis Brazil Pty Ltd. (a) - 96,867 - - - - 3,370 100,237 Goodwill The Body Shop (b) - 1,348,670 - - - - 85,699 1,434,369 Goodwill acquisition of The Body Shop stores - 1,456 - - 1,456 Relationship with retail clients 10 1,740 - - - - 247 1,987 Key money (indefinite useful life) (c) - 102,310 - - - ( 101,001 16,492 17,801 Key money (Defined useful life) (d) 3 18 48,888 - - 2,818 ( 39,283 24 12,447 Relationship with franchisees and sub franchisees (e) 7 15 590,588 - ( 17,958 - ( 371 30,699 602,958 Technology developed (by acquired subsidiary) 5 - - - - - - - Other intangible assets 2 10 121,697 145,483 ( 1,133 - ( 146,364 ( 9,395 110,288 Total cost 5,553,984 228,547 ( 19,637 2,818 ( 168,731 286,042 5,883,023 Accumulated amortization Software ( 483,666 ( 169,174 6,817 - 270 ( 3,594 ( 649,347 Trademarks and patents ( 37,898 ( 4,330 - - 154 ( 2,034 ( 44,108 Key money ( 2,835 - - - 7,336 ( 6,698 ( 2,197 Relationships with retail clients ( 1,149 ( 194 - - - ( 596 ( 1,939 Relationship with franchisees and sub franchisees ( 55,508 ( 43,150 - - 371 2,515 ( 95,772 Technology developed - - - - - - - Other intangible assets ( 22,383 ( 1,601 585 - 261 9,979 ( 13,159 Total accrued amortization ( 603,439 ( 218,449 7,402 - 8,392 ( 428 ( 806,522 Net total 4,950,545 10,098 ( 12,235 2,818 ( 160,339 285,614 5,076,501 a) Goodwill related to the acquisition of Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. b) Goodwill related to the acquisition of The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests . In addition, on June 30, 2020, The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd , for R$ 133,275 2,632,000 st , 2020 and resulted in an assigned amount of goodwill of R$ 34,251 c) Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard IFRS 16 st , 2019 3.29 r ight of u se asset, refers to contracts that the standard exempts on the initial date, that is, short-term contracts. The remaining balance is not amortized and is subject to an annual impairment test . d) Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard ( IFRS 16 st , 2019 of Use asset, refers to contracts that the standard exempt on the initial date, that is, short-term contracts. The remaining balance is amortized over the term of the agreements. e) The balance refers to identifiable intangible assets from relationship with The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 . In 2019 In addition, the balance position classified as the acquisition of a subsidiary represents the fair value of the relationship between Avon and its sales representatives.
Disclosure Of Information For Cash-generating Units	CGUs group with intangible assets with indefinite useful life as of December 31, 2020 2019 CGU groups Trademarks and patents Goodwill Total 2020 2019 2020 2019 2020 2019 Natura &Co Latam 5,403 2,566 9,994,861 - 10,000,264 2,566 Avon International 2,850,397 - 3,304,988 - 6,155,385 - TBS International 2,891,257 2,169,019 1,946,741 1,434,369 4,837,998 3,603,388 Aesop International - - 142,090 100,238 142,090 100,238 Total 5,747,057 2,171,585 15,388,680 1,534,607 21,135,737 3,706,192
Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell	The main assumptions used to calculate the fair value less cost to sell as at December 31, 2020 Aesop The Body Shop Avon International Natura &Co Latam Measurement of recoverable value (fair value less cost to sell) Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five Budgeted gross margin Gross margins are based on average amounts obtained in the 2 5 Estimated cost Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share. Perpetuity growth rate (*) Constant growth of 4.20 Constant growth of 4.10 Constant growth of 4.30 Constant growth of 5.50 Discount rate (WACC) Discount rates represent the risk assessment in the current market, specific to each group of CGU, taking into account the value of money over time and the individual risks of related assets that were not incorporated in the assumptions included in the cash flow model. These cash flows were discounted using a discount rate of 13.42 11.14 7.80 9.11 (*) The rates are based on published market analyzes and projections with regard to the operating segment in which they operate and adjusted to reflect the assumptions considered by Management in the approved projections and to reflect the inflation differential of other currencies, when applicable.

Right of Use And Lease (Tables)

Right of Use And Lease (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule of Quantitative Information About Right-Of-Use Assets	a) Right of use asset Useful life in Years (a ) 2019 Acquisition of subsidiary Additions Write-offs Impairment ( b ) Transfers ( c ) Exchange rate variation 2020 Cost Vehicles 3 40,018 42,467 61,878 ( 441 - - 13,945 157,867 Machinery and equipment 3 10 15,578 14,034 11,265 - - - 12,171 53,048 Facilities 3 10 784,900 489,740 146,695 ( 16,094 - - 211,592 1,616,833 IT equipment 10 283 18,429 6,211 ( 323 - - 5,400 30,000 Retail stores 3 10 2,350,377 - 384,502 ( 25,189 ( 148,050 ( 2,962 779,426 3,338,104 Tools and accessories 3 2,803 - - - - - 384 3,187 Total cost 3,193,959 564,670 610,551 ( 42,047 ( 148,050 ( 2,962 1,022,918 5,199,039 Accumulated depreciation Vehicles ( 8,109 - ( 54,558 192 - - ( 947 ( 63,422 Machinery and equipment ( 4,317 - ( 14,899 - - - ( 1,829 ( 21,045 Facilities ( 97,190 - ( 291,431 12,448 - - ( 23,592 ( 399,765 IT equipment ( 214 - ( 18,694 - - - ( 253 ( 19,161 Retail stores ( 463,332 - ( 643,441 3,527 - - ( 188,100 ( 1,291,346 Tools and accessories ( 936 - ( 936 - - - ( 381 ( 2,253 Total accrued depreciation ( 574,098 - ( 1,023,959 16,167 - - ( 215,102 ( 1,796,992 Net total 2,619,861 564,670 ( 413,408 ( 25,880 ( 148,050 ( 2,962 807,816 3,402,047 Useful life in Years ( i ) First-time adoption (Note 3.29 Additions Write-offs Transfers (ii) Other changes 2019 Cost Value: Vehicles 3 - 40,069 ( 146 - 95 40,018 Machinery and equipment 3 10 - 14,954 ( 40 - 664 15,578 Facilities 3 10 103,945 187,294 - 481,235 12,426 784,900 IT equipment 10 - 279 - - 4 283 Retail stores 3 10 1,819,951 416,250 ( 76,022 150,374 39,824 2,350,377 Tools and accessories 3 - 2,650 - - 153 2,803 Total cost 1,923,896 661,496 ( 76,208 631,609 53,166 3,193,959 Depreciation value: Vehicles - ( 8,083 38 - ( 64 ( 8,109 Machinery and equipment - ( 4,126 - - ( 191 ( 4,317 Facilities - ( 95,734 - - ( 1,456 ( 97,190 IT equipment - ( 209 - - ( 5 ( 214 Retail stores - ( 466,590 ( 2,968 - 6,226 ( 463,332 Tools and accessories - ( 882 - - ( 54 ( 936 Total accrued depreciation - ( 575,624 ( 2,930 - 4,456 ( 574,098 Net total 1,923,896 85,872 ( 79,138 631,609 57,622 2,619,861 (a) The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms. (b) Of the total amount of impairment recorded in 2020 144,500 (c) Refers to key money related to store rentals. This amount is transferred from right of use to intangible assets when a new commercial agreement with the lessor is not yet signed.
Schedule Of Detailed Information About Cash Outflow Related To Leases	2020 2019 Value s recognized in the income statement for the year ended December 31, 2020 and 2019 Financial expense on lease 229,544 134,579 Amortization of right of use 1,023,959 575,624 Appropriation in the result of variable lease installments not included in the measurement of rental liabilities 45,952 31,023 Sublease revenue ( 27,079 ( 2,698 Short-term rental expenses and low-value assets 72,546 126,067 Benefits granted by lessor related to Covid- 19 ( 58,700 - Other lease-related expenses 40,206 22,214 Impairment losses 144,500 - Total 1,470,928 886,809 Values recognized in the financing cash flow statement: Lease payments (principal) 843,338 497,905 Values recognized in the operating cash flow statement: Lease payments (interest) 225,420 134,579 Variable lease payments, not included in the measurement of rental liabilities 13,033 11,199 Short-term and low-value assets leases payments 51,675 69,162 Lease-related payments 41,944 26,460 Total 1,175,410 739,305
Schedule Of Lease Obligation	b) Lease liabilit y 2020 2019 Current 1,059,661 542,088 Non-current 2,798,794 1,975,477 Total 3,858,455 2,517,565
Schedule Of Changes In The Balance Of Lease Obligation	The following tables shows the changes in the balance of lease obligations for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 446,235 First-time adoption of IFRS 16 1,949,739 New agreements 627,889 Payment of leasing (principle) ( 497,905 Payment of leasing (interest) ( 134,579 Recognition of financial charges 134,579 Write-offs (a) ( 86,319 Translation effects (other comprehensive income) 77,926 Balance as of December 31, 2019 2,517,565 New leases 559,905 Acquisition of subsidiary 777,200 Lease payments (principal) ( 843,338 Lease payments (interest) ( 225,420 Recognition of financial charges 229,544 Write-offs ( a) ( 193,174 Exchange rate variation 1,036,173 Balance as of December 31, 2020 3,858,455 (a) Refers mainly to the termination of contracts related to store leases.
Schedule Of Maturities Of The Balance Of Non-current Lease Liabilities	The maturity analysis of the lease liability non-current balance of are shown bellow: 2020 2019 2021 - 374,746 2022 611,048 361,688 2023 600,785 358,274 2024 598,380 363,802 2025 988,581 516,967 Total 2,798,794 1,975,477
Schedule of lease rates applied, according to the lease terms based on maturity.	The table below shows the rates applied, according to the lease terms: As described in note 3.13.2 Contractual Payments Maturity Average discount rate 2020 2021 2022 2023 2024 2025 Onwards 2025 2020 2022 1.9 10.5 566,802 32,692 8,946 - - - - 2023 2025 1.9 14.0 32,802 304,688 305,886 302,042 298,194 271,790 - 2026 2028 1.9 10.2 69,488 74,145 78,169 83,769 90,725 98,267 661,521 2029 2031 8.2 13.6 4,778 4,778 4,778 4,778 4,778 4,778 16,324 Total 673,870 416,303 397,779 390,589 393,697 374,835 677,845 Projected inflation 1 3.40 3.40 3.40 3.60 3.60 3.60 3.80 1 Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B 3

Borrowings, Financing And Deb_2

Borrowings, Financing And Debentures (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule Of Detailed Information About Borrowing	Raised in local currency: Ref. 2020 2019 Financing Agency for Studies and Projects FINEP 73,076 101,988 Debentures A 4,042,515 4,251,231 BNDES 7,789 35,390 BNDES – FINAME 15 183 Promissory notes B 773,949 2,883,382 Working capital – Mexico Operation 14,453 31,802 Working capital – Aesop Operation - 100,438 Working capital – The Body Shop Operation C 500,835 - Working capital – Avon Operation 145,495 - Notes – Avon ( 1 D 4,033,682 - Total in local currency 9,591,809 7,404,414 Raised in Foreign currency: BNDES 1,639 8,030 Export Credit Note (NCE) - 81,210 Representative debt securities (“Notes”) ( 1 E 3,969,226 3,090,490 Resolution nº 4131 62 F 260,239 202,230 Total in foreign currency 4,231,104 3,381,960 Grand total 13,822,913 10,786,374 Current 3,805,649 3,354,355 Non-current 10,017,264 7,432,019 Debentures Current 2,169,786 246,017 Non-current 1,872,729 4,005,214 ( 1 Balances resulting from the business combinations with Avon (Note 4
Schedule Of Additional Information About Borrowings	Reference Currency Maturity Charges Effective interest rate Guarantees A Real August, 2024 Interest of 109 112 1.4 1.75 1.00 1.15 109.5 113.1 1.15 1.79 None B Real Until April, 2021 Interest of 3.25 CDI + 3.30 Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda. C British Pounds March, 2021 Libor 2.00 Libor 2.00 Approval of subsidiary Natura Cosméticos S.A. D Dollar March, 2023 and March 2043 Interest of 7.00 8.95 Interest of 7.00 8.95 None E Dollar February, 2023 Interest of 5.375 6,1 None F Dollar May, 2022 Libor 1.1 Libor 1.1 Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda.
Schedule Of Changes In Balances Of Borrowing	Changes in the balances of borrowings, financings and debentures for the year ended December 31, 2020 and 2019 Balance as of December 31, 2018 7,994,145 New borrowings and financing 5,346,145 Amortization ( 2,643,575 Financial charges accrued 494,422 Payment of financial charges ( 499,798 Foreign exchange changes (unrealized) 88,097 Foreign exchange changes 5,903 Translation effects (OCI) 1,035 Balance at December 31, 2019 10,786,374 Assumed in a business combination (note 4 7,250,735 New borrowings and financing 1,354,765 Amortization ( 8,483,892 Accrued finance costs 1,029,705 Finance costs payment ( 1,293,094 Exchange rate variation (unrealized) 973,442 Exchange rate variation (realized) 35,429 Translation effects (OCI) 2,169,449 Balance as of December 31, 2020 13,822,913
Schedule Of Maturity Analysis For Noncurrent Borrowings	The maturities of non-current portion of borrowings, financing and debentures liabilities are present bellow: 2020 2019 2021 - 2,279,759 2022 586,002 527,596 2023 6,306,782 3,052,769 2024 3,124,480 1,571,895 Total 10,017,264 7,432,019
Schedule of detailed information about Notes - Avon	Notes - Avon Main US$ Main R$ Annual percentage interest rate Maturity Unguaranteed 461,883 2,400,267 7.00 March 15, 2023 Unguaranteed 216,085 1,122,929 8.95 March 15, 2043

Trade Payables And Reverse Fa_2

Trade Payables And Reverse Factoring Operations (Tables)	12 Months Ended
	Dec. 31, 2020
Trade Payables And Reverse Factoring Operations [Abstract]
Trade payables and reverse factoring operations	2020 2019 Domestic trade payables 5,462,377 1,581,759 Foreign trade payables (a) 1,014,356 105,073 Subtotal 6,476,733 1,686,832 Reverse factoring operations (b) 297,472 142,924 Total 6,774,205 1,829,756 (a) Refers to imports mainly denominated in US dollars, Euros and British pounds (b) The Group have contracts signed with Banco Itaú Unibanco S.A. to structure a “supply chain finance” the operation with the Company’s main suppliers. Further details on these operations are included in note 3 1 6

Tax Liabilities (Tables)

Tax Liabilities (Tables)	12 Months Ended
	Dec. 31, 2020
Dislosure Of Tax Liabilities [Abstract]
Schedule of detailed information about tax liabilities	2020 2019 ICMS (ordinary) 134,165 120,300 ICMS-ST provision (a) 61,521 72,423 Taxes on invoicing – foreign abroad 364,291 145,992 Social Security Tax (INSS) - suspension of the enforceability - 50,147 Withholding tax (IRRF) 131,368 48,593 Other taxes payable - foreign subsidiaries 48,365 1,180 Income tax 15,943 1,207 PIS and COFINS payable 11,857 - INSS and service tax (ISS) payable 32,954 3,218 Others 94,357 399 894,821 443,459 Current 785,367 320,890 Noncurrent 109,454 122,569 (a) The Company's subsidiaries have discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company’s subsidiaries, and in some cases, the amounts are deposited in court, as mentioned in note 13

Provision For Tax, Civil And _2

Provision For Tax, Civil And Labor Risks (Tables)	12 Months Ended
	Dec. 31, 2020
Disclosure of other provisions [line items]
Schedule of tax, civil and labor provision and contingent liabilities	The changes in the tax, civil and labor provision and contingent liabilities are presented below: Tax Civil Labor Business Total 2020 2019 2020 2019 2020 2019 2020 2020 2019 Balance at the beginning of the year 127,842 163,852 30,653 32,300 61,571 65,655 - 220,066 261,807 Acquisition of subsidiary ( 1 671,667 - 37,364 - 163,962 - 820,103 1,693,096 - Additions 169,824 14,497 186,182 14,072 44,566 45,983 9,772 410,344 74,552 Reversals ( 71,797 ( 54,168 ( 62,013 ( 4,766 ( 4,601 ( 40,127 ( 67,482 ( 205,893 ( 99,061 Payments ( 54,590 ( 1,150 ( 31,169 ( 11,418 ( 48,792 ( 14,611 - ( 134,551 ( 27,179 Inflation adjustment 5,623 4,440 4,164 309 6,508 5,009 21,671 37,966 9,758 Exchange rate variation 83,202 371 12,525 156 27,284 ( 338 13,629 136,640 189 Transfers ( 2 - - ( 99,309 - 841 - - ( 98,468 - Balance at the end of the year 931,771 127,842 78,397 30,653 251,339 61,571 797,693 2,059,200 220,066 Current 58,756 18,650 Non-current 2,000,444 201,416 (1) Amounts arising from lawsuits with probability of possible and remote loss of tax nature in the amount of R$ 709,751 labor in the amount of R$ 54,728 55,624 3 4 additionally, the fair value of contingent liabilities includes liabilities assumed and recognized by Avon prior to the allocation of fair value, in the amount of R$ 872,993 (2) Balance arising from other obligations of the subsidiary Avon, related to reclassifications of processes previously recognized as contingent liabilities to other trade payable.

Other Liabilities (Table)

Other Liabilities (Table)	12 Months Ended
	Dec. 31, 2020
Disclosure of defined benefit plans [line items]
Schedule of detailed information about other liabilities	2020 2019 Pension and p ost-employment healthcare plans (a) 783,184 98,792 Deferred revenue from performance obligations with customers (b) 422,353 76,250 Provisions for incentives to consultants (c) 292,034 - Provisions for operating expenses (marketing / technology, etc.) (d) 535,276 156,895 Discontinued operations (e) 153,140 - Provision for store renovation 99,702 15,997 Crer Para Ver (f) 75,508 51,543 Provisions for rentals (g) 70,598 26,568 Provision for restructuring (h) 68,954 3,401 Long-term incentives ( i ) 52,745 3,022 Provisions for apportionment of benefits and partnerships payable 10,005 7,860 Other provisions (j) 373,891 67,846 Carbon credit 5,560 4,519 Exclusivity contract 3,000 5,400 Total 2,945,950 518,093 Current 1,832,811 396,391 Non-current 1,113,139 121,702 a) As of December 31, 2020, Avon's pension and post-retirement plans amounts to R$ 648,990 134,194 98,792 b) Refers to the deferral of revenue related performance obligations of loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$ 318,686 103,667 c) Provision for incentive and recognition programs for consultants. d) Refers to the Group's operating provisions mainly due to spending on provision of technology services, marketing and advertising, etc., to comply with the accrual basis. e) As of December 17, 2015, Avon has contracts that resulted in the separation of operations in the United States, Canada and Puerto Rico. These transactions were closed on March 1 st 2016 143,112 f) Refers to Social program contribution for developing the quality of education. g) Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16 h) Provision for costs directly related to the plan for changes in the organizational structure, mainly of Avon and The Body Shop organizational structures. i) Refers substantially to the variable remuneration plans for Avon executives. j) Refers to provisions for insurance coverage, indemnities and long-term contractual obligations.
Avon [member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	The change in actuarial liabilities for the year ended December 31, 2020 is shown below: Pension Plan Post-retirement benefits Total Balance at beginning of year 413,070 107,735 520,805 Cost of services - current 28,015 - 28,015 Interest cost 13,760 3,610 17,370 Administrative costs 2,476 - 2,476 Company contributions ( 17,212 - ( 17,212 Benefits paid ( 4,611 ( 27,852 ( 32,463 Actuarial gain (loss) in OCI 74,460 2,063 76,523 Reclassifications ( 14,451 - ( 14,451 Plan amendments - ( 21,147 ( 21,147 Special termination benefits - ( 29,915 ( 29,915 Transfers - ( 25,273 ( 25,273 Others ( 2,814 985 ( 1,829 Foreign currency changes 117,268 28,823 146,091 Balance at end of year 609,961 39,029 648,990
Schedule of detailed information about actuarial liabilities computation	The significant actuarial assumptions for the determination of the actuarial liability are discount rate and rate of compensation increase. The details of the assumptions are as follows: 2020 Pension Plan Post-retirement benefits Discount rate 0.30 8.50 3.95 Rate of compensation increase 1.80 6.60 n/a
Schedule of detailed information about sensitivity analysis for actuarial assumptions	The analysis of the quantitative sensitivity analysis of discount rates and increase in compensation, if the behavior of such rate increased or decreased by 0.5 Rate Chance PVO Discount rate 1.53 0.5 ( 331,549 Discount rate 1.53 0.5 372,084 Rate of compensation increase 2.74 0.5 12,472 Rate of compensation increase 2.74 0.5 ( 11,952
Schedule of expected payments of contributions to the defined benefit plan in future years	The following are the expected payments of contributions to the defined benefit plan in future years: 2021 103,363 2022 89,038 2023 87,706 2024 86,157 2025 83,276 2026 2030 395,832
Natura Cosmticos SA [Member]
Disclosure of defined benefit plans [line items]
Schedule of detailed information about movements of actuarial liabilities	The changes of actuarial liabilities for the years ended December 31, 20 20 2019 2020 2019 Balance at the beginning of the year ( 98,792 ( 78,904 Cost of the Company´s current service ( 620 ( 816 Cost of interest ( 7,223 ( 7,125 Expenses paid 2,069 2,427 Actuarial gains (losses) in OCI ( 29,628 ( 14,374 Total ( 134,194 ( 98,792
Schedule of detailed information about actuarial liabilities computation	The actuarial liability was calculated, on December 31, 2020 and 2019 2020 2019 Discount rate 7.02 7.39 Initial growth rate of medical cost 3.75 7.17 Inflation rate 3.10 3.80 Final growth rate of medical cost 6.97 7.17 Growth rate of medical costs due to aging - costs Per age range 1.25 4.75 Per age range 1.54 4.5 Growth rate of medical costs by aging - contributions 0.00 0.00 Percentage of adherence to the plan in retirement Bradesco Plan 69.00 84.00 87.00 Schedule of disabled mortality Mercer Disability Mercer Disability Schedule of mortality AT- 2000 AT- 2000 Schedule of turnover Proportional calculation at the time of service Proportional calculation at the time of service
Schedule of detailed information about sensitivity analysis for actuarial assumptions	The table below sets forth the Medical Inflation Rate and the Discount Rate sensitivity analysis, if such rates increased or decreased by 0.5 1 Rate Chance VPO Discount rate 7.02 0.5 110,383 Discount rate 7.02 0.5 165,801 Rate of compensation 6.97 1 164,501 Rate of compensation 6.97 1 110,866

Shareholder's Equity (Table)

Shareholder's Equity (Table)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Schedule of Composition of Share Capital	As of December 31, 2020, the “Treasury shares” has the following composition: Number of shares Amount R$ (thousands) Average price per share - R$ Balance as of December 31, 2019 - - - Used ( 1,102,001 ( 52,849 47.53 Acquisition 1,418,702 64,516 45.48 Balance as of December 31, 2020 316,701 11,667 38.04

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of operating segment	2020 Reconciliation to net income (loss) for the year Net revenues Performance assessed by Depreciation Financial Financial Income tax Net income Natura &Co LATAM 20,542,345 2,369,515 ( 874,584 3,402,578 ( 3,891,641 ( 428,191 577,679 Avon International 9,097,375 185,914 ( 814,678 979,267 ( 1,442,216 ( 121,603 ( 1,213,315 TBS International 5,332,922 935,255 ( 761,224 82,736 ( 157,705 ( 66,626 32,436 Aesop International 1,949,338 606,544 ( 268,092 23,152 ( 72,056 ( 55,219 234,328 Corporate expenses - ( 731,889 ( 278 250,658 ( 210,192 396,895 ( 294,806 Total 36,921,980 3,365,339 ( 2,718,856 4,738,391 ( 5,773,810 ( 274,744 ( 663,678 2019 Reconciliation to net income (loss) for the year Net revenues Performance assessed by Depreciation Financial Financial Income tax Net income (loss) Natura &Co Latam 9,113,856 1,372,172 ( 370,953 1,893,333 ( 2,613,294 41,623 322,880 TBS International 4,028,660 806,357 ( 559,921 44,953 ( 99,765 ( 37,736 153,888 Aesop International 1,302,174 351,944 ( 186,542 9,337 ( 34,204 ( 47,768 92,768 Corporate expenses - ( 61,809 - 8,161 ( 48,611 ( 311,810 ( 414,069 Total 14,444,690 2,468,664 ( 1,117,416 1,955,784 ( 2,795,874 ( 355,691 155,467 2018 Reconciliation to net income (loss) for the year Net revenues Performance Depreciation Financial Financial Income tax Net income Natura &Co Latam 8,540,167 1,442,041 ( 318,506 1,925,524 ( 2,501,451 ( 149,709 397,900 TBS International 3,795,721 341,518 ( 206,004 126,289 ( 136,019 25,994 151,778 Aesop International 1,061,531 165,084 ( 65,401 4,608 ( 2,239 ( 36,004 66,047 Corporate expenses - ( 102,039 - - - 34,693 ( 67,346 Total 13,397,419 1,846,604 ( 589,911 2,056,421 ( 2,639,709 ( 125,026 548,379
Summary of operating segments of assets and liabilities	2020 2019 Non-current Total assets Current Non-current liabilities Non- Total assets Current Non- Natura &Co Latam 20,228,016 27,644,907 12,410,585 9,060,600 4,574,087 9,328,858 3,116,454 8,235,678 Avon International 12,486,733 19,097,959 405,975 5,625,774 - - - - TBS International 7,821,884 10,474,191 2,291,459 1,812,991 6,146,960 7,369,250 1,065,447 1,477,149 Aesop International 1,395,628 2,148,869 488,662 618,531 1,033,408 1,435,830 255,616 590,917 Corporate 250,516 1,551,671 562,905 253,007 - 3,050,574 3,080,906 - Total 42,182,777 60,917,597 16,159,586 17,370,903 11,754,455 21,184,512 7,518,423 10,303,744 2019 2018 Non-current Non-current assets Non-current Non-current Non-current Total assets Current Non- Natura &Co Latam 4,574,087 9,328,858 3,116,454 8,235,678 3,992,000 8,904,065 3,650,203 7,652,955 Avon International - - - - - - - - TBS International 6,146,960 7,369,250 1,065,447 1,477,149 4,518,655 5,709,760 681,660 504,592 Aesop International 1,033,408 1,435,830 255,616 590,917 413,136 765,724 235,018 81,019 Corporate - 3,050,574 3,080,906 - - - - - Total 11,754,455 21,184,512 7,518,423 10,303,744 8,923,790 15,379,549 4,566,881 8,238,566
Summary of revenue and assets by geographical area wise	No individual or aggregate customer (economic group) represents more than 10 Net revenues Net revenues Net revenues Non-current Non-current 2020 2019 2018 2020 2019 Asia 2,929,063 782,940 666,154 768,878 368,430 North America 5,120,953 1,750,957 919,826 5,939,728 981,673 Mexico 3,205,609 767,361 616,883 3,263,833 183,250 Other 1,915,344 983,596 302,943 2,675,895 798,423 South America 16,484,363 8,340,025 8,534,263 14,810,020 4,378,675 Brazil 11,113,810 6,324,227 6,082,896 12,159,245 4,197,258 Argentina 1,999,461 794,749 711,425 1,041,392 63,050 Other 3,371,092 1,221,049 1,739,942 1,609,383 118,367 Europe, Middle East and Africa (EMEA) 11,580,586 2,909,968 2,660,243 19,615,198 5,306,111 United Kingdom 4,117,699 2,115,385 1,877,475 17,059,017 4,678,139 Other 7,462,887 794,583 782,768 2,556,181 627,972 Oceania 807,015 660,800 616,933 1,048,952 719,566 Total 36,921,980 14,444,690 13,397,419 42,182,777 11,754,455 There is no other individual foreign country that represents more than 10 2019 2018

Revenues (Tables)

Revenues (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of revenue by Geographical Area Wise	Gross revenues: 2020 2019 2018 Domestic market 15,373,742 8,907,766 8,575,971 Foreign market 31,784,934 10,739,036 9,936,334 Other sales 538,942 61,302 49,657 Subtotal 47,697,618 19,708,104 18,561,962 Returns and cancellations ( 617,140 ( 73,183 ( 54,522 Commercial discounts and rebates ( 1,062,204 ( 1,292,134 ( 1,421,251 Taxes on sales ( 9,096,294 ( 3,898,097 ( 3,688,770 Subtotal ( 10,775,638 ( 5,263,414 ( 5,164,543 Total net revenues 36,921,980 14,444,690 13,397,419

Operating Expenses and Cost o_2

Operating Expenses and Cost of Sales (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Operating Expenses and Cost of Sale	2020 2019 2018 Cost of sales 13,229,715 4,033,454 3,782,843 Selling, marketing and logistics expenses 15,702,787 6,395,586 5,828,713 Administrative, R&D, IT and project expenses 5,955,996 2,405,576 2,251,341 Total 34,888,498 12,834,616 11,862,897
Summary of Operating Expenses and Cost of Sale Breakdown by Nature	Classified by nature Cost of sales 13,229,715 4,033,454 3,782,843 Raw material/packaging material/resale 11,222,801 3,457,481 3,223,446 Employee benefits expense (note 28 638,525 293,374 276,848 Depreciation and amortization 215,355 57,443 65,157 Other 1,153,034 225,156 217,392 Selling, marketing and logistics expenses 15,702,787 6,395,586 5,828,713 Logistics costs 2,479,156 797,055 750,238 Employee benefits expense (note 28 4,198,147 1,667,202 1,656,611 Marketing, sales force and other selling expenses 7,723,827 3,164,875 3,191,895 Depreciation and amortization 1,301,657 766,454 229,969 Administrative, R&D, IT and project expenses 5,955,996 2,405,576 2,251,341 Innovation expenses 270,256 89,675 102,436 Employee benefits expense (note 28 2,498,024 1,223,586 1,036,866 Other administrative expenses 1,985,872 798,796 817,254 Depreciation and amortization 1,201,844 293,519 294,785 Total 34,888,498 12,834,616 11,862,897

Employee Benefits (Tables)

Employee Benefits (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Employee Benefit Expense	2020 2019 2018 Payroll, profit sharing and bonuses 5,407,990 2,315,517 2,350,182 Pension Plan 186,373 93,528 41,923 Share-based payments (note 28.1 163,345 58,855 40,505 Charges on restricted shares (note 28.1 68,617 59,753 22,428 Health care, food and other benefits 684,992 253,510 177,135 Charges, taxes and social contributions 635,248 231,384 181,240 INSS 188,131 171,615 156,912 Total 7,334,696 3,184,162 2,970,325
Summary of Number and Weighted Average Number of Shares	The changes in the number of outstanding stock options and their related weighted-average prices, as well as variations in the amount of restricted stocks, share are as follows: Stock Option Plan and Strategy Acceleration Plan Average exercise price per option 1 - R$ Options (thousands) 1 Balance as of December 31, 2019 16.51 17,568 Arising from the acquisition of Avon (note 4 0.01 1,994 Granted 0.01 117 Expired / Cancelled 21.25 ( 167 Exercised 16.65 ( 2,267 Balance as of December 31, 2020 16.49 17,245 Restricted shares (thousands) 1 Performance shares (thousands) 2 Balance as of December 31, 2019 3,092 688 Granted 5,026 - Expired ( 22 ( 51 Exercised ( 1,136 - Balance as of December 31, 2020 6,960 637 a) The number of restricted shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019. b) The number of performance shares granted, expired and exercised are shown considering the split of shares approved at the General Meeting on September 17, 2019.
Summary of Terms and Conditions of Share-based Payment Arrangement	The outstanding stock options and the restricted stock as at the end of the period have the following maturity dates and exercise prices: As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Exercise price - R$ Fair value – R$ Existing options (thousands) ¹ Remaining contractual life (years) Vested options (thousands) March 18, 2013 4 37.60 6.05 300 0.2 300 March 17, 2014 4 25.16 4.27 96 1.2 96 March 16, 2015 From 2 4 13.60 4.85 5.29 184 2.2 184 July 28, 2015 (Strategy acceleration) From 4 5 12.90 6.20 6.23 1,020 2.6 1,020 March 15, 2016 From 2 4 12.84 7.16 7.43 184 3.3 182 July 11, 2016 (Strategy acceleration) From 4 5 11.41 6.84 6.89 1,924 3.6 606 March 10, 2017 From 2 4 12.59 6.65 6.68 598 4.3 272 March 10, 2017 (Strategy acceleration) From 4 5 12.59 6.87 6.89 2,210 4.3 - March 12, 2018 From 2 4 16.96 7.96 8.21 1,846 5.3 488 March 12, 2018 (Strategy acceleration) From 3 5 12.16 16.96 8.21 9.67 3,800 5.3 - April 12, 2019 From 3 4 23.54 11.71 11.82 1,636 6.3 - April 12, 2019 (Strategy acceleration) From 4 5 23.54 11.51 11.71 1,900 6.3 - Between December 31, 2002 to May 09, 2017 1 0.01 19.80 65 - 65 Between March 14 to December 17, 2018 From 1 3 0.01 19.70 319 0.4 55 Between March 13 to December 16, 2019 From 1 3 0.01 19.58 1,046 0.2 1.4 33 June 8, 2020 1 0.01 16.86 117 0.7 104 17,245 3,405 ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019 As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Existing stock ( thousands) 1 Fair value (R$) Remaining contractual life (years) March 10, 2017 From 2 4 208 11.69 12.51 0.4 March 12, 2018 – Plan I From 2 4 470 15.18 15.9 0.5 1.5 March 12, 2018 – Plan III From 1 3 74 15.54 16.27 0.5 March 12, 2018 – Extraordinary Plan I From 1 3 4 15.54 16.28 0.4 August 13, 2018 – Extraordinary Plan VI From 1.6 3.6 50 12.24 13.13 0.5 1.5 April 12, 2019 – Plan I From 2 4 814 21.62 22.53 0.5 2.5 April 12, 2019 – Plan II From 1 3 312 22.14 22.85 0.5 1.5 March 27, 2020 – Co-Investment Plan From 1 3 1,789 29.00 0.5 2.5 September 29, 2020 – Long-term Incentive Plan From 3 4 3,239 73.46 3 4 6,960 ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019. As of December 31 , 2020 Grant date Conditions for acquiring the rights from grant date Existing shares (thousands) ¹ Fair value (R$) Remaining contractual life (years) Undelivered shares (thousands) May 21, 2019 From 3 4 637 23.10 45.70 1.5 2.5 - 637 - ¹ The number of restricted shares and performance shares granted, expired and exercised are shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019.

Financial Income (Expenses) (Ta

Financial Income (Expenses) (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Detailed Information About Financial Income Expense	2020 2019 2018 FINANCIAL INCOME: Interest on short-term investments 167,967 83,115 129,296 Gains on monetary and exchange rate variations (a) 1,886,940 854,025 477,297 Gains on swap and forward transactions (c) 2,532,487 961,185 1,323,470 Gains on swap and forward derivatives mark to market 12,314 1,709 2,760 Monetary adjustment reversal on provision for tax risks and tax obligations 42,378 25,469 89,151 Other financial income 96,305 30,281 34,447 Subtotal 4,738,391 1,955,784 2,056,421 FINANCIAL EXPENSES: Interest on financing ( 1,104,863 ( 503,040 ( 631,475 Interest on leases ( 229,544 ( 134,579 - Losses on monetary and exchange rate variations (b) ( 2,308,134 ( 937,925 ( 1,073,549 Losses on swap and forward transactions (d) ( 1,579,695 ( 964,116 ( 794,504 Losses on swap and forward derivatives mark to market ( 13,691 ( 1,452 ( 2,197 Adjustment of provision for tax, civil and labor risks and tax liabilities ( 15,626 ( 13,822 ( 22,026 Appropriation of funding costs (debentures and notes) ( 11,082 ( 22,671 ( 37,400 Interest on pension plan ( 10,323 - Hyperinflationary economy adjustment (Argentina) ( 20,625 ( 13,947 ( 25,066 Debt structuring expenses for Avon acquisition ( 110,741 ( 115,781 - Other financial expenses ( 369,486 ( 88,541 ( 53,492 Subtotal ( 5,773,810 ( 2,795,874 ( 2,639,709 Net financial income (expenses), net ( 1,035,419 ( 840,090 ( 583,288
Summary of Foreign Exchange Hedging Transactions and the Related Balancing Items in the Income Statement	The breakdown set forth below is intended to better explain the results of the foreign exchange rate hedging transactions entered into by the Company as well as its related items recorded in the financial income (expenses) and shown in the previous table: 2020 2019 2018 (a) Gains on monetary and exchange rate variations 1,886,940 854,025 477,297 Gains on exchange rate variation on borrowings, financing and debentures 714,681 677,462 402,345 Exchange rate variation on imports 35,218 11,221 6,385 Exchange rate variation on export receivables 69,365 26,144 42,901 Exchange rate variation on trade payable from foreign subsidiaries 450,468 132,397 25,666 Exchange variations of bank accounts in foreign currency 617,208 6,801 - (b) Losses on monetary and exchange rate variations ( 2,308,134 ( 937,925 ( 1,073,549 Losses on exchange rate variation on borrowings, financing and debentures ( 1,301,812 ( 768,939 ( 996,034 Exchange rate variation on imports ( 58,623 ( 33,718 ( 40,140 Exchange rate variation on export receivables ( 55,829 ( 23,393 ( 18,323 Exchange rate variation on trade payable from foreign subsidiaries ( 365,214 ( 86,764 ( 13,075 Exchange rate variation on financing ( 525,173 ( 297 ( 5,977 Exchange variations of bank accounts in foreign currency ( 1,483 ( 24,814 - (c) Gains on swap and forward transactions 2,532,487 961,185 1,323,470 Revenue from swap exchange coupons 207,783 182,897 170,555 Gains from exchange variations on swap instruments 2,324,704 778,288 1,152,915 (d) Losses on swap and forward transactions ( 1,579,695 ( 964,116 ( 794,504 Losses on exchange rate variation on swap instruments ( 691,941 ( 690,409 ( 402,708 Financial costs of swap instruments ( 869,890 ( 273,707 ( 391,796 Loss on interest rate swap ( 17,864 -

Other Operating Income (Expen_2

Other Operating Income (Expenses), Net (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Detailed Information About Other Operating Income (Expense)	Other operating income, net 2020 2019 2018 Result on write-off of property, plant and equipment 11,855 6,098 1,188 ICMS-ST (a) 18,653 42,336 ( 27,126 Exclusion of ICMS from PIS/COFINS base (d) - 52,631 57,242 PIS/COFINS credits (c) - 42,983 - Proceeds from the sale of customer portfolio (b) - 23,092 16,254 Tax contingencies (h) 45,057 21,402 ( 706 ICMS credit - - 2,290 Tax credits - taxation change (c) 60,177 - 23,677 Reintrega credits - - 3,058 Other operating income 10,757 - - Total other operating income 146,499 188,542 75,877 Other operating expenses, net Crer para Ver (e) ( 54,500 ( 36,156 ( 29,686 Expense on the sale of customer portfolio ( 7,498 - - Acquisition related cost (f) ( 303,916 ( 141,348 - Tax contingencies ( 10,100 - - Transformation and integration plan (g) ( 256,700 ( 51,520 ( 98,465 Other operating expenses ( 29,975 ( 8,829 12,329 Total other operating expenses ( 662,689 ( 237,853 ( 115,822 Other operating income (expenses), net ( 516,190 ( 49,311 ( 39,945 a) Refers to the requirement of ICMS tax substitution, for different Federal States (details in note 22). During 2020, provisions were reversed due to the revision of the likelihood of loss of certain States. b) Refers to the revenue from the sale of securities portfolio of customers past due over 180 c) Tax credits from prior periods related to the change on PIS and COFINS taxation. d) The Company and its subsidiary Indústria e Comércio de Cosméticos Natura Ltda. are currently litigating the non-inclusion of ICMS in the PIS and COFINS contributions calculation base. Since 2007, the Company is legally authorized to pay contributions excluding ICMS, but the balance ICMS has been provisioned for as Taxes Payable. On September 30, 2017, based on the conclusion from the judgment made by the Plenary Session of the Federal Supreme Court on the Extraordinary Appeal, with general repercussion in society, which ruled unconstitutional the inclusion of ICMS in the PIS and COFINS calculation base, the Company reverted the tax obligation. On December 31, 2019, the Company recognized principal credit of R$ 52,631 e) Allocation of operating profit from sales of “Crer Para Ver” line of non-cosmetic products to Natura Institute, specifically directed to social projects for developing the quality of education. f) Refers to expenses related to the acquisition process, of Avon, which stand out: financial structuring expenses (R$ 115,696 ), legal expenses (R$ 17,281 ), regulatory expenses (R$ 18,030 ) and executive compensation plans (R$ 152,909 ). g) Expenses related to the implementation of the transformation plan of The Body Shop and integration of Avon, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) redesign of the organization. h) One of our subsidiaries is a party to proceedings relating to the unconstitutionality of the Fator Acidentário de Prevenção, or FAP, and the increase in the rate related to Riscos Ambientais do Trabalho, or RAT, both of which labor taxes. During the year ended December 31, 2020, based on the analysis of our legal advisors, our management reassessed the chance of loss of in the legal proceedings relating to this matter. As a result of reassessment, our subsidiary reversed the provision originally constituted.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Basic Earnings Per Share	2020 2019 2018 Net income (loss) attributable to owners of the Company ( 650,196 155,467 548,379 Weighted average number of issued shares (a) 1,246,180,219 865,660,042 865,660,042 Weighted average number of treasury shares (a) ( 572,130 - - Weighted average number of outstanding shares 1,245,608,090 865,660,042 865,660,042 Basic earnings (loss) per share - R$ (b) ( 0.5220 0.1796 0.6335 (a) 2019 (b) one
Summary of Diluted Earnings Per Share	Diluted earnings per share for the year ended on December 31, 2019 and 2018 2019 2018 Net income attributable to the Company’s controlling shareholders 155,467 548,379 Weighted average number of issued shares (a) 865,660,042 865,660,042 Adjustment for stock options and restricted shares (a) 8,124,575 1,529,528 Weighted average number of ordinary shares for diluted earnings calculation 873,784,617 867,189,570 Diluted earnings per share - R$ 0.1779 0.6324 (a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and their retrospective effects.
Summary of basic earnings per share for net loss of discontinued operations	The basic earnings per share for net loss of discontinued operations for the year ended December 31, 2020 are presented below: 2020 Net loss attributable to the Company’s controlling shareholders ( 143,112 Weighted average number of issued shares (a) 1,246,180,219 Weighted average number of treasury shares (a) ( 572,130 Weighted average number of outstanding shares 1,245,608,089 Basic l oss per share - R$ (b) ( 0.1149 (a)

Related-Party Transactions (Tab

Related-Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Total Compensation of the Company's Management	The total compensation of the Company’s Management is as follows: 2020 2019 2018 Compensation Compensation Compensation Fixed Variable Total Fixed Variable Total Fixed Variable Total (a) (b) (a) (b) (a) (b) Board of Directors 16,123 65,011 81,134 22,056 30,919 52,975 13,141 24,860 38,001 Executive Board 49,187 80,218 129,405 32,963 42,142 75,105 32,739 68,540 101,279 65,310 145,229 210,539 55,019 73,061 128,080 45,880 93,400 139,280 a) The line item “Executive Board” includes the amount of R$ 1,201 2020 536 b) Refers to profit sharing regarding the Restricted Stock Plan and Strategy Acceleration Program, including charges, as applicable, to be determined in the year. The amounts include additions to and/or reversals of provisions made in the previous year, due to final assessment of the targets determined to the board members and officers, statutory and non-statutory, in relation to profit sharing.
Summary of the Company Officers and Executives' Compensation	Breakdown of the Company officers and executives’ share-based payments compensation: Grant of options 2020 2019 2018 Stock option balance (number) 1 (a) Average fair value of stock options 1 – R$ Average exercise price 1 - R$ (b) Stock option balance (number) 1 (a) Average fair value of stock options 1 – R$ Average exercise price 1 - R$ (b) Stock option balance (number) 1 (a) Average fair value of stock options 1 Average exercise price 1 (b) Officers 12,847,760 8.64 16.49 13,059,677 8.4 16.51 11,156,406 7.47 15.96 Restricted shares 2020 2019 2018 Stock option balance (number) 1 (a) Average exercise price 1 (b) Stock option balance (number) 1 (a) Average exercise price 1 (b) Stock option balance (number) 1 (a) Average exercise price 1 (b) Officers 5,293,874 51.2 1,012,641 19.23 751,794 14.81 ( 1) The number of stock options granted, expired and exercised and their respective fair values is shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019 ( 2 ) The number of restricted stock and performance shares granted, expired and exercised is shown already considering the stock split approved at the Extraordinary General Meeting on September 17, 2019 (a) Refers to the balance of the options and restricted shares vested and non-vested, not exercised, at the reporting dates. (b) Refers to the weighted-average exercise price of the option at the time of the stock option plans, adjusted for interest based on the Extended Consumer Price Index (IPCA ) through the end of the reporting period. The new Stock Option Plan implemented in 2015

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Contractual Commitments	Total minimum supply payments, measured at nominal value, according to the contract, are: 2020 2019 2018 Less than one 1,413,904 17,918 1,268 One five 885,990 13,160 4,940 Total 2,299,894 31,078 6,208

Insurance (Tables)

Insurance (Tables)	12 Months Ended
	Dec. 31, 2020
Text Block [Abstract]
Summary of Types of Insurance Coverage	As at December 31, 2020 Item Type of coverage Amount insured 2020 2019 Industrial complex and administrative sites Any damages to buildings, facilities, inventories, and machinery and equipment 3,062,806 2,322,801 Vehicles Fire, theft and collision for the Company and subsidiaries vehicles 232,459 212,027 Loss of profits No loss of profits due to material damages to facilities buildings and production machinery and equipment 1,894,813 1,582,000 Transport Damages to products in transit 46,019 32,309 Civil liability Protection against error or complaints in the exercise of professional activity that affect third parties 730,740 532,510 Environmental liability Protection against environmental accidents that may result in environmental lawsuits 30,000 30,000

Additional Information Relati_2

Additional Information Relating To The Statements Of Cash Flows (Tables)	12 Months Ended
	Dec. 31, 2020
Additional Cash Flow Information [Abstract]
Summary of Additional Information On Transactions Related To Cash Flow Statement	The following table presents additional information on transactions related to the cash flow statement: 2020 2019 2018 Non-cash items Hedge accounting, net of tax effects 116,348 70,569 51,165 Dividends and interest on equity declared and not yet paid - 110,671 111,449 Net effect of acquisition of property, plant and equipment and intangible assets not yet paid 172,104 ( 18,645 6,797 Consideration for acquisition of subsidiary 13,366,114 - -

General Information - Additiona

General Information - Additional Information (Detail)	1 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Natura Cosméticos S.A. [Member]
General Information [Line Items]
Percentage of shares held	100.00%	100.00%	100.00%	0.00%

Summary of Significant Accoun_4

Summary of Significant Accounting Polices - Summary of Information About Company Principal Subsidiaries (Detail) - BRL (R$) R$ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement [Line Items]
Income from government grants before income taxes		R$ 192686
Avon Products, Inc
Statement [Line Items]
Direct ownership		100.00%	0.00%	0.00%
Natura Cosméticos S.A. [Member]
Statement [Line Items]
Direct ownership	100.00%	100.00%	100.00%	0.00%
Natura &Co International S.à r.l.
Statement [Line Items]
Direct ownership		100.00%	0.00%	0.00%

Summary of Significant Accoun_5

Summary of Significant Accounting Polices - Additional Information (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)Store	Dec. 31, 2019BRL (R$)Store	Dec. 31, 2018
Statement1 [Line Items]
Rates of inflation	36.10%	54.50%
Gains on exchange differences on translation	R$ 32160	R$ 17666
Period covered by budgets and forecast calculations	5 years
Applicable tax rate	(70.60%)	29.20%	18.60%
Tax loss carryforward on taxable income | %	30.00%
Amount of provision reversed	R$ 297216
Amount related to loan and financing contracts subject to reference rate reform	R$ 761074
Corporate Income Tax IRPJ [Member]
Statement1 [Line Items]
Applicable tax rate	15.00%
Additional applicable tax rate	10.00%
Income Taxable	R$ 240
Social Contribution CSLL [Member]
Statement1 [Line Items]
Applicable tax rate	9.00%
Bottom of range [member]
Statement1 [Line Items]
Change in market value of hedged items | %	80.00%
Applicable tax rate	17.00%
Top of range [member]
Statement1 [Line Items]
Change in market value of hedged items | %	125.00%
Applicable tax rate	19.00%
IAS 29 [Member] | Financial Result [Member]
Statement1 [Line Items]
Effect of initial application of standards	R$ 20625	R$ 13947
IAS 29 [Member] | Net Income [Member]
Statement1 [Line Items]
Effect of initial application of standards	106,206	R$ 68940
Amendments to IFRS 16 [Member]
Statement1 [Line Items]
Recongnized Reduction in Lease Expenses	R$ 58700
Franchise Stores [Member]
Statement1 [Line Items]
Number of stores | Store	474	256
Brazil [Member]
Statement1 [Line Items]
Number of stores | Store	61	43
France Argentina and Chile [Member]
Statement1 [Line Items]
Number of stores | Store	7	9

BUSINESS COMBINATIONS - Summary

BUSINESS COMBINATIONS - Summary of the preliminary fair value calculation of the consideration transferred (Details) - Avon Products, Inc R$ / shares in Units, R$ in Thousands		Jan. 03, 2020BRL (R$)R$ / sharesshares		Dec. 31, 2020BRL (R$)
Summary of the preliminary fair value calculation of the consideration transferred
Number of Avon common shares outstanding as of January 3, 2020 | shares		536,383,776
Multiplied by the exchange ratio of 0.600 entity shares per each acquiree common share		321,830,266
Multiplied by the market price of entity shares | R$ / shares		R$ 410
Consideration in the issuance of shares		R$ 13195041000
Consideration transferred adjustment	[1]	171,073,000
Fair value of estimated consideration to be transferred		R$ 13366114	[2]	R$ 13366114
Exchange ratio per each common share of acquiree		0.600
Settlements of share-based payment plan, consideration recognised		R$ 80
Stock option plans liquidated for consideration recognised		R$ 91
[1]	Related to the effects of replacements and settlements of share-based payment plans, of which the amount of R$80 thousand refers to the share-based payment plans of Avon, in which it was substituted by Natura &Co, and R$ 91 thousand refers to the stock option plans liquidated as a result of the conclusion of the transaction. These are pre-combination installments that were regarded as a transferred compensation.
[2]	Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange.

BUSINESS COMBINATIONS - Schedul

BUSINESS COMBINATIONS - Schedule of preliminary allocation prepared by Company and resulting goodwill (Details) - Avon Products, Inc - BRL (R$) R$ in Thousands		Dec. 31, 2020		Jan. 03, 2020
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Total estimated consideration to be transferred		R$ 13366114		R$ 13366114	[1]
Fair value of acquired assets:
Cash and cash equivalent				2,636,108
Trade receivable	[2]			1,135,269
Inventories				1,919,683
Other current assets				1,031,136
Non-current assets held for sale				199,050
Property, plant and equipment				2,912,482
Deferred income tax and social contribution				667,034
Right of use	[3]			564,669
Other non-current assets				475,096
Judicial deposits				283,885
Recoverable taxes				531,930
Employee benefit plan (other assets)				553,297
Intangible		5,846,812	[4]	5,846,812	[5]
Fair value of liabilities assumed:
Borrowings, financing and debentures				7,256,583
Trade payable				2,915,418
Salaries, profit sharing and social charges				621,203
Dividends and interest on equity payable				405,916
Derivative financial instruments				15,518
Operating expenses accruals				999,653
Provision for restructuring (other liabilities)				152,896
Lease liabilities				777,200
Tax liabilities				341,258
Income tax and social contribution				30,068
Provision for tax, civil and labor risks		1,693,096	[6]	1,693,096	[7]
Liabilities from discontinued operations (other liabilities)				64,844
Deferred income tax and social contribution (6)		592,534	[8]	592,534	[9]
Other liabilities				1,007,623
Total identifiable net assets at fair value		1,882,641		1,882,641
Non-controlling interest		27,555		27,555
Goodwill arising on acquisition		R$ 11511028		R$ 11511028	[10]
[1]	Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange.
[2]	The fair value of the trade receivable amounts to R$ 1,135,269 and is equivalent to it carrying amount and, it is expected that the carrying amount can be collected.
[3]	The Company measured the acquired lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount equal to the lease liabilities and adjusted to reflect the favorable terms of the lease relative to market terms.
[4]	During the measurement period, the Company completed the identification and measurement of intangible assets obtained with the acquisition.
[5]	The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation of the fair values described below.
[6]	During the measurement period, the Company completed the identification and measurement of the contingent liabilities assumed evaluated as present obligations, as discussed above.
[7]	Contingent liabilities assumed in the acquisition that are considered present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3, to a higher amount that would be recognized in accordance with IAS 37. The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The main assumption for calculating the fair value of the contingent liabilities was the evaluation of the probability of loss of the possible and remote lawsuits.
[8]	Reflects tax effects arising from the adjustments identified in the measurement period.
[9]	Consists of deferred tax liabilities of approximately R$ 81,423 related to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities of R$ 511,111.
[10]	Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes.

BUSINESS COMBINATIONS - Sched_2

BUSINESS COMBINATIONS - Schedule of fair value of intangible assets (Details) R$ in Thousands	Jan. 03, 2020BRL (R$)
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Intangible assets acquired and recognized before the allocation of the fair value	R$ 291235
Avon Products, Inc
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	5,555,577
Avon Products, Inc | Power brands
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 517592
Estimated useful life	20 years
Avon Products, Inc | Developed technologies
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 1131573
Estimated useful life	5 years
Avon Products, Inc | Sales representatives
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value	R$ 1884249
Avon Products, Inc | Sales representatives | Minimum
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated useful life	7 years
Avon Products, Inc | Sales representatives | Maximum
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated useful life	12 years
Avon Products, Inc | Trade name “Avon”
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Estimated fair value with indefinite useful life	R$ 2022163

BUSINESS COMBINATIONS - Sched_3

BUSINESS COMBINATIONS - Schedule of total amount of contingent liabilities assumed on date of transaction, including attributed fair value (Details) - BRL (R$) R$ in Thousands	Dec. 31, 2020		Jan. 03, 2020		Dec. 31, 2019
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Financial effects of the allocation of the fair values of contingent liabilities assumed and recognized	R$ 797693				R$ 0
Avon Products, Inc
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Contingent liabilities assumed and recognized before the allocation of the fair value			R$ 872993
Financial effects of the allocation of the fair values of contingent liabilities assumed and recognized			820,103
Tax			1,381,418
Civil			92,988
Labor			218,690
Total	R$ 1693096	[1]	R$ 1693096	[2]
[1]	During the measurement period, the Company completed the identification and measurement of the contingent liabilities assumed evaluated as present obligations, as discussed above.
[2]	Contingent liabilities assumed in the acquisition that are considered present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3, to a higher amount that would be recognized in accordance with IAS 37. The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The main assumption for calculating the fair value of the contingent liabilities was the evaluation of the probability of loss of the possible and remote lawsuits.

BUSINESS COMBINATIONS - Sched_4

BUSINESS COMBINATIONS - Schedule of variation between preliminary effects and final effects presented in business combination (Details) - Avon Products, Inc - BRL (R$) R$ in Thousands		Dec. 31, 2020		Jan. 03, 2020		Dec. 31, 2019
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Total estimated consideration to be transferred		R$ 13366114		R$ 13366114	[1]
(-) Fair value of acquired assets:
Intangibles		5,846,812	[2]	5,846,812	[3]
Other assets		12,909,639
(+) Fair value of liabilities assumed:
Provision for risks and contingencies		1,693,096	[4]	1,693,096	[5]
Deferred income tax and social contribution (6)		592,534	[6]	592,534	[7]
Other liabilities		14,588,180
Total identifiable net assets at fair value		1,882,641		1,882,641
(+) Non-controlling interests		27,555		27,555
Goodwill from business combination		11,511,028		R$ 11511028	[8]
As reported in 2019
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Total estimated consideration to be transferred						R$ 13366114
(-) Fair value of acquired assets:
Intangibles	[2]					5,709,326
Other assets						12,911,674
(+) Fair value of liabilities assumed:
Provision for risks and contingencies	[4]					651,000
Deferred income tax and social contribution (6)	[6]					671,693
Other liabilities						14,571,307
Total identifiable net assets at fair value						2,727,000
(+) Non-controlling interests						27,555
Goodwill from business combination						R$ 10666669
Measurement period adjustments
Schedule of fair values of the identifiable assets and liabilities acquired as at the date of acquisition
Total estimated consideration to be transferred
(-) Fair value of acquired assets:
Intangibles	[2]	137,486
Other assets		(2,035)
(+) Fair value of liabilities assumed:
Provision for risks and contingencies	[4]	1,042,096
Deferred income tax and social contribution (6)	[6]	(79,159)
Other liabilities		16,873
Total identifiable net assets at fair value		(844,359)
(+) Non-controlling interests
Goodwill from business combination		R$ 844359
[1]	Refers to the fair value of the acquired shares, which is the amount disbursed on the shares exchange.
[2]	During the measurement period, the Company completed the identification and measurement of intangible assets obtained with the acquisition.
[3]	The fair value of intangibles includes the intangible assets acquired and recognized by Avon before the allocation of the fair value, in the amount of R$ 291,235, plus the effects of the allocation of the fair values described below.
[4]	During the measurement period, the Company completed the identification and measurement of the contingent liabilities assumed evaluated as present obligations, as discussed above.
[5]	Contingent liabilities assumed in the acquisition that are considered present obligations arising from past events and that can be measured reliably were recognized and are initially measured at fair value on the acquisition date and subsequently measured in accordance with the requirements of IFRS 3, to a higher amount that would be recognized in accordance with IAS 37. The fair value of the contingent liabilities includes the liabilities assumed and recognized by Avon before the allocation of the fair value, in the amount of R$ 872,993, plus the effects of the allocation of the fair values, which totaled R$ 820,103. The main assumption for calculating the fair value of the contingent liabilities was the evaluation of the probability of loss of the possible and remote lawsuits.
[6]	Reflects tax effects arising from the adjustments identified in the measurement period.
[7]	Consists of deferred tax liabilities of approximately R$ 81,423 related to Avon opening balance and net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities of R$ 511,111.
[8]	Goodwill is attributable to strong market position and geographic regions and will result in a more diversified and balanced global portfolio, as well as expected future profitability and operational synergies, such as supply, manufacturing, distribution and efficiency of the administrative structure and revenue growth. This goodwill arising from the transaction is not expected to result in a tax benefit, that is, deductible for tax purposes.

BUSINESS COMBINATIONS - Additio

BUSINESS COMBINATIONS - Additional information (Details) - Avon Products, Inc R$ in Thousands	Jan. 03, 2020BRL (R$)	Jan. 03, 2020BRL (R$)
Disclosure of detailed information about business combination [line items]
Percentage of voting shares acquired	100.00%	100.00%
Deferred tax liabilities	R$ 81423	R$ 81423
Net position of deferred tax asset and liabilities related to purchasing price allocation of tax liabilities	511,111	511,111
Net revenues contributed by acquiree since the acquisition date	18,612,091
Losses of acquiree since the acquisition date	R$ 1542596
Revenue of acquiree through the date the acquisition was completed		R$ 0

Critical Accounting Estimates_2

Critical Accounting Estimates And Assumptions - Additional Information (Details) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement1 [Line Items]
Tax losses carried forward	R$ 13369187	R$ 880516
Bottom of range [member]
Statement1 [Line Items]
Term for budgeted cash flow	3 years
Top of range [member]
Statement1 [Line Items]
Term for budgeted cash flow	5 years

Financial Risk Management - Sum

Financial Risk Management - Summary of Derivative Instruments (Detail) - Fair value [member] - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Derivative Financial Instruments [Line Items]
Financial derivatives	R$ 1857869	R$ 727068
Operational derivatives	(11,092)	(1,496)
Total	R$ 1846777	R$ 725572

Financial Risk Management - S_2

Financial Risk Management - Summary of Derivative Positions (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of fair value measurement of liabilities [line items]
Total net derivative financial instruments	R$ 1409102	R$ 0
Total net derivative financial instruments	232,234	64,956
Short Position CDI Floating Rate Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative Asset Notional Amount	(2,576,890)	(2,664,001)
Derivative financial assets	(2,803,797)	(3,002,623)
Gain (Loss) on Derivative Financial Assets	(172,885)	(248,028)
Short Position CDI Floating Rate Swap Contract Two [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative Liability Notional Amount	1,409,102	0
Derivative financial liabilities	(22,234)	0
Gain (Loss) on Derivative Financial Liabilities	(16,778)	0
Long Position US Dollar Swap Contract One [Member]
Disclosure of fair value measurement of liabilities [line items]
Derivative Asset Notional Amount	2,576,890	2,664,001
Derivative financial assets	4,683,900	3,729,691
Gain (Loss) on Derivative Financial Assets	421,897	312,984
Fair value [member]
Disclosure of fair value measurement of liabilities [line items]
Derivative financial assets	1,846,777	725,572
Total net derivative financial instruments	R$ 1857869	R$ 727068

Financial Risk Management - Dis

Financial Risk Management - Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	R$ 3690054
Net Position Poun To US Dollar [Member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	1,585,280	R$ 200896
Net Position Poun To US Dollar [Member] | Fair value [member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	(7,670)	(2,008)
Forward contract [member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	165,830	1,302,869
Forward contract [member] | Fair value [member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments		512
Derivative instruments	(3,422)
Derivative [Member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	1,751,110	1,503,765
Derivative [Member] | Fair value [member]
Disclosure Of Derivatives Are Measured At Fair Value With Gains And Losses Recognized In The Group Of Costs Of Products Sold [Line Items]
Derivative instruments	R$ 11092	R$ 1496

Financial Risk Management - S_3

Financial Risk Management - Summary of Net Asset Exposure (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Net Asset Exposure [Abstract]
Borrowings and financing in foreign currency in Brazil	[1]	R$ 4246692	R$ 3381959
Receivables in foreign currency in Brazil		236,782	10,007
Trade payable in foreign currencies in Brazil		(14,459)	(10,543)
Fair value of the financial derivatives		4,680,478	3,729,691
Net asset exposure		R$ 656109	R$ 347196
[1]	Excluding transaction costs.

Financial Risk Management - D_2

Financial Risk Management - Disclosure Of Net Foreign Exchange Exposure (Detail) R$ in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2020USD ($)	Dec. 31, 2020BRL (R$)	Dec. 31, 2020USD ($)	Dec. 31, 2019BRL (R$)
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives | R$			R$ 4680478		R$ 3729691
Trade receivable recorded in Brazil in foreign currency | R$			236,782		10,007
Borrowings and financing in Brazil in foreign currency | R$	[1]		(4,246,692)		(3,381,959)
Trade payable registered in Brazil in foreign currency | R$			R$ 14459		R$ 10543
Scenario - Real (5.1967 Parity - R$ vs US$)
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives				$ 4,680,478
Trade receivable recorded in Brazil in foreign currency				236,782
Borrowings and financing in Brazil in foreign currency				(4,246,692)
Trade payable registered in Brazil in foreign currency				(14,459)
Scenario - Probable (5.1880 Parity - R$ vs US$)
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives				(7,881)
Trade receivable recorded in Brazil in foreign currency				(399)
Borrowings and financing in Brazil in foreign currency				7,151
Trade payable registered in Brazil in foreign currency				24
Impact on net income and equity		$ (1,105)
Scenario I - Depreciation 25% (3.8910 Parity - R$ vs US$)
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives				(1,570,668)
Trade receivable recorded in Brazil in foreign currency				(79,459)
Borrowings and financing in Brazil in foreign currency				1,425,099
Trade payable registered in Brazil in foreign currency				4,852
Impact on net income and equity		(220,176)
Scenario II - Depreciation 50% (2.5940 Parity - R$ vs US$)
Disclosure Of Net Foreign Exchange Exposure [Line Items]
Fair value of “financial” derivatives				(4,696,241)
Trade receivable recorded in Brazil in foreign currency				(237,579)
Borrowings and financing in Brazil in foreign currency				4,260,994
Trade payable registered in Brazil in foreign currency				$ 14,508
Impact on net income and equity		$ (658,318)
[1]	Excluding transaction costs.

Financial Risk Management - D_3

Financial Risk Management - Disclosure of Detailed Information About Cash Flow Hedged Items (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of financial assets [line items]
Notional value	R$ 3690054
Fair value	1,873,764
Accumulated contract gain (loss)	243,437
Gain in the 12-month period	R$ 178006
Currency Swap Contract One [Member]
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Notional value	R$ 2576020
Fair value	1,879,348
Accumulated contract gain (loss)	249,021
Gain in the 12-month period	R$ 183342
Forward contract (The Body Shop)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Notional value	R$ 1096227
Fair value	(4,882)
Accumulated contract gain (loss)	(4,882)
Gain in the 12-month period	R$ 5135
Forward contract (Natura Indústria)
Disclosure of financial assets [line items]
Hedged item	Currency
Notional currency	BRL
Notional value	R$ 17807
Fair value	(702)
Accumulated contract gain (loss)	(702)
Gain in the 12-month period	R$ 201

Financial Risk Management - D_4

Financial Risk Management - Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of Detailed Information About Cash Flow Hedged Reserve Booked Under Other Comprehensive Income [Abstract]
Cash flow hedge beginning of balance	R$ 42729	R$ 27840
Change in the fair value of hedge instrument recognized in OCI	178,006	107,337	R$ 45202
Tax effects on fair value of hedge instrument	(61,658)	(36,768)	15,384
Cash flow hedge end of balance	R$ 159077	R$ 42729	R$ 27840

Financial Risk Management - D_5

Financial Risk Management - Disclosure of Detailed Information About Interest Rate Risks of Transactions (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of Detailed Information About Interest Rate Risks of Transactions [Abstract]
Total borrowings and financing - in local currency	R$ 9591809
Operations in foreign currency with derivatives related to CDI	(4,231,104)	[1]
Short-term investments	3,865,319
Net exposure	R$ 9957594
[1]	This refers to transactions involving derivatives related to CDI to hedge the borrowings and financing arrangements raised in foreign currency in Brazil.

Financial Risk Management - S_4

Financial Risk Management - Summary of Net Exposure to Interest Rate Risk by Scenario (Detail) - Interest rate risk [member] R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of risk management strategy related to hedge accounting [line items]
Risk	Rate increase
Probable scenario [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 3626
Scenario Two [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	(33,235)
Scenario Three [Member]
Disclosure of risk management strategy related to hedge accounting [line items]
Net liability	R$ 62844

Financial Risk Management - S_5

Financial Risk Management - Summary of Working Capital Calculation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Net current assets (liabilities) [abstract]
Total current assets	R$ 18734820	R$ 9430057
Total current liabilities	(16,159,586)	(7,518,423)	R$ 4566881
Total net working capital	R$ 2575234	R$ 1911634

Financial Risk Management - D_6

Financial Risk Management - Disclosure of Maturity Analysis for Non-Derivative Financial Liabilities (Detail) R$ in Thousands	Dec. 31, 2020BRL (R$)
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	R$ 13822913
Lease	3,858,455
Payables to related parties, trade payables and reverse factoring operations	6,774,205
Total expected cash flow [Member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	14,764,846
Lease	4,610,685
Payables to related parties, trade payables and reverse factoring operations	6,774,205
Interest to be accrued [Member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures, interest to be accrued	(941,933)
Lease, interest to be accrued	(752,230)
Payables to related parties, trade payables and reverse factoring operations
Less than one year [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	4,047,276
Lease	1,231,622
Payables to related parties, trade payables and reverse factoring operations	6,774,205
One to five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	9,165,849
Lease	2,644,292
Payables to related parties, trade payables and reverse factoring operations
Over five years [member]
Disclosure of maturity analysis for non-derivative financial liabilities [line items]
Borrowings, financing and debentures	1,551,721
Lease	734,771
Payables to related parties, trade payables and reverse factoring operations

Financial Risk Management - D_7

Financial Risk Management - Disclosure Of Carrying Amounts And Fair Values Of The Company's Financial Instruments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		R$ 4436576	R$ 3110220
Certificate of bank deposits	[1]	808,988	211,261
Repurchase transactions	[2]	576,108	1,192,101
Total		5,821,672	4,513,582	R$ 1215048	R$ 1693131
Government bonds	[3]	864,940	221,900
Restricted cash		40,425
Financial treasury bill	[4]	505,152	374,690
Loan Investment Funds		817,253	407,928
Dynamo Beauty Ventures Ltd fund		16,104	7,402
Certificate of bank deposits	[5]	292,878	21,327
Total		2,536,752	1,033,247
Trade receivable		3,597,535	1,685,764
Financial and operating derivatives		1,768,122	737,378
Lease liabilities		(3,858,455)	(2,517,565)	R$ 446235
Financial and operating derivatives		(61,201)	(11,806)
Trade payables and supply chain finance operations		(6,774,205)	(1,829,756)
Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Total		2,536,752	1,033,247
Financial and operating derivatives		1,907,978	737,378
Total		(13,822,913)	(10,786,374)
Financial and operating derivatives		(61,201)	(11,806)
Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Local currency borrowings		(9,591,809)	(7,412,443)
Foreign currency borrowings		(4,231,104)	(3,373,931)
Lease liabilities		(3,858,455)	(2,517,565)
Trade payables and supply chain finance operations		(6,774,205)	(1,829,756)
Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Carbon Credits		(5,560)	(4,519)
Financial and operating derivatives		(61,201)	(1,648)
Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		1,768,122	737,378
Financial Liabilities - Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives			(10,158)
Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		4,436,123	3,110,220
Certificate of bank deposits		808,988	211,261
Trade receivable		3,597,535	1,685,764
Judicial deposits		566,190	337,255
Sublease receivables		357,538
Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Repurchase transactions		576,108	1,192,101
Government bonds		864,940	221,900
Restricted cash		40,425
Financial treasury bill		505,152	374,690
Loan Investment Funds		817,253	407,928
Dynamo Beauty Ventures Ltd fund		16,104	7,402
Certificate of bank deposits		292,878	21,327
Carbon Credits		4,097	3,508
Financial and operating derivatives		139,856
Fair value [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Total		5,821,219	4,513,582
Fair value [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Total		2,536,752	1,033,247
Financial and operating derivatives		1,907,978	737,378
Total		(13,926,002)	(10,987,213)
Financial and operating derivatives		(61,201)	(11,806)
Fair value [member] | Financial liabilities at amortised cost, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Local currency borrowings		(9,466,921)	(7,445,672)
Foreign currency borrowings		(4,459,081)	(3,541,541)
Lease liabilities		(3,858,455)	(2,517,565)
Trade payables and supply chain finance operations		(6,774,205)	(1,829,756)
Fair value [member] | Financial liabilities at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Carbon Credits		(5,560)	(4,519)
Financial and operating derivatives		(61,201)	(1,648)
Fair value [member] | Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives		1,768,122	737,378
Fair value [member] | Financial Liabilities - Fair Value Hedge Instrument [Member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Financial and operating derivatives			(10,158)
Fair value [member] | Financial assets at amortised cost, class [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Cash and banks		4,436,123	3,110,220
Certificate of bank deposits		808,988	211,261
Trade receivable		3,597,535	1,685,764
Judicial deposits		566,190	337,255
Sublease receivables		357,538
Fair value [member] | Financial assets at fair value through profit or loss, category [member] | Level 2 [member]
Disclosure Of Carrying Amounts And Fair Values Of The Companys Financial Instruments [Line Items]
Repurchase transactions		576,108	1,192,101
Government bonds		864,940	221,900
Restricted cash		40,425
Financial treasury bill		505,152	374,690
Loan Investment Funds		817,253	407,928
Dynamo Beauty Ventures Ltd fund		16,104	7,402
Certificate of bank deposits		292,878	21,327
Carbon Credits		4,097	3,508
Financial and operating derivatives		R$ 139856
[1]	As of December 31, 2020, Certificate of Bank Deposits (“CDB”) short-term investments are remunerated at an average rate of 103.2% of CDI (106.9% of CDI as of December 31, 2019) with daily maturities redeemable with the issuer itself, without significant loss of value.
[2]	Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2020, repurchase operations are remunerated at an average rate of 100.0% of CDI (99.9% of the CDI on December 31, 2019).
[3]	As of December 31, 2020, investments in Government Bonds (LFT) are remunerated at an average rate of 105.9% of the CDI (100.4% of the CDI on December 31, 2019).
[4]	As of December 31, 2020, investments in Treasury bills are remunerated at an average rate of 136.61% of the CDI (106% as at December 31, 2019).
[5]	Investments in CDBs classified as short-term investments are remunerated at an average rate of 100.0% of the CDI (106.9% of the CDI as at December 31, 2019). As at December 31, 2020, the “Crer Para Ver” line within the exclusive fund is R$ 57,609 (R$ 38,018 as at December 31, 2019).

Financial Risk Management - Add

Financial Risk Management - Additional Information (Detail) R$ in Thousands, € in Millions	12 Months Ended
	Dec. 31, 2020BRL (R$)	Dec. 31, 2020EUR (€)	Dec. 31, 2020BRL (R$)	Dec. 31, 2019BRL (R$)
Disclosure of detailed information about financial instruments [line items]
Notional amount Hedged			R$ 3690054
Percentage of borrowings linked to CDI rate		99.10%	99.10%
Reduction in the recoverable amount			R$ 148050
Increase (decrease) in the fair value of the investment due to 1% increase (decrease) in the applied discount (15.4%)			185
Forward contract [member]
Disclosure of detailed information about financial instruments [line items]
Notional amount Hedged			R$ 165830	R$ 1302869
Seventy Million British Pounds Credit Facility [Member]
Disclosure of detailed information about financial instruments [line items]
Undrawn credit line | €		€ 70
Scenario Two [Member]
Disclosure of detailed information about financial instruments [line items]
Foreign exchange rate | R$ / Per_USD		3.89	3.89
Foreign exchange rate, percentage of decrease		25.00%	25.00%
Borrowings interest rate, percentage of increase		25.00%	25.00%
Borrowings interest rate		2.45%	2.45%
Scenario Three [Member]
Disclosure of detailed information about financial instruments [line items]
Foreign exchange rate | R$ / Per_USD		2.59	2.59
Foreign exchange rate, percentage of decrease		50.00%	50.00%
Borrowings interest rate, percentage of increase		50.00%	50.00%
Borrowings interest rate		2.94%	2.94%
Probable scenario [Member]
Disclosure of detailed information about financial instruments [line items]
Foreign exchange rate | R$ / Per_USD		5.19	5.19
Borrowings interest rate		1.96%	1.96%
Hypothetical 10% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Reduction in gains due to the hypothetical appreciation of the US dollar against foreign exchange contracts	R$ 82889
Hypothetical 25% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Reduction in gains due to the hypothetical appreciation of the US dollar against foreign exchange contracts	207,223
Hypothetical 50% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Reduction in gains due to the hypothetical appreciation of the US dollar against foreign exchange contracts	414,447
Hypothetical 10% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Increase in gains due to the depreciation of the US dollar against foreign exchange contracts	82,889
Hypothetical 25% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Increase in gains due to the depreciation of the US dollar against foreign exchange contracts	207,223
Hypothetical 50% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Increase in gains due to the depreciation of the US dollar against foreign exchange contracts	R$ 414447
Avon Products Inc [Member] | Hypothetical 10% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Appreciation, One		10.00%	10.00%
Avon Products Inc [Member] | Hypothetical 25% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Appreciation, Two		25.00%	25.00%
Avon Products Inc [Member] | Hypothetical 50% appreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Appreciation, Three		50.00%	50.00%
Avon Products Inc [Member] | Hypothetical 10% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Depreciation, One		10.00%	10.00%
Avon Products Inc [Member] | Hypothetical 25% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Depreciation, Two		25.00%	25.00%
Avon Products Inc [Member] | Hypothetical 50% depreciation of the US dollar against foreign exchange contracts
Disclosure of detailed information about financial instruments [line items]
Percentage of Hypothetical Depreciation, Three		50.00%	50.00%

Cash And Cash Equivalent - Summ

Cash And Cash Equivalent - Summary of Detailed Information About Cash And Cash Equivalents (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Text Block [Abstract]
Cash and banks		R$ 4436576	R$ 3110220
Certificate of Bank Deposits	[1]	808,988	211,261
Repurchase transactions	[2]	576,108	1,192,101
Total		R$ 5821672	R$ 4513582	R$ 1215048	R$ 1693131
[1]	As of December 31, 2020, Certificate of Bank Deposits (“CDB”) short-term investments are remunerated at an average rate of 103.2% of CDI (106.9% of CDI as of December 31, 2019) with daily maturities redeemable with the issuer itself, without significant loss of value.
[2]	Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2020, repurchase operations are remunerated at an average rate of 100.0% of CDI (99.9% of the CDI on December 31, 2019).

Cash And Cash Equivalent - Su_2

Cash And Cash Equivalent - Summary of Detailed Information About Cash And Cash Equivalents (Parenthetical) (Detail)	Dec. 31, 2020	Dec. 31, 2019
Text Block [Abstract]
Average deposit remuneration rate	103.20%	106.90%
Average repurchase operations remuneration rate	100.00%	99.90%

Short-Term Investments - Summar

Short-Term Investments - Summary of Short-Term Investments (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Short Term Investments [Abstract]
Loan investment funds		R$ 817253	R$ 407928
Certificate of bank deposits	[1]	292,878	21,327
Treasury bills	[2]	505,152	374,690
Government bonds (LFT)	[3]	864,940	221,900
Dynamo Beauty Ventures Ltd. Fund		16,104	7,402
Restricted cash		40,425
Total		2,536,752	1,033,247
Current		2,520,648	1,025,845
Non-current		R$ 16104	R$ 7402
[1]	Investments in CDBs classified as short-term investments are remunerated at an average rate of 100.0% of the CDI (106.9% of the CDI as at December 31, 2019). As at December 31, 2020, the “Crer Para Ver” line within the exclusive fund is R$ 57,609 (R$ 38,018 as at December 31, 2019).
[2]	As of December 31, 2020, investments in Treasury bills are remunerated at an average rate of 136.61% of the CDI (106% as at December 31, 2019).
[3]	As of December 31, 2020, investments in Government Bonds (LFT) are remunerated at an average rate of 105.9% of the CDI (100.4% of the CDI on December 31, 2019).

Short-Term Investments - Summ_2

Short-Term Investments - Summary of Short-Term Investments (Parenthetical) (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Short Term Investments [Line Items]
Short-term investments	R$ 2520648	R$ 1025845
Exclusive Investment Fund [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	100.00%
Certificate of Bank Deposits [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	100.00%	106.90%
Crer Para Ver [Member]
Short Term Investments [Line Items]
Short-term investments	R$ 57609	R$ 38018
Treasury Bills [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	136.61%	106.00%
Government Bonds LFT [Member]
Short Term Investments [Line Items]
Average rate of remuneration for shor-term investments	105.90%	100.40%

Short-Term Investments - Summ_3

Short-Term Investments - Summary of Detailed Information About Investment Portfolio (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Short Term Investments [Abstract]
Certificate of Bank Deposits (CDB)		R$ 292878	R$ 21327
Repurchase transactions (cash and cash equivalent)	[1]	576,108	1,192,101
Financial letter	[2]	505,152	374,690
Government bonds (LFT)	[3]	864,940	221,900
Exclusive Investment Fund Portfolio		R$ 2239078	R$ 1810018
[1]	Repurchase transactions are securities issued by banks with a commitment by the bank to repurchase the securities, and by the client to resell the security, at a defined interest rate and within a predetermined term, which are backed by public or private securities (depending on the financial institution) and are registered within the Central of Custody and Financial Settlement of Securities (“CETIP”). As of December 31, 2020, repurchase operations are remunerated at an average rate of 100.0% of CDI (99.9% of the CDI on December 31, 2019).
[2]	As of December 31, 2020, investments in Treasury bills are remunerated at an average rate of 136.61% of the CDI (106% as at December 31, 2019).
[3]	As of December 31, 2020, investments in Government Bonds (LFT) are remunerated at an average rate of 105.9% of the CDI (100.4% of the CDI on December 31, 2019).

Trade Receivables - Summary of

Trade Receivables - Summary of Detailed Information About Trade Receivables (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Disclosure of financial assets [line items]
Trade receivables	R$ 4029643	R$ 1793759
Allowance for expected credit losses	(432,108)	(107,995)
Trade Receivables, Net	R$ 3597535	R$ 1685764

Trade Receivables - Summary o_2

Trade Receivables - Summary of Carrying Amount of Each Aging Range (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of financial assets [line items]
Current Trade Receivables Gross	R$ 4029643	R$ 1793759
Allowance for expected credit losses	(432,108)	(107,995)
Current Trade Receivables	3,597,535	1,685,764
Trade Receivables [member]
Disclosure of financial assets [line items]
Allowance for expected credit losses	(432,108)	(107,995)	R$ 129242
Current [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	1,988,583	1,501,958
Current [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Allowance for expected credit losses	(53,352)
Upto Thirty Days [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	1,506,460
Upto Thirty Days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	1,506,460	142,069
Allowance for expected credit losses	(76,848)
Thirty One To Sixty Days [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	173,121
Thirty One To Sixty Days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	173,121	36,466
Allowance for expected credit losses	(56,124)
Sixty One To Ninety Days [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	111,735
Sixty One To Ninety Days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	111,735	27,789
Allowance for expected credit losses	(54,172)
Ninety One To One Hundred And Eighty Days [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	249,744
Ninety One To One Hundred And Eighty Days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Current Trade Receivables Gross	249,744	R$ 85477
Allowance for expected credit losses	R$ 191612

Trade Receivables - Summary o_3

Trade Receivables - Summary of Allowance For Credit Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Disclosure of financial assets [line items]
Beginning Balance		R$ 107995
Ending balance		(432,108)	R$ 107995
Trade Receivables [member]
Disclosure of financial assets [line items]
Beginning Balance		(107,995)	(129,242)
Additions		(640,676)	(209,515)
Write-offs	[1]	372,659	232,034
Exchange variation		(56,096)	(1,272)
Ending balance		R$ 432108	R$ 107995
[1]	(a) Refers to accounts overdue for more than 180 days which are written off when the Company has no expectation of recovering the trade accounts receivable and sales of customer portfolio.

Trade Receivables - Summary o_4

Trade Receivables - Summary of Trade Receivables by Exposure to Doubtful Accounts (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of financial assets [line items]
Trade receivables	R$ 4029643	R$ 1793759
Allowance for expected credit losses	(432,108)	(107,995)
Trade Receivables [member]
Disclosure of financial assets [line items]
Allowance for expected credit losses	(432,108)	(107,995)	R$ 129242
Current [member]
Disclosure of financial assets [line items]
Trade receivables	1,988,583	1,501,958
Current [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Allowance for expected credit losses	(53,352)
Up to 30 days [member]
Disclosure of financial assets [line items]
Trade receivables	1,506,460
Up to 30 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	1,506,460	142,069
Allowance for expected credit losses	(76,848)
31 to 60 days [member]
Disclosure of financial assets [line items]
Trade receivables	173,121
31 to 60 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	173,121	36,466
Allowance for expected credit losses	(56,124)
61 to 90 days [member]
Disclosure of financial assets [line items]
Trade receivables	111,735
61 to 90 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	111,735	27,789
Allowance for expected credit losses	(54,172)
91 to 180 days [member]
Disclosure of financial assets [line items]
Trade receivables	249,744
91 to 180 days [member] | Trade Receivables [member]
Disclosure of financial assets [line items]
Trade receivables	249,744	R$ 85477
Allowance for expected credit losses	R$ 191612

Inventories - Summary of Invent

Inventories - Summary of Inventories (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of Inventories [Abstract]
Finished products	R$ 3592864	R$ 1253145
Raw materials and packaging	1,015,156	253,063
Promotional material	170,188	82,228
Work in progress	36,025	27,346
Allowance for losses	(269,963)	(185,232)	R$ 178268
Current Inventories	R$ 4544270	R$ 1430550

Inventories - Summary of Change

Inventories - Summary of Changes In The Provision For Inventory Losses (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019
Disclosure of Changes In The Provision For Inventory Losses [Abstract]
Beginning balance		R$ 185232	R$ 178268
Additions, net	[1]	(341,799)	(147,140)
Write-offs	[2]	354,692	136,431
Exchange rate variation		(97,624)	3,745
Ending balance		R$ 269963	R$ 185232
[1]	Refer to the recognition of net allowance for losses due to discontinuation, expiration and quality, to cover expected losses on the realization of inventories, pursuant to the Company’s and its subsidiaries policy.
[2]	Consist of write-offs of products discarded by the Company.

Recoverable Taxes - Summary of

Recoverable Taxes - Summary of Current Tax Assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Text Block [Abstract]
ICMS on purchase of goods (a)	[1]	R$ 681147	R$ 434832
Taxes on purchase of goods – subsidiaries abroad		230,260	39,475
ICMS on purchases of property, plant and equipment		9,578	10,628
PIS and COFINS on purchases of property, plant and equipment (b)	[2]		3,826
PIS and COFINS on purchase of goods (c)	[3]	780,841	280,087
Withholding PIS, COFINS and CSLL		1,669	2,378
Withholding income tax		23,637
IPI (Tax on Manufactured Products) (d)	[4]	77,096	30,190
Others		199,333	3,438
Total		2,003,561	804,854
Current		1,071,349	395,640
Non-current		R$ 932212	R$ 409214
[1]	Accumulated Brazilian tax on the circulation of goods, interstate and inter-municipal transport and communication services (“ICMS”) tax credits were mainly generated from the purchases, which tax rate is higher than average sales rates and by increase in exports.
[2]	Brazilian taxes on the acquisition of fixed assets: Social Integration Programs (“PIS”) and Contribution for Social Security Financing (“COFINS”).
[3]	The accumulated tax credits for PIS and COFINS basically arise from credits on purchases of raw materials used in production. The realization of these credits normally occurs through offsetting with sales operations in the domestic market.
[4]	The balance will be used to IPI payable in future operations of the Company's subsidiaries.

Income Tax And Social Contrib_3

Income Tax And Social Contribution - Summary of Breakdown of Deferred Income Tax And Social Contribution Assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Deferred tax assets and liabilities [abstract]
Tax loss carryforwards and negative basis of social contribution tax		R$ 456567	R$ 193566
Allowance for doubtful accounts		133,162	51,151
Allowance for losses on inventories		101,237	50,593
Provision for tax, civil and labor contingencies		57,560	53,377
Provision for ICMS – ST		19,552	24,659
Allowances for losses on advances to suppliers		265	898
Accrued benefits sharing and partnerships		25,912	17,483
Provision for profit sharing		77,434	54,427
Provision carbon credits		9,848	8,297
Profit not realized in inventories		40,706	32,899
INSS with Suspended Liability			17,757
Lease		30,493	22,268
Others expenses provision	[1]	332,985	60,886
Post-employment healthcare plan		35,553	33,589
Net Operating Loss and Other Deduction Carryforwards		263,121
Stock option plan		334,416	112,095
Other temporary differences		208,279	35,323
Deferred income tax and social contribution assets		2,127,090	769,268
Effect of changes in fair value of derivative instruments, including hedge accounting transactions		(638,071)	(247,163)
Amortization and depreciation - useful life differences		(104,750)	(118,632)
Fair value of identifiable net assets in business combinations of Emeis Holdings Pty Ltd			(24,516)
Provision/(reversal) for losses - property and intangible assets		(44,544)	(4,509)
Deferred income tax and social contribution liability		(787,365)	(394,820)
Total of Deferred income tax and social contribution		R$ 1339725	R$ 374448
[1]	Refers to temporary differences arising from the provision for invoices for services and suppliers recorded for which invoices have not yet been issued.

Income Tax And Social Contrib_4

Income Tax And Social Contribution - Summary of Breakdown of Deferred Income Tax And Social Contribution Liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Statement [Line Items]
Fair value of identifiable net assets in business combination		R$ 1288045	R$ 450561
The Body Shop [Member]
Statement [Line Items]
Fair value of identifiable net assets in business combination	[1]	R$ 1288045	R$ 450561
[1]	The balance includes deferred income tax liability on the fair value of net identifiable assets in the acquisition of Avon, The Body Shop and Aesop.

Income Tax And Social Contrib_5

Income Tax And Social Contribution - Summary of tax losses carryforwards for which no deferred tax asset recognised (Detail) R$ in Thousands	Dec. 31, 2020BRL (R$)
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	R$ 11733876	[1]
Credits (b)	96,893	[2]
Other Future Deductible Items	1,538,418
Total	13,369,187
Net Operating Loss, expected expirations during 2021	31,000
Credits, expected expirations during 2021	26,000
Credits, expected expirations during 2022 to 2026	24,000
Indefinite Expiration Period [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	10,401,642	[1]
Credits (b)		[2]
Other Future Deductible Items	100,068
Total	10,501,710
Definite Expiration Period
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Net Operating Loss (a)	1,332,234	[1]
Credits (b)	96,893	[2]
Other Future Deductible Items	1,438,350
Total	R$ 2867477
[1]	During 2021, expirations of approximately R$31 million are expected, the remaining expirations would start to occur in 2022 and future period with the majority of loss/deduction carryforwards subject to expiration in 2031 and beyond.
[2]	During 2021, expirations of approximately R$26 million are expected, the remaining expirations would start to occur in 2022 with the vast majority of utilizable credits subject to expiration in 2027. In addition, R$ 2,4 million of credits are currently subject to limitation, are not utilizable and will expire unutilized during 2022 to 2026.Management continuously evaluates tax planning opportunities to prevent tax attributes from expiring unutilized. As of December 31, 2020, there are no prudent and feasible tax planning opportunities that management would and could implement. In addition, for the attributes noted above, there are no other sources of income available and as a result, these attributes remain unrecognized.

Income Tax And Social Contrib_6

Income Tax And Social Contribution - Summary of Reconciliation of Income Tax And Social Contribution (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]
Income / (loss) After income tax and social contribution			R$ 304566
Taxes on Company Formation (a)	[1]		206,592
Income / (loss) before income tax and social contribution (b)	[2]	(388,935)	511,158	673,405
Income tax and social contribution at the rate of 34%		132,238	(173,794)	(228,958)
Benefit of expenses with research and technological innovation		23,033	19,228
Tax incentives		10,018	12,457	10,724
Subsidy for investments (c)	[3]	128,173	24,864	12,505
Effect from differences of tax rates of entities abroad		(166,394)	26,907	14,077
Recognition of prior-year tax losses – USA and Mexico				70,065
Taxation of profits of subsidiaries abroad		(56,194)	(60,305)	(12,694)
Unrecognized tax benefits		(104,160)	(8,893)	(11,799)
Tax Benefits of interest on equity (IOE)		10,275	37,628	40,208
Exercise of stock options and restricted stock plans		(9,770)	9,697
Non-Deductible Donation/Contribution		(12,509)	(4,136)	(5,451)
UK Tax Law Rate Change (d)	[4]	(63,428)
Post-employment healthcare plan				30,082
Withholding Taxes		(63,754)
Imputed Income		(67,529)	(1,156)	(830)
Other permanent differences		(34,743)	(31,596)	(42,955)
Income tax and social contribution expenses		(274,744)	(149,099)	(125,026)
Income tax and social contribution - current		(292,828)	(94,780)	(182,324)
Income tax and social contribution - deferred		R$ 18084	R$ 54319	R$ 57298
Effective tax		(70.60%)	29.20%	18.60%
[1]	Tax levied on the formation of the Company resulting from the difference between Natura's accounting balances and the acquisition cost used for the purpose of the contribution of shares issued by Natura to the Company's capital stock (note 24). Management believes that, although the amount of the aforementioned special capital reserve constitutes part of the taxable profit for tax purposes in Brazil, the nature of this amount is different from the nature of other sources of taxable profit under the scope of IAS 12. The main differences are (i) the Company did not generate taxable profits and this tax is mainly related to the increase in equity that generates the special reserve for statutory purposes; (ii) the creation of the special reserve is, in substance, a matter of reclassification; (iii) the tax is levied on the entity as a result of an additional increase in the equity of the contribution made to the Company; and (iv) the Company's future profits, as well as Natura's future and historical profits will continue to be taxed in accordance with tax legislation. The tax on the formation of the Company was recognized in the income statement and presented as "Taxes on the formation of the Company".
[2]	The loss before tax consolidated related to 2020 is considering the results of continuing and discontinued operations.
[3]	The Company has tax incentives arising from its ordinary operations (Grant Investment).
[4]	During 2020, the income tax rate in the UK was changed from 17% to 19% which resulted in an increase in the Company’s Deferred Tax Liabilities associated with the UK. Such increase was accrued through deferred income tax expense during 2020.

Income Tax And Social Contrib_7

Income Tax And Social Contribution - Summary of changes In Deferred Asset And Liability Income Tax And Social Contribution (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Begining balance, asset	R$ 374448
Beginning balance, liability	(450,561)
Ending balance, asset	1,339,725
Ending balance, liability	(1,288,045)
Effect on profit or loss [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset	(19,639)
Increase decrease in deferred tax liability	37,723
Reserve for grant of options and restricted shares [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset	96,181
Increase decrease in deferred tax liability
Effect on other comprehensive income [Member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset	(61,658)
Increase decrease in deferred tax liability
Currency Translation Effect [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset	283,359
Increase decrease in deferred tax liability	(314,527)
Business combination [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Increase decrease in deferred tax asset	667,034
Increase decrease in deferred tax liability	R$ 560680

Income Tax And Social Contrib_8

Income Tax And Social Contribution - Additional Information (Details)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	(70.60%)	29.20%	18.60%
Bottom of range [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	17.00%
Top of range [member]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Applicable tax rate	19.00%

Judicial Deposits - Summary of

Judicial Deposits - Summary of Detailed Information About Judicial Deposits (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Statement [Line Items]
Judicial deposits		R$ 566190	R$ 337255	R$ 333577
Unaccrued tax lawsuits [Member]
Statement [Line Items]
Judicial deposits	[1]	262,654	203,403
Accrued tax lawsuits [Member]
Statement [Line Items]
Judicial deposits	[2]	252,961	116,415
Unaccrued civil lawsuits [Member]
Statement [Line Items]
Judicial deposits		9,671	2,541
Accrued civil lawsuits [Member]
Statement [Line Items]
Judicial deposits		2,189	426
Unaccrued labor lawsuits [Member]
Statement [Line Items]
Judicial deposits		14,166	8,683
Accrued labor lawsuits [Member]
Statement [Line Items]
Judicial deposits		R$ 24549	R$ 5787
[1]	The tax procedure related to these judicial deposits refer mainly to the ICMS-ST, disclosed in note 22.1.1, contingent liabilities - possible risk of loss.
[2]	The tax procedure related to these judicial deposits refer, substantially, to the sum of the amounts disclosed in note 22.2.1, and the amounts presented in note 21.

Judicial Deposits - Summary o_2

Judicial Deposits - Summary of Detailed Information About Changes In Judicial Deposits (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Judicial Deposits [Abstract]
Deposits - Beggining balance	R$ 337255	R$ 333577
Acquisition of subsidiary	283,885
New deposits	18,377	2,542
Redemptions	(64,761)	(7,556)
Interests	11,242	13,352
Payments / Write-offs for expenses	(17,739)	(4,660)
Exchange variance	(2,069)
Deposits - Ending balance	R$ 566190	R$ 337255

Assets Held For Sale - Summary

Assets Held For Sale - Summary of Assets held for sale (Detail) R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Assets Held for Sale Disclosure [Abstract]
Avon acquisition	R$ 199050
Additions	25,779	[1]
Transfer to fixed assets	(29,610)	[2]
Sale	(61,760)	[3]
Exchange rate variation	R$ 47820
[1]	During the fourth quarter of 2020, Avon made its operations in Saudi Arabia available for sale.
[2]	During the first quarter of 2020, Avon identified new circumstances that, previously, were considered unlikely and, as a result, decided not to proceed with the sale of two properties, one located in Brazil and the other, in Romania. As a result, the subsidiary reclassified such properties from “Held for sale” to “Property, plant and equipment” (“PP&E”). At the time of the reclassification, the depreciation was recorded, resulting in an immaterial impact on the financial statements.
[3]	During the third quarter of 2020, Avon complete the sale of two properties: (i) a distribution center located in Hungary, and (ii) a plant located in China.

Assets held for sale - Addition

Assets held for sale - Additional Information (Detail) - Avon [member] - Properties	3 Months Ended
	Sep. 30, 2020	Mar. 31, 2020
Disclosure of analysis of single amount of discontinued operations [line items]
Number of properties reclassified from held for sale to property, plant and equipment		2
Number of properties sold	2

Other Current And Non-Current_3

Other Current And Non-Current Assets - Summary of detailed information about other assets (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Other Assets [Abstract]
Marketing and advertising advances		R$ 42233	R$ 28669
Supplier advances		257,099	102,225
Employee advances		65,180	13,983
Rent advances and guarantee deposits		169,958	96,202
Prepaid insurance expenses		200,074	29,647
Surplus pension plan	[1]	683,425
Customs broker advances - Import taxes		34,016	34,932
Sublease receivables	[2]	357,538
Carbon credits		4,097	3,508
Receivables from service providers	[3]	135,030
Other		195,138	39,868
Total		2,143,788	349,034
Current		616,120	265,198
Non-current		R$ 1527668	R$ 83836
[1]	Pension plan arising from the acquisition of Avon (note 4 and 28.2).
[2]	Refers to the sublease receivable from the New York office owned by Avon.
[3]	Refers to receivables mainly arising from damage that occurred with carriers and insurance companies.

Property, Plant And Equipment -

Property, Plant And Equipment - Summary Of Detailed Information About Property, Plant And Equipment (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 1773889	R$ 2236714
Company acquisition	2,912,482
Additions	(118,870)	15,860
Write-offs	(20,500)	(22,283)
Impairment	(5,361)	(6,359)
Transfers	(75,214)	(471,270)
Other changes including exchange rate variation		21,227
Exchange rate variation	768,631
Property, Plant And Equipment, Ending	R$ 5235057	R$ 1773889
Vehicles [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Vehicles [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	5 years	5 years
Templates [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Tools And Accessories [Member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Tools And Accessories [Member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	20 years	20 years
Facilities [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Facilities [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	60 years	60 years
Machinery and accessories [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
Machinery and accessories [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	15 years	15 years
Leasehold improvements [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Leasehold improvements [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	20 years	20 years
Buildings [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	14 years	14 years
Buildings [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	60 years	60 years
Furniture and fixtures [Member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	2 years	2 years
Furniture and fixtures [Member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	25 years	25 years
IT equipment [member] | Bottom of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	3 years	3 years
IT equipment [member] | Top of range [member]
Disclosure of detailed information about property, plant and equipment [line items]
Useful life	15 years	15 years
Gross carrying amount [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	R$ 3314514	R$ 3697796
Company acquisition	2,912,482
Additions	594,251	339,203
Write-offs	(73,768)	(99,833)
Impairment	(141)	(6,359)
Transfers	(72,959)	(573,375)
Other changes including exchange rate variation		(42,918)
Exchange rate variation	871,680
Property, Plant And Equipment, Ending	7,546,059	3,314,514
Gross carrying amount [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	45,578	78,072
Company acquisition	25,789
Additions	14,594	12,463
Write-offs	(17,274)	(41,883)
Impairment
Transfers	1,184	99
Other changes including exchange rate variation		(3,173)
Exchange rate variation	9,356
Property, Plant And Equipment, Ending	79,227	45,578
Gross carrying amount [member] | Templates [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	192,556	203,814
Company acquisition
Additions	1,243	1,499
Write-offs	(19,713)	(23,823)
Impairment
Transfers	5,650	10,874
Other changes including exchange rate variation		192
Exchange rate variation	8,116
Property, Plant And Equipment, Ending	187,852	192,556
Gross carrying amount [member] | Tools And Accessories [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	11,974	8,161
Company acquisition	52,410
Additions	11,625	314
Write-offs	(1,743)	(445)
Impairment
Transfers	5,888	3,910
Other changes including exchange rate variation		34
Exchange rate variation	5,524
Property, Plant And Equipment, Ending	85,678	11,974
Gross carrying amount [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	309,772	310,282
Company acquisition	1,431
Additions	81	49
Write-offs	(3,599)
Impairment
Transfers	8,791	(1,534)
Other changes including exchange rate variation		975
Exchange rate variation	(23,005)
Property, Plant And Equipment, Ending	293,471	309,772
Gross carrying amount [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	866,451	819,919
Company acquisition	740,328
Additions	20,098	9,563
Write-offs	(5,134)	(1,259)
Impairment
Transfers	58,649	54,336
Other changes including exchange rate variation		(16,108)
Exchange rate variation	139,301
Property, Plant And Equipment, Ending	1,819,693	866,451
Gross carrying amount [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	615,103	577,217
Company acquisition	58,548
Additions	34,324	46,869
Write-offs	(8,761)	(23,243)
Impairment		(1,958)
Transfers	51,588	20,645
Other changes including exchange rate variation		(4,427)
Exchange rate variation	213,155
Property, Plant And Equipment, Ending	963,957	615,103
Gross carrying amount [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	386,957	940,002
Company acquisition	1,203,081
Additions	12,275	2,245
Write-offs
Write-offs
Impairment	(115)	(887)
Transfers	48,551	(555,221)
Other changes including exchange rate variation		818
Exchange rate variation	248,427
Property, Plant And Equipment, Ending	1,899,176	386,957
Gross carrying amount [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	397,727	362,817
Company acquisition	32,566
Additions	32,530	40,118
Write-offs	(6,300)	(3,031)
Impairment	(26)	(3,514)
Transfers	11,239	16,978
Other changes including exchange rate variation		(15,641)
Exchange rate variation	98,812
Property, Plant And Equipment, Ending	566,548	397,727
Gross carrying amount [member] | Land [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	35,157	30,525
Company acquisition	570,572
Additions	57
Write-offs
Write-offs
Impairment
Transfers	4,252	4,653
Other changes including exchange rate variation		(21)
Exchange rate variation	51,575
Property, Plant And Equipment, Ending	661,613	35,157
Gross carrying amount [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	297,228	263,524
Company acquisition	112,369
Additions	27,254	21,976
Write-offs	(10,652)	(3,902)
Impairment
Transfers	36,554	18,483
Other changes including exchange rate variation		(2,853)
Exchange rate variation	81,019
Property, Plant And Equipment, Ending	543,772	297,228
Gross carrying amount [member] | Projects In Progress [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	156,011	103,463
Company acquisition	78,965
Additions	440,170	204,107
Write-offs	(592)	(2,247)
Impairment
Transfers	(305,305)	(146,598)
Other changes including exchange rate variation		(2,714)
Exchange rate variation	39,136
Property, Plant And Equipment, Ending	408,385	156,011
Gross carrying amount [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning
Company acquisition	36,423
Additions
Write-offs
Impairment
Transfers
Exchange rate variation	264
Property, Plant And Equipment, Ending	36,687
Accumulated depreciation, amortisation and impairment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(1,540,625)	(1,461,082)
Company acquisition
Additions	(713,121)	(323,343)
Write-offs	53,268	77,550
Impairment	(5,220)
Transfers	(2,255)	102,105
Other changes including exchange rate variation		64,145
Exchange rate variation	(103,049)
Property, Plant And Equipment, Ending	(2,311,002)	(1,540,625)
Accumulated depreciation, amortisation and impairment [member] | Vehicles [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(16,924)	(31,784)
Company acquisition
Additions	(24,150)	(15,832)
Write-offs	10,081	27,478
Impairment
Transfers	(2,093)	(7)
Other changes including exchange rate variation		3,221
Exchange rate variation	44
Property, Plant And Equipment, Ending	(33,042)	(16,924)
Accumulated depreciation, amortisation and impairment [member] | Templates [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(175,938)	(191,501)
Company acquisition
Additions	(10,092)	(8,314)
Write-offs	19,684	23,739
Impairment
Transfers		148
Other changes including exchange rate variation		(10)
Exchange rate variation	(190)
Property, Plant And Equipment, Ending	(166,536)	(175,938)
Accumulated depreciation, amortisation and impairment [member] | Tools And Accessories [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(3,255)	(2,954)
Company acquisition
Additions	(42,932)	(687)
Write-offs		410
Impairment
Transfers	10
Other changes including exchange rate variation		(24)
Exchange rate variation	7,018
Property, Plant And Equipment, Ending	(39,159)	(3,255)
Accumulated depreciation, amortisation and impairment [member] | Facilities [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(167,362)	(147,309)
Company acquisition
Additions	(19,933)	(20,703)
Write-offs
Write-offs	285
Impairment
Transfers	1,044	1,234
Other changes including exchange rate variation		(584)
Exchange rate variation	9,240
Property, Plant And Equipment, Ending	(176,726)	(167,362)
Accumulated depreciation, amortisation and impairment [member] | Machinery and accessories [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(416,736)	(379,050)
Company acquisition
Additions	(193,657)	(56,617)
Write-offs	2,759	657
Impairment
Transfers	(1,202)
Other changes including exchange rate variation		18,274
Exchange rate variation	30,074
Property, Plant And Equipment, Ending	(578,762)	(416,736)
Accumulated depreciation, amortisation and impairment [member] | Leasehold improvements [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(267,371)	(217,167)
Company acquisition
Additions	(130,631)	(90,281)
Write-offs	7,124	19,089
Impairment	(4,900)
Transfers	(4,107)	5,292
Other changes including exchange rate variation		15,696
Exchange rate variation	(80,669)
Property, Plant And Equipment, Ending	(480,554)	(267,371)
Accumulated depreciation, amortisation and impairment [member] | Buildings [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(101,785)	(191,422)
Company acquisition
Additions	(88,593)	(7,315)
Write-offs
Write-offs
Impairment
Transfers		96,558
Other changes including exchange rate variation		394
Exchange rate variation	10,649
Property, Plant And Equipment, Ending	(179,729)	(101,785)
Accumulated depreciation, amortisation and impairment [member] | Furniture and fixtures [Member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(193,973)	(138,078)
Company acquisition
Additions	(81,287)	(78,988)
Write-offs	4,744	2,734
Impairment	(284)
Transfers	4,093	(184)
Other changes including exchange rate variation		20,543
Exchange rate variation	(51,904)
Property, Plant And Equipment, Ending	(318,611)	(193,973)
Accumulated depreciation, amortisation and impairment [member] | IT equipment [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning	(197,281)	(161,817)
Company acquisition
Additions	(96,768)	(44,606)
Write-offs	8,591	3,443
Impairment	(36)
Transfers		(936)
Other changes including exchange rate variation		6,635
Exchange rate variation	(26,362)
Property, Plant And Equipment, Ending	(311,856)	(197,281)
Accumulated depreciation, amortisation and impairment [member] | Other assets [member]
Disclosure of detailed information about property, plant and equipment [line items]
Property, Plant And Equipment, Beginning
Company acquisition
Additions	(25,078)
Write-offs
Impairment
Transfers
Exchange rate variation	(949)
Property, Plant And Equipment, Ending	R$ 26027

Intangibles - Disclosure Of Rec

Intangibles - Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2019
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 5076501		R$ 4950545
Acquisition of subsidiary		17,392,570
Additions		(722,893)		10,098
Write-offs		(15,055)		(12,235)
Reversal (provision) of impairment		(2,051)		2,818
Transfers		82,007		(160,339)
Other changes including exchange variation		5,106,049		285,614
Intangible assets and goodwill, Ending		R$ 26917128		R$ 5076501
Software [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		2 years 6 months		2 years 6 months
Software [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Trademarks and patents Finite [Member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		20 years		20 years
Trademarks and patents Finite [Member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		25 years		25 years
Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Key Money Finite [Member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		3 years	[1]	3 years	[2]
Key Money Finite [Member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		18 years	[1]	18 years	[2]
Relationship with franchisees and sub franchisees [Member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[3]	7 years		7 years
Relationship with franchisees and sub franchisees [Member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life	[3]	15 years		15 years
Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		5 years		5 years
Other intangible assets [member] | Bottom of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		2 years		2 years
Other intangible assets [member] | Top of range [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Useful life		10 years		10 years
Gross carrying amount [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		R$ 5883023		R$ 5553984
Acquisition of subsidiary		17,392,570
Additions		258,883		228,547
Write-offs		(30,119)		(19,637)
Reversal (provision) of impairment		(2,051)		2,818
Transfers		85,640		(168,731)
Other changes including exchange variation		5,206,224		286,042
Intangible assets and goodwill, Ending		28,794,170		5,883,023
Gross carrying amount [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		1,313,090		1,089,900
Acquisition of subsidiary		291,555
Additions		82,718		83,064
Write-offs		(15,095)		(546)
Reversal (provision) of impairment
Transfers		258,092		118,442
Other changes including exchange variation		128,790		22,230
Intangible assets and goodwill, Ending		2,059,150		1,313,090
Gross carrying amount [member] | Trademarks and patents Finite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		116,805		111,801
Acquisition of subsidiary		517,592
Additions
Write-offs
Reversal (provision) of impairment
Transfers				(154)
Other changes including exchange variation		260,181		5,158
Intangible assets and goodwill, Ending		894,578		116,805
Gross carrying amount [member] | Trademarks and patents Indefinite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		2,171,585		2,040,067
Acquisition of subsidiary		2,022,163
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		1,553,309		131,518
Intangible assets and goodwill, Ending		5,747,057		2,171,585
Gross carrying amount [member] | Goodwill Avon [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning
Acquisition of subsidiary		11,511,028
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		1,788,821
Intangible assets and goodwill, Ending		13,299,849
Gross carrying amount [member] | Goodwill Emeis Brazil Pty Ltd [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[4]	100,237		96,867
Acquisition of subsidiary	[4]
Additions	[4]
Write-offs	[4]
Reversal (provision) of impairment	[4]
Transfers	[4]
Other changes including exchange variation	[4]	41,853		3,370
Intangible assets and goodwill, Ending	[4]	142,090		100,237
Gross carrying amount [member] | Goodwill The Body Shop International Limited [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[5]	1,434,369		1,348,670
Acquisition of subsidiary	[5]	34,251
Additions	[5]
Write-offs	[5]
Reversal (provision) of impairment	[5]
Transfers	[5]
Other changes including exchange variation	[5]	478,121		85,699
Intangible assets and goodwill, Ending	[5]	1,946,741		1,434,369
Gross carrying amount [member] | Goodwill acquisition of The Body Shop stores [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		1,456		1,456
Acquisition of subsidiary
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation
Intangible assets and goodwill, Ending		1,456		1,456
Gross carrying amount [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		1,987		1,740
Acquisition of subsidiary
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		798		247
Intangible assets and goodwill, Ending		2,785		1,987
Gross carrying amount [member] | Key Money Indefinite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[2]	17,801		102,310
Acquisition of subsidiary	[2]
Additions	[2]
Write-offs	[2]
Reversal (provision) of impairment	[2]
Transfers	[2]	1,315		(101,001)
Other changes including exchange variation	[2]	7,653		16,492
Intangible assets and goodwill, Ending	[2]	26,769		17,801
Gross carrying amount [member] | Key Money Finite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		12,447	[1]	48,888	[2]
Acquisition of subsidiary	[1]
Additions		150	[1]		[2]
Write-offs			[1]		[2]
Reversal (provision) of impairment		(2,051)	[1]	2,818	[2]
Transfers		1,647	[1]	(39,283)	[2]
Other changes including exchange variation		(1,333)	[1]	24	[2]
Intangible assets and goodwill, Ending	[1]	10,860		12,447
Gross carrying amount [member] | Relationship with franchisees and sub franchisees [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning	[3]	602,958		590,588
Acquisition of subsidiary	[3]	1,884,249
Additions	[3]
Write-offs	[3]			(17,958)
Reversal (provision) of impairment	[3]
Transfers	[3]			(371)
Other changes including exchange variation	[3]	472,312		30,699
Intangible assets and goodwill, Ending	[3]	2,959,519		602,958
Gross carrying amount [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning
Acquisition of subsidiary		1,131,573
Additions
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		463,468
Intangible assets and goodwill, Ending		1,595,041
Gross carrying amount [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		110,288		121,697
Acquisition of subsidiary		159
Additions		176,015		145,483
Write-offs		(15,024)		(1,133)
Reversal (provision) of impairment
Transfers		(175,414)		(146,364)
Other changes including exchange variation		12,251		(9,395)
Intangible assets and goodwill, Ending		108,275		110,288
Accumulated depreciation, amortisation and impairment [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(806,522)		(603,439)
Acquisition of subsidiary
Additions		(981,776)		(218,449)
Write-offs		15,064		7,402
Reversal (provision) of impairment
Transfers		(3,633)		8,392
Other changes including exchange variation		(100,175)		(428)
Intangible assets and goodwill, Ending		(1,877,042)		(806,522)
Accumulated depreciation, amortisation and impairment [member] | Software [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(649,347)		(483,666)
Acquisition of subsidiary
Additions		(365,184)		(169,174)
Write-offs		44		6,817
Reversal (provision) of impairment
Transfers		(3,643)		270
Other changes including exchange variation		(4,368)		(3,594)
Intangible assets and goodwill, Ending		(1,022,498)		(649,347)
Accumulated depreciation, amortisation and impairment [member] | Trademarks and patents Finite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(44,108)		(37,898)
Acquisition of subsidiary
Additions		(36,548)		(4,330)
Write-offs
Reversal (provision) of impairment
Transfers				154
Other changes including exchange variation		(19,387)		(2,034)
Intangible assets and goodwill, Ending		(100,043)		(44,108)
Accumulated depreciation, amortisation and impairment [member] | Relationship with retail clients [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(1,939)		(1,149)
Acquisition of subsidiary
Additions		(252)		(194)
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		(648)		(596)
Intangible assets and goodwill, Ending		(2,839)		(1,939)
Accumulated depreciation, amortisation and impairment [member] | Key Money Indefinite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Acquisition of subsidiary
Additions
Write-offs
Reversal (provision) of impairment
Accumulated depreciation, amortisation and impairment [member] | Key Money Finite [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(2,197)		(2,835)
Additions		(535)
Transfers		10		7,336
Other changes including exchange variation		(6,149)		(6,698)
Intangible assets and goodwill, Ending		(8,871)		(2,197)
Accumulated depreciation, amortisation and impairment [member] | Relationship with franchisees and sub franchisees [Member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(95,772)		(55,508)
Acquisition of subsidiary
Additions		(278,048)		(43,150)
Write-offs
Reversal (provision) of impairment
Transfers				371
Other changes including exchange variation		(45,241)		2,515
Intangible assets and goodwill, Ending		(419,061)		(95,772)
Accumulated depreciation, amortisation and impairment [member] | Technology developed (by acquired subsidiary) [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning
Acquisition of subsidiary
Additions		(294,713)
Write-offs
Reversal (provision) of impairment
Transfers
Other changes including exchange variation		(24,296)
Intangible assets and goodwill, Ending		(319,009)
Accumulated depreciation, amortisation and impairment [member] | Other intangible assets [member]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Intangible assets and goodwill, Beginning		(13,159)		(22,383)
Acquisition of subsidiary
Additions		(6,496)		(1,601)
Write-offs		15,020		585
Reversal (provision) of impairment
Transfers				261
Other changes including exchange variation		(86)		9,979
Intangible assets and goodwill, Ending		R$ 4721		R$ 13159
[1]	Key money with defined useful life refers to payments made to ex-tenants or lessors, to obtain the right to rent the property under the terms of the lease and which cannot be negotiated or recovered later. This balance was considered as the scope of the lease standard ( IFRS 16), applicable from January 1st, 2019. The balance not reclassified to the Right of Use asset, refers to contracts that the standard exempt on the initial date, that is, short-term contracts. The remaining balance is amortized over the term of the agreements.
[2]	Key money with indefinite useful life refers to payments made to former tenants, to get the right to rent the property under lease and can be subsequently negotiated with future tenants in the case of termination of the lease agreement. This balance was considered the scope of the lease standard IFRS 16), applicable from January 1st, 2019 (note 3.29). The balance not reclassified to the right of use asset, refers to contracts that the standard exempts on the initial date, that is, short-term contracts. The remaining balance is not amortized and is subject to an annual impairment test.
[3]	The balance refers to identifiable intangible assets from relationship with The Body Shop franchisees and sub-franchisees (relationship where the franchisee owns all rights to operate within a territory) and sub-franchisees (relationship where a franchisee operate a single store within a market), with estimated useful life of 15 years. In 2019 there is a write-off related to agreements with sub-franchisees in Brazil. In addition, the balance position classified as the acquisition of a subsidiary represents the fair value of the relationship between Avon and its sales representatives.
[4]	Goodwill related to the acquisition of Emeis Holdings Pty Ltd. acquisition, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests.
[5]	Goodwill related to the acquisition of The Body Shop, classified as future economic benefits from synergies. It does not have defined useful life and it is subject to annual impairment tests. In addition, on June 30, 2020, The Body Shop International Limited acquired the entity Aeon Forest Co. Ltd, for R$ 133,275 (¥ 2,632,000). On October 1st, 2020, the transaction was concluded and resulted in an assigned amount of goodwill of R$ 34,251.

Intangibles - Disclosure Of Inf

Intangibles - Disclosure Of Information For Cash-generating Units (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of information for cash-generating units [line items]
Total	R$ 26917128	R$ 5076501	R$ 4950545
Trademarks And Patents [Member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	5,747,057	2,171,585
Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	15,388,680	1,534,607
Intangible Assets And Goodwill With Indefinite Useful Life [Member]
Disclosure of information for cash-generating units [line items]
Total	21,135,737	3,706,192
Natura and Co Latam [Member] | Trademarks And Patents [Member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	5,403	2,566
Natura and Co Latam [Member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	9,994,861
Natura and Co Latam [Member] | Intangible Assets And Goodwill With Indefinite Useful Life [Member]
Disclosure of information for cash-generating units [line items]
Total	10,000,264	2,566
Avon International [Member]
Disclosure of information for cash-generating units [line items]
Total
Avon International [Member] | Trademarks And Patents [Member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	2,850,397
Avon International [Member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	3,304,988
Avon International [Member] | Intangible Assets And Goodwill With Indefinite Useful Life [Member]
Disclosure of information for cash-generating units [line items]
Total	6,155,385
TBS International [Member] | Trademarks And Patents [Member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents	2,891,257	2,169,019
TBS International [Member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	1,946,741	1,434,369
TBS International [Member] | Intangible Assets And Goodwill With Indefinite Useful Life [Member]
Disclosure of information for cash-generating units [line items]
Total	4,837,998	3,603,388
Aesop International [member] | Trademarks And Patents [Member]
Disclosure of information for cash-generating units [line items]
Trademarks and patents
Aesop International [member] | Goodwill [member]
Disclosure of information for cash-generating units [line items]
Goodwill	142,090	100,238
Aesop International [member] | Intangible Assets And Goodwill With Indefinite Useful Life [Member]
Disclosure of information for cash-generating units [line items]
Total	R$ 142090	R$ 100238

Intangibles - Disclosure Of Det

Intangibles - Disclosure Of Detailed Information About Assumptions Used To Calculate The Fair Value Less Cost To Sell (Detail)	12 Months Ended
	Dec. 31, 2020
Aesop [Member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Growth rate in perpetuity	4.20%
Discount rate	9.11%
The Body Shop [Member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Growth rate in perpetuity	4.10%
Discount rate	7.80%
Avon International [Member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Growth rate in perpetuity	4.30%
Discount rate	11.14%
Natura and Co Latam [Member]
Disclosure of information for cash-generating units [line items]
Measurement of impairment value (fair value less cost of disposal)	Discounted cash flow based on financial budgets approved by Senior Management during a discretionary period of five years with a terminal value projected for the end of the period.
Budgeted gross margin	Gross margins are based on average amounts obtained in the 2 years prior to the beginning of the budgeted period and projections for the next 5 years.
Estimated costs	Costs based on historical data and market trends, optimization of retail and direct sales operations (renewal of the geographical presence of stores, revitalization of the franchise network) and physical expansion with growth in market share.
Growth rate in perpetuity	5.50%
Discount rate	13.42%

Intangibles - Additional inform

Intangibles - Additional information (Detail) - The Body Shop [Member] - Aeon Forest Co., Ltd [member] ¥ in Thousands, R$ in Thousands	Dec. 31, 2020JPY (¥)	Dec. 31, 2020BRL (R$)	Oct. 01, 2020BRL (R$)
Disclosure of detailed information about intangible assets [line items]
Purchase price of entity	¥ 2,632,000	R$ 133275
Goodwill			R$ 34251

Right of Use And Lease - Schedu

Right of Use And Lease - Schedule of Quantitative Information About Right-of-Use Assets (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 2619861
First-time adoption				R$ 1923896
Acquisition of subsidiary		564,670
Additions		(413,408)		85,872
Write-offs		(25,880)		(79,138)
Impairment		(148,050)	[1]
Transfers		(2,962)	[2]	631,609
Exchange rate variation		807,816
Others changes				57,622
Right of use, Ending		3,402,047		2,619,861
Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		3,193,959
First-time adoption				1,923,896
Acquisition of subsidiary		564,670
Additions		610,551		661,496
Write-offs		(42,047)		(76,208)
Impairment	[1]	(148,050)
Transfers		(2,962)	[2]	631,609
Exchange rate variation		1,022,918
Others changes				53,166
Right of use, Ending		5,199,039		3,193,959
Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(574,098)
First-time adoption
Acquisition of subsidiary
Additions		(1,023,959)		(575,624)
Write-offs		16,167		(2,930)
Impairment	[1]
Transfers			[2]
Exchange rate variation		(215,102)
Others changes				4,456
Right of use, Ending		R$ 1796992		R$ 574098
Vehicles [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		3 years	[3]	3 years
Vehicles [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 40018
First-time adoption
Acquisition of subsidiary		42,467
Additions		61,878		40,069
Write-offs		(441)		(146)
Impairment	[1]
Transfers			[2]
Exchange rate variation		13,945
Others changes				95
Right of use, Ending		157,867		40,018
Vehicles [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(8,109)
First-time adoption
Acquisition of subsidiary
Additions		(54,558)		(8,083)
Write-offs		192		38
Impairment	[1]
Transfers			[2]
Exchange rate variation		(947)
Others changes				(64)
Right of use, Ending		R$ 63422		R$ 8109
Machinery and equipment [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		3 years	[3]	3 years
Machinery and equipment [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		10 years	[3]	10 years
Machinery and equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 15578
First-time adoption
Acquisition of subsidiary		14,034
Additions		11,265		14,954
Write-offs				(40)
Impairment	[1]
Transfers			[2]
Exchange rate variation		12,171
Others changes				664
Right of use, Ending		53,048		15,578
Machinery and equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(4,317)
First-time adoption
Acquisition of subsidiary
Additions		(14,899)		(4,126)
Write-offs
Impairment	[1]
Transfers			[2]
Exchange rate variation		(1,829)
Others changes				(191)
Right of use, Ending		R$ 21045		R$ 4317
Facilities [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		3 years	[3]	3 years
Facilities [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		10 years	[3]	10 years
Facilities [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 784900
First-time adoption				R$ 103945
Acquisition of subsidiary		489,740
Additions		146,695		187,294
Write-offs		(16,094)
Impairment	[1]
Transfers			[2]	481,235
Exchange rate variation		211,592
Others changes				12,426
Right of use, Ending		1,616,833		784,900
Facilities [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(97,190)
First-time adoption
Acquisition of subsidiary
Additions		(291,431)		(95,734)
Write-offs		12,448
Impairment	[1]
Transfers			[2]
Exchange rate variation		(23,592)
Others changes				(1,456)
Right of use, Ending		R$ 399765		R$ 97190
IT equipment [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		10 years	[3]	10 years
IT equipment [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 283
First-time adoption
Acquisition of subsidiary		18,429
Additions		6,211		279
Write-offs		(323)
Impairment	[1]
Transfers			[2]
Exchange rate variation		5,400
Others changes				4
Right of use, Ending		30,000		283
IT equipment [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(214)
First-time adoption
Acquisition of subsidiary
Additions		(18,694)		(209)
Write-offs
Impairment	[1]
Transfers			[2]
Exchange rate variation		(253)
Others changes				(5)
Right of use, Ending		R$ 19161		R$ 214
Retail stores [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		3 years	[3]	3 years
Retail stores [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		10 years	[3]	10 years
Retail stores [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 2350377
First-time adoption				R$ 1819951
Acquisition of subsidiary
Additions		384,502		416,250
Write-offs		(25,189)		(76,022)
Impairment	[1]	(148,050)
Transfers		(2,962)	[2]	150,374
Exchange rate variation		779,426
Others changes				39,824
Right of use, Ending		3,338,104		2,350,377
Retail stores [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(463,332)
First-time adoption
Acquisition of subsidiary
Additions		(643,441)		(466,590)
Write-offs		3,527		(2,968)
Impairment	[1]
Transfers			[2]
Exchange rate variation		(188,100)
Others changes				6,226
Right of use, Ending		R$ 1291346		R$ 463332
Tools and accessories [member]
Disclosure of quantitative information about right-of-use assets [line items]
Useful life		3 years	[3]	3 years
Tools and accessories [member] | Cost Value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		R$ 2803
First-time adoption
Acquisition of subsidiary
Additions				2,650
Write-offs
Impairment	[1]
Transfers			[2]
Exchange rate variation		384
Others changes				153
Right of use, Ending		3,187		2,803
Tools and accessories [member] | Depreciation value [member]
Disclosure of quantitative information about right-of-use assets [line items]
Right of use, Beginning		(936)
First-time adoption
Acquisition of subsidiary
Additions		(936)		(882)
Write-offs
Impairment	[1]
Transfers			[2]
Exchange rate variation		(381)
Others changes				(54)
Right of use, Ending		R$ 2253		R$ 936
[1]	Of the total amount of impairment recorded in 2020, R$ 144,500 refers to the impairment loss of legacy stores of The Body Shop that were previously included in the store closure plan, which were subsequently impacted by the effects of the pandemic, predominantly in the United States.
[2]	Refers to key money related to store rentals. This amount is transferred from right of use to intangible assets when a new commercial agreement with the lessor is not yet signed.
[3]	The useful lives applied refer to the term of the contracts in which the Company is sure that it will use the assets underlying the lease contracts according to the contractual terms.

Right of Use And Lease - Sche_2

Right of Use And Lease - Schedule of Detailed information about cash outflow related to leases (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020		Dec. 31, 2019	Dec. 31, 2018
Values recognized in the income statement during 2019
Financial expense on lease	R$ 229544		R$ 134579
Amortization of right of use	1,023,959		575,624
Appropriation in the result of variable lease installments not included in the measurement of rental liabilities	45,952		31,023
Sublease revenue	(27,079)		(2,698)
Short-term rental expenses and low-value assets	72,546		126,067
Benefits Granted By Lessors Related To Covid 19	(58,700)
Other lease-related expenses	40,206		22,214
Impairment	(148,050)	[1]
Total	1,470,928		886,809
Values recognized in the financing cash flow statement
Payment of leasing (principal)	843,338		497,905	R$ 46241
Values recognized in the operating cash flow statement
Payment of leasing (interest)	225,420		134,579
Variable lease payments not included in the measurement of rental liabilities	13,033		11,199
Short-term and low-value assets leases payments	51,675		69,162
lease-related payments	41,944		26,460
Total	R$ 1175410		R$ 739305
[1]	Of the total amount of impairment recorded in 2020, R$ 144,500 refers to the impairment loss of legacy stores of The Body Shop that were previously included in the store closure plan, which were subsequently impacted by the effects of the pandemic, predominantly in the United States.

Right of Use And Lease - Sche_3

Right of Use And Lease - Schedule of Lease Obligation (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of quantitative information about right-of-use assets [abstract]
Current	R$ 1059661	R$ 542088
Non-current	2,798,794	1,975,477
Total	R$ 3858455	R$ 2517565	R$ 446235

Right of Use And Lease - Sche_4

Right of Use And Lease - Schedule of Changes In The Balance of Lease Obligations (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of quantitative information about right-of-use assets [abstract]
Beginning balance		R$ 2517565	R$ 446235
First-time adoption of IFRS 16			1,949,739
New leases		559,905	627,889
Acquisition of subsidiary		777,200
Payment of leasing (principal)		(843,338)	(497,905)	R$ 46241
Payment of leasing (interest)		(225,420)	(134,579)
Recognition of financial charges		229,544	134,579
Write-offs	[1]	(193,174)	(86,319)
Translation effects (other comprehensive income)		1,036,173	77,926
Ending balance		R$ 3858455	R$ 2517565	R$ 446235
[1]	Refers mainly to the termination of contracts related to store leases.

Right of Use And Lease - Sche_5

Right of Use And Lease - Schedule of maturities of the balance of non-current lease liabilities (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	R$ 2798794	R$ 1975477
2021 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities		374,746
2022 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	611,048	361,688
2023 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	600,785	358,274
2024 [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	598,380	363,802
2025 onwards [member]
Disclosure of quantitative information about right-of-use assets [line items]
Non-current lease liabilities	R$ 988581	R$ 516967

Right of Use And Lease - Sche_6

Right of Use And Lease - Schedule of rates applied, according to the lease terms (Detail) R$ in Thousands	Dec. 31, 2020BRL (R$)
1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 673870
Lease terms, Estimated inflation rate	3.40%	[1]
2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 416303
Lease terms, Estimated inflation rate	3.40%	[1]
3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 397779
Lease terms, Estimated inflation rate	3.40%	[1]
4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 390589
Lease terms, Estimated inflation rate	3.60%	[1]
5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 393697
Lease terms, Estimated inflation rate	3.60%	[1]
6 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 374835
Lease terms, Estimated inflation rate	3.60%	[1]
Later than Six Years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 677845
Lease terms, Estimated inflation rate	3.80%	[1]
Average discount rate 1.9 percent to 10.5 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	1.90%
Average discount rate 1.9 percent to 10.5 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	10.50%
Average discount rate 1.9 percent to 10.5 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 566802
Average discount rate 1.9 percent to 10.5 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	32,692
Average discount rate 1.9 percent to 10.5 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	8,946
Average discount rate 1.9 percent to 10.5 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation
Average discount rate 1.9 percent to 10.5 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation
Average discount rate 1.9 percent to 10.5 percent [member] | 6 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation
Average discount rate 1.9 percent to 10.5 percent [member] | Later than Six Years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation
Average discount rate 1.9 percent to 14.0 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	1.90%
Average discount rate 1.9 percent to 14.0 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	14.00%
Average discount rate 1.9 percent to 14.0 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 32802
Average discount rate 1.9 percent to 14.0 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	304,688
Average discount rate 1.9 percent to 14.0 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	305,886
Average discount rate 1.9 percent to 14.0 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	302,042
Average discount rate 1.9 percent to 14.0 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	298,194
Average discount rate 1.9 percent to 14.0 percent [member] | 6 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	271,790
Average discount rate 1.9 percent to 14.0 percent [member] | Later than Six Years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation
Average discount rate 1.9 percent to 10.2 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	1.90%
Average discount rate 1.9 percent to 10.2 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	10.20%
Average discount rate 1.9 percent to 10.2 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 69488
Average discount rate 1.9 percent to 10.2 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	74,145
Average discount rate 1.9 percent to 10.2 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	78,169
Average discount rate 1.9 percent to 10.2 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	83,769
Average discount rate 1.9 percent to 10.2 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	90,725
Average discount rate 1.9 percent to 10.2 percent [member] | 6 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	98,267
Average discount rate 1.9 percent to 10.2 percent [member] | Later than Six Years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 661521
Average discount rate 8.2 percent to 13.6 percent [member] | Bottom of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	8.20%
Average discount rate 8.2 percent to 13.6 percent [member] | Top of range [member]
Disclosure of quantitative information about right-of-use assets [line items]
Lease terms, average discount rate	13.60%
Average discount rate 8.2 percent to 13.6 percent [member] | 1 year [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 4778
Average discount rate 8.2 percent to 13.6 percent [member] | 2 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,778
Average discount rate 8.2 percent to 13.6 percent [member] | 3 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,778
Average discount rate 8.2 percent to 13.6 percent [member] | 4 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,778
Average discount rate 8.2 percent to 13.6 percent [member] | 5 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,778
Average discount rate 8.2 percent to 13.6 percent [member] | 6 years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	4,778
Average discount rate 8.2 percent to 13.6 percent [member] | Later than Six Years [member]
Disclosure of quantitative information about right-of-use assets [line items]
Estimated future lease payment flows indexed to inflation	R$ 16324
[1]	Rates obtained through future prices of DI coupons versus National Consumer Price Index (IPCA) observed in B3, applied to Brazilian contracts.

Borrowings, Financing And Deb_3

Borrowings, Financing And Debentures - Schedule Of Detailed Information About Borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of detailed information about borrowings [line items]
Borrowings	R$ 13822913	R$ 10786374	R$ 7994145
Current	3,805,649	3,354,355
Non-current	10,017,264	7,432,019
Debentures Current	2,169,786	246,017
Debentures Non-current	1,872,729	4,005,214
BNDES [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	7,789	35,390
BNDES FINAME [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	15	183
BRL | FINEP [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	73,076	101,988
BRL | Debentures [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	4,042,515	4,251,231
BRL | Promissory Notes [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	773,949	2,883,382
BRL | Operations The Body Shop [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	500,835
BRL | Operations Avon [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	145,495
BRL | Notes - Avon [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	4,033,682
MXN | Operations Mexico [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	14,453	31,802
AUD | Operations Aesop [Member] | Working Capital Loan [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings		100,438
Local Currency
Disclosure of detailed information about borrowings [line items]
Borrowings	9,591,809	7,404,414
USD | BNDES [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	1,639	8,030
USD | Export Credit Note NCE [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings		81,210
USD | Representative debt securities (“Notes”) [member]
Disclosure of detailed information about borrowings [line items]
Borrowings	3,969,226	3,090,490
USD | Resolution [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings	260,239	202,230
Foreign Currency
Disclosure of detailed information about borrowings [line items]
Borrowings	R$ 4231104	R$ 3381960

Borrowings, Financing And Deb_4

Borrowings, Financing And Debentures - Schedule Of Detailed Information About Borrowings Charges (Detail)	12 Months Ended
	Dec. 31, 2020
Debentures [member] | BRL
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Real
Borrowings, maturity	August, 2024
Description of borrowing charges	Interest of 109% to 112% of CDI (International Deposit Certificate) , and 1.4% + CDI 1.75% + CDI, 1.00% + CDI and 1.15% + CDI, as maturing on March, 2020; September, 2020; September, 2021; September 2022 and August 2024.
Description of effective interest rate for borrowings	109.5% - 113.1%   CDI + 1.15% - CDI + 1.79%
Description of guarantees provided for borrowings	None
Working capital loan [member] | British Pounds | Operations The Body Shop [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	British Pounds
Borrowings, maturity	March, 2021
Description of guarantees provided for borrowings	Approval of subsidiary Natura Cosméticos S.A.
Working capital loan [member] | USD | Operations Avon [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	March, 2023 and March 2043
Description of borrowing charges	Interest of 7.00% p.a. and Interest of 8.95% p.a.
Description of guarantees provided for borrowings	None
Promissory notes [member] | BRL
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Real
Borrowings, maturity	Until April, 2021
Description of borrowing charges	Interest of 3.25% p.a. + CDI
Description of effective interest rate for borrowings	CDI + 3.30%
Description of guarantees provided for borrowings	Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda.
Representative debt securities (“Notes”) [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	February, 2023
Description of borrowing charges	Interest of 5.375% p.a.
Description of effective interest rate for borrowings	6,1%
Description of guarantees provided for borrowings	None
Resolution [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, original currency	Dollar
Borrowings, maturity	May, 2022
Description of borrowing charges	Libor + interest 1.1% p.a.
Description of effective interest rate for borrowings	Libor + interest 1.1% p.a.
Description of guarantees provided for borrowings	Approval of subsidiary Indústria e Comércio de Cosméticos Natura Ltda.

Borrowings, Financing And Deb_5

Borrowings, Financing And Debentures - Schedule of detailed information about borrowings (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2020
Bottom of range [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, effective interest rate basis	CDI + 1.15%
Borrowings effective interest rate	109.50%
Top of range [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, effective interest rate basis	CDI + 1.79%
Borrowings effective interest rate	113.10%
Debentures maturing march 2020 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	109% to 112% of CDI (International Deposit Certificate)
Debentures maturing march 2020 [member] | BRL | Bottom of range [member]
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	109.00%
Debentures maturing march 2020 [member] | BRL | Top of range [member]
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	112.00%
Debentures maturing september 2020 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.40%
Debentures maturing september 2021 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.75%
Debentures maturing september 2022 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.00%
Debentures maturing august 2024 [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.15%
Working capital loan [member] | British Pounds | Operations The Body Shop [Member]
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	Libor + interest of 2.00% p.a.
Borrowings, adjustment to interest rate basis	2.00%
Borrowings, effective interest rate basis	Libor + interest of 2.00% p.a.
Borrowings, adjustment to effective interest rate basis	2.00%
Promissory notes [member] | BRL
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	3.25%
Borrowings, Interest rate basis	3.25% p.a. + CD
Borrowings effective interest rate	3.30%
Representative debt securities (“Notes”) [member] | USD
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	5.375%
Borrowings, Interest rate basis	Interest of 5.375% p.a.
Borrowings, effective interest rate basis	6.1
Notes - Avon [Member] | Notes maturing March 2023 [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	Interest of 7.00% p.a.
Borrowings, adjustment to interest rate basis	7.00%
Borrowings, effective interest rate basis	Interest of 7.00% p.a.
Borrowings, adjustment to effective interest rate basis	7.00%
Notes - Avon [Member] | Notes maturing March 2043 [member] | USD
Disclosure of detailed information about borrowings [line items]
Borrowings, Interest rate basis	Interest of 8.95% p.a.
Borrowings, adjustment to interest rate basis	8.95%
Borrowings, effective interest rate basis	Interest of 8.95% p.a.
Borrowings, adjustment to effective interest rate basis	8.95%
Resolution no 413162 [member] | USD
Disclosure of detailed information about borrowings [line items]
Annual percentage interest rate	1.10%
Borrowings, Interest rate basis	Libor +interest 1.1% p.a

Borrowings, Financing And Deb_6

Borrowings, Financing And Debentures - Schedule Of Changes In Balances Of Borrowings (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of detailed information about borrowings [line items]
Balance at December 31, 2018	R$ 10786374	R$ 7994145
Assumed in a business combination	7,250,735
New borrowings and financing	1,354,765	5,346,145	R$ 5015278
Amortizations	(8,483,892)	(2,643,575)
Financial charges accrued	1,029,705	494,422
Payment of financial charges	(1,293,094)	(499,798)
Exchange variation (unrealized)	973,442	88,097
Exchange variation (realized)	35,429	5,903
Translation effects (other comprehensive income)	2,169,449	1,035
Balance at December 31, 2019	R$ 13822913	R$ 10786374	R$ 7994145

Borrowings, Financing And Deb_7

Borrowings, Financing And Debentures - Schedule of maturity analysis for non-current borrowings (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	R$ 10017264	R$ 7432019
2021 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures		2,279,759
2022 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	586,002	527,596
2023 [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	6,306,782	3,052,769
2024 onwards [member]
Disclosure of detailed information about borrowings [line items]
Borrowings, financing and debentures	R$ 3124480	R$ 1571895

Borrowings, Financing And Deb_8

Borrowings, Financing And Debentures - Schedule Of detailed information about Notes - Avon (Details) R$ in Thousands, $ in Thousands	Dec. 31, 2020BRL (R$)	Dec. 31, 2020USD ($)
Disclosure of detailed information about borrowings [line items]
Main	R$ 3690054
Unsecured Debt [Member]
Disclosure of detailed information about borrowings [line items]
Main	R$ 1122929	$ 216,085
Annual percentage interest rate	8.95%	8.95%
Notes - Avon [Member]
Disclosure of detailed information about borrowings [line items]
Effects of allocation of fair values from the business combination	R$ 449712
Notes 7 Percent Due March 15, 2023 [Member] | Unsecured Debt [Member]
Disclosure of detailed information about borrowings [line items]
Main	R$ 2400267	$ 461,883
Annual percentage interest rate	7.00%	7.00%

Borrowings, Financing And Deb_9

Borrowings, Financing And Debentures - Additional Information (Detail) R$ in Thousands, $ in Thousands, £ in Millions

Jun. 29, 2020BRL (R$)

Jan. 14, 2020BRL (R$)

Jul. 22, 2019BRL (R$)

Sep. 28, 2018BRL (R$)

Sep. 21, 2018BRL (R$)

Feb. 16, 2018BRL (R$)

Sep. 28, 2017BRL (R$)

Mar. 16, 2015BRL (R$)

Feb. 25, 2014BRL (R$)

Dec. 31, 2020BRL (R$)

Dec. 31, 2019BRL (R$)

Dec. 31, 2020USD ($)

Apr. 29, 2020BRL (R$)

Dec. 31, 2019GBP (£)

Dec. 31, 2019BRL (R$)

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 3690054

Unsecured Debt [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

1,122,929

$ 216,085

Unsecured Debentures [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 1576450

R$ 1000000

R$ 2600000

R$ 800000

R$ 600000

Number Of Debentures Issued

157,645

100,000

260,000

80,000

60,000

Nominal Unit Value

R$ 10000

Interest Costs

3,888

R$ 4760

Debt Issuance Cost

9,466

R$ 13354

Unsecured Debentures Due on February 24, 2017 [Member]

Disclosure of detailed information about borrowings [line items]

Proceeds From Issue Of Debentures

R$ 214385

Unsecured Debentures Due on February 24, 2017 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

20,000

Borrowings Adjustment To Interest Rate Basis

107.00%

Borrowings Maturity

February 24, 2017

Unsecured Debentures Due on February 25, 2018 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

20,000

Borrowings Adjustment To Interest Rate Basis

107.50%

Borrowings Maturity

February 25, 2018

Unsecured Debentures Due on February 25, 2019 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

20,000

Borrowings Adjustment To Interest Rate Basis

108.00%

Borrowings Maturity

February 25, 2019

Unsecured Debentures Due on March 16, 2018 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

40,000

Borrowings Adjustment To Interest Rate Basis

107.00%

Borrowings Maturity

March 16, 2018

Unsecured Debentures Due on March 16, 2019 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

25,000

Borrowings Adjustment To Interest Rate Basis

108.25%

Borrowings Maturity

March 16, 2019

Unsecured Debentures Due on March 16, 2020 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

15,000

Borrowings Adjustment To Interest Rate Basis

109.00%

Borrowings Maturity

March 16, 2020

Repayments Of Debentures

92,820

Unsecured Debentures Due on September 25, 2020 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

77,273

Borrowings Maturity

September 25, 2020

Borrowings Interest Rate Basis

CDI rate + 1.4% p.a.

Repayments Of Debentures

664,090

Unsecured Debentures Due on September 25, 2021 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

382,960

Unsecured Debentures Due on September 25, 2021 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

182,727

Borrowings Maturity

September 25, 2021

Borrowings Interest Rate Basis

CDI rate + 1.75% p.a.

Unsecured Debentures Due August 14, 2019 [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 1400000

Borrowings Adjustment To Interest Rate Basis

110.00%

Borrowings Maturity

August 14, 2019

Repayments Of Debentures

R$ 400000

400,000

Amortization Of Borrowings

R$ 1000000

Unsecured Debentures Due September 21, 2020 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

38,904

Borrowings Adjustment To Interest Rate Basis

109.50%

Borrowings Maturity

September 21, 2020

Unsecured Debentures Due September 21, 2021 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

30,831

Borrowings Adjustment To Interest Rate Basis

110.50%

Borrowings Maturity

September 21, 2021

Unsecured Debentures Due September 21, 2022 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

30,265

Borrowings Adjustment To Interest Rate Basis

112.00%

Borrowings Maturity

September 21, 2022

Unsecured Debentures Due August 26, 2024 [Member] | Tranche One [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

40,000

Borrowings Adjustment To Interest Rate Basis

1.00%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

9,570

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Three [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

68,623

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Unsecured Debentures Due August 26, 2024 [Member] | Tranche Four [Member]

Disclosure of detailed information about borrowings [line items]

Number Of Debentures Issued

39,452

Borrowings Adjustment To Interest Rate Basis

1.15%

Borrowings Maturity

August 26, 2024

Borrowings Interest Rate Basis

100% of the cumulative variation of the Brazilian Interbank Deposits (“DI”) average daily rates plus 1.15%

Promissory notes [member]

Disclosure of detailed information about borrowings [line items]

Notes Issuance Costs

25,205

R$ 11135

Deferred Notes Issuance Costs

2,121

R$ 20962

Promissory notes [member] | Tranche One [Member] | Series One [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

R$ 370000

R$ 1830000

Promissory notes [member] | Tranche One [Member] | Series Two [Member]

Disclosure of detailed information about borrowings [line items]

Repayments Of Debentures

R$ 140000

Promissory notes [member] | Tranche Two [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 500000

Promissory notes [member] | Tranche Four [Member]

Disclosure of detailed information about borrowings [line items]

Notional Amount

R$ 250000

Working capital loan [member] | Operations The Body Shop [Member] | Unsecured Debt [Member]

Disclosure of detailed information about borrowings [line items]

Line of Credit Facility, Maximum Borrowing Capacity

R$ 500835

£ 70

Borrowings Interest Rate Basis

Libor + 2%

Trade Payables And Reverse Fa_3

Trade Payables And Reverse Factoring Operations (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables		R$ 6476733	R$ 1686832
Reverse Factoring Operations	[1]	297,472	142,924
Trade payables		6,774,205	1,829,756
Domestic market [member]
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables		5,462,377	1,581,759
Foreign countries [member]
Trade Payables And Reverse Factoring Operations [Line Items]
Trade and other payables	[2]	R$ 1014356	R$ 105073
[1]	The Group have contracts signed with Banco Itaú Unibanco S.A. to structure a “supply chain finance” the operation with the Company’s main suppliers. Further details on these operations are included in note 3.16.
[2]	Refers to imports mainly denominated in US dollars, Euros and British pounds

Tax Liabilities - Schedule of d

Tax Liabilities - Schedule of detailed information about tax liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Dislosure Of Tax Liabilities [Line Items]
ICMS (ordinary)		R$ 134165	R$ 120300
ICMS-ST provision	[1]	61,521	72,423
Taxes on invoicing – foreign abroad		364,291	145,992
Social Security Tax (INSS) - suspension of the enforceability			50,147
Withholding tax (IRRF)		131,368	48,593
Other taxes payable - foreign subsidiaries		48,365	1,180
Income tax		15,943	1,207
PIS and COFINS payable		11,857
INSS and service tax (ISS) payable		32,954	3,218
Others		94,357	399
Total		894,821	443,459
Current		785,367	320,890
Noncurrent		R$ 109454	R$ 122569
[1]	The Company's subsidiaries have discussions about the illegality of changes in state laws to charge ICMS-ST. Part of the amount recorded as tax payable but not yet paid is being discussed in court by the Company’s subsidiaries, and in some cases, the amounts are deposited in court, as mentioned in note 13.

Provision For Tax, Civil And _3

Provision For Tax, Civil And Labor Risks - Schedule of detailed information about other provisions (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year	R$ 220066	R$ 261807
Acquisition of subsidiary	1,693,096
Additions	410,344	74,552
Reversals	(205,893)	(99,061)
Payments	(134,551)	(27,179)
Inflation adjustment	37,966	9,758
Exchange rate variation	136,640	189
Transfers	(98,468)
Balance as of December 31, 2020	2,059,200	220,066
Current	58,756	18,650
Non-current	2,000,444	201,416
Business Combination
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year
Acquisition of subsidiary	820,103
Additions	9,772
Reversals	(67,482)
Payments
Inflation adjustment	21,671
Exchange rate variation	13,629
Transfers
Balance as of December 31, 2020	797,693
Amounts arising from lawsuits with probability of possible and remote loss	872,993
Tax
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year	127,842	163,852
Acquisition of subsidiary	671,667
Additions	169,824	14,497
Reversals	(71,797)	(54,168)
Payments	(54,590)	(1,150)
Inflation adjustment	5,623	4,440
Exchange rate variation	83,202	371
Transfers
Balance as of December 31, 2020	931,771	127,842
Amounts arising from lawsuits with probability of possible and remote loss	709,751
Civil
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year	30,653	32,300
Acquisition of subsidiary	37,364
Additions	186,182	14,072
Reversals	(62,013)	(4,766)
Payments	(31,169)	(11,418)
Inflation adjustment	4,164	309
Exchange rate variation	12,525	156
Transfers	(99,309)
Balance as of December 31, 2020	78,397	30,653
Amounts arising from lawsuits with probability of possible and remote loss	55,624
Labour
Tax, civil and labor provision and contingent liabilities
Balance at the beginning of the year	61,571	65,655
Acquisition of subsidiary	163,962
Additions	44,566	45,983
Reversals	(4,601)	(40,127)
Payments	(48,792)	(14,611)
Inflation adjustment	6,508	5,009
Exchange rate variation	27,284	(338)
Transfers	841
Balance as of December 31, 2020	251,339	R$ 61571
Amounts arising from lawsuits with probability of possible and remote loss	R$ 54728

Provision For Tax, Civil And _4

Provision For Tax, Civil And Labor Risks - Contingent liabilities additional information (Detail 2) R$ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2020BRL (R$)	Dec. 31, 2020BRL (R$)	Dec. 31, 2019BRL (R$)
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 9559550	R$ 9559550	R$ 3642219
Contingencies resulting from the business combinations	797,693	797,693	0
Contingent assets	133,397	133,397	26,933
Avon [member]
Disclosure of contingent liabilities [line items]
Settlement amount to be paid by entity		75,352	14,500
Civil, commercial and other lawsuits [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 133302	R$ 133302	61,532
Civil, commercial and other lawsuits [member] | Avon [member]
Disclosure of contingent liabilities [line items]
Number of pending individual cases	164	164
Number of new proceedings filed	31
Number of cases dismissed, settled or otherwise resolved	14
Settlement amount		R$ 10393	2,000
Labor [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 220648	220,648	77,295
IPI tax debts, due to the alleged non-observance of the minimum tax base [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	9,205,601	9,205,601	3,503,392
IPI tax debts, due to the alleged non-observance of the minimum tax base [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,963,984	1,963,984
Related to Decree nº 8.393/2015 [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,660,532	1,660,532	389,017
Related to Collection of ICMS and ICMS-ST [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,503,657	1,503,657	406,002
Related to IRPJ and CSLL tax debts [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	1,396,782	1,396,782	1,379,189
Related to collection of ICMS-ST by Finance Department of the São Paulo Federal State [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	529,660	529,660	521,903
IPI tax debts for disagreeing with the tax classification [member] | Tax Contingency [member]
Disclosure of contingent liabilities [line items]
Contingencies assessed as possible risk of loss	R$ 524500	R$ 524500	R$ 218204

Provision For Tax, Civil And _5

Provision For Tax, Civil And Labor Risks - Schedule of detailed information about changes In other provisions Labor Risk (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of other provisions [line items]
Deposits - Additions	R$ 18377	R$ 2542

Other Liabilities - Schedule of

Other Liabilities - Schedule of detailed information about other liabilities (Detail) - BRL (R$) R$ in Thousands		Dec. 31, 2020	Dec. 31, 2019
Disclosure Of Other Liabilities [Abstract]
Pension and post-employment healthcare plans	[1]	R$ 783184	R$ 98792
Deferred revenue from performance obligations with customers	[2]	422,353	76,250
Provisions for incentives to consultants	[3]	292,034
Provisions for operating expenses (marketing / technology, etc.)	[4]	535,276	156,895
Discontinued operations	[5]	153,140
Provision for store renovation		99,702	15,997
Crer para Ver	[6]	75,508	51,543
Provisions for rentals	[7]	70,598	26,568
Provision for restructuring	[8]	68,954	3,401
Long-term incentives	[9]	52,745	3,022
Provisions for apportionment of benefits and partnerships payable		10,005	7,860
Other provision	[10]	373,891	67,846
Carbon credit		5,560	4,519
Exclusivity contract		3,000	5,400
Total		2,945,950	518,093
Current		1,832,811	396,391
Noncurrent		R$ 1113139	R$ 121702
[1]	As of December 31, 2020, Avon's pension and post-retirement plans amounts to R$ 648,990 and Natura's post-employment healthcare plans amounts to R$ 134,194 (R$ 98,792 as of December 31, 2019).
[2]	Refers to the deferral of revenue related performance obligations of loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$ 318,686 related Avon and R$ 103,667 related to Natura.
[3]	Provision for incentive and recognition programs for consultants.
[4]	Refers to the Group's operating provisions mainly due to spending on provision of technology services, marketing and advertising, etc., to comply with the accrual basis.
[5]	As of December 17, 2015, Avon has contracts that resulted in the separation of operations in the United States, Canada and Puerto Rico. These transactions were closed on March 1st, 2016. From that date, contingent liabilities prior to this transaction and related operations in the United States, Canada and Puerto Rico, are treated as discontinued operations. During the year ended December 31, 2020, Avon recorded R$ 143,112 as administrative expenses related to these provisions.
[6]	Refers to Social program contribution for developing the quality of education.
[7]	Refers to the (grace) period granted by lessors for the start of payment of rental of certain retail stores, for rental agreements that were not included in the initial measurement of lease liabilities / right-of-use of the subsidiary The Body Shop, in accordance with the exceptions permitted under IFRS 16.
[8]	Provision for costs directly related to the plan for changes in the organizational structure, mainly of Avon and The Body Shop organizational structures.
[9]	Refers substantially to the variable remuneration plans for Avon executives.
[10]	Refers to provisions for insurance coverage, indemnities and long-term contractual obligations.

Other Liabilities - Schedule _2

Other Liabilities - Schedule of change in actuarial liabilities (Detail) - Avon [member] R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year ended	R$ 520805
Cost of services - current	28,015
Interest cost	17,370
Administrative costs	2,476
Company contributions	(17,212)
Benefits paid	(32,463)
Actuarial gain (loss) in OCI	76,523
Reclassifications	(14,451)
Plan amendments	(21,147)
Special termination benefits	(29,915)
Transfers	(25,273)
Others	(1,829)
Foreign currency changes	146,091
Balance at the end of the year ended	648,990
Pension Plan [member]
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year ended	413,070
Cost of services - current	28,015
Interest cost	13,760
Administrative costs	2,476
Company contributions	(17,212)
Benefits paid	(4,611)
Actuarial gain (loss) in OCI	74,460
Reclassifications	(14,451)
Plan amendments
Special termination benefits
Transfers
Others	(2,814)
Foreign currency changes	117,268
Balance at the end of the year ended	609,961
Post-retirement benefits [member]
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year ended	107,735
Cost of services - current
Interest cost	3,610
Administrative costs
Company contributions
Benefits paid	(27,852)
Actuarial gain (loss) in OCI	2,063
Reclassifications
Plan amendments	(21,147)
Special termination benefits	(29,915)
Transfers	(25,273)
Others	985
Foreign currency changes	28,823
Balance at the end of the year ended	R$ 39029

Other Liabilities - Schedule _3

Other Liabilities - Schedule of details of assumptions (Detail) - Avon [member]	Dec. 31, 2020
Pension Plan [member] | Bottom of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	0.30%
Rate of compensation increase	1.80%
Pension Plan [member] | Top of range [member]
Disclosure of defined benefit plans [line items]
Discount rate	8.50%
Rate of compensation increase	6.60%
Post-retirement benefits [member]
Disclosure of defined benefit plans [line items]
Discount rate	3.95%

Other Liabilities - Schedule _4

Other Liabilities - Schedule of detailed information about quantitative sensitivity analysis of discount rates and increase in compensation (Details) - Avon [member] R$ in Thousands	Dec. 31, 2020BRL (R$)
Discount rate [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	1.53%
Percentage of reasonably possible increase in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 331549
Decreased Actuarial Assumption Percentage	1.53%
Percentage of reasonably possible decrease in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 372084
Rate of compensation increase [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	2.74%
Percentage of reasonably possible increase in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 12472
Decreased Actuarial Assumption Percentage	2.74%
Percentage of reasonably possible decrease in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 11952

Other Liabilities - Schedule _5

Other Liabilities - Schedule of detailed information about expected payments of contributions to the defined benefit plan in future years (Details) - Avon [member] R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)
Disclosure of defined benefit plans [line items]
2021	R$ 103363
2022	89,038
2023	87,706
2024	86,157
2025	83,276
2026 to 2030	R$ 395832

Other Liabilities - Schedule _6

Other Liabilities - Schedule of detailed information about actuarial liabilities computation (Detail) - Natura Cosmticos SA [Member]	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of defined benefit plans [line items]
Discount rate	7.02%	7.39%
Initial growth rate of medical cost	3.75%	7.17%
Inflation rate	3.10%	3.80%
Final growth rate of medical cost	6.97%	7.17%
Growth rate of medical costs by aging - contributions	0.00%	0.00%
Percentage of adherence to the plan in retirement		87.00%
Schedule of disabled mortality	Mercer Disability	Mercer Disability
Schedule of mortality	AT-2000	AT-2000
Schedule of turnover	Proportional calculation at the time of service	Proportional calculation at the time of service
Bottom of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	1.25%	1.54%
Top of range [member]
Disclosure of defined benefit plans [line items]
Growth rate of medical costs due to aging - costs	4.75%	4.50%
Bradesco Plan [Member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	69.00%
Unimed Plan [Member]
Disclosure of defined benefit plans [line items]
Percentage of adherence to the plan in retirement	84.00%

Other Liabilities - Schedule _7

Other Liabilities - Schedule of detailed information about sensitivity analysis for actuarial assumptions (Detail) - Natura Cosmticos SA [Member] R$ in Thousands	Dec. 31, 2020BRL (R$)
Discount rate [member]
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	7.02%
Percentage of reasonably possible increase in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 110383
Decreased Actuarial Assumption Percentage	7.02%
Percentage of reasonably possible decrease in actuarial assumption	0.50%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 165801
Rate of compensation
Disclosure of sensitivity analysis for actuarial assumptions [line items]
Increased Actuarial Assumption Percentage	6.97%
Percentage of reasonably possible increase in actuarial assumption	1.00%
Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption	R$ 164501
Decreased Actuarial Assumption Percentage	6.97%
Percentage of reasonably possible decrease in actuarial assumption	1.00%
Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption	R$ 110866

Other Liabilities - Schedule _8

Other Liabilities - Schedule of detailed information about movements of actuarial liabilities (Detail) - Natura Cosmticos SA [Member] - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of defined benefit plans [line items]
Balance at the beginning of the year ended	R$ 98792	R$ 78904
Cost of the Company´s current service	(620)	(816)
Cost of interest	(7,223)	(7,125)
Expenses paid	2,069	2,427
Actuarial gains (losses) in OCI	(29,628)	(14,374)
Balance at the end of the year ended	R$ 134194	R$ 98792

Other Liabilities - Additional

Other Liabilities - Additional Information (Detail) R$ in Thousands		12 Months Ended
		Dec. 31, 2020BRL (R$)Employees	Dec. 31, 2019BRL (R$)Employees
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment healthcare plans	[1]	R$ 783184	R$ 98792
Deferred revenue from performance obligations with customers	[2]	422,353	76,250
Avon [member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment healthcare plans		648,990
Deferred revenue from performance obligations with customers		318,686
Administrative expenses		R$ 143112
Average duration of the defined benefit plan obligation		9 years 1 month 17 days
Natura Cosmticos SA [Member]
Disclosure Of Other Liabilities [Line Items]
Pension and post-employment healthcare plans		R$ 134194	R$ 98792
Deferred revenue from performance obligations with customers		R$ 103667
Weighted average of life expectancy after retirement		19 years 9 months 18 days	20 years 9 months 18 days
Number of active employees | Employees		1,064	1,175
Number of retired and dependent employees. | Employees		537	477
Actuarial assumption of initial level of growth in medical cost.		3.75%
Actuarial assumption of discount rates		7.39%	7.02%
Actuarial gains (loss)		R$ 3891
[1]	As of December 31, 2020, Avon's pension and post-retirement plans amounts to R$ 648,990 and Natura's post-employment healthcare plans amounts to R$ 134,194 (R$ 98,792 as of December 31, 2019).
[2]	Refers to the deferral of revenue related performance obligations of loyalty programs based on points, sale of gift cards not yet converted into products and programs and events to honor direct selling consultants, of which R$ 318,686 related Avon and R$ 103,667 related to Natura.

Shareholder's Equity - Schedule

Shareholder's Equity - Schedule of changes in treasury shares (Detail) R$ / shares in Units, R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)R$ / sharesshares
Disclosure of classes of share capital [line items]
Balance at beginning of period | R$
Balance at end of period | R$	R$ 11667
Bottom of range [member]
Disclosure of classes of share capital [line items]
Average price per share, outstanding at beginning of period	R$ 25.00
Average price per share, outstanding at end of period	25
Top of range [member]
Disclosure of classes of share capital [line items]
Average price per share, outstanding at beginning of period	49.71
Average price per share, outstanding at end of period	R$ 49.71
Treasury shares [member]
Disclosure of classes of share capital [line items]
Balance at beginning of period | R$
Average price per share, outstanding at beginning of period
Used | R$	R$ 52849
Used (in shares) | shares	(1,102,001)
Average price per share, issued	R$ 47.53
Share repurchase | R$	R$ 64516
Acquisition (in shares) | shares	1,418,702
Average price per share, purchased	R$ 45.48
Balance at end of period | R$	R$ 11667
Total shares capital subscribed and paid-up (in shares) | shares	316,701
Average price per share, outstanding at end of period	R$ 38.04

Shareholder's Equity - Addition

Shareholder's Equity - Additional Information (Detail) - BRL (R$) R$ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2020	Jan. 03, 2020	Dec. 31, 2019
Statements [Line Items]
Issued capital		R$ 12377999		R$ 1485436
Capital reserve		R$ 11052135		R$ 999931
Dividend Rate		30.00%
Nominal common shares		1,375,158,636		865,659,942
Profit reserve related to retained earnings		R$ 6864		R$ 1428
Capital reserve [member]
Statements [Line Items]
Increase (decrease) through transfer to statutory reserve, equity	R$ 2000000	52,041
Increase (decrease) in equity	R$ 1118	147,592
Increase (decrease) through other changes, equity		58,496
Profit Reserve [Member]
Statements [Line Items]
Increase (decrease) through transfer to statutory reserve, equity		147,592
Increase (decrease) in equity		155,884
Increase (decrease) through other changes, equity		8,292
Natura Cosmetics [Member]
Statements [Line Items]
Total subscription price			R$ 13274894
Issued capital			3,397,746
Capital reserve		R$ 11052470	R$ 9877148	R$ 999931

Segment Information - Summary o

Segment Information - Summary of operating segment (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of operating segments [line items]
Net revenues	R$ 36921980	R$ 14444690	R$ 13397419
Performance Assessed By Company	3,365,339	2,468,664	1,846,604
Depreciation and amortization	(2,718,856)	(1,117,416)	(589,911)
Financial income	4,738,391	1,955,784	2,056,421
Financial expenses	(5,773,810)	(2,795,874)	(2,639,709)
Income tax	(274,744)	(355,691)	(125,026)
Net income (loss)	(663,678)	155,467	548,379
Natura &Co LATAM
Disclosure of operating segments [line items]
Net revenues	20,542,345	9,113,856	8,540,167
Performance Assessed By Company	2,369,515	1,372,172	1,442,041
Depreciation and amortization	(874,584)	(370,953)	(318,506)
Financial income	3,402,578	1,893,333	1,925,524
Financial expenses	(3,891,641)	(2,613,294)	(2,501,451)
Income tax	(428,191)	41,623	(149,709)
Net income (loss)	577,679	322,880	397,900
Avon International [Member]
Disclosure of operating segments [line items]
Net revenues	9,097,375
Performance Assessed By Company	185,914
Depreciation and amortization	(814,678)
Financial income	979,267
Financial expenses	(1,442,216)
Income tax	(121,603)
Net income (loss)	(1,213,315)
TBS International
Disclosure of operating segments [line items]
Net revenues	5,332,922	4,028,660	3,795,721
Performance Assessed By Company	935,255	806,357	341,518
Depreciation and amortization	(761,224)	(559,921)	(206,004)
Financial income	82,736	44,953	126,289
Financial expenses	(157,705)	(99,765)	(136,019)
Income tax	(66,626)	(37,736)	25,994
Net income (loss)	32,436	153,888	151,778
Aesop International [member]
Disclosure of operating segments [line items]
Net revenues	1,949,338	1,302,174	1,061,531
Performance Assessed By Company	606,544	351,944	165,084
Depreciation and amortization	(268,092)	(186,542)	(65,401)
Financial income	23,152	9,337	4,608
Financial expenses	(72,056)	(34,204)	(2,239)
Income tax	(55,219)	(47,768)	(36,004)
Net income (loss)	234,328	92,768	66,047
Corporate Expenses [Member]
Disclosure of operating segments [line items]
Net revenues
Performance Assessed By Company	(731,889)	(61,809)	(102,039)
Depreciation and amortization	(278)
Financial income	250,658	8,161
Financial expenses	(210,192)	(48,611)
Income tax	396,895	(311,810)	34,693
Net income (loss)	R$ 294806	R$ 414069	R$ 67346

Segment Information - Summary_2

Segment Information - Summary of operating segments of assets and liabilities (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	R$ 42182777	R$ 11754455	R$ 8923790
Total assets	60,917,597	21,184,512	15,379,549
Current liabilities	16,159,586	7,518,423	4,566,881
Non-current liabilities	17,370,903	10,303,744	8,238,566
Natura &Co LATAM
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	20,228,016	4,574,087	3,992,000
Total assets	27,644,907	9,328,858	8,904,065
Current liabilities	12,410,585	3,116,454	3,650,203
Non-current liabilities	9,060,600	8,235,678	7,652,955
Avon International [Member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	12,486,733
Total assets	19,097,959
Current liabilities	405,975
Non-current liabilities	5,625,774
TBS International
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	7,821,884	6,146,960	4,518,655
Total assets	10,474,191	7,369,250	5,709,760
Current liabilities	2,291,459	1,065,447	681,660
Non-current liabilities	1,812,991	1,477,149	504,592
Aesop International [member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	1,395,628	1,033,408	413,136
Total assets	2,148,869	1,435,830	765,724
Current liabilities	488,662	255,616	235,018
Non-current liabilities	618,531	590,917	81,019
Corporate Expenses [Member]
Disclosure Of Operating Segments Of Assets And Liabilities [Line Items]
Non-current assets	250,516
Total assets	1,551,671	3,050,574
Current liabilities	562,905	R$ 3080906
Non-current liabilities	R$ 253007

Segment Information - Summary_3

Segment Information - Summary of revenue and assets by geographical area wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	R$ 36921980	R$ 14444690	R$ 13397419
Non-current assets	42,182,777	11,754,455	8,923,790
Natura &Co LATAM
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	20,542,345	9,113,856	8,540,167
Non-current assets	20,228,016	4,574,087	3,992,000
Avon International [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	9,097,375
Non-current assets	12,486,733
TBS International
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	5,332,922	4,028,660	3,795,721
Non-current assets	7,821,884	6,146,960	4,518,655
Aesop International [member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	1,949,338	1,302,174	1,061,531
Non-current assets	1,395,628	1,033,408	413,136
Asia [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	2,929,063	782,940	666,154
Non-current assets	768,878	368,430
North America [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	5,120,953	1,750,957	919,826
Non-current assets	5,939,728	981,673
Mexico [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	3,205,609	767,361	616,883
Non-current assets	3,263,833	183,250
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	1,915,344	983,596	302,943
Non-current assets	2,675,895	798,423
South America [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	16,484,363	8,340,025	8,534,263
Non-current assets	14,810,020	4,378,675
Brazil [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	11,113,810	6,324,227	6,082,896
Non-current assets	12,159,245	4,197,258
Argentina [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	1,999,461	794,749	711,425
Non-current assets	1,041,392	63,050
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	3,371,092	1,221,049	1,739,942
Non-current assets	1,609,383	118,367
Europe [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	11,580,586	2,909,968	2,660,243
Non-current assets	19,615,198	5,306,111
United Kingdom [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	4,117,699	2,115,385	1,877,475
Non-current assets	17,059,017	4,678,139
Other [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	7,462,887	794,583	782,768
Non-current assets	2,556,181	627,972
Oceania [Member]
Disclosure Of Revenue And Assets By Geographical Area Wise [Line Items]
NET REVENUE	807,015	660,800	R$ 616933
Non-current assets	R$ 1048952	R$ 719566

Segment Information - Additiona

Segment Information - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2020
Statement [Line Items]
Number of operating segment	4
Major Customer [Member]
Statement [Line Items]
Number of major customers	0
Benchmark for major customer	10.00%
Natura &Co LATAM
Statement [Line Items]
Percentage of entity's revenue	56.00%
Avon International [Member]
Statement [Line Items]
Percentage of entity's revenue	25.00%
TBS International
Statement [Line Items]
Percentage of entity's revenue	14.00%
Aesop International [member]
Statement [Line Items]
Percentage of entity's revenue	5.00%

Net Revenue - Summary of Revenu

Net Revenue - Summary of Revenue by Geographical Area Wise (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of geographical areas [line items]
Gross revenue	R$ 47697618	R$ 19708104	R$ 18561962
Returns and cancellations	(617,140)	(73,183)	(54,522)
Commercial discounts and rebates	(1,062,204)	(1,292,134)	(1,421,251)
Taxes on sales	(9,096,294)	(3,898,097)	(3,688,770)
Subtotal	(10,775,638)	(5,263,414)	(5,164,543)
Total net revenues	36,921,980	14,444,690	13,397,419
Domestic market [member]
Disclosure of geographical areas [line items]
Gross revenue	15,373,742	8,907,766	8,575,971
Foreign Market [member]
Disclosure of geographical areas [line items]
Gross revenue	31,784,934	10,739,036	9,936,334
Other sales [member]
Disclosure of geographical areas [line items]
Gross revenue	R$ 538942	R$ 61302	R$ 49657

Operating Expenses and Cost o_3

Operating Expenses and Cost of Sales - Summary of Operating Expenses and Cost of Sale (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of operating expenses and cost of sale [line Items]
Cost of sales	R$ 13229715	R$ 4033454	R$ 3782843
Selling, marketing and logistics expenses	15,702,787	6,395,586	5,828,713
Administrative, R&D, IT and Project expenses	5,955,996	2,405,576	2,251,341
Total	R$ 34888498	R$ 12834616	R$ 11862897

Operating Expenses and Cost o_4

Operating Expenses and Cost of Sales - Summary of Operating Expenses and Cost of Sale Breakdown by Nature (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of operating expenses and cost of sale breakdown by nature [line Items]
Cost of sales	R$ 13229715	R$ 4033454	R$ 3782843
Selling, marketing and logistics expenses	15,702,787	6,395,586	5,828,713
Administrative, R&D, IT and project expenses	5,955,996	2,405,576	2,251,341
Employee benefits expense	210,539	128,080	139,280
Depreciation and amortization	2,718,856	1,117,416	589,911
Total	34,888,498	12,834,616	11,862,897
Cost of sales [member]
Disclosure of operating expenses and cost of sale breakdown by nature [line Items]
Cost of sales	13,229,715	4,033,454	3,782,843
Raw material/packaging material/resale	11,222,801	3,457,481	3,223,446
Employee benefits expense	638,525	293,374	276,848
Depreciation and amortization	215,355	57,443	65,157
Other	1,153,034	225,156	217,392
Selling, marketing and logistics expenses [member]
Disclosure of operating expenses and cost of sale breakdown by nature [line Items]
Selling, marketing and logistics expenses	15,702,787	6,395,586	5,828,713
Logistics costs	2,479,156	797,055	750,238
Employee benefits expense	4,198,147	1,667,202	1,656,611
Marketing, sales force and other selling expenses	7,723,827	3,164,875	3,191,895
Depreciation and amortization	1,301,657	766,454	229,969
Administrative RD IT and project expenses [member]
Disclosure of operating expenses and cost of sale breakdown by nature [line Items]
Administrative, R&D, IT and project expenses	5,955,996	2,405,576	2,251,341
Innovation expenses	270,256	89,675	102,436
Employee benefits expense	2,498,024	1,223,586	1,036,866
Other administrative expenses	1,985,872	798,796	817,254
Depreciation and amortization	R$ 1201844	R$ 293519	R$ 294785

Employee Benefits - Summary of

Employee Benefits - Summary of Employee Benefit Expense (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Disclosure of defined benefit plans [line items]
Payroll, profit sharing and bonuses	R$ 5407990	R$ 2315517	R$ 2350182
Pension Plan	186,373	93,528	41,923
Share-based payments	163,345	58,855	40,505
Charges on restricted shares	68,617	59,753	22,428
Health care, food and other benefits	684,992	253,510	177,135
Charges, taxes and social contributions	635,248	231,384	181,240
INSS	188,131	171,615	156,912
Total	R$ 7334696	R$ 3184162	R$ 2970325

Employee Benefits - Summary o_2

Employee Benefits - Summary of Number and Weighted Average Number of Shares (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2020sharesR$ / shares	Dec. 31, 2019sharesR$ / shares
DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsline item [Line Items]
Options, Balance	17,568
Options, Exercised	(3,405)	(604)
Options, Balance	17,245	17,568
Stock Option [Member]
DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsline item [Line Items]
Average exercise price per option, Balance | R$ / shares	R$ 16.51
Average exercise price per option, Granted | R$ / shares	0.01
Average exercise price per option, Expired / Cancelled | R$ / shares	21.25
Average exercise price per option, Exercised | R$ / shares	16.65
Average exercise price per option, Balance | R$ / shares	R$ 16.49	R$ 16.51
Options, Balance	17,568
Options, Granted	117
Options, Expired / Cancelled	(167)
Options, Exercised	(2,267)
Options, Balance		17,568
Stock Option [Member] | Avon [member]
DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsline item [Line Items]
Average exercise price per option, Granted | R$ / shares	R$ 0.01
Options, Granted	1,994
Restricted Stock [Member]
DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsline item [Line Items]
Shares, Balance	3,092
Shares, Granted	5,026
Shares, Expired	(22)
Shares, Exercised	(1,136)
Shares, Balance	6,960	3,092
Performance Shares [Member]
DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsline item [Line Items]
Shares, Balance	688
Shares, Granted
Shares, Expired	(51)
Shares, Exercised
Shares, Balance	637	688

Employee Benefits - Summary o_3

Employee Benefits - Summary of Terms and Conditions of Share-based Payment Arrangement (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2020sharesR$ / shares	Dec. 31, 2019shares
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing options | shares	17,245	17,568
Vested options | shares	3,405	604
Between December 31, 2002 to May 09, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	Between December 31, 2002 to May 09, 2017
Right acquisition conditions	1 year of service
Exercise price	R$ 0.01
Fair value	R$ 19.80
Existing options | shares	65
Vested options | shares	65
Between March 14 to December 17, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	Between March 14 to December 17, 2018
Right acquisition conditions	From 1 to 3 years of service
Exercise price	R$ 0.01
Fair value	R$ 19.70
Existing options | shares	319
Remaining contractual life	4 months 24 days
Vested options | shares	55
Between March 13 to December 16, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	Between March 13 to December 16, 2019
Right acquisition conditions	From 1 to 3 years of service
Exercise price	R$ 0.01
Fair value	R$ 19.58
Existing options | shares	1,046
Vested options | shares	33
June 8, 2020
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	June 8, 2020
Right acquisition conditions	1 year of service
Exercise price	R$ 0.01
Fair value	R$ 16.86
Existing options | shares	117
Remaining contractual life	8 months 12 days
Vested options | shares	104
March 27, 2020 - Co-Investment Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 27, 2020 – Co-Investment Plan
Right acquisition conditions	From 1 to 3 years of service
Fair value	R$ 29.00
Existing stock | shares	1,789
September 29, 2020 - Long-term Incentive Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	September 29, 2020 – Long-term Incentive Plan
Right acquisition conditions	From 3 to 4 years of service
Fair value	R$ 73.46
Existing stock | shares	3,239
Bottom of range [member] | Between March 13 to December 16, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	2 months 12 days
Bottom of range [member] | March 27, 2020 - Co-Investment Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	6 months
Bottom of range [member] | September 29, 2020 - Long-term Incentive Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	3 years
Top of range [member] | Between March 13 to December 16, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	1 year 4 months 24 days
Top of range [member] | March 27, 2020 - Co-Investment Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	2 years 6 months
Top of range [member] | September 29, 2020 - Long-term Incentive Plan
Disclosure of terms and conditions of share-based payment arrangement [line items]
Remaining contractual life	4 years
Stock Option [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing options | shares		17,568
Vested options | shares	2,267
Stock Option [Member] | March 18, 2013
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 18, 2013
Right acquisition conditions	4 years of service
Exercise price	R$ 37.60
Fair value	R$ 6.05
Existing options | shares	300
Remaining contractual life	2 months 12 days
Vested options | shares	300
Stock Option [Member] | March 17, 2014
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 17, 2014
Right acquisition conditions	4 years of service
Exercise price	R$ 25.16
Fair value	R$ 4.27
Existing options | shares	96
Remaining contractual life	1 year 2 months 12 days
Vested options | shares	96
Stock Option [Member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 16, 2015
Right acquisition conditions	From 2 to 4 years of service
Exercise price	R$ 13.60
Existing options | shares	184
Remaining contractual life	2 years 2 months 12 days
Vested options | shares	184
Stock Option [Member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	July 28, 2015 (Strategy acceleration)
Right acquisition conditions	From 4 to 5 years of service
Exercise price	R$ 12.90
Existing options | shares	1,020
Remaining contractual life	2 years 7 months 6 days
Vested options | shares	1,020
Stock Option [Member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 15, 2016
Right acquisition conditions	From 2 to 4 years of service
Exercise price	R$ 12.84
Existing options | shares	184
Remaining contractual life	3 years 3 months 18 days
Vested options | shares	182
Stock Option [Member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	July 11, 2016 (Strategy acceleration)
Right acquisition conditions	From 4 to 5 years of service
Exercise price	R$ 11.41
Existing options | shares	1,924
Remaining contractual life	3 years 7 months 6 days
Vested options | shares	606
Stock Option [Member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 10, 2017
Right acquisition conditions	From 2 to 4 years of service
Exercise price	R$ 12.59
Existing options | shares	598
Remaining contractual life	4 years 3 months 18 days
Vested options | shares	272
Stock Option [Member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 10, 2017 (Strategy acceleration)
Right acquisition conditions	From 4 to 5 years of service
Exercise price	R$ 12.59
Existing options | shares	2,210
Remaining contractual life	4 years 3 months 18 days
Stock Option [Member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018
Right acquisition conditions	From 2 to 4 years of service
Exercise price	R$ 16.96
Existing options | shares	1,846
Remaining contractual life	5 years 3 months 18 days
Vested options | shares	488
Stock Option [Member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 (Strategy acceleration)
Right acquisition conditions	From 3 to 5 years of service
Existing options | shares	3,800
Remaining contractual life	5 years 3 months 18 days
Stock Option [Member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019
Right acquisition conditions	From 3 to 4 years of service
Exercise price	R$ 23.54
Existing options | shares	1,636
Remaining contractual life	6 years 3 months 18 days
Stock Option [Member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 (Strategy acceleration)
Right acquisition conditions	From 4 to 5 years of service
Exercise price	R$ 23.54
Existing options | shares	1,900
Remaining contractual life	6 years 3 months 18 days
Stock Option [Member] | Bottom of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 4.85
Stock Option [Member] | Bottom of range [member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.20
Stock Option [Member] | Bottom of range [member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.16
Stock Option [Member] | Bottom of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.84
Stock Option [Member] | Bottom of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.65
Stock Option [Member] | Bottom of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.87
Stock Option [Member] | Bottom of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.96
Stock Option [Member] | Bottom of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price	12.16
Fair value	8.21
Stock Option [Member] | Bottom of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.71
Stock Option [Member] | Bottom of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.51
Stock Option [Member] | Top of range [member] | March 16, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	5.29
Stock Option [Member] | Top of range [member] | July 28, 2015 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.23
Stock Option [Member] | Top of range [member] | March 15, 2016
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	7.43
Stock Option [Member] | Top of range [member] | July 11, 2016 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.89
Stock Option [Member] | Top of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.68
Stock Option [Member] | Top of range [member] | March 10, 2017 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	6.89
Stock Option [Member] | Top of range [member] | March 12, 2018
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	8.21
Stock Option [Member] | Top of range [member] | March 12, 2018 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exercise price	16.96
Fair value	9.67
Stock Option [Member] | Top of range [member] | April 12, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	11.82
Stock Option [Member] | Top of range [member] | April 12, 2019 (Strategy acceleration)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 11.71
Restricted Stock [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing stock | shares	6,960
Vested stock | shares	6,960	3,092
Restricted Stock [Member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 10, 2017
Right acquisition conditions	From 2 to 4 years of service
Remaining contractual life	4 months 24 days
Existing stock | shares	208
Restricted Stock [Member] | March 12, 2018 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 – Plan I
Right acquisition conditions	From 2 to 4 years of service
Existing stock | shares	470
Restricted Stock [Member] | March 12, 2018 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 – Plan III
Right acquisition conditions	From 1 to 3 years of service
Remaining contractual life	6 months
Existing stock | shares	74
Restricted Stock [Member] | March 12, 2018 – Extraordinary Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	March 12, 2018 – Extraordinary Plan I
Right acquisition conditions	From 1 to 3 years of service
Remaining contractual life	4 months 24 days
Existing stock | shares	4
Restricted Stock [Member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	August 13, 2018 – Extraordinary Plan VI
Right acquisition conditions	From 1.6 to 3.6 years of service
Existing stock | shares	50
Restricted Stock [Member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 – Plan I
Right acquisition conditions	From 2 to 4 years of service
Existing stock | shares	814
Restricted Stock [Member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	April 12, 2019 – Plan II
Right acquisition conditions	From 1 to 3 years of service
Existing stock | shares	312
Restricted Stock [Member] | Bottom of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 11.69
Restricted Stock [Member] | Bottom of range [member] | March 12, 2018 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 15.18
Remaining contractual life	6 months
Restricted Stock [Member] | Bottom of range [member] | March 12, 2018 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 15.54
Restricted Stock [Member] | Bottom of range [member] | March 12, 2018 – Extraordinary Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	15.54
Restricted Stock [Member] | Bottom of range [member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 12.24
Remaining contractual life	6 months
Restricted Stock [Member] | Bottom of range [member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 21.62
Remaining contractual life	6 months
Restricted Stock [Member] | Bottom of range [member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 22.14
Remaining contractual life	6 months
Restricted Stock [Member] | Top of range [member] | March 10, 2017
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 12.51
Restricted Stock [Member] | Top of range [member] | March 12, 2018 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 15.9
Remaining contractual life	1 year 6 months
Restricted Stock [Member] | Top of range [member] | March 12, 2018 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 16.27
Restricted Stock [Member] | Top of range [member] | March 12, 2018 – Extraordinary Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	16.28
Restricted Stock [Member] | Top of range [member] | August 13, 2018 – Extraordinary Plan VI
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 13.13
Remaining contractual life	1 year 6 months
Restricted Stock [Member] | Top of range [member] | April 12, 2019 – Plan I
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 22.53
Remaining contractual life	2 years 6 months
Restricted Stock [Member] | Top of range [member] | April 12, 2019 – Plan II
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 22.85
Remaining contractual life	1 year 6 months
Performance Shares [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Existing stock | shares	637
Vested stock | shares	637	688
Performance Shares [Member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Grant date	May 21, 2019
Right acquisition conditions	From 3 to 4 years of service as from the grant date and fulfilment of the performance conditions
Existing stock | shares	637
Performance Shares [Member] | Bottom of range [member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 23.10
Remaining contractual life	1 year 6 months
Performance Shares [Member] | Top of range [member] | May 21, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]
Fair value	R$ 45.70
Remaining contractual life	2 years 6 months

Employee Benefits - Additional

Employee Benefits - Additional Information (Detail) R$ / shares in Units, shares in Thousands, R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)sharesR$ / shares	Dec. 31, 2019BRL (R$)sharesR$ / shares
Text Block [Abstract]
Number of options outstanding	17,245	17,568
Number of options exercised	3,405	604
Share based compensation expense | R$	R$ 231939	R$ 119659
Share Price | R$ / shares	R$ 52.50	R$ 38.67

Employee Benefits - Avon Produc

Employee Benefits - Avon Products Inc. plans - Additional Information (Detail) - Avon Products, Inc R$ in Thousands	12 Months Ended
	Dec. 31, 2020BRL (R$)Plans
Disclosure of terms and conditions of share-based payment arrangement [line items]
Number of share-based incentive plans | Plans	2
UNITED KINGDOM
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity	R$ 39200
Personal Savings Account Plan (PSA) | UNITED STATES
Disclosure of terms and conditions of share-based payment arrangement [line items]
Matching contributions made by entity	R$ 5200
Maximum Percentage of Eligible Compensation by Eligible Participants	25.00%
Retirement Savings Account ("RSA") | UNITED STATES
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years
Stock Option [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years
Percentage of premium price which was equal to exercise price	25.00%
Restricted Stock Unit RSU [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Exchange ratio per each common share of acquiree	0.30
Performance Restricted Stock Units (PRSU)
Disclosure of terms and conditions of share-based payment arrangement [line items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Period	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Performance Period	3 years
Exchange ratio per each common share of acquiree	0.30

Financial Income (Expenses) - S

Financial Income (Expenses) - Summary of Detailed Information About Financial Income Expense (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
FINANCIAL INCOME:
Interest on short-term investments	R$ 167967	R$ 83115	R$ 129296
Gains on monetary and exchange rate variations	1,886,940	854,025	477,297
Gains on swap and forward transactions	2,532,487	961,185	1,323,470
Gains on swap and forward derivatives mark to market	12,314	1,709	2,760
Monetary adjustment reversal on provision for tax risks and tax obligations	42,378	25,469	89,151
Other financial income	96,305	30,281	34,447
Total finance income	4,738,391	1,955,784	2,056,421
FINANCIAL EXPENSES:
Interest on financing	(1,104,863)	(503,040)	(631,475)
Interest on leases	(229,544)	(134,579)
Losses on monetary and exchange rate variations	(2,308,134)	(937,925)	(1,073,549)
Losses on swap and forward transactions	(1,579,695)	(964,116)	(794,504)
Losses on swap and forward derivatives mark to market	(13,691)	(1,452)	(2,197)
Adjustment of provision for tax, civil and labor risks and tax liabilities	(15,626)	(13,822)	(22,026)
Appropriation of funding costs (debentures and notes)	(11,082)	(22,671)	(37,400)
Interest on pension plan	(10,323)
Hyperinflationary economy adjustment (Argentina)	(20,625)	(13,947)	(25,066)
Debt structuring expenses for Avon acquisition	(110,741)	(115,781)
Other finance cost	(369,486)	(88,541)	(53,492)
Total finance expenses	(5,773,810)	(2,795,874)	(2,639,709)
Net financial income (expenses), net	R$ 1035419	R$ 840090	R$ 583288

Financial Income (Expenses) -_2

Financial Income (Expenses) - Summary of Foreign Exchange Hedging Transactions and the Related Balancing Items in the Income Statement (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	R$ 1886940	R$ 854025	R$ 477297
Losses on monetary and exchange rate variations	(2,308,134)	(937,925)	(1,073,549)
Gains on swap and forward transactions	2,532,487	961,185	1,323,470
Revenue from swap exchange coupons	207,783	182,897	170,555
Gains from exchange variations on swap instruments	2,324,704	778,288	1,152,915
Losses on swap and forward transactions	(1,579,695)	(964,116)	(794,504)
Losses on exchange rate variation on swap instruments	(691,941)	(690,409)	(402,708)
Financial costs of swap instruments	(869,890)	(273,707)	(391,796)
Loss on interest rate swap	(17,864)
Variation on borrowings, financing and debentures [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	714,681	677,462	402,345
Losses on monetary and exchange rate variations	(1,301,812)	(768,939)	(996,034)
Variation on imports [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	35,218	11,221	6,385
Losses on monetary and exchange rate variations	(58,623)	(33,718)	(40,140)
Variation on export receivables [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	69,365	26,144	42,901
Losses on monetary and exchange rate variations	(55,829)	(23,393)	(18,323)
Variation on trade payable from foreign subsidiaries [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	450,468	132,397	25,666
Losses on monetary and exchange rate variations	(365,214)	(86,764)	(13,075)
Variation on financing [member]
Finance Income Cost [line items]
Losses on monetary and exchange rate variations	(525,173)	(297)	(5,977)
Variations of bank accounts in foreign currency [member]
Finance Income Cost [line items]
Gains on monetary and exchange rate variations	617,208	6,801
Losses on monetary and exchange rate variations	R$ 1483	R$ 24814

Other Operating Income (Expen_3

Other Operating Income (Expenses), Net - Summary of Detailed Information About Other Operating Income (Expense) (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019		Dec. 31, 2018
Others operating income, net
Result on write-off of property, plant and equipment		R$ 11855	R$ 6098		R$ 1188
ICMS-ST	[1]	18,653	42,336		(27,126)
Exclusion of ICMS from PIS/COFINS base			52,631	[2]	57,242	[2]
PIS/COFINS credits			42,983	[3]
Proceeds from the sale of customer portfolio			23,092	[4]	16,254	[4]
Tax contingencies	[5]	45,057	21,402		(706)
ICMS credit					2,290
Tax credits - taxation change		60,177			23,677	[3]
Reintrega credits					3,058
Other operating income		10,757
Total Other operating income		146,499	188,542		75,877
Other operating expenses, net
Crer para Ver	[6]	(54,500)	(36,156)		(29,686)
Expense on the sale of customer portfolio		(7,498)
Acquisition related cost	[7]	(303,916)	(141,348)
Tax contingencies		(10,100)
Transformation and integration plan	[8]	(256,700)	(51,520)		(98,465)
Other operating expenses		(29,975)	(8,829)		12,329
Total other operating expenses		(662,689)	(237,853)		(115,822)
Other operating income (expenses), net		R$ 516190	R$ 49311		R$ 39945
[1]	Refers to the requirement of ICMS tax substitution, for different Federal States (details in note 22). During 2020, provisions were reversed due to the revision of the likelihood of loss of certain States.
[2]	The Company and its subsidiary Indústria e Comércio de Cosméticos Natura Ltda. are currently litigating the non-inclusion of ICMS in the PIS and COFINS contributions calculation base. Since 2007, the Company is legally authorized to pay contributions excluding ICMS, but the balance ICMS has been provisioned for as Taxes Payable. On September 30, 2017, based on the conclusion from the judgment made by the Plenary Session of the Federal Supreme Court on the Extraordinary Appeal, with general repercussion in society, which ruled unconstitutional the inclusion of ICMS in the PIS and COFINS calculation base, the Company reverted the tax obligation. On December 31, 2019, the Company recognized principal credit of R$52,631, which is no longer a contingent asset, arising from the final and unappealable decision.
[3]	Tax credits from prior periods related to the change on PIS and COFINS taxation.
[4]	Refers to the revenue from the sale of securities portfolio of customers past due over 180 days, net of legal costs with lawsuits filed by debtors against the company acquiring the portfolio. Proceeds from the sale of portfolio, as well as reimbursement of legal costs, are received after write-off of overdue securities.
[5]	One of our subsidiaries is a party to proceedings relating to the unconstitutionality of the Fator Acidentário de Prevenção, or FAP, and the increase in the rate related to Riscos Ambientais do Trabalho, or RAT, both of which labor taxes. During the year ended December 31, 2020, based on the analysis of our legal advisors, our management reassessed the chance of loss of in the legal proceedings relating to this matter. As a result of reassessment, our subsidiary reversed the provision originally constituted.
[6]	Allocation of operating profit from sales of “Crer Para Ver” line of non-cosmetic products to Natura Institute, specifically directed to social projects for developing the quality of education.
[7]	Refers to expenses related to the acquisition process, of Avon, which stand out: financial structuring expenses (R$ ), legal expenses (R$ ), regulatory expenses (R$ ) and executive compensation plans (R$ ).
[8]	Expenses related to the implementation of the transformation plan of The Body Shop and integration of Avon, which is based on five pillars, namely: (1) renewal of the brand; (2) optimization of retail operations; (3) improvement of omni-channel; (4) improvement of operating efficiency; and (5) redesign of the organization.

Other Operating Income (Expen_4

Other Operating Income (Expenses), Net - Additional Information (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement [Line Items]
Principal credit arising from the final and unappealable decision, which is no longer a contingent asset		R$ 52631
Avon [member]
Statement [Line Items]
Financial structuring expense	R$ 115696
Legal expenses	17,281
Regulatory expenses	18,030
Executive compensation plans	R$ 152909

Earnings Per Share - Summary of

Earnings Per Share - Summary of Basic Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Earnings per share [abstract]
Net income (loss) attributable to owners of the Company		R$ 650196		R$ 155467		R$ 548379
Weighted average number of issued shares	[1]	1,246,180,219		865,660,042		865,660,042
Weighted average number of treasury shares		(572,130)	[1]
Weighted average number of outstanding shares		1,245,608,090		865,660,042	[1]	865,660,042	[1]
Basic earnings (loss) per share - R$		R$ 0.5220	[2]	R$ 0.1796		R$ 0.6335
[1]	(a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and its retrospective effect.
[2]	(b) As at December 31, 2020, the basic earnings (loss) per share is equal to the diluted one, due to the loss for the year.

Earnings Per Share - Summary _2

Earnings Per Share - Summary of Diluted Earnings Per Share (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019		Dec. 31, 2018
Earnings per share [line items]
Net income attributable to the Company’s controlling shareholders		R$ 663678	R$ 155467		R$ 548379
Weighted average number of issued shares		1,245,608,090	865,660,042	[1]	865,660,042	[1]
Adjustment for stock options and restricted shares	[1]		8,124,575		1,529,528
Weighted average number of ordinary shares for diluted earnings calculation			873,784,617		867,189,570
Diluted earnings per share			R$ 0.1779		R$ 0.6324
[1]	(a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and its retrospective effect.

Earnings Per Share - Summary _3

Earnings Per Share - Summary of basic earnings per share for net loss of discontinued operations (Detail) - BRL (R$) R$ / shares in Units, R$ in Thousands		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2019		Dec. 31, 2018
Text Block [Abstract]
Net loss attributable to the Company’s controlling shareholders		R$ 143112
Weighted average number of issued shares	[1]	1,246,180,219		865,660,042		865,660,042
Weighted average number of treasury shares		(572,130)	[1]
Weighted average number of outstanding shares		1,245,608,090		865,660,042	[1]	865,660,042	[1]
Basic loss per share - R$		R$ 0.1149
[1]	(a) The number of shares and earnings per share already consider the stock split on September 17, 2019 and its retrospective effect.

Related-Party Transactions - Ad

Related-Party Transactions - Additional Information (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disclosure of subsidiaries [line items]
Amortisation of intangible assets	R$ 15055	R$ 12235
Confidentiality and NonCompete Agreement [Member]
Disclosure of subsidiaries [line items]
Amortisation of intangible assets	1,201	536
Buildings [member]
Disclosure of subsidiaries [line items]
Purchases of property and other assets related party transaction	39,346	44,244
Rent Paid	13,086
Fundo de Investimento Essencial [Member]
Disclosure of subsidiaries [line items]
Investments	3,414	3,766
Natura Cosmticos SA [Member]
Disclosure of subsidiaries [line items]
Reimbursement of transaction cost of acquisition	148,274
Donations associated with maintenance	R$ 692
Percentage of corresponding net income	0.50%
Donations associated with sale	R$ 35000	R$ 23000

Related-Party Transactions - Su

Related-Party Transactions - Summary of Total Compensation of the Company's Management (Detail) - BRL (R$) R$ in Thousands		12 Months Ended
		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Key Management Personnel Compensation [Line Items]
Fixed	[1]	R$ 65310	R$ 55019	R$ 45880
Variable	[2]	145,229	73,061	93,400
Total		210,539	128,080	139,280
Board of Directors [Member]
Key Management Personnel Compensation [Line Items]
Fixed	[1]	16,123	22,056	13,141
Variable	[2]	65,011	30,919	24,860
Total		81,134	52,975	38,001
Executive Board [Member]
Key Management Personnel Compensation [Line Items]
Fixed	[1]	49,187	32,963	32,739
Variable	[2]	80,218	42,142	68,540
Total		R$ 129405	R$ 75105	R$ 101279
[1]	The line item “Executive Board” includes the amount of R$ 1,201 referred to the amortization of the Confidentiality and Non-Compete Agreement during the fiscal year ended December 31, 2020 (R$ 536 in the fiscal year ended December 31, 2019).
[2]	Refers to profit sharing regarding the Restricted Stock Plan and Strategy Acceleration Program, including charges, as applicable, to be determined in the year. The amounts include additions to and/or reversals of provisions made in the previous year, due to final assessment of the targets determined to the board members and officers, statutory and non-statutory, in relation to profit sharing.

Related-Party Transactions - _2

Related-Party Transactions - Summary of the Company Officers and Executives' compensation (Detail)		12 Months Ended
		Dec. 31, 2020sharesR$ / shares	Dec. 31, 2019sharesR$ / shares	Dec. 31, 2018sharesR$ / shares
Officers and executives compensation [Line Items]
Stock option balance | shares		17,245,000	17,568,000
Officers [member]
Officers and executives compensation [Line Items]
Stock option balance | shares	[1],[2]	12,847,760	13,059,677	11,156,406
Average fair value of stock options | R$ / shares	[2]	R$ 8.64	R$ 8.4	R$ 7.47
Average exercise price | R$ / shares	[2],[3]	R$ 16.49	R$ 16.51	R$ 15.96
Officers [member] | Restricted Shares [Member]
Officers and executives compensation [Line Items]
Stock option balance | shares	[1],[2]	5,293,874	1,012,641	751,794
Average exercise price | R$ / shares	[2],[3]	R$ 51.2	R$ 19.23	R$ 14.81
[1]	Refers to the balance of the options and restricted shares vested and non-vested, not exercised, at the reporting dates.
[2]	The number of stock options granted, expired and exercised and their respective fair values is shown already considering the stock split approved at the Extraordinary Shareholders Meeting held on September 17, 2019.
[3]	Refers to the weighted-average exercise price of the option at the time of the stock option plans, adjusted for interest based on the Extended Consumer Price Index (IPCA) through the end of the reporting period. The new Stock Option Plan implemented in 2015, include no monetary adjustment.

Commitments - Additional Inform

Commitments - Additional Information (Detail) R$ in Thousands	Dec. 31, 2020BRL (R$)
Agreements that started in 2018 and effective up to 2020 [member] | Bottom of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	R$ 265
Agreements that started in 2018 and effective up to 2020 [member] | Top of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	363
Agreements that started in 2019 and effective up to 2022 [member] | Bottom of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	155
Agreements that started in 2019 and effective up to 2022 [member] | Top of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	305
Agreements that started in 2020 and effective up to 2022 [member] | Bottom of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	204
Agreements that started in 2020 and effective up to 2022 [member] | Top of range [member]
Contractual Commitments Disclosure [Line Items]
Value of Megawatts/h	R$ 238

Commitments - Summary of Contra

Commitments - Summary of Contractual Commitments (Detail) - BRL (R$) R$ in Thousands	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Contractual commitments disclosure [line items]
Total	R$ 2299894	R$ 31078	R$ 6208
Less than one year [member]
Contractual commitments disclosure [line items]
Total	1,413,904	17,918	1,268
One to five years [member]
Contractual commitments disclosure [line items]
Total	R$ 885990	R$ 13160	R$ 4940

Insurance - Summary of Types of

Insurance - Summary of Types of Insurance Coverage (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Industrial complex and administrative sites [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Any damages to buildings, facilities, inventories, and machinery and equipment
Amount insured	R$ 3062806	R$ 2322801
Vehicles [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Fire, theft and collision for the Company and subsidiaries vehicles
Amount insured	R$ 232459	212,027
Loss of profits [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	No loss of profits due to material damages to facilities buildings and production machinery and equipment
Amount insured	R$ 1894813	1,582,000
Transport [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Damages to products in transit
Amount insured	R$ 46019	32,309
Civil liability [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Protection against error or complaints in the exercise of professional activity that affect third parties
Amount insured	R$ 730740	532,510
Environmental liability [member]
Disclosure of types of insurance contracts [line items]
Type of coverage	Protection against environmental accidents that may result in environmental lawsuits
Amount insured	R$ 30000	R$ 30000

Additional Information Relati_3

Additional Information Relating To The Statements Of Cash Flows - Summary of additional information on transactions related to the cash flow statement (Detail) - BRL (R$) R$ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Non-cash items
Hedge accounting, net of tax effects	R$ 116348	R$ 70569	R$ 51165
Dividends and interest on equity declared and not yet paid		110,671	111,449
Net effect of acquisition of property, plant and equipment and intangible assets not yet paid	172,104	(18,645)	6,797
Consideration for acquisition of subsidiary	R$ 13366114

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - BRL (R$)	Apr. 15, 2021	Jan. 08, 2021	Dec. 31, 2020
Lease Agreement | Natura Cosmticos SA [Member] | Bresco IX
Subsequent Event
Total investment foreseen		R$ 113742000
Lease term (in years)		15 years
Major Borrowings [Member] | Promissory Notes Due 2021 [Member]
Subsequent Event
Redemption of notes	R$ 500000
Major Borrowings [Member] | Promissory Notes Due 2021 [Member] | Natura Cosmticos SA [Member]
Subsequent Event
Redemption of notes	R$ 250000
Major Borrowings [Member] | Working Capital Loan [Member] | Natura Cosmticos SA [Member] | Operations The Body Shop [Member]
Subsequent Event
Borrowings, Interest rate basis			LIBOR plus 2%
Major Borrowings [Member] | Working Capital Loan [Member] | Natura Cosmticos SA [Member] | Operations The Body Shop [Member] | Top of range [member]
Subsequent Event
Undrawn credit facility			R$ 70000